data_1z7t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z7t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.239 0.55 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -139.32 160.53 39.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.516 1.127 . . . . 0.0 111.297 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.06 157.09 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.13 15.27 5.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 112.158 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.73 159.76 38.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.093 1.757 . . . . 0.0 107.984 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -79.29 141.14 37.3 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.98 -0.45 . . . . 0.0 109.879 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.79 -152.87 19.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.34 136.42 49.99 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.05 73.7 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.326 1.05 . . . . 0.0 111.542 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -27.18 -60.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.252 2.621 . . . . 0.0 114.01 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -146.3 161.87 39.37 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.714 1.206 . . . . 0.0 108.76 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.7 146.24 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.35 -19.96 5.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.74 0.416 . . . . 0.0 111.896 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.2 m -74.71 165.89 2.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.899 0.857 . . . . 0.0 111.942 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.56 159.67 43.49 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.72 2.008 . . . . 0.0 105.74 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.14 46.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.08 75.23 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.654 1.121 . . . . 0.0 113.378 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -71.67 163.74 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.453 1.626 . . . . 0.0 110.306 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -108.6 136.83 47.54 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.14 159.33 37.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -137.63 144.39 41.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -50.05 123.21 7.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.893 0.77 . . . . 0.0 110.359 -176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.39 -7.96 80.59 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.032 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -64.71 141.38 58.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.691 1.745 . . . . 0.0 107.814 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.86 143.21 55.85 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.44 -37.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.997 1.319 . . . . 0.0 109.512 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.28 -179.67 8.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.902 0.881 . . . . 0.0 109.536 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -135.56 142.94 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -119.14 134.05 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.633 1.973 . . . . 0.0 106.736 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.65 124.85 49.61 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -169.25 166.81 10.54 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.009 1.324 . . . . 0.0 107.879 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.7 mtm 55.41 30.95 15.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 51.84 35.11 14.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.875 1.67 . . . . 0.0 112.576 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -142.31 173.48 11.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.473 1.909 . . . . 0.0 108.566 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -119.16 143.48 47.2 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.64 127.41 17.52 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.66 150.28 68.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.953 1.768 . . . . 0.0 110.244 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -124.79 132.31 71.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -124.36 162.19 26.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.869 1.268 . . . . 0.0 110.286 -169.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 122.61 16.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.51 -22.38 61.79 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.82 0.448 . . . . 0.0 111.671 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.83 157.71 38.3 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 108.913 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -69.77 155.65 40.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.792 0.837 . . . . 0.0 111.227 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.14 176.86 37.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.755 0.693 . . . . 0.0 111.761 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.66 135.24 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -68.59 106.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.27 -40.93 62.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.3 161.5 40.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.34 132.79 70.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.22 -1.26 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.2 1.0 . . . . 0.0 112.369 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -139.8 176.17 8.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.269 1.428 . . . . 0.0 109.409 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -144.74 169.83 17.27 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.659 1.183 . . . . 0.0 108.734 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.76 133.69 47.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 0.0 109.685 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.0 -0.59 62.08 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.188 1.375 . . . . 0.0 114.325 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -71.43 153.06 42.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.977 1.888 . . . . 0.0 110.452 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -66.47 142.86 57.41 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.31 160.1 15.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.715 0.806 . . . . 0.0 109.692 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.12 167.26 22.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.4 -173.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.37 113.52 2.69 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.95 1.68 72.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.839 1.209 . . . . 0.0 113.086 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.94 126.57 31.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.443 1.621 . . . . 0.0 108.183 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.63 144.28 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 109.543 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.2 tp -109.95 -48.19 3.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.933 1.693 . . . . 0.0 109.393 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.98 170.86 19.36 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.782 0.719 . . . . 0.0 111.064 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -130.65 148.61 52.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.343 1.457 . . . . 0.0 108.104 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.234 0.244 0 C-N-CA 125.338 1.455 . . . . 0.0 111.371 -169.707 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.235 0.332 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -137.49 166.77 23.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.857 1.263 . . . . 0.0 110.951 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.53 150.3 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 29.08 4.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 0.0 110.51 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -145.1 162.59 36.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 107.385 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.75 133.6 42.84 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 169.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.24 -148.36 12.55 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.52 140.13 51.34 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.24 71.7 10.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -26.47 -59.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.501 2.72 . . . . 0.0 114.0 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.16 163.28 35.87 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.999 1.32 . . . . 0.0 108.385 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.64 147.42 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.62 27.18 4.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.145 0.978 . . . . 0.0 111.785 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.52 164.82 33.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.575 1.15 . . . . 0.0 110.301 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.31 158.35 44.04 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.901 1.681 . . . . 0.0 106.876 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.8 54.15 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.6 -8.96 78.76 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.88 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.14 166.81 17.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.122 1.461 . . . . 0.0 109.666 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -124.17 138.65 54.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.726 1.21 . . . . 0.0 107.774 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 pt -128.5 162.28 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.42 1.088 . . . . 0.0 108.429 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -131.29 145.35 51.84 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.462 1.505 . . . . 0.0 107.346 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.04 129.9 24.76 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.259 0.624 . . . . 0.0 110.537 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.48 -6.45 72.9 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.411 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.62 137.57 57.44 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.654 1.727 . . . . 0.0 107.816 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.79 135.88 56.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.74 -18.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.449 1.1 . . . . 0.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.95 178.91 9.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.245 0.93 . . . . 0.0 109.301 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -135.41 143.52 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.24 131.11 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.198 2.199 . . . . 0.0 106.552 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.35 125.55 50.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.57 167.2 8.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.4 1.48 . . . . 0.0 107.752 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 mtm 55.25 32.26 18.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.913 0.885 . . . . 0.0 111.745 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 51.65 33.72 11.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.864 1.666 . . . . 0.0 112.58 -172.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.6 mmm -140.87 172.05 13.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.646 1.979 . . . . 0.0 108.52 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -124.15 140.47 52.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.62 133.89 17.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.02 158.61 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.107 1.871 . . . . 0.0 111.795 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mm -125.6 126.33 70.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.99 157.47 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.014 1.326 . . . . 0.0 110.468 -169.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 121.94 15.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.594 0.757 . . . . 0.0 108.981 175.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.29 -25.85 66.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.052 0.541 . . . . 0.0 111.66 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 162.11 39.78 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.158 1.383 . . . . 0.0 108.981 169.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -65.18 158.17 26.8 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.951 0.9 . . . . 0.0 110.928 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.18 179.32 39.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.82 134.87 27.67 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.49 105.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.98 -47.89 67.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -160.11 150.13 18.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.46 0.573 . . . . 0.0 109.747 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.05 137.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -110.66 9.73 22.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.495 0.718 . . . . 0.0 111.851 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -147.45 -179.49 6.89 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.085 1.754 . . . . 0.0 108.595 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -143.03 168.11 20.48 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.891 1.276 . . . . 0.0 108.369 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.08 132.12 42.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.849 0.859 . . . . 0.0 109.17 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 -1.4 73.62 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.055 1.312 . . . . 0.0 114.161 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.21 153.13 42.69 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.865 1.833 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.9 143.15 57.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.92 158.7 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.167 0.987 . . . . 0.0 109.586 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.17 164.05 33.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.306 0.642 . . . . 0.0 110.793 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.21 112.76 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.98 0.912 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.52 -6.49 59.18 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.007 1.289 . . . . 0.0 112.714 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.04 139.18 46.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.279 1.539 . . . . 0.0 108.69 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.89 140.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.93 -53.48 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.544 1.538 . . . . 0.0 108.347 175.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.99 168.06 25.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.535 0.683 . . . . 0.0 111.119 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -125.3 144.3 50.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.832 2.053 . . . . 0.0 106.309 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.519 -0.246 0 C-N-CA 124.618 1.167 . . . . 0.0 110.633 -169.291 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.238 0.461 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.61 158.9 43.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.836 1.254 . . . . 0.0 111.332 -169.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -76.91 153.91 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.01 17.65 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.28 1.432 . . . . 0.0 111.574 -170.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.04 156.24 34.06 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.651 1.581 . . . . 0.0 108.061 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.74 140.3 42.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.663 0.385 . . . . 0.0 110.226 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.29 -152.04 17.06 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.14 139.07 52.09 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.6 71.93 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.659 1.183 . . . . 0.0 111.331 -169.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -28.48 -59.21 0.12 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.987 2.515 . . . . 0.0 114.11 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.71 163.53 35.63 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.01 1.324 . . . . 0.0 108.624 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.16 148.26 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.63 23.86 4.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.191 0.996 . . . . 0.0 111.664 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.49 161.94 36.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.437 1.095 . . . . 0.0 110.1 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.75 159.64 43.95 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.927 1.691 . . . . 0.0 107.242 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 134.24 53.81 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -7.11 82.38 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.64 1.115 . . . . 0.0 113.269 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -69.94 165.07 22.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.439 1.619 . . . . 0.0 110.111 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -112.94 138.5 49.72 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.502 1.521 . . . . 0.0 107.018 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -128.92 163.93 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.958 0.903 . . . . 0.0 108.638 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -138.86 140.33 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -45.44 123.16 3.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.082 0.953 . . . . 0.0 110.852 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.15 74.72 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.442 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.34 139.63 58.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.663 1.732 . . . . 0.0 108.344 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.49 138.36 58.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.29 -19.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.215 1.006 . . . . 0.0 111.889 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.44 9.18 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.444 1.02 . . . . 0.0 109.302 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -134.96 145.66 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -119.87 131.41 55.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.072 2.149 . . . . 0.0 106.608 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.43 125.94 51.56 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -170.53 169.31 7.37 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.922 1.289 . . . . 0.0 107.838 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.4 ptt? 44.64 40.82 4.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 0.0 113.073 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 52.53 33.89 14.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.232 1.813 . . . . 0.0 113.098 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.3 mtt -143.82 170.92 14.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.115 1.766 . . . . 0.0 108.984 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -123.84 138.13 54.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.16 133.35 18.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.46 155.16 70.05 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.842 1.695 . . . . 0.0 111.076 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.27 127.52 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.6 157.28 17.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.38 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 116.43 5.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.71 1.204 . . . . 0.0 108.172 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.95 -25.02 66.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.037 0.535 . . . . 0.0 111.489 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -157.08 156.54 32.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.144 1.377 . . . . 0.0 108.763 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 m -74.97 156.41 36.33 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.645 0.778 . . . . 0.0 110.918 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.98 175.26 33.83 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.82 -0.55 . . . . 0.0 112.681 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.92 135.13 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 108.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -70.83 -46.62 62.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -159.47 156.03 27.56 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.9 135.97 47.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.01 1.83 24.67 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.317 0.647 . . . . 0.0 112.372 -169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -141.43 176.97 8.44 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.101 1.36 . . . . 0.0 109.444 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.8 163.22 35.7 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.886 1.275 . . . . 0.0 108.566 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.57 128.64 35.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.515 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.2 87.4 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.135 1.35 . . . . 0.0 113.942 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.4 154.32 42.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.985 1.892 . . . . 0.0 110.572 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.27 143.2 57.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.94 159.97 15.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 109.282 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.21 167.77 22.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.39 -171.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.32 111.36 1.73 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.05 1.83 66.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.951 1.262 . . . . 0.0 112.841 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -78.25 130.73 36.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.334 1.567 . . . . 0.0 108.002 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.37 143.34 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.268 0.485 . . . . 0.0 109.745 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.0 tp -100.51 -51.86 3.5 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.107 1.363 . . . . 0.0 108.902 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.89 168.49 23.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 111.719 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.75 141.72 51.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.973 2.109 . . . . 0.0 106.202 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 N--CA 1.462 0.136 0 C-N-CA 124.272 1.029 . . . . 0.0 110.353 -169.582 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.238 0.483 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -141.35 163.12 33.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.307 1.443 . . . . 0.0 111.162 -168.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.21 152.81 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.56 26.81 4.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.501 1.12 . . . . 0.0 111.381 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.5 155.95 32.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.445 1.498 . . . . 0.0 108.001 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.32 140.29 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 122.072 -0.393 . . . . 0.0 110.019 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.42 -150.79 15.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.45 142.16 50.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -84.15 74.6 10.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.305 1.042 . . . . 0.0 110.552 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.43 -57.5 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.8 2.44 . . . . 0.0 113.865 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -147.11 161.75 40.23 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.998 1.319 . . . . 0.0 108.7 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.23 146.7 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -129.97 25.1 5.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.207 1.003 . . . . 0.0 111.525 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.59 163.68 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.416 1.087 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -147.55 156.72 43.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.22 1.808 . . . . 0.0 106.316 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 132.96 52.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.77 74.81 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.839 1.209 . . . . 0.0 113.066 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.68 163.44 27.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.331 1.566 . . . . 0.0 110.274 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -108.96 139.17 44.18 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.272 1.429 . . . . 0.0 107.148 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.18 163.18 34.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 170.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -139.63 137.34 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -44.33 123.2 3.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.2 1.0 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.48 71.82 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.639 -1.09 . . . . 0.0 113.54 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.1 138.85 58.03 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.512 1.656 . . . . 0.0 108.211 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.9 141.95 57.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.87 -18.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.814 1.245 . . . . 0.0 111.011 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.85 178.51 10.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.268 0.94 . . . . 0.0 109.061 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -133.86 145.05 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -117.61 133.15 56.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.287 2.235 . . . . 0.0 106.253 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -107.21 121.69 45.04 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 t -166.63 166.82 15.83 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.93 1.292 . . . . 0.0 108.1 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 51.66 29.81 6.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.34 1.056 . . . . 0.0 111.9 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 50.72 37.32 16.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.478 1.511 . . . . 0.0 112.306 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.7 mtm -139.36 170.37 16.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.529 1.932 . . . . 0.0 107.9 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -119.89 139.63 52.11 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.59 129.95 15.47 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.91 156.05 66.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.709 1.606 . . . . 0.0 111.14 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 125.77 72.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 156.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.821 1.249 . . . . 0.0 110.53 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 114.28 3.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.43 -24.8 67.29 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.571 0.349 . . . . 0.0 111.338 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -157.32 155.89 31.44 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.694 1.598 . . . . 0.0 108.565 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 m -77.49 158.37 29.98 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.731 0.812 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.86 177.28 35.72 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.8 mm -85.36 135.56 24.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.38 106.75 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -75.69 -39.58 57.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.05 158.14 38.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 109.37 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.46 124.88 73.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -92.41 -5.43 52.04 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 112.022 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -137.0 177.5 7.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.499 1.119 . . . . 0.0 109.617 -170.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -141.87 165.92 26.14 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.63 134.51 57.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.43 82.45 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.219 -1.323 . . . . 0.0 114.122 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -72.58 155.14 40.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.113 1.956 . . . . 0.0 110.685 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -66.37 143.88 56.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.35 160.24 17.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.066 0.946 . . . . 0.0 109.146 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.29 168.4 20.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.538 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.98 110.46 1.57 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.26 1.77 64.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.104 1.335 . . . . 0.0 112.839 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.8 128.38 33.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.287 1.544 . . . . 0.0 108.162 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 t -68.88 138.49 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -91.01 -51.89 5.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.592 1.157 . . . . 0.0 108.617 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.77 168.33 27.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.966 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.23 147.56 50.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.353 1.861 . . . . 0.0 106.621 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--O 1.231 0.093 0 C-N-CA 124.69 1.196 . . . . 0.0 111.278 -169.276 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.239 0.5 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -140.0 166.09 25.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.755 1.622 . . . . 0.0 109.913 -169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -94.59 155.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -132.9 27.61 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.787 1.235 . . . . 0.0 111.23 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 153.16 30.84 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.044 1.338 . . . . 0.0 108.05 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.48 138.58 40.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.48 -153.31 18.69 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.09 138.87 45.56 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.69 121.17 14.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -71.89 -54.83 8.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -150.09 161.09 43.05 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.573 1.549 . . . . 0.0 108.481 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.52 143.27 39.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.97 -21.58 7.06 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 111.942 -169.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.08 165.41 2.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.773 0.797 . . . . 0.0 111.44 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -147.6 153.94 40.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.48 129.88 44.17 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.22 -12.21 63.61 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.814 1.197 . . . . 0.0 112.639 -174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -70.08 168.69 15.0 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.906 1.353 . . . . 0.0 109.875 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -125.05 138.42 54.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.725 1.21 . . . . 0.0 107.901 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -129.29 158.8 41.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -135.86 142.22 44.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -47.03 120.95 3.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.704 0.684 . . . . 0.0 110.98 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.15 -11.34 67.5 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.849 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -64.47 142.84 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.551 1.676 . . . . 0.0 108.245 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.84 143.46 54.55 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -134.44 -37.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.595 1.158 . . . . 0.0 110.06 -171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.4 -179.02 7.78 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.08 0.952 . . . . 0.0 109.3 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -137.03 139.5 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -113.79 133.36 55.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.581 1.952 . . . . 0.0 106.943 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.88 124.12 47.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -167.57 166.47 14.09 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.507 1.123 . . . . 0.0 108.565 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.77 44.98 1.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.841 1.656 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.41 31.8 12.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.965 1.706 . . . . 0.0 113.126 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -139.14 169.35 17.95 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.177 1.791 . . . . 0.0 108.694 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.8 140.13 50.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.64 126.83 16.12 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.7 151.9 44.8 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.578 2.185 . . . . 0.0 112.432 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -128.15 131.95 68.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 169.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.67 160.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.094 1.358 . . . . 0.0 109.59 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.04 116.95 5.35 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.88 1.272 . . . . 0.0 108.52 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.22 -26.72 66.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.99 0.516 . . . . 0.0 111.4 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -157.77 161.16 38.43 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.568 1.547 . . . . 0.0 108.966 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -80.39 157.6 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 111.214 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.03 179.8 36.0 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.95 0.786 . . . . 0.0 111.857 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -85.94 136.48 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.54 98.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -69.53 -39.78 77.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -155.85 166.33 33.8 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.8 t -125.21 134.12 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -103.83 0.03 29.77 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.9 176.44 9.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.875 1.27 . . . . 0.0 109.966 -170.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.38 165.3 31.51 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 108.675 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.66 136.26 50.7 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.951 0.901 . . . . 0.0 108.799 172.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.11 -8.9 65.21 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.616 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -74.88 152.36 38.89 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.972 1.886 . . . . 0.0 110.942 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -68.14 145.22 54.58 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.067 0.947 . . . . 0.0 109.195 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 m -142.86 161.04 18.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 123.856 0.863 . . . . 0.0 109.721 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -144.07 167.27 22.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.347 -174.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.59 109.62 1.45 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.39 -0.35 57.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.339 1.447 . . . . 0.0 112.849 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.68 126.57 31.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.435 1.617 . . . . 0.0 108.697 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.8 145.41 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -113.77 -44.65 3.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.249 1.42 . . . . 0.0 109.411 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 171.0 18.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.981 0.81 . . . . 0.0 111.017 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -126.94 137.84 53.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.974 1.71 . . . . 0.0 106.577 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 111.305 -172.254 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.239 0.534 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -139.05 158.66 43.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 110.646 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.74 149.74 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -112.0 8.09 20.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.262 0.625 . . . . 0.0 111.91 -170.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -158.53 159.17 35.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.093 1.357 . . . . 0.0 108.918 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.04 140.49 41.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 110.291 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.92 -151.97 16.23 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.52 142.42 50.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.36 76.9 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.133 0.973 . . . . 0.0 110.649 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -37.68 -57.79 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.952 2.101 . . . . 0.0 113.43 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -148.28 161.4 41.59 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.183 1.393 . . . . 0.0 108.635 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -136.38 146.49 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -131.26 24.05 4.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.86 0.864 . . . . 0.0 112.094 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 m -131.83 162.18 39.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.561 1.144 . . . . 0.0 109.959 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.3 162.62 38.58 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.066 1.747 . . . . 0.0 107.155 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 135.76 43.68 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.84 -8.27 73.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.727 -1.04 . . . . 0.0 113.061 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.7 164.85 24.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.25 1.525 . . . . 0.0 110.033 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -120.03 140.55 50.81 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.96 1.304 . . . . 0.0 108.174 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -130.89 158.87 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.6 145.05 46.49 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -48.76 121.65 4.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.582 0.628 . . . . 0.0 110.525 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.28 78.37 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.601 -1.11 . . . . 0.0 113.824 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -63.52 138.66 58.59 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.66 1.73 . . . . 0.0 107.881 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.48 139.74 53.94 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.63 -30.69 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.64 1.176 . . . . 0.0 110.688 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.78 -178.93 7.72 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.7 1.136 . . . . 0.0 109.528 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.33 140.06 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.87 137.21 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.71 2.004 . . . . 0.0 106.336 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -114.78 124.06 50.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -169.31 169.76 8.91 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.958 1.303 . . . . 0.0 107.849 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 18.9 ptt? 44.7 41.27 4.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.767 1.227 . . . . 0.0 112.856 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.71 31.5 12.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.351 1.86 . . . . 0.0 113.183 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.38 170.04 16.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.71 1.604 . . . . 0.0 109.356 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.22 140.56 50.99 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.12 128.06 17.32 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.54 154.06 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.889 1.726 . . . . 0.0 110.756 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.65 133.02 69.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.6 m -125.06 161.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.389 1.076 . . . . 0.0 110.217 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.93 3.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.59 -20.45 65.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 0.0 111.756 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -154.23 160.29 41.75 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.656 1.582 . . . . 0.0 108.479 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -70.36 157.23 38.13 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.389 0.676 . . . . 0.0 110.805 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.65 -174.38 42.06 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.754 -0.591 . . . . 0.0 112.352 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.52 134.48 46.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.56 114.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -76.35 -46.37 27.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.49 155.53 30.51 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.74 129.2 70.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.96 -3.33 45.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.011 0.924 . . . . 0.0 112.569 -169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -136.55 177.44 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.307 1.043 . . . . 0.0 109.532 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -143.15 159.99 41.27 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.69 1.196 . . . . 0.0 108.224 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.34 130.77 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.53 86.97 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.182 1.372 . . . . 0.0 113.637 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.58 155.7 40.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.888 1.844 . . . . 0.0 110.799 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -67.55 144.94 55.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.37 159.84 15.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.06 0.944 . . . . 0.0 109.134 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.6 168.46 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.045 0.538 . . . . 0.0 111.701 -171.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.56 114.01 2.74 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.93 4.75 81.82 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.83 1.205 . . . . 0.0 113.005 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -79.87 123.43 27.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.382 1.591 . . . . 0.0 107.884 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.52 141.52 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.144 0.578 . . . . 0.0 109.695 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -106.71 -46.16 4.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.87 1.268 . . . . 0.0 109.46 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.24 161.44 41.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.129 0.877 . . . . 0.0 111.589 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -126.31 143.36 51.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.717 2.007 . . . . 0.0 106.272 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 CA--C 1.521 -0.158 0 C-N-CA 123.997 0.919 . . . . 0.0 109.54 -169.393 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--O 1.238 0.45 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -140.1 152.49 46.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.433 1.093 . . . . 0.0 111.229 -169.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -66.82 147.23 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 26.19 5.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.529 0.732 . . . . 0.0 111.828 -171.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.43 164.34 38.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.806 2.042 . . . . 0.0 107.432 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -82.25 143.42 31.36 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 109.918 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.0 -152.27 17.97 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 117.972 0.351 . . . . 0.0 112.262 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.97 133.24 45.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 116.96 13.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -71.08 -62.32 1.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.179 0.592 . . . . 0.0 109.98 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -148.44 157.6 43.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.6 1.16 . . . . 0.0 110.262 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.17 149.19 28.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -124.47 -22.16 4.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 0.0 111.363 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.77 162.78 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.577 0.704 . . . . 0.0 111.657 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -148.71 160.93 42.71 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.276 1.831 . . . . 0.0 106.885 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 133.85 51.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.46 0.573 . . . . 0.0 109.552 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.29 -1.92 87.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.582 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -68.6 163.46 23.61 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.51 1.655 . . . . 0.0 110.036 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -108.35 138.58 44.4 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -129.22 160.06 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -138.85 140.76 38.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -47.17 120.88 3.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.029 0.831 . . . . 0.0 110.595 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.47 -8.65 66.65 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.55 -1.139 . . . . 0.0 113.855 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.99 134.1 54.41 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.69 1.745 . . . . 0.0 108.244 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.67 132.87 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.2 -22.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.932 0.893 . . . . 0.0 111.743 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 179.12 9.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.381 1.072 . . . . 0.0 109.218 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.2 mt -135.64 145.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -122.33 136.0 54.82 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.759 2.024 . . . . 0.0 106.799 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.57 124.14 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -169.33 166.34 10.49 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 107.862 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.8 mtm 55.62 31.78 17.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.909 0.884 . . . . 0.0 111.587 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 51.81 33.66 11.74 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.849 1.659 . . . . 0.0 112.567 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.2 mmt -141.24 173.34 11.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.745 2.018 . . . . 0.0 108.737 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.82 138.54 54.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.09 130.04 17.26 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.46 151.78 70.8 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.879 1.719 . . . . 0.0 110.425 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.29 124.02 70.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.44 158.51 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 110.196 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 115.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.718 1.207 . . . . 0.0 108.108 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.72 -23.57 66.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.099 0.56 . . . . 0.0 111.51 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -155.76 157.08 35.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.686 1.595 . . . . 0.0 108.483 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -71.66 157.68 37.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.22 -178.1 38.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 122.141 -0.349 . . . . 0.0 112.276 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.52 136.23 27.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.61 113.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.1 -52.4 9.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.01 131.87 8.86 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.335 0.516 . . . . 0.0 109.781 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.13 141.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -119.36 7.94 11.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.853 0.861 . . . . 0.0 112.621 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -141.71 175.12 9.95 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.679 1.192 . . . . 0.0 109.982 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -148.67 167.1 26.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.392 1.877 . . . . 0.0 108.254 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -59.69 135.25 57.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.712 0.805 . . . . 0.0 109.447 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.71 -1.48 77.96 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.052 1.31 . . . . 0.0 113.874 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.41 151.46 41.15 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.62 1.71 . . . . 0.0 110.529 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.49 144.85 53.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.44 159.78 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.632 0.773 . . . . 0.0 109.914 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.46 166.96 23.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.305 -174.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.14 112.46 2.65 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.64 59.89 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.169 1.366 . . . . 0.0 112.765 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -76.35 127.04 32.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.171 1.485 . . . . 0.0 108.961 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 t -66.18 128.33 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.641 0.776 . . . . 0.0 109.427 -170.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.01 -44.88 12.67 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.15 0.98 . . . . 0.0 108.981 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -156.21 162.81 40.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.663 0.665 . . . . 0.0 112.371 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -115.11 147.58 40.04 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.454 2.302 . . . . 0.0 106.977 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--O 1.232 0.175 0 C-N-CA 124.626 1.17 . . . . 0.0 110.821 -169.576 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -140.43 160.01 40.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.49 1.116 . . . . 0.0 111.709 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -76.11 152.91 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.76 15.86 5.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.313 1.445 . . . . 0.0 111.609 -169.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.28 157.38 35.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.664 1.585 . . . . 0.0 108.04 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.21 141.06 41.89 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.607 0.363 . . . . 0.0 110.214 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -152.68 18.27 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.48 138.52 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.16 71.73 9.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.839 1.255 . . . . 0.0 111.155 -169.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -30.61 -58.61 0.2 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.099 2.56 . . . . 0.0 114.069 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -146.83 160.51 42.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.038 1.335 . . . . 0.0 108.645 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -137.85 142.44 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -122.35 -22.5 5.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.768 0.427 . . . . 0.0 111.845 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.84 159.78 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.444 0.64 . . . . 0.0 111.185 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.42 160.08 44.01 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 126.328 1.851 . . . . 0.0 106.954 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.08 45.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.824 0.738 . . . . 0.0 109.429 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.16 -8.46 79.77 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.863 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -68.91 163.38 24.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.205 1.502 . . . . 0.0 109.881 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -119.9 139.52 52.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.866 1.266 . . . . 0.0 107.901 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 pt -129.81 157.34 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -133.99 144.18 48.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.54 122.37 7.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.885 0.766 . . . . 0.0 110.422 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.47 71.54 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.746 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -64.69 141.21 58.85 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.542 1.671 . . . . 0.0 108.121 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.36 144.32 55.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.195 0.598 . . . . 0.0 109.409 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 t -134.93 -38.35 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.385 . . . . 0.0 109.585 -170.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.53 -178.43 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.354 1.062 . . . . 0.0 108.994 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -134.1 145.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.88 128.13 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.593 1.957 . . . . 0.0 106.673 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.89 124.33 43.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.86 166.83 9.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.251 1.42 . . . . 0.0 107.757 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.4 mtm 54.98 32.49 18.17 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.95 0.9 . . . . 0.0 111.63 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 51.96 33.28 11.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.065 1.746 . . . . 0.0 112.629 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.9 mmt -141.05 173.52 11.4 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.665 1.986 . . . . 0.0 108.406 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.84 140.14 53.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.99 128.92 17.88 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.69 153.41 36.42 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.647 2.232 . . . . 0.0 112.732 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -126.38 130.01 71.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -124.62 159.3 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 124.712 1.205 . . . . 0.0 110.156 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 119.21 8.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.781 1.232 . . . . 0.0 109.022 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.6 -19.11 62.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.434 0.693 . . . . 0.0 111.935 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -154.16 159.73 41.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.812 1.645 . . . . 0.0 108.733 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -73.33 154.57 40.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.64 0.776 . . . . 0.0 110.496 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.7 -173.81 42.71 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.255 0.455 . . . . 0.0 112.255 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.14 136.81 40.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.74 115.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.3 -46.61 15.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -156.09 156.6 34.62 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.4 t -117.34 134.96 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.79 3.46 34.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.629 1.172 . . . . 0.0 113.064 -169.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -141.65 179.13 7.01 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.104 . . . . 0.0 109.298 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.67 161.33 40.11 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.324 1.45 . . . . 0.0 107.917 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.69 134.15 52.61 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.36 0.1 85.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.308 1.432 . . . . 0.0 113.789 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -72.24 156.06 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.647 . . . . 0.0 110.437 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.67 143.38 56.0 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.92 160.24 13.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.249 1.02 . . . . 0.0 109.396 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.9 167.03 23.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -172.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 114.7 3.11 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.797 0.839 . . . . 0.0 108.969 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.0 74.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.866 1.222 . . . . 0.0 112.809 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -75.87 129.6 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.366 1.583 . . . . 0.0 108.31 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.34 141.47 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.9 tp -108.03 -43.31 4.44 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.781 1.232 . . . . 0.0 110.329 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.08 165.51 36.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.231 0.923 . . . . 0.0 111.713 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -126.92 146.0 50.47 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.857 2.063 . . . . 0.0 106.605 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.232 0.147 0 C-N-CA 124.585 1.154 . . . . 0.0 110.3 -169.453 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 C--O 1.239 0.531 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 m -142.65 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.475 1.51 . . . . 0.0 110.283 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.03 157.81 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.991 1.316 . . . . 0.0 107.831 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -136.1 26.02 3.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.116 1.367 . . . . 0.0 111.269 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 156.46 34.14 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.615 1.566 . . . . 0.0 107.909 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.34 139.28 36.65 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.658 -0.651 . . . . 0.0 109.62 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.74 -152.54 16.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.22 138.9 51.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 tp -83.0 71.69 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 111.111 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -27.49 -60.27 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.84 2.456 . . . . 0.0 113.731 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -145.09 162.7 36.35 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.244 1.018 . . . . 0.0 109.489 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.39 147.03 29.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -125.04 -27.43 3.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.042 0.537 . . . . 0.0 111.152 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.18 158.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.643 0.735 . . . . 0.0 110.841 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -153.35 156.56 38.56 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.226 1.81 . . . . 0.0 106.787 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 130.76 45.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.692 0.678 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.77 83.25 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.081 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -66.95 165.53 15.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.267 1.533 . . . . 0.0 109.502 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -123.38 139.66 53.8 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.146 . . . . 0.0 107.925 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -130.24 158.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.105 0.962 . . . . 0.0 108.628 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.78 146.42 49.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -48.26 121.45 4.38 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.634 0.652 . . . . 0.0 110.292 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.53 78.1 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.596 -1.113 . . . . 0.0 113.991 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -65.19 141.5 58.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.607 1.704 . . . . 0.0 108.115 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.09 145.06 56.28 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.046 0.538 . . . . 0.0 109.553 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -135.14 -38.7 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.2 1.4 . . . . 0.0 109.684 -172.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.65 -178.28 7.23 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.041 0.937 . . . . 0.0 109.521 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -135.4 143.76 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.11 132.03 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.822 2.049 . . . . 0.0 106.868 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -103.82 125.87 50.56 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -169.06 169.88 9.2 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.727 1.211 . . . . 0.0 107.872 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.6 ptt? 44.61 40.98 4.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.015 1.326 . . . . 0.0 113.032 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.28 33.32 15.27 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.313 1.845 . . . . 0.0 113.04 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -144.16 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.018 1.727 . . . . 0.0 109.158 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -120.78 139.37 53.21 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 169.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.16 132.05 19.98 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.4 153.03 74.95 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.844 1.696 . . . . 0.0 110.665 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -126.52 133.75 67.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.38 161.42 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.819 1.248 . . . . 0.0 110.404 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 117.48 6.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.375 1.47 . . . . 0.0 108.877 171.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.55 -22.07 65.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.961 0.505 . . . . 0.0 111.77 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -155.22 161.24 41.22 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.612 1.565 . . . . 0.0 108.836 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -72.72 159.17 34.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.886 0.874 . . . . 0.0 111.287 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.65 -176.33 38.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.436 0.541 . . . . 0.0 111.978 172.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.1 137.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.66 104.58 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -68.8 -51.07 44.72 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -160.22 135.39 7.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.235 0.471 . . . . 0.0 109.771 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.89 139.1 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.75 7.78 18.67 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.742 0.817 . . . . 0.0 111.643 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -142.82 177.2 8.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.263 1.825 . . . . 0.0 108.616 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -144.59 171.94 13.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.7 134.77 51.58 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.561 0.745 . . . . 0.0 109.582 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.17 2.78 54.71 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.01 1.291 . . . . 0.0 114.473 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -70.45 153.47 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.864 1.832 . . . . 0.0 110.118 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -66.02 143.56 57.28 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.04 159.32 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.798 0.839 . . . . 0.0 109.384 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.44 167.16 23.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.386 -172.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.66 110.47 1.73 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.24 1.2 62.8 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.144 1.354 . . . . 0.0 113.094 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -78.83 130.08 35.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.427 1.613 . . . . 0.0 108.434 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.37 149.12 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.806 . . . . 0.0 109.84 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.1 tp -119.65 -48.13 2.39 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.208 1.403 . . . . 0.0 109.654 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.08 166.31 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.75 0.705 . . . . 0.0 111.836 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.61 145.29 48.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.153 2.181 . . . . 0.0 106.77 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.232 0.184 0 C-N-CA 124.178 0.991 . . . . 0.0 112.567 -168.913 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.241 0.618 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -138.22 159.52 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.889 1.676 . . . . 0.0 110.089 -169.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.65 146.57 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -107.0 8.98 30.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 111.813 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.48 159.92 36.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.257 1.423 . . . . 0.0 108.891 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.96 142.38 38.38 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.782 0.433 . . . . 0.0 110.169 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.12 -152.81 19.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.52 139.05 45.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.45 118.16 10.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -69.85 -54.18 14.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -149.78 161.54 42.04 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.655 1.582 . . . . 0.0 108.069 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.6 t -134.3 140.6 45.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -115.42 -23.76 8.69 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.74 0.416 . . . . 0.0 111.631 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.19 165.09 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 123.76 0.824 . . . . 0.0 111.759 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -147.1 154.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.94 130.78 48.42 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.7 -10.59 68.6 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.563 1.078 . . . . 0.0 112.74 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -69.39 168.53 14.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.018 1.409 . . . . 0.0 109.815 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -125.48 140.73 52.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.863 1.265 . . . . 0.0 107.776 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -129.26 162.5 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.624 1.17 . . . . 0.0 108.495 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -133.19 141.61 48.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.711 1.604 . . . . 0.0 106.932 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -48.44 127.5 13.23 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.375 0.67 . . . . 0.0 110.937 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 -10.35 71.15 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.479 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.44 142.12 58.28 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.527 1.663 . . . . 0.0 107.167 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.68 152.88 44.53 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.644 0.735 . . . . 0.0 109.893 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -141.26 -35.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.337 1.455 . . . . 0.0 109.376 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.15 -179.15 7.44 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.942 0.897 . . . . 0.0 109.065 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.63 140.37 43.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -114.54 128.9 56.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.958 2.103 . . . . 0.0 106.82 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.32 125.88 45.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -170.45 169.6 7.37 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.82 1.248 . . . . 0.0 108.061 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.1 ptt? 44.66 40.34 4.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.136 1.374 . . . . 0.0 113.202 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.95 33.98 15.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.139 1.776 . . . . 0.0 112.853 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -143.73 170.9 14.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.264 1.825 . . . . 0.0 109.028 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -124.38 137.98 54.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.97 126.44 16.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.78 153.5 75.61 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.36 1.373 . . . . 0.0 111.014 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.99 130.12 74.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.54 159.77 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 124.622 1.169 . . . . 0.0 110.855 -169.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 116.59 5.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 108.439 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.84 -25.14 65.4 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.004 0.522 . . . . 0.0 111.696 173.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -156.17 154.01 30.16 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.673 1.589 . . . . 0.0 108.443 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -66.16 157.35 31.51 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.573 0.749 . . . . 0.0 110.394 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.69 -179.31 38.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -87.66 137.55 20.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.7 102.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -71.52 -41.19 69.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -156.63 162.56 39.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.55 134.03 67.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -102.43 -4.06 26.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.073 0.949 . . . . 0.0 112.732 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -141.36 179.55 6.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.746 1.218 . . . . 0.0 110.278 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -148.96 163.8 36.43 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.341 1.456 . . . . 0.0 108.634 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.85 137.19 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.8 0.84 . . . . 0.0 109.103 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.94 66.4 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.648 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.17 152.29 38.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.84 1.82 . . . . 0.0 111.066 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -68.17 146.0 53.82 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.026 0.931 . . . . 0.0 109.256 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.68 160.55 14.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 110.08 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -140.71 167.78 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.47 0.708 . . . . 0.0 110.992 -175.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.17 116.13 3.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.53 2.56 79.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.783 1.182 . . . . 0.0 113.119 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -78.28 123.19 26.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.468 1.634 . . . . 0.0 107.803 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 t -64.87 145.88 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.277 0.631 . . . . 0.0 109.808 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.7 tp -113.35 -45.89 3.11 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.786 1.235 . . . . 0.0 109.803 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.65 160.53 42.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.394 0.997 . . . . 0.0 112.315 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.63 141.46 51.99 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.015 2.126 . . . . 0.0 105.898 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.812 -169.576 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.238 0.472 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.6 m -138.89 165.05 28.06 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.801 1.24 . . . . 0.0 110.844 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.16 156.33 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 170.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.0 27.08 3.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.781 1.232 . . . . 0.0 110.892 -175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 156.82 34.35 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.733 1.613 . . . . 0.0 107.814 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.66 140.73 35.5 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.28 -151.91 16.76 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.56 137.01 45.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.55 119.91 23.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -76.84 -51.34 11.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.033 0.933 . . . . 0.0 111.049 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -150.31 158.91 44.68 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.824 1.649 . . . . 0.0 107.659 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.6 t -135.76 147.91 28.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -130.0 23.47 5.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 111.808 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.35 164.8 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.433 1.093 . . . . 0.0 110.564 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -146.79 158.2 43.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.137 1.775 . . . . 0.0 106.482 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.32 135.35 53.77 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.64 -7.96 80.79 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.833 1.206 . . . . 0.0 113.297 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.71 164.7 24.54 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.329 1.564 . . . . 0.0 110.372 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -109.58 137.58 47.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 107.255 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -128.83 162.29 36.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -137.13 144.55 43.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -49.98 124.63 10.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.81 0.732 . . . . 0.0 110.354 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.03 -8.41 77.95 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.62 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.66 134.63 54.67 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.569 1.684 . . . . 0.0 107.934 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -67.88 131.7 45.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.96 -19.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.231 1.013 . . . . 0.0 111.787 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.13 179.83 8.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 109.773 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -134.44 143.39 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.84 140.54 48.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.006 2.123 . . . . 0.0 107.105 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.46 123.14 47.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 t -167.41 169.66 12.07 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.789 1.235 . . . . 0.0 107.799 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 19.8 ptt? 44.96 39.9 4.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.807 1.243 . . . . 0.0 113.028 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 53.05 34.14 16.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.287 1.835 . . . . 0.0 112.821 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.5 mtp -144.08 167.8 21.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.088 1.755 . . . . 0.0 109.182 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.3 139.04 51.94 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.56 131.44 18.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.14 155.1 68.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.997 1.798 . . . . 0.0 111.087 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.74 124.5 66.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.75 156.31 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.952 1.301 . . . . 0.0 110.247 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.91 12.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.925 1.29 . . . . 0.0 108.868 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.36 -23.04 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.24 0.616 . . . . 0.0 111.992 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -154.58 161.6 41.54 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.183 1.793 . . . . 0.0 108.027 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -73.88 157.01 37.09 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.414 0.686 . . . . 0.0 110.504 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.47 36.24 Favored Glycine 0 CA--C 1.524 0.597 0 O-C-N 121.736 -0.602 . . . . 0.0 112.092 170.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.15 135.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.14 101.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -69.33 -41.3 76.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -156.57 163.53 39.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.567 0.621 . . . . 0.0 109.341 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -124.76 137.75 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -118.55 3.48 11.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -139.79 171.25 14.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.973 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -148.31 171.88 15.28 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.838 1.655 . . . . 0.0 108.913 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -57.98 133.44 55.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.08 0.552 . . . . 0.0 109.511 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.89 74.35 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.878 1.228 . . . . 0.0 113.562 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.22 139.63 50.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.301 1.551 . . . . 0.0 109.228 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -65.9 140.97 58.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.66 157.98 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.51 166.33 26.01 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.978 -171.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.3 108.19 1.05 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.35 0.1 58.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.266 1.413 . . . . 0.0 113.061 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -79.78 130.51 35.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.599 1.7 . . . . 0.0 108.65 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.66 150.05 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.757 0.823 . . . . 0.0 110.066 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.17 -51.61 2.21 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.935 1.694 . . . . 0.0 108.427 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.02 171.92 15.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.987 0.515 . . . . 0.0 110.799 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.92 148.73 50.95 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.478 1.111 . . . . 0.0 108.396 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--O 1.233 0.195 0 C-N-CA 125.057 1.343 . . . . 0.0 112.415 -169.165 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 C--O 1.239 0.512 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -138.12 161.73 36.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.183 0.993 . . . . 0.0 111.982 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -80.52 153.39 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -132.14 27.84 4.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.57 157.35 35.17 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.697 1.599 . . . . 0.0 107.858 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.63 141.97 34.46 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 171.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 -152.51 20.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.63 136.52 51.75 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.19 71.89 9.24 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.906 1.282 . . . . 0.0 111.03 -169.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -24.82 -59.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.431 2.692 . . . . 0.0 114.292 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -144.9 163.84 32.91 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.639 1.176 . . . . 0.0 108.991 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.88 146.52 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -122.68 -17.99 6.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.043 0.537 . . . . 0.0 111.648 -169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.98 166.73 2.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.685 0.755 . . . . 0.0 111.961 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -149.55 162.09 40.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.373 1.869 . . . . 0.0 106.039 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.49 138.23 51.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.706 0.685 . . . . 0.0 109.513 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.26 -5.94 70.2 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.727 -1.041 . . . . 0.0 113.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.86 166.84 18.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.311 1.555 . . . . 0.0 109.448 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -122.25 141.68 51.24 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -129.88 162.65 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.493 1.117 . . . . 0.0 108.292 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.73 140.66 44.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -46.4 123.81 5.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 110.788 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.69 -10.03 75.93 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.619 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.51 139.25 58.47 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.571 1.686 . . . . 0.0 108.145 170.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 142.99 57.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.15 -21.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.031 1.332 . . . . 0.0 110.728 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 179.42 8.73 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.62 0.768 . . . . 0.0 109.038 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -135.61 146.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.47 133.64 53.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.025 2.13 . . . . 0.0 106.358 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -107.87 125.3 51.3 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -170.01 165.97 9.34 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.039 1.336 . . . . 0.0 107.851 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 mtm 56.22 29.99 15.8 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.945 0.898 . . . . 0.0 111.856 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 52.0 35.61 16.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.586 1.555 . . . . 0.0 112.308 -171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.54 172.93 12.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.602 1.961 . . . . 0.0 108.737 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -125.2 136.95 54.08 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.25 130.4 14.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.21 155.03 68.96 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.59 1.527 . . . . 0.0 110.555 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.3 mm -120.79 124.64 72.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 173.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 m -113.89 156.26 14.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.858 1.263 . . . . 0.0 110.678 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.61 118.66 8.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.507 1.123 . . . . 0.0 108.193 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.73 -25.78 67.45 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.147 0.579 . . . . 0.0 111.48 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -157.33 155.49 30.72 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.233 1.413 . . . . 0.0 108.621 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -70.93 157.34 38.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.421 0.688 . . . . 0.0 110.707 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.9 177.53 35.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 122.1 -0.375 . . . . 0.0 112.513 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.88 133.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 110.81 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.81 -44.9 60.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -156.78 159.42 38.27 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.36 138.11 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -116.67 12.38 14.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.236 1.014 . . . . 0.0 112.154 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -146.79 178.62 8.18 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.037 1.735 . . . . 0.0 108.763 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -144.84 169.61 17.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.065 1.346 . . . . 0.0 108.278 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.67 133.06 46.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.774 0.83 . . . . 0.0 109.232 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.54 -1.61 65.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.045 1.307 . . . . 0.0 114.15 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -71.31 153.31 42.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.807 1.803 . . . . 0.0 110.475 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -66.25 143.82 56.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.07 160.12 17.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.103 0.961 . . . . 0.0 109.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.18 166.62 24.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.285 -174.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 112.98 2.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.58 -1.94 64.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.15 1.357 . . . . 0.0 112.81 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -76.56 132.84 39.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.217 1.509 . . . . 0.0 109.106 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.26 130.27 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.455 0.702 . . . . 0.0 109.481 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -82.84 -50.88 8.18 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.677 1.191 . . . . 0.0 108.494 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.32 171.05 20.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.96 148.8 51.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.115 1.366 . . . . 0.0 108.337 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 C--O 1.232 0.143 0 C-N-CA 125.44 1.496 . . . . 0.0 109.779 -170.52 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 C--O 1.239 0.506 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -137.65 155.59 48.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.834 1.253 . . . . 0.0 111.173 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -70.11 148.01 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -109.21 6.58 24.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.403 -0.811 . . . . 0.0 112.375 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 159.5 38.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.006 1.322 . . . . 0.0 108.945 -169.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.47 140.14 38.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.835 0.454 . . . . 0.0 109.912 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.21 -151.51 17.76 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.31 141.69 51.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.8 tp -83.06 77.25 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.437 1.095 . . . . 0.0 110.958 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -37.22 -56.33 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.232 2.213 . . . . 0.0 113.554 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -147.02 160.72 42.04 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.931 1.293 . . . . 0.0 108.832 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.74 142.58 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -120.78 -22.51 6.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.196 0.598 . . . . 0.0 111.216 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 m -74.97 161.32 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.659 0.742 . . . . 0.0 111.619 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -149.91 157.13 42.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.626 1.97 . . . . 0.0 106.284 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.86 130.91 45.52 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.795 0.725 . . . . 0.0 109.147 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.23 -9.06 77.0 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.467 1.032 . . . . 0.0 112.997 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.64 166.4 17.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.221 1.511 . . . . 0.0 109.831 170.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -122.92 142.28 50.98 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.3 pt -131.76 161.64 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 123.797 0.839 . . . . 0.0 108.871 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.94 143.76 40.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -46.1 122.94 4.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.981 0.81 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.61 -8.26 78.86 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.92 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -63.86 132.97 52.45 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.683 1.741 . . . . 0.0 107.402 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.0 137.07 43.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.2 -20.06 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.334 1.454 . . . . 0.0 110.878 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.17 -179.34 7.81 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.638 0.775 . . . . 0.0 108.989 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.63 145.61 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -121.15 130.62 53.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.152 2.181 . . . . 0.0 106.44 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.87 124.97 49.39 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -170.03 169.5 8.03 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.851 1.261 . . . . 0.0 107.852 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.0 ptt? 44.42 41.35 4.51 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.025 1.33 . . . . 0.0 112.922 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.78 31.93 11.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.378 1.871 . . . . 0.0 113.107 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.41 170.44 15.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.327 1.851 . . . . 0.0 109.093 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.46 139.19 54.15 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.58 129.44 17.52 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -169.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.45 149.29 80.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.53 1.487 . . . . 0.0 110.308 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.98 123.55 71.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -113.06 155.64 14.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.138 1.375 . . . . 0.0 110.91 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 121.04 12.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.801 1.24 . . . . 0.0 108.497 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.24 -30.17 70.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.162 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -157.16 155.86 31.68 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 109.207 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 m -71.75 155.47 40.42 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.736 0.814 . . . . 0.0 110.85 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.04 178.75 38.55 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.24 0.448 . . . . 0.0 112.008 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.62 134.96 27.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.45 107.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.21 -40.89 29.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.45 154.53 32.01 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 t -114.16 134.74 56.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.3 -3.52 31.15 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.873 0.869 . . . . 0.0 112.714 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -137.66 178.01 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.412 1.085 . . . . 0.0 109.958 -170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -142.42 163.61 32.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.779 1.232 . . . . 0.0 107.785 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -60.99 136.78 58.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.46 -4.3 78.46 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.314 -1.27 . . . . 0.0 114.06 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -72.67 155.31 40.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.005 1.903 . . . . 0.0 110.717 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.08 144.53 56.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.93 160.82 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.035 0.934 . . . . 0.0 109.238 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -145.93 166.69 25.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.052 -172.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.37 113.92 2.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 2.2 75.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.794 1.188 . . . . 0.0 112.892 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -77.81 127.29 32.18 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 1.566 . . . . 0.0 107.507 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.78 137.35 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.08 -50.93 5.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.817 1.247 . . . . 0.0 108.9 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 168.01 24.51 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.583 0.629 . . . . 0.0 112.081 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -126.78 141.97 51.68 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.225 1.81 . . . . 0.0 106.921 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 CA--C 1.519 -0.214 0 C-N-CA 124.407 1.083 . . . . 0.0 110.766 -169.457 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--O 1.237 0.425 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m -140.56 159.53 41.99 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.993 1.317 . . . . 0.0 111.127 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 mm -77.55 156.55 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.76 15.62 4.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.451 1.5 . . . . 0.0 111.512 -169.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.33 157.76 36.24 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.647 1.579 . . . . 0.0 108.114 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.61 140.84 41.17 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.5 -153.91 20.0 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.93 135.65 50.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.46 70.74 8.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.846 1.258 . . . . 0.0 111.096 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -25.76 -59.82 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.431 2.692 . . . . 0.0 114.127 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -144.75 163.17 34.83 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.618 1.167 . . . . 0.0 108.923 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.43 146.38 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -124.48 -18.62 5.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.915 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.17 164.77 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.758 0.79 . . . . 0.0 111.68 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -150.1 157.81 43.51 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.597 1.959 . . . . 0.0 106.042 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.19 132.5 50.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.39 -8.99 78.91 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.525 1.059 . . . . 0.0 113.068 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.03 162.27 27.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.241 1.52 . . . . 0.0 109.896 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -113.17 141.99 46.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 pt -130.94 158.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.49 143.75 46.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -46.88 119.98 2.79 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.874 0.761 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.08 68.6 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.015 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.5 135.66 55.43 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.708 1.754 . . . . 0.0 108.175 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.69 134.55 52.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.85 -22.17 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.308 1.043 . . . . 0.0 111.495 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.55 -178.88 7.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.074 0.852 . . . . 0.0 109.808 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -135.91 145.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.92 134.79 54.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.779 2.032 . . . . 0.0 106.528 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.71 125.82 53.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.86 166.76 7.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.163 1.385 . . . . 0.0 107.788 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 56.06 30.28 16.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.919 0.888 . . . . 0.0 111.86 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 51.88 35.8 16.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.641 1.577 . . . . 0.0 112.279 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.77 173.03 11.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.625 1.97 . . . . 0.0 108.799 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.57 137.69 53.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.48 131.15 16.08 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.66 155.39 69.02 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.857 1.704 . . . . 0.0 110.61 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.0 mm -124.65 125.22 69.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.59 156.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 110.179 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.17 121.54 13.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.671 1.188 . . . . 0.0 108.425 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.71 -25.81 66.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.108 0.563 . . . . 0.0 111.535 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.38 156.95 33.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.343 1.457 . . . . 0.0 108.882 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -73.43 157.01 37.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.685 0.794 . . . . 0.0 111.061 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.42 -177.19 40.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.504 0.573 . . . . 0.0 112.261 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.6 mm -99.65 129.83 49.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.86 109.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -73.46 -45.47 54.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -157.16 157.14 33.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.82 135.81 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.41 8.07 29.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.24 1.016 . . . . 0.0 111.967 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -146.56 178.75 8.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.937 1.695 . . . . 0.0 108.783 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -144.74 169.42 18.06 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.904 1.282 . . . . 0.0 108.38 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.62 133.4 46.59 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.958 0.903 . . . . 0.0 109.325 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.11 -1.57 63.58 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.112 1.339 . . . . 0.0 114.158 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.9 152.02 44.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.844 1.822 . . . . 0.0 110.511 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -65.95 142.74 57.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.88 160.64 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.099 0.96 . . . . 0.0 109.665 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.86 167.05 23.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.59 -173.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.14 114.78 3.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.694 0.798 . . . . 0.0 108.94 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.81 68.39 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.194 1.378 . . . . 0.0 112.921 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.49 128.11 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.18 1.49 . . . . 0.0 109.293 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.5 131.58 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.506 0.722 . . . . 0.0 109.559 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.6 tp -85.32 -50.83 7.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 124.538 1.135 . . . . 0.0 108.787 170.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.29 168.95 24.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.212 0.529 . . . . 0.0 111.025 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -129.24 143.79 50.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.274 1.829 . . . . 0.0 106.937 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 110.337 -169.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.9 t . . . . . 0 C--O 1.238 0.491 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -140.13 159.17 42.78 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.684 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -78.14 157.24 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 14.56 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.441 1.496 . . . . 0.0 111.722 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -156.31 157.98 36.66 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.572 1.549 . . . . 0.0 108.136 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.06 140.34 40.28 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.012 -0.43 . . . . 0.0 110.036 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.81 -153.91 18.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 137.12 51.38 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.53 71.83 8.56 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.94 1.296 . . . . 0.0 111.332 -169.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -29.57 -59.26 0.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.941 2.496 . . . . 0.0 114.01 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.87 163.08 37.25 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.114 1.366 . . . . 0.0 108.633 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.77 148.38 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -131.18 26.11 4.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.99 0.916 . . . . 0.0 112.005 -169.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.37 162.35 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.562 1.145 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.79 159.25 44.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.089 1.756 . . . . 0.0 107.641 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.37 133.44 49.7 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 -6.4 83.54 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.222 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.01 165.82 20.99 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.483 1.642 . . . . 0.0 110.163 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -113.36 141.2 47.33 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.575 1.55 . . . . 0.0 107.009 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -130.52 163.36 36.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.055 0.942 . . . . 0.0 108.734 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -137.38 139.63 40.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -47.0 124.2 6.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.056 0.942 . . . . 0.0 110.634 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.56 74.35 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.66 -1.078 . . . . 0.0 113.763 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -64.41 143.65 57.75 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.469 1.635 . . . . 0.0 107.869 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.85 144.22 57.41 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.73 -31.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 110.346 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 -178.78 7.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 119.533 1.061 . . . . 0.0 109.416 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -134.67 145.01 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.36 128.64 52.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.652 1.981 . . . . 0.0 106.588 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.96 124.21 43.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.64 167.67 9.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.194 1.397 . . . . 0.0 107.753 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.2 mtm 54.99 31.59 16.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.057 0.943 . . . . 0.0 111.76 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.27 34.57 14.98 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.932 1.693 . . . . 0.0 112.585 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.4 mtt -142.7 173.66 11.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.479 1.911 . . . . 0.0 108.508 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -120.96 140.61 51.64 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.53 132.19 19.67 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.74 153.87 74.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.932 1.755 . . . . 0.0 110.843 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 mm -126.54 134.9 65.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.87 163.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.373 1.069 . . . . 0.0 110.253 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.39 113.04 2.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.631 1.173 . . . . 0.0 107.842 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.2 -17.04 62.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.311 0.244 . . . . 0.0 111.371 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.32 155.49 30.76 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.057 1.743 . . . . 0.0 108.959 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 m -69.23 158.21 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.903 0.881 . . . . 0.0 110.923 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.37 177.36 33.4 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 122.265 -0.272 . . . . 0.0 112.538 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -85.68 135.08 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -68.62 115.41 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -84.28 -48.3 9.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -157.66 129.55 7.01 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -81.93 137.2 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -110.02 5.3 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.048 0.939 . . . . 0.0 112.124 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -143.84 179.06 7.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.315 1.446 . . . . 0.0 108.612 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -145.38 163.9 33.15 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.548 1.139 . . . . 0.0 108.915 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.23 130.12 43.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.968 0.907 . . . . 0.0 109.716 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.17 -1.61 84.4 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.258 1.409 . . . . 0.0 113.804 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -70.64 153.74 42.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.767 1.783 . . . . 0.0 110.53 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.13 143.86 56.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.61 160.77 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.02 0.928 . . . . 0.0 109.488 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.48 167.72 21.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.976 -172.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 115.55 3.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 108.957 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.68 -0.7 74.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.052 1.311 . . . . 0.0 112.88 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -77.48 126.7 31.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.358 1.579 . . . . 0.0 109.093 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.71 129.74 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.16 -44.97 9.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.339 1.056 . . . . 0.0 109.331 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.78 165.12 37.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.751 0.786 . . . . 0.0 111.884 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -118.32 143.82 46.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.81 2.044 . . . . 0.0 106.586 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.519 -0.246 0 C-N-CA 124.72 1.208 . . . . 0.0 108.514 -174.261 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.237 0.406 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -138.44 155.28 48.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.927 1.291 . . . . 0.0 111.045 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -70.02 147.67 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -108.6 4.69 24.27 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 ptp -154.11 163.68 39.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.279 0.945 . . . . 0.0 109.575 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.9 141.45 49.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.784 0.434 . . . . 0.0 110.175 173.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.19 -152.93 20.32 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.91 140.15 51.8 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.9 tp -80.78 75.78 7.7 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.455 1.102 . . . . 0.0 111.592 -169.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -35.2 -58.15 0.56 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.348 2.259 . . . . 0.0 113.789 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -147.61 160.63 42.44 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.794 1.237 . . . . 0.0 108.743 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.2 143.58 32.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -124.32 -21.34 4.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.832 0.453 . . . . 0.0 111.992 -169.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.2 162.01 4.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.468 0.651 . . . . 0.0 111.557 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -149.59 158.91 44.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.266 1.826 . . . . 0.0 106.763 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.88 47.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.09 -6.94 83.2 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.112 -178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -68.42 164.93 19.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.316 1.558 . . . . 0.0 109.842 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -119.41 144.57 46.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.522 1.129 . . . . 0.0 108.005 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.25 159.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -133.69 143.99 48.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -48.54 121.31 4.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.874 0.761 . . . . 0.0 110.438 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.56 67.49 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -64.61 134.72 54.92 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.695 1.747 . . . . 0.0 108.074 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -67.7 133.03 48.59 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.32 -21.67 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.271 1.028 . . . . 0.0 111.424 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.74 8.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.151 0.981 . . . . 0.0 109.514 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.41 147.24 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -124.02 131.52 53.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.885 2.074 . . . . 0.0 106.515 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.23 124.71 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -169.07 166.4 10.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.824 1.249 . . . . 0.0 108.047 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.9 mtm 55.18 31.52 16.6 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.932 0.893 . . . . 0.0 111.854 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 52.22 35.21 16.23 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.79 1.636 . . . . 0.0 112.496 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.44 173.76 11.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.667 1.987 . . . . 0.0 108.665 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -118.61 142.53 47.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.49 128.44 19.14 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 -169.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.1 147.94 68.23 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.831 1.687 . . . . 0.0 109.996 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -121.08 121.88 66.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 m -114.95 157.2 15.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.631 1.173 . . . . 0.0 110.177 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 119.73 9.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.687 1.195 . . . . 0.0 108.25 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.18 -26.13 68.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.42 0.688 . . . . 0.0 111.572 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -157.38 155.51 30.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.581 1.552 . . . . 0.0 108.476 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 m -69.38 157.58 36.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.342 0.657 . . . . 0.0 110.605 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.39 -176.17 40.33 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 122.106 -0.371 . . . . 0.0 112.473 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -99.84 133.64 42.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.63 111.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -77.0 -45.2 28.14 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.39 151.66 26.58 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.55 134.19 48.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -106.27 3.76 28.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.672 0.789 . . . . 0.0 112.461 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -138.7 178.4 7.18 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.064 1.346 . . . . 0.0 109.284 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.04 159.89 41.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.648 1.179 . . . . 0.0 108.136 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.27 132.05 51.4 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.99 -3.62 86.9 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.093 1.33 . . . . 0.0 113.763 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -70.35 154.46 41.87 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.865 1.833 . . . . 0.0 110.68 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -66.47 143.39 57.12 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.42 160.54 14.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.038 0.935 . . . . 0.0 109.219 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.04 167.36 22.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.282 -171.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.31 113.39 2.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.98 5.7 85.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.487 1.041 . . . . 0.0 113.063 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.01 130.23 37.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.439 1.619 . . . . 0.0 107.233 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.17 141.42 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.84 -50.24 3.9 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.166 1.386 . . . . 0.0 108.661 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 165.83 33.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 111.928 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -128.69 139.15 52.38 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.44 1.896 . . . . 0.0 106.403 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.233 0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 110.274 -169.364 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.239 0.502 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -137.75 155.3 49.21 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.718 1.207 . . . . 0.0 111.458 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.26 147.86 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -108.51 5.38 25.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 ptp -153.88 163.03 40.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 109.827 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.53 140.86 50.07 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.653 0.381 . . . . 0.0 110.227 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.95 -153.65 21.91 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.23 137.62 44.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.64 121.18 14.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.84 -51.69 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -149.11 159.93 43.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.586 1.555 . . . . 0.0 108.493 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.09 142.89 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -120.76 -22.08 6.42 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.036 0.534 . . . . 0.0 111.506 -170.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.76 165.96 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.977 0.894 . . . . 0.0 111.153 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.73 154.09 36.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.43 50.65 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.67 -9.94 62.45 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.451 1.501 . . . . 0.0 112.989 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.4 172.22 12.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.913 1.357 . . . . 0.0 110.667 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -115.87 138.19 51.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.727 1.611 . . . . 0.0 107.094 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 pt -128.48 160.67 38.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.0 143.9 38.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -48.57 120.85 4.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.774 0.715 . . . . 0.0 110.467 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.81 -8.25 70.71 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.826 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.4 135.22 55.91 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.589 1.694 . . . . 0.0 108.051 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.41 133.69 49.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.12 -22.29 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.293 1.037 . . . . 0.0 111.617 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.06 178.06 10.12 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.592 0.757 . . . . 0.0 109.694 169.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.4 mt -136.78 142.03 39.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -120.46 131.19 54.64 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.278 1.831 . . . . 0.0 106.882 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.87 124.36 43.73 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -168.84 166.78 11.32 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.969 1.308 . . . . 0.0 108.065 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.2 mtm 55.26 31.32 16.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.015 0.926 . . . . 0.0 111.795 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.64 34.6 16.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.71 1.604 . . . . 0.0 112.515 -172.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.08 173.53 11.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.517 1.927 . . . . 0.0 108.659 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -118.72 141.67 48.39 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.66 128.31 18.92 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.45 149.63 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.947 1.764 . . . . 0.0 110.203 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mm -122.46 120.94 62.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.18 156.18 15.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.792 1.237 . . . . 0.0 110.183 -172.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 116.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.038 1.335 . . . . 0.0 108.63 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.43 -23.32 65.52 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.082 0.553 . . . . 0.0 111.768 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -154.54 162.04 41.34 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.522 1.529 . . . . 0.0 108.796 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -75.17 157.32 34.77 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.82 0.848 . . . . 0.0 110.96 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.62 174.75 33.83 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.354 0.502 . . . . 0.0 112.0 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.3 mm -85.57 134.3 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.74 101.77 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -71.48 -40.66 70.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -156.02 164.13 38.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.568 0.622 . . . . 0.0 109.335 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 t -125.87 135.09 64.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -105.5 -0.84 25.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 111.863 -169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -141.29 177.04 8.37 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.817 1.247 . . . . 0.0 110.693 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.16 169.01 21.68 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.311 1.444 . . . . 0.0 108.501 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.62 139.68 49.24 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.728 0.811 . . . . 0.0 109.271 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.45 -7.78 56.24 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.376 -1.236 . . . . 0.0 113.737 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -75.83 152.85 37.17 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.817 1.809 . . . . 0.0 110.952 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.91 145.38 54.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.034 0.934 . . . . 0.0 109.325 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.19 161.59 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.877 0.871 . . . . 0.0 109.952 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.36 168.48 19.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.091 -175.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.23 114.65 3.0 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.37 82.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.472 1.034 . . . . 0.0 112.976 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -78.87 125.82 29.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.454 1.627 . . . . 0.0 107.847 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.61 132.13 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.483 0.713 . . . . 0.0 109.961 -169.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.89 -50.53 7.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.931 1.292 . . . . 0.0 107.686 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -154.35 169.58 23.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.455 0.645 . . . . 0.0 111.893 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.24 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.517 1.927 . . . . 0.0 106.8 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.234 0.25 0 C-N-CA 124.199 1.0 . . . . 0.0 110.556 -169.828 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 C--O 1.235 0.341 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -136.62 154.59 50.61 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 110.635 -169.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -69.6 141.84 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -102.77 5.66 38.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.695 -0.628 . . . . 0.0 112.529 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -156.27 164.28 38.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.3 1.04 . . . . 0.0 109.532 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.69 142.86 42.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.729 0.411 . . . . 0.0 110.312 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.54 -151.72 16.99 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.73 132.39 45.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 113.66 10.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -70.66 -59.18 2.97 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.015 0.926 . . . . 0.0 110.564 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -149.42 158.33 44.08 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.968 1.307 . . . . 0.0 109.182 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.28 145.73 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.171 1.389 . . . . 0.0 107.434 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.89 24.83 4.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.412 1.085 . . . . 0.0 111.055 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 m -132.83 165.52 32.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.083 1.353 . . . . 0.0 110.129 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -146.7 156.19 42.99 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.985 1.714 . . . . 0.0 106.519 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.32 133.52 55.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.46 -10.12 74.75 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.513 1.054 . . . . 0.0 112.864 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.08 170.35 11.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.045 1.422 . . . . 0.0 109.658 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -126.46 143.26 51.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 107.986 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.51 164.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.616 1.166 . . . . 0.0 108.784 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -136.05 141.64 44.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.708 1.203 . . . . 0.0 107.817 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -45.62 116.55 1.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 110.691 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -10.68 62.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.714 -1.048 . . . . 0.0 113.66 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -66.63 140.41 57.93 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.497 1.648 . . . . 0.0 108.499 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.94 138.99 56.39 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.5 -19.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.981 0.912 . . . . 0.0 112.151 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.53 178.4 9.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.705 1.202 . . . . 0.0 108.688 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -134.76 148.86 29.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -123.56 133.67 53.94 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.738 2.015 . . . . 0.0 106.745 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 123.8 46.42 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -168.83 167.3 11.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.764 1.225 . . . . 0.0 107.951 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 mtm 55.48 30.61 15.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.854 0.862 . . . . 0.0 111.861 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 53.13 35.3 19.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.857 1.663 . . . . 0.0 111.995 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -144.0 173.62 11.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.484 1.914 . . . . 0.0 108.644 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -119.23 140.53 50.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.3 131.79 19.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.56 152.46 74.79 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.892 1.728 . . . . 0.0 110.754 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.9 mm -123.46 118.65 55.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.85 157.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.466 1.106 . . . . 0.0 110.293 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 108.23 1.13 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.264 1.426 . . . . 0.0 107.441 170.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.02 -15.13 62.97 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 155.72 34.46 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.673 1.589 . . . . 0.0 108.509 171.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.94 159.66 33.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.18 0.992 . . . . 0.0 110.975 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.57 179.19 37.01 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 121.829 -0.544 . . . . 0.0 112.377 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -85.45 134.05 28.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.51 100.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -70.34 -40.24 74.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -156.87 162.88 39.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -114.83 7.98 15.91 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.741 0.816 . . . . 0.0 112.557 -168.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -140.73 175.59 9.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.761 1.224 . . . . 0.0 109.588 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -143.3 160.34 40.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.326 1.85 . . . . 0.0 107.182 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.36 127.64 33.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.23 -7.51 64.25 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.504 1.526 . . . . 0.0 113.407 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -74.77 153.66 38.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.5 1.65 . . . . 0.0 111.414 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.62 145.32 54.03 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.551 0.74 . . . . 0.0 109.117 170.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.55 159.83 14.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.752 0.821 . . . . 0.0 110.108 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.92 166.11 25.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -176.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.8 117.84 5.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.12 -0.8 82.15 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.682 1.134 . . . . 0.0 113.044 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.25 131.69 41.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.274 1.537 . . . . 0.0 108.176 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 t -70.95 135.09 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 -50.94 5.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 125.462 1.505 . . . . 0.0 108.894 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.18 168.75 20.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 112.062 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.24 140.09 52.09 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.663 1.985 . . . . 0.0 106.378 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 123.886 0.875 . . . . 0.0 112.446 -169.074 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.238 0.458 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 m -139.68 160.12 40.59 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.694 1.198 . . . . 0.0 111.03 -168.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.63 156.81 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.59 15.63 4.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.445 1.098 . . . . 0.0 112.129 -169.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 158.29 36.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.099 1.76 . . . . 0.0 107.91 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.71 141.08 38.18 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.884 -0.51 . . . . 0.0 109.762 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -153.43 19.43 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.68 133.71 45.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.85 113.55 13.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -66.52 -56.09 12.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.045 0.938 . . . . 0.0 110.203 -170.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.52 161.4 42.21 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.419 1.488 . . . . 0.0 107.943 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.21 146.69 28.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.44 -19.77 5.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.029 0.532 . . . . 0.0 112.03 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.76 166.17 2.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.794 0.807 . . . . 0.0 111.791 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.78 160.26 42.92 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.627 1.971 . . . . 0.0 105.93 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.12 137.83 45.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.18 -7.39 75.67 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.472 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -70.74 162.85 28.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.448 1.624 . . . . 0.0 110.339 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -108.71 137.56 46.44 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 pt -128.2 161.27 36.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -138.73 141.68 38.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -47.51 120.64 3.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.959 0.8 . . . . 0.0 110.69 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -10.25 64.63 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.894 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.52 135.85 56.44 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.552 1.676 . . . . 0.0 108.237 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.21 134.13 49.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.53 -22.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.126 0.97 . . . . 0.0 111.534 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.57 -178.82 7.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.79 0.836 . . . . 0.0 109.615 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -137.28 146.37 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -121.53 136.21 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.677 1.991 . . . . 0.0 107.197 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -104.34 124.08 48.54 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.26 167.82 10.05 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 125.004 1.322 . . . . 0.0 107.923 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 54.9 32.72 18.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.906 0.883 . . . . 0.0 111.656 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.23 32.73 11.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.985 1.714 . . . . 0.0 112.681 -173.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.8 mmm -142.16 173.26 11.68 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.579 1.952 . . . . 0.0 108.746 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -119.46 141.99 48.66 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.84 130.29 18.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.87 152.51 73.7 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.87 1.713 . . . . 0.0 110.566 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -123.68 121.83 63.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 m -113.39 157.72 13.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.726 1.21 . . . . 0.0 109.977 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 119.82 9.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.713 1.205 . . . . 0.0 108.237 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.77 -26.07 65.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.945 0.498 . . . . 0.0 111.336 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -157.12 155.87 31.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.536 1.534 . . . . 0.0 108.855 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.46 156.81 36.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.05 0.94 . . . . 0.0 111.085 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.8 177.23 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.363 0.506 . . . . 0.0 112.392 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -85.8 133.35 29.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 169.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.15 111.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -73.88 -46.66 43.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -156.57 158.92 37.97 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.55 131.53 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.83 -6.02 27.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.979 0.912 . . . . 0.0 112.555 -169.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -138.86 173.6 11.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.184 1.394 . . . . 0.0 109.045 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -147.79 170.53 17.39 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 109.129 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.28 128.91 39.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.66 1.02 87.7 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.148 1.356 . . . . 0.0 113.507 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.74 153.09 42.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.32 1.56 . . . . 0.0 110.097 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -76.02 143.39 41.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.72 159.62 14.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.592 0.711 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.77 167.01 23.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.308 -172.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 113.08 2.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.31 72.22 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.898 1.237 . . . . 0.0 113.106 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.83 126.33 30.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.435 1.618 . . . . 0.0 108.206 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.86 144.59 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.31 -49.5 2.96 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.514 1.526 . . . . 0.0 108.479 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.84 169.2 19.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.338 0.589 . . . . 0.0 111.642 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.48 144.89 51.45 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.311 1.845 . . . . 0.0 106.844 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.523 -0.095 0 C-N-CA 124.854 1.262 . . . . 0.0 110.66 -169.201 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.239 0.524 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -140.76 155.82 46.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.238 . . . . 0.0 110.667 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.8 mm -73.88 152.13 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.621 1.168 . . . . 0.0 107.993 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.89 11.61 14.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.386 0.675 . . . . 0.0 111.948 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -143.67 161.21 39.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.558 1.543 . . . . 0.0 108.343 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -90.01 131.51 35.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.63 11.55 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.4 142.35 50.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.0 tp -85.74 72.21 10.58 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.978 0.911 . . . . 0.0 110.833 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -27.68 -59.1 0.11 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.083 2.553 . . . . 0.0 114.081 -174.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.6 162.42 38.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.119 1.368 . . . . 0.0 108.527 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.87 147.67 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -131.34 25.46 4.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.192 0.997 . . . . 0.0 111.559 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.76 165.04 32.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.388 1.075 . . . . 0.0 110.484 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -148.97 158.08 43.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.983 1.713 . . . . 0.0 106.795 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.43 53.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.55 77.48 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.528 1.061 . . . . 0.0 112.787 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.05 167.68 17.1 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.142 1.471 . . . . 0.0 109.815 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -125.02 138.1 54.22 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -126.56 162.84 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.368 1.067 . . . . 0.0 108.198 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.9 143.11 48.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -47.87 126.96 11.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.58 0.752 . . . . 0.0 110.5 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.56 78.45 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.507 -1.163 . . . . 0.0 113.617 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.85 138.65 58.03 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.688 1.744 . . . . 0.0 107.884 169.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.89 137.94 57.52 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.06 -19.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.868 1.267 . . . . 0.0 111.429 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.88 -179.49 8.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.435 1.016 . . . . 0.0 109.336 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -136.19 139.02 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -106.11 136.11 46.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.803 2.041 . . . . 0.0 106.614 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.31 120.93 44.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -162.02 166.4 26.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 53.33 24.61 3.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt 47.38 42.68 14.46 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 126.12 1.768 . . . . 0.0 111.839 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.6 mmt -137.12 164.64 27.96 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.402 2.281 . . . . 0.0 106.988 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -112.14 140.73 46.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.73 122.79 14.61 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.24 151.59 35.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.988 2.458 . . . . 0.0 112.723 174.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mm -126.4 123.23 62.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.32 155.41 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.234 1.413 . . . . 0.0 110.105 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.28 124.09 21.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.145 0.978 . . . . 0.0 108.674 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -29.05 69.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.806 0.442 . . . . 0.0 111.573 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.1 ptm85 -157.21 156.61 32.87 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.611 1.164 . . . . 0.0 108.895 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -70.31 155.14 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.34 0.656 . . . . 0.0 110.492 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.17 177.2 36.71 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 122.119 -0.363 . . . . 0.0 112.39 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -85.42 133.39 29.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.6 109.59 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -78.06 -43.43 29.24 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -152.18 156.86 40.61 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.488 0.585 . . . . 0.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.4 129.47 74.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.4 -0.55 35.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.694 0.798 . . . . 0.0 111.983 -169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -139.73 176.26 8.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.821 1.249 . . . . 0.0 109.581 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.44 164.57 31.13 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.93 1.292 . . . . 0.0 108.579 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.4 128.13 32.84 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.955 0.902 . . . . 0.0 109.561 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.71 86.79 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.187 1.375 . . . . 0.0 114.02 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -70.5 154.74 41.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.955 1.877 . . . . 0.0 110.597 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.73 143.11 57.14 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.12 160.21 15.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -143.79 167.13 23.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.178 0.591 . . . . 0.0 111.017 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.18 114.53 3.49 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.55 1.58 74.22 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.972 1.272 . . . . 0.0 113.151 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.96 128.64 34.22 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.52 1.66 . . . . 0.0 108.123 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.64 133.78 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.335 0.654 . . . . 0.0 110.127 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.0 tp -87.28 -52.09 5.59 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.05 168.38 27.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.713 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 148.24 52.57 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.585 1.154 . . . . 0.0 108.337 174.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.516 -0.359 0 C-N-CA 125.358 1.463 . . . . 0.0 109.802 -169.125 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.154 0.502 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.14 146.48 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 169.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -139.32 160.53 39.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.516 1.127 . . . . 0.0 111.297 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.06 157.09 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.13 15.27 5.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 112.158 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.73 159.76 38.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.093 1.757 . . . . 0.0 107.984 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -79.29 141.14 37.3 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.98 -0.45 . . . . 0.0 109.879 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.79 -152.87 19.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.34 136.42 49.99 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.05 73.7 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.326 1.05 . . . . 0.0 111.542 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -27.18 -60.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.252 2.621 . . . . 0.0 114.01 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -146.3 161.87 39.37 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.714 1.206 . . . . 0.0 108.76 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.7 146.24 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.35 -19.96 5.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.74 0.416 . . . . 0.0 111.896 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.2 m -74.71 165.89 2.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.899 0.857 . . . . 0.0 111.942 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.56 159.67 43.49 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.72 2.008 . . . . 0.0 105.74 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.14 46.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.08 75.23 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.654 1.121 . . . . 0.0 113.378 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -71.67 163.74 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.453 1.626 . . . . 0.0 110.306 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -108.6 136.83 47.54 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.14 159.33 37.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -137.63 144.39 41.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -50.05 123.21 7.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.893 0.77 . . . . 0.0 110.359 -176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.39 -7.96 80.59 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.032 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -64.71 141.38 58.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.691 1.745 . . . . 0.0 107.814 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.86 143.21 55.85 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.44 -37.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.997 1.319 . . . . 0.0 109.512 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.28 -179.67 8.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.902 0.881 . . . . 0.0 109.536 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -135.56 142.94 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -119.14 134.05 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.633 1.973 . . . . 0.0 106.736 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.65 124.85 49.61 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -169.25 166.81 10.54 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.009 1.324 . . . . 0.0 107.879 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.7 mtm 55.41 30.95 15.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 51.84 35.11 14.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.875 1.67 . . . . 0.0 112.576 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -142.31 173.48 11.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.473 1.909 . . . . 0.0 108.566 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -119.16 143.48 47.2 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.64 127.41 17.52 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.66 150.28 68.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.953 1.768 . . . . 0.0 110.244 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -124.79 132.31 71.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -124.36 162.19 26.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.869 1.268 . . . . 0.0 110.286 -169.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 122.61 16.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.51 -22.38 61.79 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.82 0.448 . . . . 0.0 111.671 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.83 157.71 38.3 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 108.913 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -69.77 155.65 40.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.792 0.837 . . . . 0.0 111.227 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.14 176.86 37.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.755 0.693 . . . . 0.0 111.761 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.66 135.24 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -68.59 106.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.27 -40.93 62.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.3 161.5 40.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.34 132.79 70.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.22 -1.26 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.2 1.0 . . . . 0.0 112.369 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -139.8 176.17 8.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.269 1.428 . . . . 0.0 109.409 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -144.74 169.83 17.27 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.659 1.183 . . . . 0.0 108.734 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.76 133.69 47.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 0.0 109.685 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.0 -0.59 62.08 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.188 1.375 . . . . 0.0 114.325 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -71.43 153.06 42.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.977 1.888 . . . . 0.0 110.452 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -66.47 142.86 57.41 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.31 160.1 15.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.715 0.806 . . . . 0.0 109.692 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.12 167.26 22.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.4 -173.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.37 113.52 2.69 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.95 1.68 72.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.839 1.209 . . . . 0.0 113.086 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.94 126.57 31.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.443 1.621 . . . . 0.0 108.183 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.63 144.28 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 109.543 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.2 tp -109.95 -48.19 3.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.933 1.693 . . . . 0.0 109.393 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.98 170.86 19.36 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.782 0.719 . . . . 0.0 111.064 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -130.65 148.61 52.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.343 1.457 . . . . 0.0 108.104 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.29 165.57 14.67 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.338 1.455 . . . . 0.0 111.371 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -54.34 147.28 13.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.405 1.482 . . . . 0.0 111.726 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.17 152.94 39.71 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 m -58.85 -20.46 50.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -68.18 -28.68 67.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.488 1.115 . . . . 0.0 112.391 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.973 0.909 . . . . 0.0 109.395 -175.159 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.77 143.83 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -137.49 166.77 23.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.857 1.263 . . . . 0.0 110.951 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.53 150.3 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 29.08 4.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 0.0 110.51 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -145.1 162.59 36.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 107.385 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.75 133.6 42.84 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 169.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.24 -148.36 12.55 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.52 140.13 51.34 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.24 71.7 10.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -26.47 -59.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.501 2.72 . . . . 0.0 114.0 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.16 163.28 35.87 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.999 1.32 . . . . 0.0 108.385 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.64 147.42 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.62 27.18 4.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.145 0.978 . . . . 0.0 111.785 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.52 164.82 33.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.575 1.15 . . . . 0.0 110.301 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.31 158.35 44.04 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.901 1.681 . . . . 0.0 106.876 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.8 54.15 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.6 -8.96 78.76 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.88 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.14 166.81 17.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.122 1.461 . . . . 0.0 109.666 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -124.17 138.65 54.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.726 1.21 . . . . 0.0 107.774 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 pt -128.5 162.28 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.42 1.088 . . . . 0.0 108.429 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -131.29 145.35 51.84 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.462 1.505 . . . . 0.0 107.346 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.04 129.9 24.76 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.259 0.624 . . . . 0.0 110.537 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.48 -6.45 72.9 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.411 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.62 137.57 57.44 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.654 1.727 . . . . 0.0 107.816 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.79 135.88 56.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.74 -18.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.449 1.1 . . . . 0.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.95 178.91 9.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.245 0.93 . . . . 0.0 109.301 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -135.41 143.52 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.24 131.11 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.198 2.199 . . . . 0.0 106.552 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.35 125.55 50.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.57 167.2 8.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.4 1.48 . . . . 0.0 107.752 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 mtm 55.25 32.26 18.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.913 0.885 . . . . 0.0 111.745 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 51.65 33.72 11.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.864 1.666 . . . . 0.0 112.58 -172.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.6 mmm -140.87 172.05 13.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.646 1.979 . . . . 0.0 108.52 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -124.15 140.47 52.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.62 133.89 17.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.02 158.61 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.107 1.871 . . . . 0.0 111.795 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mm -125.6 126.33 70.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.99 157.47 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.014 1.326 . . . . 0.0 110.468 -169.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 121.94 15.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.594 0.757 . . . . 0.0 108.981 175.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.29 -25.85 66.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.052 0.541 . . . . 0.0 111.66 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 162.11 39.78 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.158 1.383 . . . . 0.0 108.981 169.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -65.18 158.17 26.8 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.951 0.9 . . . . 0.0 110.928 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.18 179.32 39.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.82 134.87 27.67 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.49 105.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.98 -47.89 67.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -160.11 150.13 18.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.46 0.573 . . . . 0.0 109.747 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.05 137.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -110.66 9.73 22.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.495 0.718 . . . . 0.0 111.851 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -147.45 -179.49 6.89 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.085 1.754 . . . . 0.0 108.595 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -143.03 168.11 20.48 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.891 1.276 . . . . 0.0 108.369 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.08 132.12 42.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.849 0.859 . . . . 0.0 109.17 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 -1.4 73.62 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.055 1.312 . . . . 0.0 114.161 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.21 153.13 42.69 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.865 1.833 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.9 143.15 57.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.92 158.7 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.167 0.987 . . . . 0.0 109.586 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.17 164.05 33.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.306 0.642 . . . . 0.0 110.793 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.21 112.76 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.98 0.912 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.52 -6.49 59.18 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.007 1.289 . . . . 0.0 112.714 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.04 139.18 46.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.279 1.539 . . . . 0.0 108.69 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.89 140.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.93 -53.48 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.544 1.538 . . . . 0.0 108.347 175.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.99 168.06 25.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.535 0.683 . . . . 0.0 111.119 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -125.3 144.3 50.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.832 2.053 . . . . 0.0 106.309 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt -122.13 169.58 10.73 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.618 1.167 . . . . 0.0 110.633 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.0 p -55.49 -41.22 72.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.717 0.807 . . . . 0.0 109.219 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.66 -33.62 23.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.732 1.613 . . . . 0.0 113.3 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -63.35 -15.95 58.96 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.121 0.873 . . . . 0.0 113.257 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -61.83 -23.16 66.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.42 1.009 . . . . 0.0 112.243 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 126.628 1.971 . . . . 0.0 110.747 175.458 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.77 142.36 41.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.61 158.9 43.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.836 1.254 . . . . 0.0 111.332 -169.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -76.91 153.91 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.01 17.65 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.28 1.432 . . . . 0.0 111.574 -170.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.04 156.24 34.06 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.651 1.581 . . . . 0.0 108.061 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.74 140.3 42.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.663 0.385 . . . . 0.0 110.226 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.29 -152.04 17.06 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.14 139.07 52.09 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.6 71.93 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.659 1.183 . . . . 0.0 111.331 -169.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -28.48 -59.21 0.12 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.987 2.515 . . . . 0.0 114.11 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.71 163.53 35.63 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.01 1.324 . . . . 0.0 108.624 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.16 148.26 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.63 23.86 4.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.191 0.996 . . . . 0.0 111.664 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.49 161.94 36.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.437 1.095 . . . . 0.0 110.1 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.75 159.64 43.95 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.927 1.691 . . . . 0.0 107.242 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 134.24 53.81 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -7.11 82.38 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.64 1.115 . . . . 0.0 113.269 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -69.94 165.07 22.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.439 1.619 . . . . 0.0 110.111 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -112.94 138.5 49.72 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.502 1.521 . . . . 0.0 107.018 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -128.92 163.93 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.958 0.903 . . . . 0.0 108.638 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -138.86 140.33 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -45.44 123.16 3.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.082 0.953 . . . . 0.0 110.852 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.15 74.72 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.442 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.34 139.63 58.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.663 1.732 . . . . 0.0 108.344 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.49 138.36 58.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.29 -19.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.215 1.006 . . . . 0.0 111.889 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.44 9.18 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.444 1.02 . . . . 0.0 109.302 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -134.96 145.66 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -119.87 131.41 55.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.072 2.149 . . . . 0.0 106.608 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.43 125.94 51.56 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -170.53 169.31 7.37 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.922 1.289 . . . . 0.0 107.838 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.4 ptt? 44.64 40.82 4.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 0.0 113.073 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 52.53 33.89 14.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.232 1.813 . . . . 0.0 113.098 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.3 mtt -143.82 170.92 14.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.115 1.766 . . . . 0.0 108.984 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -123.84 138.13 54.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.16 133.35 18.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.46 155.16 70.05 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.842 1.695 . . . . 0.0 111.076 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.27 127.52 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.6 157.28 17.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.38 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 116.43 5.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.71 1.204 . . . . 0.0 108.172 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.95 -25.02 66.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.037 0.535 . . . . 0.0 111.489 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -157.08 156.54 32.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.144 1.377 . . . . 0.0 108.763 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 m -74.97 156.41 36.33 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.645 0.778 . . . . 0.0 110.918 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.98 175.26 33.83 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.82 -0.55 . . . . 0.0 112.681 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.92 135.13 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 108.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -70.83 -46.62 62.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -159.47 156.03 27.56 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.9 135.97 47.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.01 1.83 24.67 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.317 0.647 . . . . 0.0 112.372 -169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -141.43 176.97 8.44 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.101 1.36 . . . . 0.0 109.444 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.8 163.22 35.7 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.886 1.275 . . . . 0.0 108.566 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.57 128.64 35.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.515 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.2 87.4 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.135 1.35 . . . . 0.0 113.942 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.4 154.32 42.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.985 1.892 . . . . 0.0 110.572 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.27 143.2 57.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.94 159.97 15.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 109.282 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.21 167.77 22.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.39 -171.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.32 111.36 1.73 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.05 1.83 66.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.951 1.262 . . . . 0.0 112.841 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -78.25 130.73 36.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.334 1.567 . . . . 0.0 108.002 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.37 143.34 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.268 0.485 . . . . 0.0 109.745 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.0 tp -100.51 -51.86 3.5 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.107 1.363 . . . . 0.0 108.902 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.89 168.49 23.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 111.719 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.75 141.72 51.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.973 2.109 . . . . 0.0 106.202 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.7 mt -120.9 156.44 32.01 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.272 1.029 . . . . 0.0 110.353 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -82.25 10.6 6.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.11 1.364 . . . . 0.0 111.803 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -145.72 150.24 35.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.956 1.702 . . . . 0.0 108.386 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.2 m 43.24 44.4 4.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 112.464 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -146.34 147.07 30.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.807 2.043 . . . . 0.0 106.492 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.606 1.563 . . . . 0.0 107.151 179.292 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t -129.77 129.87 66.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -141.35 163.12 33.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.307 1.443 . . . . 0.0 111.162 -168.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.21 152.81 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.56 26.81 4.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.501 1.12 . . . . 0.0 111.381 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.5 155.95 32.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.445 1.498 . . . . 0.0 108.001 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.32 140.29 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 122.072 -0.393 . . . . 0.0 110.019 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.42 -150.79 15.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.45 142.16 50.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -84.15 74.6 10.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.305 1.042 . . . . 0.0 110.552 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.43 -57.5 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.8 2.44 . . . . 0.0 113.865 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -147.11 161.75 40.23 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.998 1.319 . . . . 0.0 108.7 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.23 146.7 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -129.97 25.1 5.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.207 1.003 . . . . 0.0 111.525 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.59 163.68 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.416 1.087 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -147.55 156.72 43.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.22 1.808 . . . . 0.0 106.316 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 132.96 52.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.77 74.81 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.839 1.209 . . . . 0.0 113.066 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.68 163.44 27.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.331 1.566 . . . . 0.0 110.274 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -108.96 139.17 44.18 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.272 1.429 . . . . 0.0 107.148 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.18 163.18 34.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 170.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -139.63 137.34 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -44.33 123.2 3.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.2 1.0 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.48 71.82 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.639 -1.09 . . . . 0.0 113.54 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.1 138.85 58.03 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.512 1.656 . . . . 0.0 108.211 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.9 141.95 57.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.87 -18.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.814 1.245 . . . . 0.0 111.011 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.85 178.51 10.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.268 0.94 . . . . 0.0 109.061 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -133.86 145.05 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -117.61 133.15 56.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.287 2.235 . . . . 0.0 106.253 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -107.21 121.69 45.04 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 t -166.63 166.82 15.83 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.93 1.292 . . . . 0.0 108.1 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 51.66 29.81 6.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.34 1.056 . . . . 0.0 111.9 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 50.72 37.32 16.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.478 1.511 . . . . 0.0 112.306 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.7 mtm -139.36 170.37 16.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.529 1.932 . . . . 0.0 107.9 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -119.89 139.63 52.11 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.59 129.95 15.47 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.91 156.05 66.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.709 1.606 . . . . 0.0 111.14 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 125.77 72.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 156.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.821 1.249 . . . . 0.0 110.53 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 114.28 3.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.43 -24.8 67.29 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.571 0.349 . . . . 0.0 111.338 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -157.32 155.89 31.44 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.694 1.598 . . . . 0.0 108.565 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 m -77.49 158.37 29.98 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.731 0.812 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.86 177.28 35.72 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.8 mm -85.36 135.56 24.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.38 106.75 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -75.69 -39.58 57.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.05 158.14 38.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 109.37 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.46 124.88 73.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -92.41 -5.43 52.04 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 112.022 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -137.0 177.5 7.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.499 1.119 . . . . 0.0 109.617 -170.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -141.87 165.92 26.14 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.63 134.51 57.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.43 82.45 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.219 -1.323 . . . . 0.0 114.122 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -72.58 155.14 40.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.113 1.956 . . . . 0.0 110.685 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -66.37 143.88 56.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.35 160.24 17.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.066 0.946 . . . . 0.0 109.146 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.29 168.4 20.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.538 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.98 110.46 1.57 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.26 1.77 64.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.104 1.335 . . . . 0.0 112.839 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.8 128.38 33.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.287 1.544 . . . . 0.0 108.162 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 t -68.88 138.49 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -91.01 -51.89 5.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.592 1.157 . . . . 0.0 108.617 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.77 168.33 27.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.966 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.23 147.56 50.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.353 1.861 . . . . 0.0 106.621 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.99 166.53 14.33 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.69 1.196 . . . . 0.0 111.278 -169.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.2 p -60.11 -25.73 65.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.096 1.758 . . . . 0.0 113.557 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -152.81 170.72 19.62 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.614 1.566 . . . . 0.0 108.249 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 42.63 27.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 111.988 173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -76.27 26.6 0.12 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.774 1.629 . . . . 0.0 113.596 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 124.229 1.011 . . . . 0.0 109.302 176.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.9 t -83.28 140.35 16.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -140.0 166.09 25.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.755 1.622 . . . . 0.0 109.913 -169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -94.59 155.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -132.9 27.61 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.787 1.235 . . . . 0.0 111.23 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 153.16 30.84 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.044 1.338 . . . . 0.0 108.05 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.48 138.58 40.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.48 -153.31 18.69 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.09 138.87 45.56 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.69 121.17 14.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -71.89 -54.83 8.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -150.09 161.09 43.05 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.573 1.549 . . . . 0.0 108.481 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.52 143.27 39.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.97 -21.58 7.06 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 111.942 -169.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.08 165.41 2.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.773 0.797 . . . . 0.0 111.44 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -147.6 153.94 40.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.48 129.88 44.17 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.22 -12.21 63.61 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.814 1.197 . . . . 0.0 112.639 -174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -70.08 168.69 15.0 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.906 1.353 . . . . 0.0 109.875 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -125.05 138.42 54.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.725 1.21 . . . . 0.0 107.901 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -129.29 158.8 41.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -135.86 142.22 44.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -47.03 120.95 3.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.704 0.684 . . . . 0.0 110.98 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.15 -11.34 67.5 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.849 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -64.47 142.84 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.551 1.676 . . . . 0.0 108.245 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.84 143.46 54.55 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -134.44 -37.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.595 1.158 . . . . 0.0 110.06 -171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.4 -179.02 7.78 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.08 0.952 . . . . 0.0 109.3 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -137.03 139.5 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -113.79 133.36 55.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.581 1.952 . . . . 0.0 106.943 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.88 124.12 47.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -167.57 166.47 14.09 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.507 1.123 . . . . 0.0 108.565 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.77 44.98 1.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.841 1.656 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.41 31.8 12.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.965 1.706 . . . . 0.0 113.126 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -139.14 169.35 17.95 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.177 1.791 . . . . 0.0 108.694 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.8 140.13 50.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.64 126.83 16.12 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.7 151.9 44.8 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.578 2.185 . . . . 0.0 112.432 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -128.15 131.95 68.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 169.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.67 160.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.094 1.358 . . . . 0.0 109.59 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.04 116.95 5.35 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.88 1.272 . . . . 0.0 108.52 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.22 -26.72 66.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.99 0.516 . . . . 0.0 111.4 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -157.77 161.16 38.43 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.568 1.547 . . . . 0.0 108.966 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -80.39 157.6 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 111.214 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.03 179.8 36.0 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.95 0.786 . . . . 0.0 111.857 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -85.94 136.48 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.54 98.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -69.53 -39.78 77.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -155.85 166.33 33.8 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.8 t -125.21 134.12 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -103.83 0.03 29.77 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.9 176.44 9.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.875 1.27 . . . . 0.0 109.966 -170.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.38 165.3 31.51 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 108.675 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.66 136.26 50.7 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.951 0.901 . . . . 0.0 108.799 172.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.11 -8.9 65.21 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.616 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -74.88 152.36 38.89 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.972 1.886 . . . . 0.0 110.942 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -68.14 145.22 54.58 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.067 0.947 . . . . 0.0 109.195 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 m -142.86 161.04 18.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 123.856 0.863 . . . . 0.0 109.721 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -144.07 167.27 22.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.347 -174.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.59 109.62 1.45 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.39 -0.35 57.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.339 1.447 . . . . 0.0 112.849 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.68 126.57 31.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.435 1.617 . . . . 0.0 108.697 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.8 145.41 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -113.77 -44.65 3.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.249 1.42 . . . . 0.0 109.411 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 171.0 18.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.981 0.81 . . . . 0.0 111.017 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -126.94 137.84 53.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.974 1.71 . . . . 0.0 106.577 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -118.78 159.24 24.07 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 111.305 -172.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.9 p -64.38 -30.0 71.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.113 0.965 . . . . 0.0 111.196 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -53.07 139.52 28.07 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.05 1.74 . . . . 0.0 112.054 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 m -139.58 13.63 2.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.898 1.279 . . . . 0.0 111.479 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -130.54 -41.24 1.21 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.995 0.816 . . . . 0.0 111.944 -169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.659 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.8 146.71 30.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -170.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -139.05 158.66 43.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 110.646 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.74 149.74 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -112.0 8.09 20.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.262 0.625 . . . . 0.0 111.91 -170.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -158.53 159.17 35.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.093 1.357 . . . . 0.0 108.918 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.04 140.49 41.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 110.291 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.92 -151.97 16.23 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.52 142.42 50.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.36 76.9 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.133 0.973 . . . . 0.0 110.649 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -37.68 -57.79 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.952 2.101 . . . . 0.0 113.43 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -148.28 161.4 41.59 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.183 1.393 . . . . 0.0 108.635 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -136.38 146.49 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -131.26 24.05 4.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.86 0.864 . . . . 0.0 112.094 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 m -131.83 162.18 39.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.561 1.144 . . . . 0.0 109.959 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.3 162.62 38.58 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.066 1.747 . . . . 0.0 107.155 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 135.76 43.68 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.84 -8.27 73.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.727 -1.04 . . . . 0.0 113.061 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.7 164.85 24.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.25 1.525 . . . . 0.0 110.033 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -120.03 140.55 50.81 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.96 1.304 . . . . 0.0 108.174 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -130.89 158.87 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.6 145.05 46.49 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -48.76 121.65 4.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.582 0.628 . . . . 0.0 110.525 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.28 78.37 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.601 -1.11 . . . . 0.0 113.824 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -63.52 138.66 58.59 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.66 1.73 . . . . 0.0 107.881 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.48 139.74 53.94 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.63 -30.69 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.64 1.176 . . . . 0.0 110.688 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.78 -178.93 7.72 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.7 1.136 . . . . 0.0 109.528 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.33 140.06 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.87 137.21 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.71 2.004 . . . . 0.0 106.336 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -114.78 124.06 50.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -169.31 169.76 8.91 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.958 1.303 . . . . 0.0 107.849 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 18.9 ptt? 44.7 41.27 4.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.767 1.227 . . . . 0.0 112.856 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.71 31.5 12.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.351 1.86 . . . . 0.0 113.183 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.38 170.04 16.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.71 1.604 . . . . 0.0 109.356 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.22 140.56 50.99 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.12 128.06 17.32 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.54 154.06 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.889 1.726 . . . . 0.0 110.756 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.65 133.02 69.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.6 m -125.06 161.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.389 1.076 . . . . 0.0 110.217 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.93 3.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.59 -20.45 65.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 0.0 111.756 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -154.23 160.29 41.75 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.656 1.582 . . . . 0.0 108.479 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -70.36 157.23 38.13 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.389 0.676 . . . . 0.0 110.805 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.65 -174.38 42.06 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.754 -0.591 . . . . 0.0 112.352 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.52 134.48 46.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.56 114.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -76.35 -46.37 27.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.49 155.53 30.51 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.74 129.2 70.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.96 -3.33 45.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.011 0.924 . . . . 0.0 112.569 -169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -136.55 177.44 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.307 1.043 . . . . 0.0 109.532 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -143.15 159.99 41.27 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.69 1.196 . . . . 0.0 108.224 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.34 130.77 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.53 86.97 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.182 1.372 . . . . 0.0 113.637 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.58 155.7 40.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.888 1.844 . . . . 0.0 110.799 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -67.55 144.94 55.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.37 159.84 15.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.06 0.944 . . . . 0.0 109.134 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.6 168.46 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.045 0.538 . . . . 0.0 111.701 -171.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.56 114.01 2.74 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.93 4.75 81.82 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.83 1.205 . . . . 0.0 113.005 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -79.87 123.43 27.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.382 1.591 . . . . 0.0 107.884 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.52 141.52 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.144 0.578 . . . . 0.0 109.695 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -106.71 -46.16 4.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.87 1.268 . . . . 0.0 109.46 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.24 161.44 41.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.129 0.877 . . . . 0.0 111.589 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -126.31 143.36 51.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.717 2.007 . . . . 0.0 106.272 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.49 153.65 33.82 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.997 0.919 . . . . 0.0 109.54 -169.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 m -61.65 -31.63 71.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.261 0.624 . . . . 0.0 111.731 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -23.43 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.418 0.687 . . . . 0.0 111.203 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 m -84.18 -41.27 17.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.669 0.788 . . . . 0.0 110.435 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.8 p -81.41 -36.85 29.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.513 0.597 . . . . 0.0 112.224 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 126.426 1.89 . . . . 0.0 110.742 -174.574 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.16 128.1 44.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -140.1 152.49 46.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.433 1.093 . . . . 0.0 111.229 -169.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -66.82 147.23 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 26.19 5.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.529 0.732 . . . . 0.0 111.828 -171.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.43 164.34 38.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.806 2.042 . . . . 0.0 107.432 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -82.25 143.42 31.36 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 109.918 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.0 -152.27 17.97 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 117.972 0.351 . . . . 0.0 112.262 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.97 133.24 45.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 116.96 13.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -71.08 -62.32 1.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.179 0.592 . . . . 0.0 109.98 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -148.44 157.6 43.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.6 1.16 . . . . 0.0 110.262 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.17 149.19 28.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -124.47 -22.16 4.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 0.0 111.363 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.77 162.78 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.577 0.704 . . . . 0.0 111.657 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -148.71 160.93 42.71 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.276 1.831 . . . . 0.0 106.885 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 133.85 51.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.46 0.573 . . . . 0.0 109.552 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.29 -1.92 87.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.582 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -68.6 163.46 23.61 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.51 1.655 . . . . 0.0 110.036 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -108.35 138.58 44.4 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -129.22 160.06 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -138.85 140.76 38.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -47.17 120.88 3.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.029 0.831 . . . . 0.0 110.595 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.47 -8.65 66.65 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.55 -1.139 . . . . 0.0 113.855 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.99 134.1 54.41 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.69 1.745 . . . . 0.0 108.244 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.67 132.87 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.2 -22.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.932 0.893 . . . . 0.0 111.743 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 179.12 9.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.381 1.072 . . . . 0.0 109.218 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.2 mt -135.64 145.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -122.33 136.0 54.82 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.759 2.024 . . . . 0.0 106.799 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.57 124.14 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -169.33 166.34 10.49 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 107.862 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.8 mtm 55.62 31.78 17.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.909 0.884 . . . . 0.0 111.587 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 51.81 33.66 11.74 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.849 1.659 . . . . 0.0 112.567 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.2 mmt -141.24 173.34 11.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.745 2.018 . . . . 0.0 108.737 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.82 138.54 54.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.09 130.04 17.26 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.46 151.78 70.8 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.879 1.719 . . . . 0.0 110.425 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.29 124.02 70.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.44 158.51 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 110.196 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 115.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.718 1.207 . . . . 0.0 108.108 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.72 -23.57 66.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.099 0.56 . . . . 0.0 111.51 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -155.76 157.08 35.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.686 1.595 . . . . 0.0 108.483 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -71.66 157.68 37.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.22 -178.1 38.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 122.141 -0.349 . . . . 0.0 112.276 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.52 136.23 27.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.61 113.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.1 -52.4 9.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.01 131.87 8.86 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.335 0.516 . . . . 0.0 109.781 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.13 141.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -119.36 7.94 11.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.853 0.861 . . . . 0.0 112.621 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -141.71 175.12 9.95 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.679 1.192 . . . . 0.0 109.982 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -148.67 167.1 26.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.392 1.877 . . . . 0.0 108.254 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -59.69 135.25 57.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.712 0.805 . . . . 0.0 109.447 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.71 -1.48 77.96 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.052 1.31 . . . . 0.0 113.874 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.41 151.46 41.15 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.62 1.71 . . . . 0.0 110.529 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.49 144.85 53.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.44 159.78 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.632 0.773 . . . . 0.0 109.914 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.46 166.96 23.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.305 -174.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.14 112.46 2.65 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.64 59.89 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.169 1.366 . . . . 0.0 112.765 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -76.35 127.04 32.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.171 1.485 . . . . 0.0 108.961 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 t -66.18 128.33 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.641 0.776 . . . . 0.0 109.427 -170.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.01 -44.88 12.67 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.15 0.98 . . . . 0.0 108.981 169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -156.21 162.81 40.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.663 0.665 . . . . 0.0 112.371 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -115.11 147.58 40.04 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.454 2.302 . . . . 0.0 106.977 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.2 mt -125.23 153.26 43.42 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.626 1.17 . . . . 0.0 110.821 -169.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -79.01 44.58 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.499 1.52 . . . . 0.0 110.175 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.51 -35.35 74.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.277 1.031 . . . . 0.0 112.438 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 m -137.99 156.18 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.991 1.316 . . . . 0.0 108.989 -172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -56.71 134.23 54.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.41 1.084 . . . . 0.0 109.271 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.516 1.526 . . . . 0.0 108.279 -173.287 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.56 145.45 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -140.43 160.01 40.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.49 1.116 . . . . 0.0 111.709 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -76.11 152.91 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.76 15.86 5.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.313 1.445 . . . . 0.0 111.609 -169.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.28 157.38 35.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.664 1.585 . . . . 0.0 108.04 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.21 141.06 41.89 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.607 0.363 . . . . 0.0 110.214 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -152.68 18.27 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.48 138.52 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.16 71.73 9.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.839 1.255 . . . . 0.0 111.155 -169.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -30.61 -58.61 0.2 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.099 2.56 . . . . 0.0 114.069 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -146.83 160.51 42.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.038 1.335 . . . . 0.0 108.645 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -137.85 142.44 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -122.35 -22.5 5.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.768 0.427 . . . . 0.0 111.845 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.84 159.78 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.444 0.64 . . . . 0.0 111.185 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.42 160.08 44.01 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 126.328 1.851 . . . . 0.0 106.954 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.08 45.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.824 0.738 . . . . 0.0 109.429 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.16 -8.46 79.77 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.863 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -68.91 163.38 24.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.205 1.502 . . . . 0.0 109.881 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -119.9 139.52 52.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.866 1.266 . . . . 0.0 107.901 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 pt -129.81 157.34 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -133.99 144.18 48.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.54 122.37 7.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.885 0.766 . . . . 0.0 110.422 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.47 71.54 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.746 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -64.69 141.21 58.85 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.542 1.671 . . . . 0.0 108.121 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.36 144.32 55.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.195 0.598 . . . . 0.0 109.409 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 t -134.93 -38.35 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.385 . . . . 0.0 109.585 -170.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.53 -178.43 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.354 1.062 . . . . 0.0 108.994 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -134.1 145.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.88 128.13 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.593 1.957 . . . . 0.0 106.673 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.89 124.33 43.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.86 166.83 9.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.251 1.42 . . . . 0.0 107.757 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.4 mtm 54.98 32.49 18.17 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.95 0.9 . . . . 0.0 111.63 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 51.96 33.28 11.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.065 1.746 . . . . 0.0 112.629 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.9 mmt -141.05 173.52 11.4 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.665 1.986 . . . . 0.0 108.406 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.84 140.14 53.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.99 128.92 17.88 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.69 153.41 36.42 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.647 2.232 . . . . 0.0 112.732 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -126.38 130.01 71.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -124.62 159.3 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 124.712 1.205 . . . . 0.0 110.156 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 119.21 8.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.781 1.232 . . . . 0.0 109.022 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.6 -19.11 62.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.434 0.693 . . . . 0.0 111.935 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -154.16 159.73 41.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.812 1.645 . . . . 0.0 108.733 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -73.33 154.57 40.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.64 0.776 . . . . 0.0 110.496 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.7 -173.81 42.71 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.255 0.455 . . . . 0.0 112.255 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.14 136.81 40.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.74 115.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.3 -46.61 15.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -156.09 156.6 34.62 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.4 t -117.34 134.96 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.79 3.46 34.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.629 1.172 . . . . 0.0 113.064 -169.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -141.65 179.13 7.01 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.104 . . . . 0.0 109.298 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.67 161.33 40.11 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.324 1.45 . . . . 0.0 107.917 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.69 134.15 52.61 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.36 0.1 85.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.308 1.432 . . . . 0.0 113.789 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -72.24 156.06 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.647 . . . . 0.0 110.437 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.67 143.38 56.0 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.92 160.24 13.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.249 1.02 . . . . 0.0 109.396 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.9 167.03 23.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -172.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 114.7 3.11 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.797 0.839 . . . . 0.0 108.969 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.0 74.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.866 1.222 . . . . 0.0 112.809 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -75.87 129.6 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.366 1.583 . . . . 0.0 108.31 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.34 141.47 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.9 tp -108.03 -43.31 4.44 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.781 1.232 . . . . 0.0 110.329 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.08 165.51 36.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.231 0.923 . . . . 0.0 111.713 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -126.92 146.0 50.47 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.857 2.063 . . . . 0.0 106.605 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.8 mt -119.27 155.82 31.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.585 1.154 . . . . 0.0 110.3 -169.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 m -70.37 -7.88 46.35 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.23 160.39 42.53 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.517 1.053 . . . . 0.0 109.645 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -62.95 -42.67 99.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 m -148.12 144.37 27.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.77 0.714 . . . . 0.0 109.832 -169.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 . . . . . 0 C--O 1.248 1.01 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.55 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.58 144.72 35.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 m -142.65 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.475 1.51 . . . . 0.0 110.283 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.03 157.81 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.991 1.316 . . . . 0.0 107.831 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -136.1 26.02 3.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.116 1.367 . . . . 0.0 111.269 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 156.46 34.14 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.615 1.566 . . . . 0.0 107.909 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.34 139.28 36.65 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.658 -0.651 . . . . 0.0 109.62 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.74 -152.54 16.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.22 138.9 51.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 tp -83.0 71.69 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 111.111 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -27.49 -60.27 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.84 2.456 . . . . 0.0 113.731 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -145.09 162.7 36.35 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.244 1.018 . . . . 0.0 109.489 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.39 147.03 29.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -125.04 -27.43 3.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.042 0.537 . . . . 0.0 111.152 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.18 158.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.643 0.735 . . . . 0.0 110.841 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -153.35 156.56 38.56 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.226 1.81 . . . . 0.0 106.787 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 130.76 45.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.692 0.678 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.77 83.25 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.081 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -66.95 165.53 15.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.267 1.533 . . . . 0.0 109.502 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -123.38 139.66 53.8 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.146 . . . . 0.0 107.925 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -130.24 158.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.105 0.962 . . . . 0.0 108.628 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.78 146.42 49.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -48.26 121.45 4.38 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.634 0.652 . . . . 0.0 110.292 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.53 78.1 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.596 -1.113 . . . . 0.0 113.991 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -65.19 141.5 58.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.607 1.704 . . . . 0.0 108.115 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.09 145.06 56.28 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.046 0.538 . . . . 0.0 109.553 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -135.14 -38.7 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.2 1.4 . . . . 0.0 109.684 -172.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.65 -178.28 7.23 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.041 0.937 . . . . 0.0 109.521 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -135.4 143.76 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.11 132.03 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.822 2.049 . . . . 0.0 106.868 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -103.82 125.87 50.56 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -169.06 169.88 9.2 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.727 1.211 . . . . 0.0 107.872 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.6 ptt? 44.61 40.98 4.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.015 1.326 . . . . 0.0 113.032 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.28 33.32 15.27 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.313 1.845 . . . . 0.0 113.04 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -144.16 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.018 1.727 . . . . 0.0 109.158 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -120.78 139.37 53.21 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 169.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.16 132.05 19.98 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.4 153.03 74.95 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.844 1.696 . . . . 0.0 110.665 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -126.52 133.75 67.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.38 161.42 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.819 1.248 . . . . 0.0 110.404 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 117.48 6.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.375 1.47 . . . . 0.0 108.877 171.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.55 -22.07 65.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.961 0.505 . . . . 0.0 111.77 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -155.22 161.24 41.22 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.612 1.565 . . . . 0.0 108.836 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -72.72 159.17 34.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.886 0.874 . . . . 0.0 111.287 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.65 -176.33 38.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.436 0.541 . . . . 0.0 111.978 172.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.1 137.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.66 104.58 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -68.8 -51.07 44.72 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -160.22 135.39 7.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.235 0.471 . . . . 0.0 109.771 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.89 139.1 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.75 7.78 18.67 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.742 0.817 . . . . 0.0 111.643 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -142.82 177.2 8.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.263 1.825 . . . . 0.0 108.616 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -144.59 171.94 13.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.7 134.77 51.58 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.561 0.745 . . . . 0.0 109.582 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.17 2.78 54.71 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.01 1.291 . . . . 0.0 114.473 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -70.45 153.47 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.864 1.832 . . . . 0.0 110.118 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -66.02 143.56 57.28 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.04 159.32 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.798 0.839 . . . . 0.0 109.384 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.44 167.16 23.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.386 -172.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.66 110.47 1.73 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.24 1.2 62.8 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.144 1.354 . . . . 0.0 113.094 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -78.83 130.08 35.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.427 1.613 . . . . 0.0 108.434 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.37 149.12 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.806 . . . . 0.0 109.84 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.1 tp -119.65 -48.13 2.39 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.208 1.403 . . . . 0.0 109.654 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.08 166.31 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.75 0.705 . . . . 0.0 111.836 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.61 145.29 48.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.153 2.181 . . . . 0.0 106.77 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt -124.03 165.44 17.47 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.178 0.991 . . . . 0.0 112.567 -168.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -137.27 170.83 15.43 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.294 2.238 . . . . 0.0 108.235 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -152.3 165.59 34.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.427 1.891 . . . . 0.0 106.219 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 m -56.19 -16.76 5.77 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 114.19 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -68.24 -11.4 59.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.89 1.676 . . . . 0.0 113.419 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.035 1.334 . . . . 0.0 110.373 178.597 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.1 147.86 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -138.22 159.52 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.889 1.676 . . . . 0.0 110.089 -169.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.65 146.57 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -107.0 8.98 30.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 111.813 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.48 159.92 36.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.257 1.423 . . . . 0.0 108.891 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.96 142.38 38.38 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.782 0.433 . . . . 0.0 110.169 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.12 -152.81 19.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.52 139.05 45.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.45 118.16 10.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -69.85 -54.18 14.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -149.78 161.54 42.04 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.655 1.582 . . . . 0.0 108.069 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.6 t -134.3 140.6 45.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -115.42 -23.76 8.69 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.74 0.416 . . . . 0.0 111.631 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.19 165.09 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 123.76 0.824 . . . . 0.0 111.759 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -147.1 154.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.94 130.78 48.42 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.7 -10.59 68.6 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.563 1.078 . . . . 0.0 112.74 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -69.39 168.53 14.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.018 1.409 . . . . 0.0 109.815 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -125.48 140.73 52.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.863 1.265 . . . . 0.0 107.776 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -129.26 162.5 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.624 1.17 . . . . 0.0 108.495 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -133.19 141.61 48.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.711 1.604 . . . . 0.0 106.932 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -48.44 127.5 13.23 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.375 0.67 . . . . 0.0 110.937 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 -10.35 71.15 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.479 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.44 142.12 58.28 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.527 1.663 . . . . 0.0 107.167 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.68 152.88 44.53 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.644 0.735 . . . . 0.0 109.893 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -141.26 -35.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.337 1.455 . . . . 0.0 109.376 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.15 -179.15 7.44 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.942 0.897 . . . . 0.0 109.065 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.63 140.37 43.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -114.54 128.9 56.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.958 2.103 . . . . 0.0 106.82 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.32 125.88 45.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -170.45 169.6 7.37 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.82 1.248 . . . . 0.0 108.061 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.1 ptt? 44.66 40.34 4.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.136 1.374 . . . . 0.0 113.202 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.95 33.98 15.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.139 1.776 . . . . 0.0 112.853 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -143.73 170.9 14.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.264 1.825 . . . . 0.0 109.028 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -124.38 137.98 54.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.97 126.44 16.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.78 153.5 75.61 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.36 1.373 . . . . 0.0 111.014 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.99 130.12 74.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.54 159.77 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 124.622 1.169 . . . . 0.0 110.855 -169.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 116.59 5.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 108.439 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.84 -25.14 65.4 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.004 0.522 . . . . 0.0 111.696 173.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -156.17 154.01 30.16 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.673 1.589 . . . . 0.0 108.443 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -66.16 157.35 31.51 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.573 0.749 . . . . 0.0 110.394 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.69 -179.31 38.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -87.66 137.55 20.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.7 102.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -71.52 -41.19 69.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -156.63 162.56 39.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.55 134.03 67.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -102.43 -4.06 26.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.073 0.949 . . . . 0.0 112.732 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -141.36 179.55 6.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.746 1.218 . . . . 0.0 110.278 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -148.96 163.8 36.43 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.341 1.456 . . . . 0.0 108.634 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.85 137.19 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.8 0.84 . . . . 0.0 109.103 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.94 66.4 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.648 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.17 152.29 38.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.84 1.82 . . . . 0.0 111.066 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -68.17 146.0 53.82 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.026 0.931 . . . . 0.0 109.256 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.68 160.55 14.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 110.08 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -140.71 167.78 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.47 0.708 . . . . 0.0 110.992 -175.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.17 116.13 3.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.53 2.56 79.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.783 1.182 . . . . 0.0 113.119 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -78.28 123.19 26.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.468 1.634 . . . . 0.0 107.803 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 t -64.87 145.88 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.277 0.631 . . . . 0.0 109.808 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.7 tp -113.35 -45.89 3.11 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.786 1.235 . . . . 0.0 109.803 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.65 160.53 42.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.394 0.997 . . . . 0.0 112.315 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.63 141.46 51.99 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.015 2.126 . . . . 0.0 105.898 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -126.47 158.29 36.45 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.812 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.3 p -60.04 -43.38 95.39 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.467 0.651 . . . . 0.0 109.568 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -79.22 28.62 0.23 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.572 1.949 . . . . 0.0 112.427 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.0 m -78.82 49.99 0.96 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.486 -1.384 . . . . 0.0 110.213 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -61.7 155.59 22.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.318 1.447 . . . . 0.0 110.992 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.248 0.986 0 C-N-CA 125.77 1.628 . . . . 0.0 107.159 178.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t -129.5 139.39 51.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.6 m -138.89 165.05 28.06 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.801 1.24 . . . . 0.0 110.844 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.16 156.33 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 170.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.0 27.08 3.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.781 1.232 . . . . 0.0 110.892 -175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 156.82 34.35 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.733 1.613 . . . . 0.0 107.814 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.66 140.73 35.5 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.28 -151.91 16.76 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.56 137.01 45.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.55 119.91 23.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -76.84 -51.34 11.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.033 0.933 . . . . 0.0 111.049 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -150.31 158.91 44.68 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.824 1.649 . . . . 0.0 107.659 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.6 t -135.76 147.91 28.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -130.0 23.47 5.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 111.808 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.35 164.8 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.433 1.093 . . . . 0.0 110.564 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -146.79 158.2 43.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.137 1.775 . . . . 0.0 106.482 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.32 135.35 53.77 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.64 -7.96 80.79 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.833 1.206 . . . . 0.0 113.297 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.71 164.7 24.54 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.329 1.564 . . . . 0.0 110.372 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -109.58 137.58 47.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 107.255 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -128.83 162.29 36.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -137.13 144.55 43.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -49.98 124.63 10.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.81 0.732 . . . . 0.0 110.354 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.03 -8.41 77.95 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.62 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.66 134.63 54.67 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.569 1.684 . . . . 0.0 107.934 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -67.88 131.7 45.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.96 -19.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.231 1.013 . . . . 0.0 111.787 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.13 179.83 8.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 109.773 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -134.44 143.39 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.84 140.54 48.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.006 2.123 . . . . 0.0 107.105 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.46 123.14 47.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 t -167.41 169.66 12.07 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.789 1.235 . . . . 0.0 107.799 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 19.8 ptt? 44.96 39.9 4.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.807 1.243 . . . . 0.0 113.028 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 53.05 34.14 16.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.287 1.835 . . . . 0.0 112.821 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.5 mtp -144.08 167.8 21.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.088 1.755 . . . . 0.0 109.182 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.3 139.04 51.94 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.56 131.44 18.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.14 155.1 68.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.997 1.798 . . . . 0.0 111.087 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.74 124.5 66.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.75 156.31 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.952 1.301 . . . . 0.0 110.247 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.91 12.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.925 1.29 . . . . 0.0 108.868 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.36 -23.04 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.24 0.616 . . . . 0.0 111.992 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -154.58 161.6 41.54 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.183 1.793 . . . . 0.0 108.027 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -73.88 157.01 37.09 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.414 0.686 . . . . 0.0 110.504 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.47 36.24 Favored Glycine 0 CA--C 1.524 0.597 0 O-C-N 121.736 -0.602 . . . . 0.0 112.092 170.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.15 135.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.14 101.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -69.33 -41.3 76.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -156.57 163.53 39.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.567 0.621 . . . . 0.0 109.341 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -124.76 137.75 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -118.55 3.48 11.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -139.79 171.25 14.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.973 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -148.31 171.88 15.28 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.838 1.655 . . . . 0.0 108.913 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -57.98 133.44 55.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.08 0.552 . . . . 0.0 109.511 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.89 74.35 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.878 1.228 . . . . 0.0 113.562 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.22 139.63 50.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.301 1.551 . . . . 0.0 109.228 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -65.9 140.97 58.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.66 157.98 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.51 166.33 26.01 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.978 -171.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.3 108.19 1.05 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.35 0.1 58.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.266 1.413 . . . . 0.0 113.061 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -79.78 130.51 35.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.599 1.7 . . . . 0.0 108.65 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.66 150.05 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.757 0.823 . . . . 0.0 110.066 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.17 -51.61 2.21 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.935 1.694 . . . . 0.0 108.427 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.02 171.92 15.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.987 0.515 . . . . 0.0 110.799 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.92 148.73 50.95 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.478 1.111 . . . . 0.0 108.396 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -125.23 168.73 13.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.057 1.343 . . . . 0.0 112.415 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 p -54.92 143.91 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.366 1.466 . . . . 0.0 110.482 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -161.16 -51.82 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.797 0.839 . . . . 0.0 110.147 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 m -117.23 10.51 13.8 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 110.498 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -73.35 -12.08 60.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.526 2.731 . . . . 0.0 112.506 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 C--O 1.248 0.993 0 C-N-CA 126.65 1.98 . . . . 0.0 107.693 178.145 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 121.184 0.516 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.02 143.87 38.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -138.12 161.73 36.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.183 0.993 . . . . 0.0 111.982 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -80.52 153.39 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -132.14 27.84 4.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.57 157.35 35.17 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.697 1.599 . . . . 0.0 107.858 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.63 141.97 34.46 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 171.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 -152.51 20.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.63 136.52 51.75 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.19 71.89 9.24 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.906 1.282 . . . . 0.0 111.03 -169.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -24.82 -59.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.431 2.692 . . . . 0.0 114.292 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -144.9 163.84 32.91 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.639 1.176 . . . . 0.0 108.991 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.88 146.52 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -122.68 -17.99 6.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.043 0.537 . . . . 0.0 111.648 -169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.98 166.73 2.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.685 0.755 . . . . 0.0 111.961 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -149.55 162.09 40.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.373 1.869 . . . . 0.0 106.039 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.49 138.23 51.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.706 0.685 . . . . 0.0 109.513 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.26 -5.94 70.2 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.727 -1.041 . . . . 0.0 113.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.86 166.84 18.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.311 1.555 . . . . 0.0 109.448 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -122.25 141.68 51.24 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -129.88 162.65 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.493 1.117 . . . . 0.0 108.292 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.73 140.66 44.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -46.4 123.81 5.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 110.788 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.69 -10.03 75.93 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.619 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.51 139.25 58.47 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.571 1.686 . . . . 0.0 108.145 170.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 142.99 57.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.15 -21.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.031 1.332 . . . . 0.0 110.728 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 179.42 8.73 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.62 0.768 . . . . 0.0 109.038 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -135.61 146.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.47 133.64 53.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.025 2.13 . . . . 0.0 106.358 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -107.87 125.3 51.3 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -170.01 165.97 9.34 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.039 1.336 . . . . 0.0 107.851 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 mtm 56.22 29.99 15.8 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.945 0.898 . . . . 0.0 111.856 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 52.0 35.61 16.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.586 1.555 . . . . 0.0 112.308 -171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.54 172.93 12.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.602 1.961 . . . . 0.0 108.737 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -125.2 136.95 54.08 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.25 130.4 14.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.21 155.03 68.96 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.59 1.527 . . . . 0.0 110.555 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.3 mm -120.79 124.64 72.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 173.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 m -113.89 156.26 14.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.858 1.263 . . . . 0.0 110.678 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.61 118.66 8.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.507 1.123 . . . . 0.0 108.193 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.73 -25.78 67.45 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.147 0.579 . . . . 0.0 111.48 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -157.33 155.49 30.72 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.233 1.413 . . . . 0.0 108.621 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -70.93 157.34 38.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.421 0.688 . . . . 0.0 110.707 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.9 177.53 35.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 122.1 -0.375 . . . . 0.0 112.513 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.88 133.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 110.81 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.81 -44.9 60.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -156.78 159.42 38.27 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.36 138.11 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -116.67 12.38 14.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.236 1.014 . . . . 0.0 112.154 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -146.79 178.62 8.18 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.037 1.735 . . . . 0.0 108.763 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -144.84 169.61 17.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.065 1.346 . . . . 0.0 108.278 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.67 133.06 46.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.774 0.83 . . . . 0.0 109.232 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.54 -1.61 65.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.045 1.307 . . . . 0.0 114.15 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -71.31 153.31 42.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.807 1.803 . . . . 0.0 110.475 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -66.25 143.82 56.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.07 160.12 17.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.103 0.961 . . . . 0.0 109.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.18 166.62 24.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.285 -174.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 112.98 2.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.58 -1.94 64.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.15 1.357 . . . . 0.0 112.81 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -76.56 132.84 39.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.217 1.509 . . . . 0.0 109.106 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.26 130.27 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.455 0.702 . . . . 0.0 109.481 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -82.84 -50.88 8.18 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.677 1.191 . . . . 0.0 108.494 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.32 171.05 20.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.96 148.8 51.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.115 1.366 . . . . 0.0 108.337 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -118.82 154.01 33.55 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.44 1.496 . . . . 0.0 109.779 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -75.57 30.75 0.1 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.726 1.611 . . . . 0.0 112.947 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.75 146.99 47.66 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -65.56 -17.04 64.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.829 1.252 . . . . 0.0 114.13 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -137.27 163.63 30.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 110.151 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.068 172.412 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.61 141.11 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -137.65 155.59 48.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.834 1.253 . . . . 0.0 111.173 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -70.11 148.01 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -109.21 6.58 24.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.403 -0.811 . . . . 0.0 112.375 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 159.5 38.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.006 1.322 . . . . 0.0 108.945 -169.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.47 140.14 38.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.835 0.454 . . . . 0.0 109.912 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.21 -151.51 17.76 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.31 141.69 51.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.8 tp -83.06 77.25 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.437 1.095 . . . . 0.0 110.958 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -37.22 -56.33 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.232 2.213 . . . . 0.0 113.554 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -147.02 160.72 42.04 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.931 1.293 . . . . 0.0 108.832 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.74 142.58 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -120.78 -22.51 6.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.196 0.598 . . . . 0.0 111.216 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 m -74.97 161.32 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.659 0.742 . . . . 0.0 111.619 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -149.91 157.13 42.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.626 1.97 . . . . 0.0 106.284 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.86 130.91 45.52 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.795 0.725 . . . . 0.0 109.147 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.23 -9.06 77.0 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.467 1.032 . . . . 0.0 112.997 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.64 166.4 17.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.221 1.511 . . . . 0.0 109.831 170.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -122.92 142.28 50.98 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.3 pt -131.76 161.64 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 123.797 0.839 . . . . 0.0 108.871 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.94 143.76 40.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -46.1 122.94 4.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.981 0.81 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.61 -8.26 78.86 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.92 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -63.86 132.97 52.45 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.683 1.741 . . . . 0.0 107.402 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.0 137.07 43.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.2 -20.06 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.334 1.454 . . . . 0.0 110.878 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.17 -179.34 7.81 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.638 0.775 . . . . 0.0 108.989 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.63 145.61 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -121.15 130.62 53.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.152 2.181 . . . . 0.0 106.44 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.87 124.97 49.39 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -170.03 169.5 8.03 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.851 1.261 . . . . 0.0 107.852 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.0 ptt? 44.42 41.35 4.51 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.025 1.33 . . . . 0.0 112.922 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.78 31.93 11.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.378 1.871 . . . . 0.0 113.107 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.41 170.44 15.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.327 1.851 . . . . 0.0 109.093 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.46 139.19 54.15 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.58 129.44 17.52 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -169.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.45 149.29 80.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.53 1.487 . . . . 0.0 110.308 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.98 123.55 71.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -113.06 155.64 14.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.138 1.375 . . . . 0.0 110.91 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 121.04 12.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.801 1.24 . . . . 0.0 108.497 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.24 -30.17 70.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.162 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -157.16 155.86 31.68 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 109.207 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 m -71.75 155.47 40.42 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.736 0.814 . . . . 0.0 110.85 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.04 178.75 38.55 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.24 0.448 . . . . 0.0 112.008 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.62 134.96 27.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.45 107.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.21 -40.89 29.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.45 154.53 32.01 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 t -114.16 134.74 56.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.3 -3.52 31.15 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.873 0.869 . . . . 0.0 112.714 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -137.66 178.01 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.412 1.085 . . . . 0.0 109.958 -170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -142.42 163.61 32.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.779 1.232 . . . . 0.0 107.785 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -60.99 136.78 58.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.46 -4.3 78.46 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.314 -1.27 . . . . 0.0 114.06 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -72.67 155.31 40.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.005 1.903 . . . . 0.0 110.717 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.08 144.53 56.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.93 160.82 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.035 0.934 . . . . 0.0 109.238 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -145.93 166.69 25.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.052 -172.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.37 113.92 2.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 2.2 75.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.794 1.188 . . . . 0.0 112.892 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -77.81 127.29 32.18 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 1.566 . . . . 0.0 107.507 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.78 137.35 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.08 -50.93 5.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.817 1.247 . . . . 0.0 108.9 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 168.01 24.51 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.583 0.629 . . . . 0.0 112.081 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -126.78 141.97 51.68 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.225 1.81 . . . . 0.0 106.921 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.65 167.74 10.49 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.407 1.083 . . . . 0.0 110.766 -169.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 p -54.47 -39.37 67.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 110.531 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -64.92 -20.31 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.851 1.261 . . . . 0.0 113.489 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.5 m -76.3 6.52 5.42 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 p -57.33 153.98 11.39 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.17 0.895 . . . . 0.0 110.923 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 C--O 1.251 1.151 0 C-N-CA 125.881 1.673 . . . . 0.0 106.884 177.159 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.65 127.04 63.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m -140.56 159.53 41.99 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.993 1.317 . . . . 0.0 111.127 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 mm -77.55 156.55 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.76 15.62 4.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.451 1.5 . . . . 0.0 111.512 -169.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.33 157.76 36.24 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.647 1.579 . . . . 0.0 108.114 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.61 140.84 41.17 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.5 -153.91 20.0 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.93 135.65 50.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.46 70.74 8.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.846 1.258 . . . . 0.0 111.096 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -25.76 -59.82 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.431 2.692 . . . . 0.0 114.127 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -144.75 163.17 34.83 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.618 1.167 . . . . 0.0 108.923 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.43 146.38 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -124.48 -18.62 5.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.915 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.17 164.77 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.758 0.79 . . . . 0.0 111.68 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -150.1 157.81 43.51 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.597 1.959 . . . . 0.0 106.042 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.19 132.5 50.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.39 -8.99 78.91 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.525 1.059 . . . . 0.0 113.068 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.03 162.27 27.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.241 1.52 . . . . 0.0 109.896 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -113.17 141.99 46.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 pt -130.94 158.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.49 143.75 46.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -46.88 119.98 2.79 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.874 0.761 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.08 68.6 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.015 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.5 135.66 55.43 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.708 1.754 . . . . 0.0 108.175 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.69 134.55 52.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.85 -22.17 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.308 1.043 . . . . 0.0 111.495 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.55 -178.88 7.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.074 0.852 . . . . 0.0 109.808 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -135.91 145.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.92 134.79 54.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.779 2.032 . . . . 0.0 106.528 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.71 125.82 53.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.86 166.76 7.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.163 1.385 . . . . 0.0 107.788 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 56.06 30.28 16.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.919 0.888 . . . . 0.0 111.86 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 51.88 35.8 16.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.641 1.577 . . . . 0.0 112.279 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.77 173.03 11.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.625 1.97 . . . . 0.0 108.799 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.57 137.69 53.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.48 131.15 16.08 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.66 155.39 69.02 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.857 1.704 . . . . 0.0 110.61 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.0 mm -124.65 125.22 69.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.59 156.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 110.179 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.17 121.54 13.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.671 1.188 . . . . 0.0 108.425 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.71 -25.81 66.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.108 0.563 . . . . 0.0 111.535 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.38 156.95 33.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.343 1.457 . . . . 0.0 108.882 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -73.43 157.01 37.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.685 0.794 . . . . 0.0 111.061 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.42 -177.19 40.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.504 0.573 . . . . 0.0 112.261 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.6 mm -99.65 129.83 49.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.86 109.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -73.46 -45.47 54.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -157.16 157.14 33.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.82 135.81 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.41 8.07 29.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.24 1.016 . . . . 0.0 111.967 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -146.56 178.75 8.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.937 1.695 . . . . 0.0 108.783 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -144.74 169.42 18.06 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.904 1.282 . . . . 0.0 108.38 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.62 133.4 46.59 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.958 0.903 . . . . 0.0 109.325 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.11 -1.57 63.58 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.112 1.339 . . . . 0.0 114.158 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.9 152.02 44.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.844 1.822 . . . . 0.0 110.511 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -65.95 142.74 57.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.88 160.64 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.099 0.96 . . . . 0.0 109.665 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.86 167.05 23.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.59 -173.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.14 114.78 3.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.694 0.798 . . . . 0.0 108.94 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.81 68.39 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.194 1.378 . . . . 0.0 112.921 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.49 128.11 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.18 1.49 . . . . 0.0 109.293 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.5 131.58 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.506 0.722 . . . . 0.0 109.559 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.6 tp -85.32 -50.83 7.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 124.538 1.135 . . . . 0.0 108.787 170.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.29 168.95 24.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.212 0.529 . . . . 0.0 111.025 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -129.24 143.79 50.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.274 1.829 . . . . 0.0 106.937 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -116.71 155.63 28.53 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 110.337 -169.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -70.24 160.37 32.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.98 1.312 . . . . 0.0 110.525 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -149.04 160.62 43.16 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.846 1.258 . . . . 0.0 108.997 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -60.74 -24.61 65.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.804 1.241 . . . . 0.0 113.145 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 m -129.37 127.45 41.06 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.222 1.409 . . . . 0.0 108.098 -171.253 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.9 t -137.98 140.5 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -140.13 159.17 42.78 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.684 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -78.14 157.24 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 14.56 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.441 1.496 . . . . 0.0 111.722 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -156.31 157.98 36.66 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.572 1.549 . . . . 0.0 108.136 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.06 140.34 40.28 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.012 -0.43 . . . . 0.0 110.036 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.81 -153.91 18.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 137.12 51.38 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.53 71.83 8.56 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.94 1.296 . . . . 0.0 111.332 -169.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -29.57 -59.26 0.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.941 2.496 . . . . 0.0 114.01 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.87 163.08 37.25 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.114 1.366 . . . . 0.0 108.633 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.77 148.38 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -131.18 26.11 4.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.99 0.916 . . . . 0.0 112.005 -169.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.37 162.35 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.562 1.145 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.79 159.25 44.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.089 1.756 . . . . 0.0 107.641 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.37 133.44 49.7 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 -6.4 83.54 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.222 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.01 165.82 20.99 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.483 1.642 . . . . 0.0 110.163 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -113.36 141.2 47.33 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.575 1.55 . . . . 0.0 107.009 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -130.52 163.36 36.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.055 0.942 . . . . 0.0 108.734 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -137.38 139.63 40.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -47.0 124.2 6.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.056 0.942 . . . . 0.0 110.634 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.56 74.35 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.66 -1.078 . . . . 0.0 113.763 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -64.41 143.65 57.75 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.469 1.635 . . . . 0.0 107.869 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.85 144.22 57.41 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.73 -31.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 110.346 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 -178.78 7.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 119.533 1.061 . . . . 0.0 109.416 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -134.67 145.01 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.36 128.64 52.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.652 1.981 . . . . 0.0 106.588 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.96 124.21 43.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.64 167.67 9.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.194 1.397 . . . . 0.0 107.753 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.2 mtm 54.99 31.59 16.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.057 0.943 . . . . 0.0 111.76 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.27 34.57 14.98 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.932 1.693 . . . . 0.0 112.585 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.4 mtt -142.7 173.66 11.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.479 1.911 . . . . 0.0 108.508 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -120.96 140.61 51.64 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.53 132.19 19.67 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.74 153.87 74.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.932 1.755 . . . . 0.0 110.843 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 mm -126.54 134.9 65.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.87 163.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.373 1.069 . . . . 0.0 110.253 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.39 113.04 2.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.631 1.173 . . . . 0.0 107.842 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.2 -17.04 62.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.311 0.244 . . . . 0.0 111.371 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.32 155.49 30.76 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.057 1.743 . . . . 0.0 108.959 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 m -69.23 158.21 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.903 0.881 . . . . 0.0 110.923 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.37 177.36 33.4 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 122.265 -0.272 . . . . 0.0 112.538 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -85.68 135.08 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -68.62 115.41 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -84.28 -48.3 9.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -157.66 129.55 7.01 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -81.93 137.2 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -110.02 5.3 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.048 0.939 . . . . 0.0 112.124 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -143.84 179.06 7.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.315 1.446 . . . . 0.0 108.612 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -145.38 163.9 33.15 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.548 1.139 . . . . 0.0 108.915 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.23 130.12 43.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.968 0.907 . . . . 0.0 109.716 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.17 -1.61 84.4 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.258 1.409 . . . . 0.0 113.804 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -70.64 153.74 42.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.767 1.783 . . . . 0.0 110.53 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.13 143.86 56.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.61 160.77 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.02 0.928 . . . . 0.0 109.488 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.48 167.72 21.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.976 -172.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 115.55 3.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 108.957 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.68 -0.7 74.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.052 1.311 . . . . 0.0 112.88 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -77.48 126.7 31.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.358 1.579 . . . . 0.0 109.093 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.71 129.74 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.16 -44.97 9.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.339 1.056 . . . . 0.0 109.331 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.78 165.12 37.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.751 0.786 . . . . 0.0 111.884 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -118.32 143.82 46.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.81 2.044 . . . . 0.0 106.586 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.64 162.26 18.31 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.72 1.208 . . . . 0.0 108.514 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -57.99 -35.07 70.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.048 -0.408 . . . . 0.0 110.135 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.75 -28.19 67.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.536 1.135 . . . . 0.0 113.113 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.6 m -71.66 -20.27 61.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.714 0.688 . . . . 0.0 111.73 177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -80.37 134.28 36.01 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 125.642 1.577 . . . . 0.0 107.012 -178.678 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.67 138.91 52.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -138.44 155.28 48.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.927 1.291 . . . . 0.0 111.045 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -70.02 147.67 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -108.6 4.69 24.27 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 ptp -154.11 163.68 39.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.279 0.945 . . . . 0.0 109.575 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.9 141.45 49.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.784 0.434 . . . . 0.0 110.175 173.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.19 -152.93 20.32 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.91 140.15 51.8 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.9 tp -80.78 75.78 7.7 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.455 1.102 . . . . 0.0 111.592 -169.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -35.2 -58.15 0.56 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.348 2.259 . . . . 0.0 113.789 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -147.61 160.63 42.44 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.794 1.237 . . . . 0.0 108.743 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.2 143.58 32.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -124.32 -21.34 4.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.832 0.453 . . . . 0.0 111.992 -169.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.2 162.01 4.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.468 0.651 . . . . 0.0 111.557 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -149.59 158.91 44.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.266 1.826 . . . . 0.0 106.763 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.88 47.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.09 -6.94 83.2 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.112 -178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -68.42 164.93 19.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.316 1.558 . . . . 0.0 109.842 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -119.41 144.57 46.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.522 1.129 . . . . 0.0 108.005 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.25 159.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -133.69 143.99 48.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -48.54 121.31 4.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.874 0.761 . . . . 0.0 110.438 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.56 67.49 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -64.61 134.72 54.92 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.695 1.747 . . . . 0.0 108.074 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -67.7 133.03 48.59 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.32 -21.67 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.271 1.028 . . . . 0.0 111.424 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.74 8.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.151 0.981 . . . . 0.0 109.514 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.41 147.24 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -124.02 131.52 53.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.885 2.074 . . . . 0.0 106.515 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.23 124.71 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -169.07 166.4 10.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.824 1.249 . . . . 0.0 108.047 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.9 mtm 55.18 31.52 16.6 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.932 0.893 . . . . 0.0 111.854 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 52.22 35.21 16.23 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.79 1.636 . . . . 0.0 112.496 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.44 173.76 11.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.667 1.987 . . . . 0.0 108.665 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -118.61 142.53 47.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.49 128.44 19.14 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 -169.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.1 147.94 68.23 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.831 1.687 . . . . 0.0 109.996 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -121.08 121.88 66.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 m -114.95 157.2 15.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.631 1.173 . . . . 0.0 110.177 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 119.73 9.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.687 1.195 . . . . 0.0 108.25 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.18 -26.13 68.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.42 0.688 . . . . 0.0 111.572 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -157.38 155.51 30.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.581 1.552 . . . . 0.0 108.476 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 m -69.38 157.58 36.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.342 0.657 . . . . 0.0 110.605 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.39 -176.17 40.33 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 122.106 -0.371 . . . . 0.0 112.473 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -99.84 133.64 42.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.63 111.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -77.0 -45.2 28.14 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.39 151.66 26.58 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.55 134.19 48.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -106.27 3.76 28.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.672 0.789 . . . . 0.0 112.461 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -138.7 178.4 7.18 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.064 1.346 . . . . 0.0 109.284 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.04 159.89 41.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.648 1.179 . . . . 0.0 108.136 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.27 132.05 51.4 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.99 -3.62 86.9 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.093 1.33 . . . . 0.0 113.763 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -70.35 154.46 41.87 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.865 1.833 . . . . 0.0 110.68 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -66.47 143.39 57.12 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.42 160.54 14.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.038 0.935 . . . . 0.0 109.219 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.04 167.36 22.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.282 -171.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.31 113.39 2.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.98 5.7 85.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.487 1.041 . . . . 0.0 113.063 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.01 130.23 37.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.439 1.619 . . . . 0.0 107.233 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.17 141.42 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.84 -50.24 3.9 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.166 1.386 . . . . 0.0 108.661 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 165.83 33.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 111.928 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -128.69 139.15 52.38 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.44 1.896 . . . . 0.0 106.403 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt -116.57 154.54 30.27 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 110.274 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -72.02 140.24 48.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.548 0.739 . . . . 0.0 109.412 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -155.6 138.17 15.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 169.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.03 -24.75 67.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.478 1.111 . . . . 0.0 113.671 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -20.69 63.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.788 0.722 . . . . 0.0 111.921 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.763 -178.459 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.649 0.262 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.94 141.92 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -137.75 155.3 49.21 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.718 1.207 . . . . 0.0 111.458 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.26 147.86 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -108.51 5.38 25.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 ptp -153.88 163.03 40.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 109.827 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.53 140.86 50.07 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.653 0.381 . . . . 0.0 110.227 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.95 -153.65 21.91 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.23 137.62 44.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.64 121.18 14.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.84 -51.69 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -149.11 159.93 43.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.586 1.555 . . . . 0.0 108.493 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.09 142.89 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -120.76 -22.08 6.42 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.036 0.534 . . . . 0.0 111.506 -170.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.76 165.96 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.977 0.894 . . . . 0.0 111.153 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.73 154.09 36.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.43 50.65 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.67 -9.94 62.45 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.451 1.501 . . . . 0.0 112.989 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.4 172.22 12.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.913 1.357 . . . . 0.0 110.667 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -115.87 138.19 51.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.727 1.611 . . . . 0.0 107.094 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 pt -128.48 160.67 38.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.0 143.9 38.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -48.57 120.85 4.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.774 0.715 . . . . 0.0 110.467 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.81 -8.25 70.71 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.826 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.4 135.22 55.91 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.589 1.694 . . . . 0.0 108.051 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.41 133.69 49.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.12 -22.29 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.293 1.037 . . . . 0.0 111.617 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.06 178.06 10.12 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.592 0.757 . . . . 0.0 109.694 169.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.4 mt -136.78 142.03 39.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -120.46 131.19 54.64 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.278 1.831 . . . . 0.0 106.882 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.87 124.36 43.73 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -168.84 166.78 11.32 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.969 1.308 . . . . 0.0 108.065 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.2 mtm 55.26 31.32 16.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.015 0.926 . . . . 0.0 111.795 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.64 34.6 16.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.71 1.604 . . . . 0.0 112.515 -172.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.08 173.53 11.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.517 1.927 . . . . 0.0 108.659 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -118.72 141.67 48.39 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.66 128.31 18.92 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.45 149.63 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.947 1.764 . . . . 0.0 110.203 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mm -122.46 120.94 62.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.18 156.18 15.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.792 1.237 . . . . 0.0 110.183 -172.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 116.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.038 1.335 . . . . 0.0 108.63 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.43 -23.32 65.52 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.082 0.553 . . . . 0.0 111.768 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -154.54 162.04 41.34 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.522 1.529 . . . . 0.0 108.796 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -75.17 157.32 34.77 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.82 0.848 . . . . 0.0 110.96 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.62 174.75 33.83 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.354 0.502 . . . . 0.0 112.0 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.3 mm -85.57 134.3 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.74 101.77 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -71.48 -40.66 70.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -156.02 164.13 38.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.568 0.622 . . . . 0.0 109.335 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 t -125.87 135.09 64.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -105.5 -0.84 25.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 111.863 -169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -141.29 177.04 8.37 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.817 1.247 . . . . 0.0 110.693 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.16 169.01 21.68 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.311 1.444 . . . . 0.0 108.501 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.62 139.68 49.24 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.728 0.811 . . . . 0.0 109.271 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.45 -7.78 56.24 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.376 -1.236 . . . . 0.0 113.737 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -75.83 152.85 37.17 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.817 1.809 . . . . 0.0 110.952 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.91 145.38 54.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.034 0.934 . . . . 0.0 109.325 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.19 161.59 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.877 0.871 . . . . 0.0 109.952 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.36 168.48 19.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.091 -175.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.23 114.65 3.0 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.37 82.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.472 1.034 . . . . 0.0 112.976 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -78.87 125.82 29.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.454 1.627 . . . . 0.0 107.847 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.61 132.13 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.483 0.713 . . . . 0.0 109.961 -169.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.89 -50.53 7.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.931 1.292 . . . . 0.0 107.686 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -154.35 169.58 23.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.455 0.645 . . . . 0.0 111.893 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.24 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.517 1.927 . . . . 0.0 106.8 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.35 151.08 42.86 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.199 1.0 . . . . 0.0 110.556 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -66.82 163.78 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.661 0.784 . . . . 0.0 109.546 169.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -58.79 150.95 22.42 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.149 -0.345 . . . . 0.0 110.133 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.6 m -58.99 -20.01 48.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 113.969 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -132.64 145.84 51.41 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.569 1.548 . . . . 0.0 108.131 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.129 1.372 . . . . 0.0 107.302 -177.07 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.85 138.82 51.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 169.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -136.62 154.59 50.61 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 110.635 -169.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -69.6 141.84 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -102.77 5.66 38.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.695 -0.628 . . . . 0.0 112.529 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -156.27 164.28 38.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.3 1.04 . . . . 0.0 109.532 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.69 142.86 42.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.729 0.411 . . . . 0.0 110.312 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.54 -151.72 16.99 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.73 132.39 45.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 113.66 10.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -70.66 -59.18 2.97 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.015 0.926 . . . . 0.0 110.564 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -149.42 158.33 44.08 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.968 1.307 . . . . 0.0 109.182 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.28 145.73 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.171 1.389 . . . . 0.0 107.434 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.89 24.83 4.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.412 1.085 . . . . 0.0 111.055 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 m -132.83 165.52 32.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.083 1.353 . . . . 0.0 110.129 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -146.7 156.19 42.99 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.985 1.714 . . . . 0.0 106.519 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.32 133.52 55.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.46 -10.12 74.75 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.513 1.054 . . . . 0.0 112.864 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.08 170.35 11.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.045 1.422 . . . . 0.0 109.658 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -126.46 143.26 51.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 107.986 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.51 164.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.616 1.166 . . . . 0.0 108.784 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -136.05 141.64 44.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.708 1.203 . . . . 0.0 107.817 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -45.62 116.55 1.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 110.691 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -10.68 62.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.714 -1.048 . . . . 0.0 113.66 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -66.63 140.41 57.93 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.497 1.648 . . . . 0.0 108.499 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.94 138.99 56.39 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.5 -19.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.981 0.912 . . . . 0.0 112.151 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.53 178.4 9.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.705 1.202 . . . . 0.0 108.688 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -134.76 148.86 29.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -123.56 133.67 53.94 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.738 2.015 . . . . 0.0 106.745 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 123.8 46.42 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -168.83 167.3 11.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.764 1.225 . . . . 0.0 107.951 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 mtm 55.48 30.61 15.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.854 0.862 . . . . 0.0 111.861 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 53.13 35.3 19.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.857 1.663 . . . . 0.0 111.995 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -144.0 173.62 11.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.484 1.914 . . . . 0.0 108.644 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -119.23 140.53 50.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.3 131.79 19.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.56 152.46 74.79 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.892 1.728 . . . . 0.0 110.754 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.9 mm -123.46 118.65 55.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.85 157.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.466 1.106 . . . . 0.0 110.293 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 108.23 1.13 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.264 1.426 . . . . 0.0 107.441 170.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.02 -15.13 62.97 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 155.72 34.46 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.673 1.589 . . . . 0.0 108.509 171.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.94 159.66 33.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.18 0.992 . . . . 0.0 110.975 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.57 179.19 37.01 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 121.829 -0.544 . . . . 0.0 112.377 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -85.45 134.05 28.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.51 100.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -70.34 -40.24 74.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -156.87 162.88 39.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -114.83 7.98 15.91 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.741 0.816 . . . . 0.0 112.557 -168.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -140.73 175.59 9.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.761 1.224 . . . . 0.0 109.588 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -143.3 160.34 40.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.326 1.85 . . . . 0.0 107.182 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.36 127.64 33.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.23 -7.51 64.25 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.504 1.526 . . . . 0.0 113.407 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -74.77 153.66 38.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.5 1.65 . . . . 0.0 111.414 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.62 145.32 54.03 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.551 0.74 . . . . 0.0 109.117 170.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.55 159.83 14.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.752 0.821 . . . . 0.0 110.108 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.92 166.11 25.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -176.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.8 117.84 5.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.12 -0.8 82.15 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.682 1.134 . . . . 0.0 113.044 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.25 131.69 41.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.274 1.537 . . . . 0.0 108.176 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 t -70.95 135.09 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 -50.94 5.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 125.462 1.505 . . . . 0.0 108.894 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.18 168.75 20.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 112.062 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.24 140.09 52.09 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.663 1.985 . . . . 0.0 106.378 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt -123.23 169.48 11.24 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.886 0.875 . . . . 0.0 112.446 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p -58.92 -15.59 13.54 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.741 2.016 . . . . 0.0 114.183 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -143.83 161.47 38.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.606 1.562 . . . . 0.0 109.651 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.17 -61.16 1.91 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.066 0.946 . . . . 0.0 109.791 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -153.21 151.65 30.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.18 1.392 . . . . 0.0 108.928 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.666 1.986 . . . . 0.0 106.414 170.102 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 118.56 -0.733 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.93 126.1 59.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 m -139.68 160.12 40.59 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.694 1.198 . . . . 0.0 111.03 -168.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.63 156.81 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.59 15.63 4.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.445 1.098 . . . . 0.0 112.129 -169.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 158.29 36.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.099 1.76 . . . . 0.0 107.91 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.71 141.08 38.18 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.884 -0.51 . . . . 0.0 109.762 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -153.43 19.43 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.68 133.71 45.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.85 113.55 13.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -66.52 -56.09 12.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.045 0.938 . . . . 0.0 110.203 -170.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.52 161.4 42.21 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.419 1.488 . . . . 0.0 107.943 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.21 146.69 28.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.44 -19.77 5.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.029 0.532 . . . . 0.0 112.03 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.76 166.17 2.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.794 0.807 . . . . 0.0 111.791 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.78 160.26 42.92 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.627 1.971 . . . . 0.0 105.93 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.12 137.83 45.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.18 -7.39 75.67 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.472 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -70.74 162.85 28.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.448 1.624 . . . . 0.0 110.339 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -108.71 137.56 46.44 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 pt -128.2 161.27 36.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -138.73 141.68 38.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -47.51 120.64 3.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.959 0.8 . . . . 0.0 110.69 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -10.25 64.63 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.894 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.52 135.85 56.44 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.552 1.676 . . . . 0.0 108.237 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.21 134.13 49.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.53 -22.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.126 0.97 . . . . 0.0 111.534 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.57 -178.82 7.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.79 0.836 . . . . 0.0 109.615 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -137.28 146.37 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -121.53 136.21 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.677 1.991 . . . . 0.0 107.197 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -104.34 124.08 48.54 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.26 167.82 10.05 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 125.004 1.322 . . . . 0.0 107.923 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 54.9 32.72 18.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.906 0.883 . . . . 0.0 111.656 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.23 32.73 11.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.985 1.714 . . . . 0.0 112.681 -173.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.8 mmm -142.16 173.26 11.68 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.579 1.952 . . . . 0.0 108.746 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -119.46 141.99 48.66 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.84 130.29 18.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.87 152.51 73.7 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.87 1.713 . . . . 0.0 110.566 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -123.68 121.83 63.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 m -113.39 157.72 13.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.726 1.21 . . . . 0.0 109.977 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 119.82 9.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.713 1.205 . . . . 0.0 108.237 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.77 -26.07 65.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.945 0.498 . . . . 0.0 111.336 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -157.12 155.87 31.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.536 1.534 . . . . 0.0 108.855 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.46 156.81 36.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.05 0.94 . . . . 0.0 111.085 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.8 177.23 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.363 0.506 . . . . 0.0 112.392 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -85.8 133.35 29.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 169.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.15 111.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -73.88 -46.66 43.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -156.57 158.92 37.97 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.55 131.53 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.83 -6.02 27.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.979 0.912 . . . . 0.0 112.555 -169.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -138.86 173.6 11.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.184 1.394 . . . . 0.0 109.045 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -147.79 170.53 17.39 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 109.129 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.28 128.91 39.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.66 1.02 87.7 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.148 1.356 . . . . 0.0 113.507 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.74 153.09 42.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.32 1.56 . . . . 0.0 110.097 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -76.02 143.39 41.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.72 159.62 14.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.592 0.711 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.77 167.01 23.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.308 -172.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 113.08 2.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.31 72.22 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.898 1.237 . . . . 0.0 113.106 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.83 126.33 30.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.435 1.618 . . . . 0.0 108.206 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.86 144.59 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.31 -49.5 2.96 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.514 1.526 . . . . 0.0 108.479 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.84 169.2 19.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.338 0.589 . . . . 0.0 111.642 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.48 144.89 51.45 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.311 1.845 . . . . 0.0 106.844 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.6 152.17 39.58 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.854 1.262 . . . . 0.0 110.66 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 m -76.2 -14.52 60.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.121 0.568 . . . . 0.0 110.888 169.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.93 76.89 4.45 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.8 m -69.87 72.56 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.895 1.678 . . . . 0.0 111.338 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 p -59.93 -25.89 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.021 1.328 . . . . 0.0 113.224 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 126.218 1.807 . . . . 0.0 107.0 -172.174 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -130.57 137.63 55.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -140.76 155.82 46.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.238 . . . . 0.0 110.667 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.8 mm -73.88 152.13 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.621 1.168 . . . . 0.0 107.993 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.89 11.61 14.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.386 0.675 . . . . 0.0 111.948 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -143.67 161.21 39.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.558 1.543 . . . . 0.0 108.343 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -90.01 131.51 35.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.63 11.55 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.4 142.35 50.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.0 tp -85.74 72.21 10.58 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.978 0.911 . . . . 0.0 110.833 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -27.68 -59.1 0.11 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.083 2.553 . . . . 0.0 114.081 -174.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.6 162.42 38.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.119 1.368 . . . . 0.0 108.527 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.87 147.67 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -131.34 25.46 4.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.192 0.997 . . . . 0.0 111.559 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.76 165.04 32.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.388 1.075 . . . . 0.0 110.484 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -148.97 158.08 43.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.983 1.713 . . . . 0.0 106.795 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.43 53.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.55 77.48 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.528 1.061 . . . . 0.0 112.787 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.05 167.68 17.1 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.142 1.471 . . . . 0.0 109.815 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -125.02 138.1 54.22 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -126.56 162.84 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.368 1.067 . . . . 0.0 108.198 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.9 143.11 48.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -47.87 126.96 11.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.58 0.752 . . . . 0.0 110.5 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.56 78.45 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.507 -1.163 . . . . 0.0 113.617 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.85 138.65 58.03 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.688 1.744 . . . . 0.0 107.884 169.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.89 137.94 57.52 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.06 -19.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.868 1.267 . . . . 0.0 111.429 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.88 -179.49 8.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.435 1.016 . . . . 0.0 109.336 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -136.19 139.02 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -106.11 136.11 46.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.803 2.041 . . . . 0.0 106.614 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.31 120.93 44.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -162.02 166.4 26.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 53.33 24.61 3.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt 47.38 42.68 14.46 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 126.12 1.768 . . . . 0.0 111.839 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.6 mmt -137.12 164.64 27.96 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.402 2.281 . . . . 0.0 106.988 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -112.14 140.73 46.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.73 122.79 14.61 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.24 151.59 35.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.988 2.458 . . . . 0.0 112.723 174.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mm -126.4 123.23 62.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.32 155.41 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.234 1.413 . . . . 0.0 110.105 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.28 124.09 21.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.145 0.978 . . . . 0.0 108.674 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -29.05 69.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.806 0.442 . . . . 0.0 111.573 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.1 ptm85 -157.21 156.61 32.87 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.611 1.164 . . . . 0.0 108.895 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -70.31 155.14 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.34 0.656 . . . . 0.0 110.492 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.17 177.2 36.71 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 122.119 -0.363 . . . . 0.0 112.39 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -85.42 133.39 29.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.6 109.59 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -78.06 -43.43 29.24 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -152.18 156.86 40.61 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.488 0.585 . . . . 0.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.4 129.47 74.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.4 -0.55 35.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.694 0.798 . . . . 0.0 111.983 -169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -139.73 176.26 8.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.821 1.249 . . . . 0.0 109.581 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.44 164.57 31.13 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.93 1.292 . . . . 0.0 108.579 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.4 128.13 32.84 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.955 0.902 . . . . 0.0 109.561 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.71 86.79 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.187 1.375 . . . . 0.0 114.02 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -70.5 154.74 41.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.955 1.877 . . . . 0.0 110.597 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.73 143.11 57.14 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.12 160.21 15.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -143.79 167.13 23.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.178 0.591 . . . . 0.0 111.017 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.18 114.53 3.49 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.55 1.58 74.22 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.972 1.272 . . . . 0.0 113.151 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.96 128.64 34.22 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.52 1.66 . . . . 0.0 108.123 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.64 133.78 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.335 0.654 . . . . 0.0 110.127 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.0 tp -87.28 -52.09 5.59 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.05 168.38 27.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.713 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 148.24 52.57 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.585 1.154 . . . . 0.0 108.337 174.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.16 147.42 43.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.358 1.463 . . . . 0.0 109.802 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 m -61.16 -22.45 64.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.5 0.72 . . . . 0.0 112.066 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.96 -34.53 65.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.477 1.111 . . . . 0.0 112.54 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 m -125.28 -19.46 5.09 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.9 m -71.37 -36.21 71.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.379 0.536 . . . . 0.0 110.087 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 . . . . . 0 C--O 1.249 1.049 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.644 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.239 0.55 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -139.32 160.53 39.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.516 1.127 . . . . 0.0 111.297 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.06 157.09 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.13 15.27 5.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 112.158 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.73 159.76 38.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.093 1.757 . . . . 0.0 107.984 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -79.29 141.14 37.3 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.98 -0.45 . . . . 0.0 109.879 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.79 -152.87 19.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.34 136.42 49.99 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.05 73.7 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.326 1.05 . . . . 0.0 111.542 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -27.18 -60.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.252 2.621 . . . . 0.0 114.01 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -146.3 161.87 39.37 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.714 1.206 . . . . 0.0 108.76 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.7 146.24 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.35 -19.96 5.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.74 0.416 . . . . 0.0 111.896 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.2 m -74.71 165.89 2.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.899 0.857 . . . . 0.0 111.942 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.56 159.67 43.49 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.72 2.008 . . . . 0.0 105.74 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.14 46.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.08 75.23 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.654 1.121 . . . . 0.0 113.378 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -71.67 163.74 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.453 1.626 . . . . 0.0 110.306 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -108.6 136.83 47.54 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.14 159.33 37.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -137.63 144.39 41.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -50.05 123.21 7.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.893 0.77 . . . . 0.0 110.359 -176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.39 -7.96 80.59 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.032 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -64.71 141.38 58.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.691 1.745 . . . . 0.0 107.814 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.86 143.21 55.85 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.44 -37.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.997 1.319 . . . . 0.0 109.512 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.28 -179.67 8.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.902 0.881 . . . . 0.0 109.536 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -135.56 142.94 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.8 tm? -119.14 134.05 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.633 1.973 . . . . 0.0 106.736 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.65 124.85 49.61 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -169.25 166.81 10.54 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.009 1.324 . . . . 0.0 107.879 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.7 mtm 55.41 30.95 15.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 51.84 35.11 14.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.875 1.67 . . . . 0.0 112.576 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -142.31 173.48 11.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.473 1.909 . . . . 0.0 108.566 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -119.16 143.48 47.2 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.64 127.41 17.52 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.66 150.28 68.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.953 1.768 . . . . 0.0 110.244 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -124.79 132.31 71.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -124.36 162.19 26.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.869 1.268 . . . . 0.0 110.286 -169.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 122.61 16.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.51 -22.38 61.79 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.82 0.448 . . . . 0.0 111.671 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.83 157.71 38.3 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 108.913 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -69.77 155.65 40.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.792 0.837 . . . . 0.0 111.227 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.14 176.86 37.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.755 0.693 . . . . 0.0 111.761 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.66 135.24 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -68.59 106.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.27 -40.93 62.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.3 161.5 40.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.34 132.79 70.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.22 -1.26 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.2 1.0 . . . . 0.0 112.369 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -139.8 176.17 8.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.269 1.428 . . . . 0.0 109.409 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -144.74 169.83 17.27 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.659 1.183 . . . . 0.0 108.734 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.76 133.69 47.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 0.0 109.685 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.0 -0.59 62.08 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.188 1.375 . . . . 0.0 114.325 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -71.43 153.06 42.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.977 1.888 . . . . 0.0 110.452 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -66.47 142.86 57.41 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.31 160.1 15.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.715 0.806 . . . . 0.0 109.692 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.12 167.26 22.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.4 -173.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.37 113.52 2.69 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.95 1.68 72.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.839 1.209 . . . . 0.0 113.086 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.94 126.57 31.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.443 1.621 . . . . 0.0 108.183 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.63 144.28 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 109.543 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.2 tp -109.95 -48.19 3.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.933 1.693 . . . . 0.0 109.393 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.98 170.86 19.36 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.782 0.719 . . . . 0.0 111.064 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -130.65 148.61 52.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.343 1.457 . . . . 0.0 108.104 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.234 0.244 0 C-N-CA 125.338 1.455 . . . . 0.0 111.371 -169.707 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.235 0.332 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -137.49 166.77 23.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.857 1.263 . . . . 0.0 110.951 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 7' ' ' MET . 5.0 mp -87.53 150.3 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 169.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 29.08 4.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 0.0 110.51 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.444 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.9 mpp? -145.1 162.59 36.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 107.385 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.75 133.6 42.84 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 169.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.24 -148.36 12.55 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.52 140.13 51.34 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.24 71.7 10.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -26.47 -59.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.501 2.72 . . . . 0.0 114.0 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.16 163.28 35.87 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.999 1.32 . . . . 0.0 108.385 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.64 147.42 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.62 27.18 4.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.145 0.978 . . . . 0.0 111.785 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.52 164.82 33.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.575 1.15 . . . . 0.0 110.301 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.31 158.35 44.04 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.901 1.681 . . . . 0.0 106.876 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.8 54.15 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.6 -8.96 78.76 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.88 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.14 166.81 17.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.122 1.461 . . . . 0.0 109.666 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -124.17 138.65 54.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.726 1.21 . . . . 0.0 107.774 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 pt -128.5 162.28 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.42 1.088 . . . . 0.0 108.429 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -131.29 145.35 51.84 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.462 1.505 . . . . 0.0 107.346 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.04 129.9 24.76 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.259 0.624 . . . . 0.0 110.537 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.48 -6.45 72.9 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.411 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.62 137.57 57.44 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.654 1.727 . . . . 0.0 107.816 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.79 135.88 56.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.74 -18.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.449 1.1 . . . . 0.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.95 178.91 9.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.245 0.93 . . . . 0.0 109.301 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -135.41 143.52 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.24 131.11 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.198 2.199 . . . . 0.0 106.552 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.35 125.55 50.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.57 167.2 8.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.4 1.48 . . . . 0.0 107.752 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 mtm 55.25 32.26 18.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.913 0.885 . . . . 0.0 111.745 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 51.65 33.72 11.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.864 1.666 . . . . 0.0 112.58 -172.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.6 mmm -140.87 172.05 13.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.646 1.979 . . . . 0.0 108.52 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -124.15 140.47 52.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.62 133.89 17.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.02 158.61 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.107 1.871 . . . . 0.0 111.795 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mm -125.6 126.33 70.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.99 157.47 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.014 1.326 . . . . 0.0 110.468 -169.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 121.94 15.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.594 0.757 . . . . 0.0 108.981 175.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.29 -25.85 66.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.052 0.541 . . . . 0.0 111.66 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 162.11 39.78 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.158 1.383 . . . . 0.0 108.981 169.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -65.18 158.17 26.8 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.951 0.9 . . . . 0.0 110.928 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.18 179.32 39.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.82 134.87 27.67 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.49 105.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.98 -47.89 67.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -160.11 150.13 18.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.46 0.573 . . . . 0.0 109.747 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.05 137.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -110.66 9.73 22.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.495 0.718 . . . . 0.0 111.851 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -147.45 -179.49 6.89 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.085 1.754 . . . . 0.0 108.595 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -143.03 168.11 20.48 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.891 1.276 . . . . 0.0 108.369 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.08 132.12 42.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.849 0.859 . . . . 0.0 109.17 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 -1.4 73.62 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.055 1.312 . . . . 0.0 114.161 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.21 153.13 42.69 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.865 1.833 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.9 143.15 57.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.92 158.7 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.167 0.987 . . . . 0.0 109.586 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.17 164.05 33.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.306 0.642 . . . . 0.0 110.793 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.21 112.76 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.98 0.912 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.52 -6.49 59.18 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.007 1.289 . . . . 0.0 112.714 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.04 139.18 46.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.279 1.539 . . . . 0.0 108.69 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.89 140.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.93 -53.48 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.544 1.538 . . . . 0.0 108.347 175.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.99 168.06 25.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.535 0.683 . . . . 0.0 111.119 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -125.3 144.3 50.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.832 2.053 . . . . 0.0 106.309 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.519 -0.246 0 C-N-CA 124.618 1.167 . . . . 0.0 110.633 -169.291 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.238 0.461 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.61 158.9 43.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.836 1.254 . . . . 0.0 111.332 -169.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 5' ' ' ILE . 4.9 mp -76.91 153.91 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.01 17.65 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.28 1.432 . . . . 0.0 111.574 -170.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.04 156.24 34.06 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.651 1.581 . . . . 0.0 108.061 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.74 140.3 42.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.663 0.385 . . . . 0.0 110.226 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.29 -152.04 17.06 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.14 139.07 52.09 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.6 71.93 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.659 1.183 . . . . 0.0 111.331 -169.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -28.48 -59.21 0.12 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.987 2.515 . . . . 0.0 114.11 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.71 163.53 35.63 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.01 1.324 . . . . 0.0 108.624 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.16 148.26 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.63 23.86 4.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.191 0.996 . . . . 0.0 111.664 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.49 161.94 36.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.437 1.095 . . . . 0.0 110.1 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.75 159.64 43.95 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.927 1.691 . . . . 0.0 107.242 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 134.24 53.81 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -7.11 82.38 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.64 1.115 . . . . 0.0 113.269 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -69.94 165.07 22.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.439 1.619 . . . . 0.0 110.111 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -112.94 138.5 49.72 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.502 1.521 . . . . 0.0 107.018 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -128.92 163.93 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.958 0.903 . . . . 0.0 108.638 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -138.86 140.33 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -45.44 123.16 3.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.082 0.953 . . . . 0.0 110.852 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.15 74.72 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.442 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.34 139.63 58.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.663 1.732 . . . . 0.0 108.344 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.49 138.36 58.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.29 -19.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.215 1.006 . . . . 0.0 111.889 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.44 9.18 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.444 1.02 . . . . 0.0 109.302 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -134.96 145.66 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -119.87 131.41 55.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.072 2.149 . . . . 0.0 106.608 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.43 125.94 51.56 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -170.53 169.31 7.37 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.922 1.289 . . . . 0.0 107.838 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.4 ptt? 44.64 40.82 4.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 0.0 113.073 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 52.53 33.89 14.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.232 1.813 . . . . 0.0 113.098 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.3 mtt -143.82 170.92 14.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.115 1.766 . . . . 0.0 108.984 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -123.84 138.13 54.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.16 133.35 18.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.46 155.16 70.05 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.842 1.695 . . . . 0.0 111.076 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.27 127.52 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.6 157.28 17.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.38 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 116.43 5.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.71 1.204 . . . . 0.0 108.172 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.95 -25.02 66.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.037 0.535 . . . . 0.0 111.489 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -157.08 156.54 32.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.144 1.377 . . . . 0.0 108.763 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 m -74.97 156.41 36.33 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.645 0.778 . . . . 0.0 110.918 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.98 175.26 33.83 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.82 -0.55 . . . . 0.0 112.681 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.92 135.13 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 108.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -70.83 -46.62 62.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -159.47 156.03 27.56 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.9 135.97 47.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.01 1.83 24.67 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.317 0.647 . . . . 0.0 112.372 -169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -141.43 176.97 8.44 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.101 1.36 . . . . 0.0 109.444 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.8 163.22 35.7 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.886 1.275 . . . . 0.0 108.566 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.57 128.64 35.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.515 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.2 87.4 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.135 1.35 . . . . 0.0 113.942 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.4 154.32 42.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.985 1.892 . . . . 0.0 110.572 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.27 143.2 57.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.94 159.97 15.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 109.282 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.21 167.77 22.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.39 -171.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.32 111.36 1.73 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.05 1.83 66.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.951 1.262 . . . . 0.0 112.841 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -78.25 130.73 36.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.334 1.567 . . . . 0.0 108.002 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.37 143.34 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.268 0.485 . . . . 0.0 109.745 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.0 tp -100.51 -51.86 3.5 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.107 1.363 . . . . 0.0 108.902 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.89 168.49 23.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 111.719 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.75 141.72 51.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.973 2.109 . . . . 0.0 106.202 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 N--CA 1.462 0.136 0 C-N-CA 124.272 1.029 . . . . 0.0 110.353 -169.582 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.238 0.483 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -141.35 163.12 33.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.307 1.443 . . . . 0.0 111.162 -168.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.21 152.81 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.56 26.81 4.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.501 1.12 . . . . 0.0 111.381 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.5 155.95 32.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.445 1.498 . . . . 0.0 108.001 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.32 140.29 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 122.072 -0.393 . . . . 0.0 110.019 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.42 -150.79 15.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.45 142.16 50.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -84.15 74.6 10.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.305 1.042 . . . . 0.0 110.552 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.43 -57.5 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.8 2.44 . . . . 0.0 113.865 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -147.11 161.75 40.23 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.998 1.319 . . . . 0.0 108.7 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.23 146.7 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -129.97 25.1 5.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.207 1.003 . . . . 0.0 111.525 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.59 163.68 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.416 1.087 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -147.55 156.72 43.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.22 1.808 . . . . 0.0 106.316 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 132.96 52.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.77 74.81 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.839 1.209 . . . . 0.0 113.066 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.68 163.44 27.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.331 1.566 . . . . 0.0 110.274 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -108.96 139.17 44.18 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.272 1.429 . . . . 0.0 107.148 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.18 163.18 34.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 170.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -139.63 137.34 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -44.33 123.2 3.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.2 1.0 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.48 71.82 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.639 -1.09 . . . . 0.0 113.54 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.1 138.85 58.03 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.512 1.656 . . . . 0.0 108.211 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.9 141.95 57.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.87 -18.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.814 1.245 . . . . 0.0 111.011 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.85 178.51 10.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.268 0.94 . . . . 0.0 109.061 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -133.86 145.05 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -117.61 133.15 56.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.287 2.235 . . . . 0.0 106.253 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -107.21 121.69 45.04 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 t -166.63 166.82 15.83 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.93 1.292 . . . . 0.0 108.1 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 51.66 29.81 6.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.34 1.056 . . . . 0.0 111.9 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 50.72 37.32 16.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.478 1.511 . . . . 0.0 112.306 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.7 mtm -139.36 170.37 16.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.529 1.932 . . . . 0.0 107.9 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -119.89 139.63 52.11 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.59 129.95 15.47 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.91 156.05 66.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.709 1.606 . . . . 0.0 111.14 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 125.77 72.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 156.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.821 1.249 . . . . 0.0 110.53 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 114.28 3.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.43 -24.8 67.29 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.571 0.349 . . . . 0.0 111.338 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -157.32 155.89 31.44 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.694 1.598 . . . . 0.0 108.565 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 m -77.49 158.37 29.98 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.731 0.812 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.86 177.28 35.72 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.8 mm -85.36 135.56 24.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.38 106.75 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -75.69 -39.58 57.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.05 158.14 38.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 109.37 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.46 124.88 73.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -92.41 -5.43 52.04 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 112.022 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -137.0 177.5 7.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.499 1.119 . . . . 0.0 109.617 -170.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -141.87 165.92 26.14 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.63 134.51 57.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.43 82.45 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.219 -1.323 . . . . 0.0 114.122 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -72.58 155.14 40.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.113 1.956 . . . . 0.0 110.685 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -66.37 143.88 56.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.35 160.24 17.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.066 0.946 . . . . 0.0 109.146 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.29 168.4 20.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.538 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.98 110.46 1.57 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.26 1.77 64.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.104 1.335 . . . . 0.0 112.839 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.8 128.38 33.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.287 1.544 . . . . 0.0 108.162 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 t -68.88 138.49 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -91.01 -51.89 5.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.592 1.157 . . . . 0.0 108.617 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.77 168.33 27.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.966 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.23 147.56 50.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.353 1.861 . . . . 0.0 106.621 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--O 1.231 0.093 0 C-N-CA 124.69 1.196 . . . . 0.0 111.278 -169.276 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.239 0.5 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -140.0 166.09 25.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.755 1.622 . . . . 0.0 109.913 -169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -94.59 155.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -132.9 27.61 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.787 1.235 . . . . 0.0 111.23 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 153.16 30.84 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.044 1.338 . . . . 0.0 108.05 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.48 138.58 40.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.48 -153.31 18.69 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.09 138.87 45.56 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.69 121.17 14.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -71.89 -54.83 8.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -150.09 161.09 43.05 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.573 1.549 . . . . 0.0 108.481 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.52 143.27 39.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.97 -21.58 7.06 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 111.942 -169.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.08 165.41 2.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.773 0.797 . . . . 0.0 111.44 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -147.6 153.94 40.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.48 129.88 44.17 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.22 -12.21 63.61 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.814 1.197 . . . . 0.0 112.639 -174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -70.08 168.69 15.0 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.906 1.353 . . . . 0.0 109.875 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -125.05 138.42 54.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.725 1.21 . . . . 0.0 107.901 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -129.29 158.8 41.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -135.86 142.22 44.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -47.03 120.95 3.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.704 0.684 . . . . 0.0 110.98 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.15 -11.34 67.5 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.849 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -64.47 142.84 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.551 1.676 . . . . 0.0 108.245 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.84 143.46 54.55 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -134.44 -37.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.595 1.158 . . . . 0.0 110.06 -171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.4 -179.02 7.78 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.08 0.952 . . . . 0.0 109.3 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -137.03 139.5 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -113.79 133.36 55.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.581 1.952 . . . . 0.0 106.943 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.88 124.12 47.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -167.57 166.47 14.09 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.507 1.123 . . . . 0.0 108.565 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.77 44.98 1.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.841 1.656 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.41 31.8 12.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.965 1.706 . . . . 0.0 113.126 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -139.14 169.35 17.95 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.177 1.791 . . . . 0.0 108.694 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.8 140.13 50.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.64 126.83 16.12 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.7 151.9 44.8 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.578 2.185 . . . . 0.0 112.432 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -128.15 131.95 68.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 169.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.67 160.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.094 1.358 . . . . 0.0 109.59 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.04 116.95 5.35 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.88 1.272 . . . . 0.0 108.52 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.22 -26.72 66.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.99 0.516 . . . . 0.0 111.4 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -157.77 161.16 38.43 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.568 1.547 . . . . 0.0 108.966 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -80.39 157.6 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 111.214 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.03 179.8 36.0 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.95 0.786 . . . . 0.0 111.857 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -85.94 136.48 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.54 98.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -69.53 -39.78 77.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -155.85 166.33 33.8 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.8 t -125.21 134.12 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -103.83 0.03 29.77 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.9 176.44 9.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.875 1.27 . . . . 0.0 109.966 -170.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.38 165.3 31.51 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 108.675 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.66 136.26 50.7 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.951 0.901 . . . . 0.0 108.799 172.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.11 -8.9 65.21 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.616 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -74.88 152.36 38.89 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.972 1.886 . . . . 0.0 110.942 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -68.14 145.22 54.58 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.067 0.947 . . . . 0.0 109.195 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 m -142.86 161.04 18.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 123.856 0.863 . . . . 0.0 109.721 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -144.07 167.27 22.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.347 -174.476 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.59 109.62 1.45 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.39 -0.35 57.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.339 1.447 . . . . 0.0 112.849 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.68 126.57 31.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.435 1.617 . . . . 0.0 108.697 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.8 145.41 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -113.77 -44.65 3.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.249 1.42 . . . . 0.0 109.411 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 171.0 18.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.981 0.81 . . . . 0.0 111.017 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -126.94 137.84 53.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.974 1.71 . . . . 0.0 106.577 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 111.305 -172.254 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.239 0.534 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -139.05 158.66 43.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 110.646 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.74 149.74 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -112.0 8.09 20.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.262 0.625 . . . . 0.0 111.91 -170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -158.53 159.17 35.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.093 1.357 . . . . 0.0 108.918 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.04 140.49 41.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 110.291 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.92 -151.97 16.23 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.52 142.42 50.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.36 76.9 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.133 0.973 . . . . 0.0 110.649 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -37.68 -57.79 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.952 2.101 . . . . 0.0 113.43 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -148.28 161.4 41.59 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.183 1.393 . . . . 0.0 108.635 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -136.38 146.49 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -131.26 24.05 4.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.86 0.864 . . . . 0.0 112.094 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 m -131.83 162.18 39.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.561 1.144 . . . . 0.0 109.959 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.3 162.62 38.58 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.066 1.747 . . . . 0.0 107.155 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 135.76 43.68 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.84 -8.27 73.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.727 -1.04 . . . . 0.0 113.061 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.7 164.85 24.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.25 1.525 . . . . 0.0 110.033 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -120.03 140.55 50.81 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.96 1.304 . . . . 0.0 108.174 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -130.89 158.87 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.6 145.05 46.49 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -48.76 121.65 4.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.582 0.628 . . . . 0.0 110.525 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.28 78.37 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.601 -1.11 . . . . 0.0 113.824 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -63.52 138.66 58.59 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.66 1.73 . . . . 0.0 107.881 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.48 139.74 53.94 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.63 -30.69 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.64 1.176 . . . . 0.0 110.688 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.78 -178.93 7.72 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.7 1.136 . . . . 0.0 109.528 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.33 140.06 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.87 137.21 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.71 2.004 . . . . 0.0 106.336 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -114.78 124.06 50.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -169.31 169.76 8.91 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.958 1.303 . . . . 0.0 107.849 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 18.9 ptt? 44.7 41.27 4.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.767 1.227 . . . . 0.0 112.856 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.71 31.5 12.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.351 1.86 . . . . 0.0 113.183 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.38 170.04 16.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.71 1.604 . . . . 0.0 109.356 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.22 140.56 50.99 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.12 128.06 17.32 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.54 154.06 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.889 1.726 . . . . 0.0 110.756 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.65 133.02 69.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.6 m -125.06 161.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.389 1.076 . . . . 0.0 110.217 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.93 3.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.59 -20.45 65.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 0.0 111.756 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -154.23 160.29 41.75 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.656 1.582 . . . . 0.0 108.479 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -70.36 157.23 38.13 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.389 0.676 . . . . 0.0 110.805 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.65 -174.38 42.06 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.754 -0.591 . . . . 0.0 112.352 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.52 134.48 46.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.56 114.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -76.35 -46.37 27.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.49 155.53 30.51 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.74 129.2 70.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.96 -3.33 45.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.011 0.924 . . . . 0.0 112.569 -169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -136.55 177.44 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.307 1.043 . . . . 0.0 109.532 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -143.15 159.99 41.27 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.69 1.196 . . . . 0.0 108.224 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.34 130.77 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.53 86.97 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.182 1.372 . . . . 0.0 113.637 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.58 155.7 40.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.888 1.844 . . . . 0.0 110.799 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -67.55 144.94 55.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.37 159.84 15.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.06 0.944 . . . . 0.0 109.134 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.6 168.46 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.045 0.538 . . . . 0.0 111.701 -171.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.56 114.01 2.74 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.93 4.75 81.82 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.83 1.205 . . . . 0.0 113.005 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -79.87 123.43 27.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.382 1.591 . . . . 0.0 107.884 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.52 141.52 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.144 0.578 . . . . 0.0 109.695 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -106.71 -46.16 4.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.87 1.268 . . . . 0.0 109.46 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.24 161.44 41.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.129 0.877 . . . . 0.0 111.589 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -126.31 143.36 51.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.717 2.007 . . . . 0.0 106.272 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 CA--C 1.521 -0.158 0 C-N-CA 123.997 0.919 . . . . 0.0 109.54 -169.393 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--O 1.238 0.45 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 19.8 m -140.1 152.49 46.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.433 1.093 . . . . 0.0 111.229 -169.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.3 mp -66.82 147.23 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 26.19 5.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.529 0.732 . . . . 0.0 111.828 -171.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.43 164.34 38.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.806 2.042 . . . . 0.0 107.432 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -82.25 143.42 31.36 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 109.918 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.0 -152.27 17.97 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 117.972 0.351 . . . . 0.0 112.262 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.97 133.24 45.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 116.96 13.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -71.08 -62.32 1.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.179 0.592 . . . . 0.0 109.98 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -148.44 157.6 43.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.6 1.16 . . . . 0.0 110.262 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.17 149.19 28.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -124.47 -22.16 4.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 0.0 111.363 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.77 162.78 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.577 0.704 . . . . 0.0 111.657 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -148.71 160.93 42.71 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.276 1.831 . . . . 0.0 106.885 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 133.85 51.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.46 0.573 . . . . 0.0 109.552 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.29 -1.92 87.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.582 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -68.6 163.46 23.61 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.51 1.655 . . . . 0.0 110.036 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -108.35 138.58 44.4 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -129.22 160.06 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -138.85 140.76 38.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -47.17 120.88 3.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.029 0.831 . . . . 0.0 110.595 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.47 -8.65 66.65 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.55 -1.139 . . . . 0.0 113.855 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.99 134.1 54.41 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.69 1.745 . . . . 0.0 108.244 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.67 132.87 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.2 -22.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.932 0.893 . . . . 0.0 111.743 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 179.12 9.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.381 1.072 . . . . 0.0 109.218 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.2 mt -135.64 145.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.451 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -122.33 136.0 54.82 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.759 2.024 . . . . 0.0 106.799 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.57 124.14 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -169.33 166.34 10.49 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 107.862 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.8 mtm 55.62 31.78 17.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.909 0.884 . . . . 0.0 111.587 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 51.81 33.66 11.74 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.849 1.659 . . . . 0.0 112.567 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.2 mmt -141.24 173.34 11.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.745 2.018 . . . . 0.0 108.737 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.82 138.54 54.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.09 130.04 17.26 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.46 151.78 70.8 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.879 1.719 . . . . 0.0 110.425 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.29 124.02 70.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.44 158.51 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 110.196 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 115.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.718 1.207 . . . . 0.0 108.108 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.72 -23.57 66.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.099 0.56 . . . . 0.0 111.51 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -155.76 157.08 35.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.686 1.595 . . . . 0.0 108.483 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -71.66 157.68 37.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.22 -178.1 38.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 122.141 -0.349 . . . . 0.0 112.276 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.52 136.23 27.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.61 113.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.1 -52.4 9.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.01 131.87 8.86 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.335 0.516 . . . . 0.0 109.781 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.13 141.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -119.36 7.94 11.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.853 0.861 . . . . 0.0 112.621 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -141.71 175.12 9.95 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.679 1.192 . . . . 0.0 109.982 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -148.67 167.1 26.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.392 1.877 . . . . 0.0 108.254 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -59.69 135.25 57.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.712 0.805 . . . . 0.0 109.447 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.71 -1.48 77.96 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.052 1.31 . . . . 0.0 113.874 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.41 151.46 41.15 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.62 1.71 . . . . 0.0 110.529 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.49 144.85 53.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.44 159.78 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.632 0.773 . . . . 0.0 109.914 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.46 166.96 23.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.305 -174.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.14 112.46 2.65 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.64 59.89 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.169 1.366 . . . . 0.0 112.765 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -76.35 127.04 32.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.171 1.485 . . . . 0.0 108.961 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 t -66.18 128.33 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.641 0.776 . . . . 0.0 109.427 -170.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' H ' ' HA ' ' A' ' 4' ' ' SER . 65.1 tp -85.01 -44.88 12.67 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.15 0.98 . . . . 0.0 108.981 169.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -156.21 162.81 40.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.663 0.665 . . . . 0.0 112.371 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -115.11 147.58 40.04 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.454 2.302 . . . . 0.0 106.977 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--O 1.232 0.175 0 C-N-CA 124.626 1.17 . . . . 0.0 110.821 -169.576 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -140.43 160.01 40.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.49 1.116 . . . . 0.0 111.709 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 5' ' ' ILE . 4.5 mp -76.11 152.91 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.76 15.86 5.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.313 1.445 . . . . 0.0 111.609 -169.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.28 157.38 35.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.664 1.585 . . . . 0.0 108.04 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.21 141.06 41.89 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.607 0.363 . . . . 0.0 110.214 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -152.68 18.27 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.48 138.52 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.16 71.73 9.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.839 1.255 . . . . 0.0 111.155 -169.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -30.61 -58.61 0.2 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.099 2.56 . . . . 0.0 114.069 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -146.83 160.51 42.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.038 1.335 . . . . 0.0 108.645 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -137.85 142.44 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -122.35 -22.5 5.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.768 0.427 . . . . 0.0 111.845 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.84 159.78 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.444 0.64 . . . . 0.0 111.185 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.42 160.08 44.01 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 126.328 1.851 . . . . 0.0 106.954 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.08 45.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.824 0.738 . . . . 0.0 109.429 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.16 -8.46 79.77 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.863 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -68.91 163.38 24.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.205 1.502 . . . . 0.0 109.881 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -119.9 139.52 52.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.866 1.266 . . . . 0.0 107.901 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 pt -129.81 157.34 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -133.99 144.18 48.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.54 122.37 7.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.885 0.766 . . . . 0.0 110.422 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.47 71.54 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.746 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -64.69 141.21 58.85 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.542 1.671 . . . . 0.0 108.121 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.36 144.32 55.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.195 0.598 . . . . 0.0 109.409 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 t -134.93 -38.35 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.385 . . . . 0.0 109.585 -170.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.53 -178.43 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.354 1.062 . . . . 0.0 108.994 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -134.1 145.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.88 128.13 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.593 1.957 . . . . 0.0 106.673 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.89 124.33 43.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.86 166.83 9.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.251 1.42 . . . . 0.0 107.757 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.4 mtm 54.98 32.49 18.17 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.95 0.9 . . . . 0.0 111.63 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 51.96 33.28 11.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.065 1.746 . . . . 0.0 112.629 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.9 mmt -141.05 173.52 11.4 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.665 1.986 . . . . 0.0 108.406 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.84 140.14 53.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.99 128.92 17.88 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.69 153.41 36.42 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.647 2.232 . . . . 0.0 112.732 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -126.38 130.01 71.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -124.62 159.3 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 124.712 1.205 . . . . 0.0 110.156 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 119.21 8.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.781 1.232 . . . . 0.0 109.022 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.6 -19.11 62.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.434 0.693 . . . . 0.0 111.935 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -154.16 159.73 41.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.812 1.645 . . . . 0.0 108.733 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -73.33 154.57 40.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.64 0.776 . . . . 0.0 110.496 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.7 -173.81 42.71 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.255 0.455 . . . . 0.0 112.255 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.14 136.81 40.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.74 115.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.3 -46.61 15.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -156.09 156.6 34.62 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.4 t -117.34 134.96 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.79 3.46 34.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.629 1.172 . . . . 0.0 113.064 -169.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -141.65 179.13 7.01 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.104 . . . . 0.0 109.298 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.67 161.33 40.11 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.324 1.45 . . . . 0.0 107.917 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.69 134.15 52.61 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.36 0.1 85.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.308 1.432 . . . . 0.0 113.789 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -72.24 156.06 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.647 . . . . 0.0 110.437 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.67 143.38 56.0 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.92 160.24 13.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.249 1.02 . . . . 0.0 109.396 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.9 167.03 23.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -172.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 114.7 3.11 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.797 0.839 . . . . 0.0 108.969 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.0 74.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.866 1.222 . . . . 0.0 112.809 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -75.87 129.6 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.366 1.583 . . . . 0.0 108.31 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.34 141.47 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.9 tp -108.03 -43.31 4.44 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.781 1.232 . . . . 0.0 110.329 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.08 165.51 36.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.231 0.923 . . . . 0.0 111.713 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -126.92 146.0 50.47 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.857 2.063 . . . . 0.0 106.605 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.232 0.147 0 C-N-CA 124.585 1.154 . . . . 0.0 110.3 -169.453 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 C--O 1.239 0.531 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 m -142.65 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.475 1.51 . . . . 0.0 110.283 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.03 157.81 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.991 1.316 . . . . 0.0 107.831 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -136.1 26.02 3.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.116 1.367 . . . . 0.0 111.269 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 156.46 34.14 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.615 1.566 . . . . 0.0 107.909 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.34 139.28 36.65 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.658 -0.651 . . . . 0.0 109.62 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.74 -152.54 16.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.22 138.9 51.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 tp -83.0 71.69 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 111.111 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -27.49 -60.27 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.84 2.456 . . . . 0.0 113.731 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -145.09 162.7 36.35 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.244 1.018 . . . . 0.0 109.489 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.39 147.03 29.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -125.04 -27.43 3.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.042 0.537 . . . . 0.0 111.152 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.18 158.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.643 0.735 . . . . 0.0 110.841 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -153.35 156.56 38.56 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.226 1.81 . . . . 0.0 106.787 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 130.76 45.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.692 0.678 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.77 83.25 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.081 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -66.95 165.53 15.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.267 1.533 . . . . 0.0 109.502 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -123.38 139.66 53.8 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.146 . . . . 0.0 107.925 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -130.24 158.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.105 0.962 . . . . 0.0 108.628 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.78 146.42 49.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -48.26 121.45 4.38 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.634 0.652 . . . . 0.0 110.292 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.53 78.1 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.596 -1.113 . . . . 0.0 113.991 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -65.19 141.5 58.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.607 1.704 . . . . 0.0 108.115 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.09 145.06 56.28 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.046 0.538 . . . . 0.0 109.553 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -135.14 -38.7 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.2 1.4 . . . . 0.0 109.684 -172.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.65 -178.28 7.23 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.041 0.937 . . . . 0.0 109.521 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -135.4 143.76 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.11 132.03 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.822 2.049 . . . . 0.0 106.868 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -103.82 125.87 50.56 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -169.06 169.88 9.2 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.727 1.211 . . . . 0.0 107.872 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.6 ptt? 44.61 40.98 4.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.015 1.326 . . . . 0.0 113.032 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.28 33.32 15.27 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.313 1.845 . . . . 0.0 113.04 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -144.16 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.018 1.727 . . . . 0.0 109.158 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -120.78 139.37 53.21 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 169.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.16 132.05 19.98 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.4 153.03 74.95 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.844 1.696 . . . . 0.0 110.665 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -126.52 133.75 67.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.38 161.42 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.819 1.248 . . . . 0.0 110.404 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 117.48 6.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.375 1.47 . . . . 0.0 108.877 171.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.55 -22.07 65.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.961 0.505 . . . . 0.0 111.77 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -155.22 161.24 41.22 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.612 1.565 . . . . 0.0 108.836 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -72.72 159.17 34.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.886 0.874 . . . . 0.0 111.287 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.65 -176.33 38.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.436 0.541 . . . . 0.0 111.978 172.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.1 137.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.66 104.58 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -68.8 -51.07 44.72 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -160.22 135.39 7.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.235 0.471 . . . . 0.0 109.771 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.89 139.1 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.75 7.78 18.67 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.742 0.817 . . . . 0.0 111.643 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -142.82 177.2 8.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.263 1.825 . . . . 0.0 108.616 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -144.59 171.94 13.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.7 134.77 51.58 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.561 0.745 . . . . 0.0 109.582 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.17 2.78 54.71 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.01 1.291 . . . . 0.0 114.473 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -70.45 153.47 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.864 1.832 . . . . 0.0 110.118 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -66.02 143.56 57.28 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.04 159.32 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.798 0.839 . . . . 0.0 109.384 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.44 167.16 23.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.386 -172.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.66 110.47 1.73 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.24 1.2 62.8 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.144 1.354 . . . . 0.0 113.094 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -78.83 130.08 35.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.427 1.613 . . . . 0.0 108.434 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.37 149.12 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.806 . . . . 0.0 109.84 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.1 tp -119.65 -48.13 2.39 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.208 1.403 . . . . 0.0 109.654 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.08 166.31 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.75 0.705 . . . . 0.0 111.836 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.61 145.29 48.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.153 2.181 . . . . 0.0 106.77 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.232 0.184 0 C-N-CA 124.178 0.991 . . . . 0.0 112.567 -168.913 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.241 0.618 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -138.22 159.52 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.889 1.676 . . . . 0.0 110.089 -169.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.65 146.57 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -107.0 8.98 30.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 111.813 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.48 159.92 36.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.257 1.423 . . . . 0.0 108.891 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.96 142.38 38.38 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.782 0.433 . . . . 0.0 110.169 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.12 -152.81 19.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.52 139.05 45.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.45 118.16 10.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -69.85 -54.18 14.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -149.78 161.54 42.04 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.655 1.582 . . . . 0.0 108.069 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.6 t -134.3 140.6 45.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -115.42 -23.76 8.69 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.74 0.416 . . . . 0.0 111.631 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.19 165.09 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 123.76 0.824 . . . . 0.0 111.759 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -147.1 154.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.94 130.78 48.42 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.7 -10.59 68.6 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.563 1.078 . . . . 0.0 112.74 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -69.39 168.53 14.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.018 1.409 . . . . 0.0 109.815 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -125.48 140.73 52.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.863 1.265 . . . . 0.0 107.776 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -129.26 162.5 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.624 1.17 . . . . 0.0 108.495 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -133.19 141.61 48.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.711 1.604 . . . . 0.0 106.932 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -48.44 127.5 13.23 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.375 0.67 . . . . 0.0 110.937 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 -10.35 71.15 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.479 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.44 142.12 58.28 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.527 1.663 . . . . 0.0 107.167 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.68 152.88 44.53 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.644 0.735 . . . . 0.0 109.893 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -141.26 -35.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.337 1.455 . . . . 0.0 109.376 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.15 -179.15 7.44 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.942 0.897 . . . . 0.0 109.065 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.63 140.37 43.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -114.54 128.9 56.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.958 2.103 . . . . 0.0 106.82 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.32 125.88 45.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -170.45 169.6 7.37 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.82 1.248 . . . . 0.0 108.061 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.1 ptt? 44.66 40.34 4.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.136 1.374 . . . . 0.0 113.202 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.95 33.98 15.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.139 1.776 . . . . 0.0 112.853 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -143.73 170.9 14.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.264 1.825 . . . . 0.0 109.028 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -124.38 137.98 54.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.97 126.44 16.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.78 153.5 75.61 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.36 1.373 . . . . 0.0 111.014 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.99 130.12 74.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.54 159.77 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 124.622 1.169 . . . . 0.0 110.855 -169.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 116.59 5.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 108.439 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.84 -25.14 65.4 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.004 0.522 . . . . 0.0 111.696 173.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -156.17 154.01 30.16 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.673 1.589 . . . . 0.0 108.443 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -66.16 157.35 31.51 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.573 0.749 . . . . 0.0 110.394 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.69 -179.31 38.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -87.66 137.55 20.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.7 102.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -71.52 -41.19 69.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -156.63 162.56 39.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.55 134.03 67.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -102.43 -4.06 26.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.073 0.949 . . . . 0.0 112.732 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -141.36 179.55 6.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.746 1.218 . . . . 0.0 110.278 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -148.96 163.8 36.43 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.341 1.456 . . . . 0.0 108.634 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.85 137.19 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.8 0.84 . . . . 0.0 109.103 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.94 66.4 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.648 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.17 152.29 38.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.84 1.82 . . . . 0.0 111.066 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -68.17 146.0 53.82 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.026 0.931 . . . . 0.0 109.256 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.68 160.55 14.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 110.08 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -140.71 167.78 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.47 0.708 . . . . 0.0 110.992 -175.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.17 116.13 3.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.53 2.56 79.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.783 1.182 . . . . 0.0 113.119 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -78.28 123.19 26.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.468 1.634 . . . . 0.0 107.803 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 t -64.87 145.88 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.277 0.631 . . . . 0.0 109.808 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.7 tp -113.35 -45.89 3.11 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.786 1.235 . . . . 0.0 109.803 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.65 160.53 42.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.394 0.997 . . . . 0.0 112.315 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.63 141.46 51.99 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.015 2.126 . . . . 0.0 105.898 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.812 -169.576 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.238 0.472 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.6 m -138.89 165.05 28.06 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.801 1.24 . . . . 0.0 110.844 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.16 156.33 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 170.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.0 27.08 3.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.781 1.232 . . . . 0.0 110.892 -175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 156.82 34.35 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.733 1.613 . . . . 0.0 107.814 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.66 140.73 35.5 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.28 -151.91 16.76 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.56 137.01 45.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.55 119.91 23.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -76.84 -51.34 11.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.033 0.933 . . . . 0.0 111.049 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -150.31 158.91 44.68 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.824 1.649 . . . . 0.0 107.659 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.6 t -135.76 147.91 28.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -130.0 23.47 5.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 111.808 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.35 164.8 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.433 1.093 . . . . 0.0 110.564 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -146.79 158.2 43.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.137 1.775 . . . . 0.0 106.482 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.32 135.35 53.77 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.64 -7.96 80.79 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.833 1.206 . . . . 0.0 113.297 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.71 164.7 24.54 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.329 1.564 . . . . 0.0 110.372 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -109.58 137.58 47.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 107.255 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -128.83 162.29 36.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -137.13 144.55 43.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -49.98 124.63 10.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.81 0.732 . . . . 0.0 110.354 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.03 -8.41 77.95 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.62 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.66 134.63 54.67 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.569 1.684 . . . . 0.0 107.934 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -67.88 131.7 45.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.96 -19.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.231 1.013 . . . . 0.0 111.787 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.13 179.83 8.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 109.773 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -134.44 143.39 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -114.84 140.54 48.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.006 2.123 . . . . 0.0 107.105 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.46 123.14 47.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 t -167.41 169.66 12.07 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.789 1.235 . . . . 0.0 107.799 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 19.8 ptt? 44.96 39.9 4.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.807 1.243 . . . . 0.0 113.028 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 53.05 34.14 16.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.287 1.835 . . . . 0.0 112.821 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.5 mtp -144.08 167.8 21.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.088 1.755 . . . . 0.0 109.182 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.3 139.04 51.94 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.56 131.44 18.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.14 155.1 68.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.997 1.798 . . . . 0.0 111.087 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.74 124.5 66.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.75 156.31 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.952 1.301 . . . . 0.0 110.247 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.91 12.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.925 1.29 . . . . 0.0 108.868 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.36 -23.04 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.24 0.616 . . . . 0.0 111.992 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -154.58 161.6 41.54 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.183 1.793 . . . . 0.0 108.027 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -73.88 157.01 37.09 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.414 0.686 . . . . 0.0 110.504 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.47 36.24 Favored Glycine 0 CA--C 1.524 0.597 0 O-C-N 121.736 -0.602 . . . . 0.0 112.092 170.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.15 135.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.14 101.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -69.33 -41.3 76.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -156.57 163.53 39.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.567 0.621 . . . . 0.0 109.341 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -124.76 137.75 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -118.55 3.48 11.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -139.79 171.25 14.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.973 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -148.31 171.88 15.28 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.838 1.655 . . . . 0.0 108.913 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -57.98 133.44 55.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.08 0.552 . . . . 0.0 109.511 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.89 74.35 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.878 1.228 . . . . 0.0 113.562 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.22 139.63 50.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.301 1.551 . . . . 0.0 109.228 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -65.9 140.97 58.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.66 157.98 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.51 166.33 26.01 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.978 -171.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.3 108.19 1.05 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.35 0.1 58.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.266 1.413 . . . . 0.0 113.061 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -79.78 130.51 35.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.599 1.7 . . . . 0.0 108.65 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.66 150.05 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.757 0.823 . . . . 0.0 110.066 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.17 -51.61 2.21 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.935 1.694 . . . . 0.0 108.427 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.02 171.92 15.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.987 0.515 . . . . 0.0 110.799 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.92 148.73 50.95 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.478 1.111 . . . . 0.0 108.396 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--O 1.233 0.195 0 C-N-CA 125.057 1.343 . . . . 0.0 112.415 -169.165 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 C--O 1.239 0.512 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 20.4 m -138.12 161.73 36.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.183 0.993 . . . . 0.0 111.982 -169.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -80.52 153.39 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -132.14 27.84 4.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.57 157.35 35.17 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.697 1.599 . . . . 0.0 107.858 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.63 141.97 34.46 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 171.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 -152.51 20.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.63 136.52 51.75 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.19 71.89 9.24 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.906 1.282 . . . . 0.0 111.03 -169.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -24.82 -59.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.431 2.692 . . . . 0.0 114.292 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -144.9 163.84 32.91 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.639 1.176 . . . . 0.0 108.991 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.88 146.52 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -122.68 -17.99 6.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.043 0.537 . . . . 0.0 111.648 -169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.98 166.73 2.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.685 0.755 . . . . 0.0 111.961 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -149.55 162.09 40.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.373 1.869 . . . . 0.0 106.039 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.49 138.23 51.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.706 0.685 . . . . 0.0 109.513 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.26 -5.94 70.2 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.727 -1.041 . . . . 0.0 113.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.86 166.84 18.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.311 1.555 . . . . 0.0 109.448 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -122.25 141.68 51.24 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -129.88 162.65 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.493 1.117 . . . . 0.0 108.292 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.73 140.66 44.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -46.4 123.81 5.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 110.788 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.69 -10.03 75.93 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.619 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.51 139.25 58.47 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.571 1.686 . . . . 0.0 108.145 170.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 142.99 57.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.15 -21.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.031 1.332 . . . . 0.0 110.728 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 179.42 8.73 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.62 0.768 . . . . 0.0 109.038 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -135.61 146.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.47 133.64 53.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.025 2.13 . . . . 0.0 106.358 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -107.87 125.3 51.3 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -170.01 165.97 9.34 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.039 1.336 . . . . 0.0 107.851 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 mtm 56.22 29.99 15.8 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.945 0.898 . . . . 0.0 111.856 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 52.0 35.61 16.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.586 1.555 . . . . 0.0 112.308 -171.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.54 172.93 12.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.602 1.961 . . . . 0.0 108.737 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -125.2 136.95 54.08 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.25 130.4 14.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.21 155.03 68.96 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.59 1.527 . . . . 0.0 110.555 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.3 mm -120.79 124.64 72.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 173.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 m -113.89 156.26 14.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.858 1.263 . . . . 0.0 110.678 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.61 118.66 8.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.507 1.123 . . . . 0.0 108.193 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.73 -25.78 67.45 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.147 0.579 . . . . 0.0 111.48 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -157.33 155.49 30.72 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.233 1.413 . . . . 0.0 108.621 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -70.93 157.34 38.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.421 0.688 . . . . 0.0 110.707 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.9 177.53 35.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 122.1 -0.375 . . . . 0.0 112.513 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.88 133.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 110.81 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.81 -44.9 60.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -156.78 159.42 38.27 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.36 138.11 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -116.67 12.38 14.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.236 1.014 . . . . 0.0 112.154 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -146.79 178.62 8.18 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.037 1.735 . . . . 0.0 108.763 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -144.84 169.61 17.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.065 1.346 . . . . 0.0 108.278 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.67 133.06 46.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.774 0.83 . . . . 0.0 109.232 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.54 -1.61 65.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.045 1.307 . . . . 0.0 114.15 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -71.31 153.31 42.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.807 1.803 . . . . 0.0 110.475 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -66.25 143.82 56.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.07 160.12 17.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.103 0.961 . . . . 0.0 109.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.18 166.62 24.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.285 -174.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 112.98 2.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.58 -1.94 64.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.15 1.357 . . . . 0.0 112.81 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -76.56 132.84 39.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.217 1.509 . . . . 0.0 109.106 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.26 130.27 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.455 0.702 . . . . 0.0 109.481 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 4' ' ' SER . 56.8 tp -82.84 -50.88 8.18 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.677 1.191 . . . . 0.0 108.494 169.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.32 171.05 20.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -171.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.96 148.8 51.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.115 1.366 . . . . 0.0 108.337 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 C--O 1.232 0.143 0 C-N-CA 125.44 1.496 . . . . 0.0 109.779 -170.52 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 C--O 1.239 0.506 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -137.65 155.59 48.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.834 1.253 . . . . 0.0 111.173 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.4 mp -70.11 148.01 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -109.21 6.58 24.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.403 -0.811 . . . . 0.0 112.375 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 159.5 38.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.006 1.322 . . . . 0.0 108.945 -169.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.47 140.14 38.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.835 0.454 . . . . 0.0 109.912 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.21 -151.51 17.76 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.31 141.69 51.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.8 tp -83.06 77.25 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.437 1.095 . . . . 0.0 110.958 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -37.22 -56.33 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.232 2.213 . . . . 0.0 113.554 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -147.02 160.72 42.04 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.931 1.293 . . . . 0.0 108.832 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.74 142.58 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -120.78 -22.51 6.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.196 0.598 . . . . 0.0 111.216 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 m -74.97 161.32 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.659 0.742 . . . . 0.0 111.619 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -149.91 157.13 42.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.626 1.97 . . . . 0.0 106.284 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.86 130.91 45.52 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.795 0.725 . . . . 0.0 109.147 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.23 -9.06 77.0 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.467 1.032 . . . . 0.0 112.997 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.64 166.4 17.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.221 1.511 . . . . 0.0 109.831 170.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -122.92 142.28 50.98 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.3 pt -131.76 161.64 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 123.797 0.839 . . . . 0.0 108.871 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.94 143.76 40.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -46.1 122.94 4.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.981 0.81 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.61 -8.26 78.86 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.92 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -63.86 132.97 52.45 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.683 1.741 . . . . 0.0 107.402 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.0 137.07 43.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.2 -20.06 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.334 1.454 . . . . 0.0 110.878 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.17 -179.34 7.81 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.638 0.775 . . . . 0.0 108.989 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.63 145.61 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -121.15 130.62 53.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.152 2.181 . . . . 0.0 106.44 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.87 124.97 49.39 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -170.03 169.5 8.03 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.851 1.261 . . . . 0.0 107.852 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.0 ptt? 44.42 41.35 4.51 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.025 1.33 . . . . 0.0 112.922 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.78 31.93 11.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.378 1.871 . . . . 0.0 113.107 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.41 170.44 15.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.327 1.851 . . . . 0.0 109.093 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.46 139.19 54.15 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.58 129.44 17.52 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -169.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.45 149.29 80.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.53 1.487 . . . . 0.0 110.308 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.98 123.55 71.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -113.06 155.64 14.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.138 1.375 . . . . 0.0 110.91 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 121.04 12.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.801 1.24 . . . . 0.0 108.497 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.24 -30.17 70.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.162 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -157.16 155.86 31.68 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 109.207 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 m -71.75 155.47 40.42 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.736 0.814 . . . . 0.0 110.85 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.04 178.75 38.55 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.24 0.448 . . . . 0.0 112.008 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.62 134.96 27.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.45 107.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.21 -40.89 29.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.45 154.53 32.01 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 t -114.16 134.74 56.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.3 -3.52 31.15 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.873 0.869 . . . . 0.0 112.714 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -137.66 178.01 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.412 1.085 . . . . 0.0 109.958 -170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -142.42 163.61 32.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.779 1.232 . . . . 0.0 107.785 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -60.99 136.78 58.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.46 -4.3 78.46 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.314 -1.27 . . . . 0.0 114.06 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -72.67 155.31 40.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.005 1.903 . . . . 0.0 110.717 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.08 144.53 56.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.93 160.82 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.035 0.934 . . . . 0.0 109.238 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -145.93 166.69 25.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.052 -172.591 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.37 113.92 2.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 2.2 75.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.794 1.188 . . . . 0.0 112.892 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -77.81 127.29 32.18 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 1.566 . . . . 0.0 107.507 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.78 137.35 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.08 -50.93 5.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.817 1.247 . . . . 0.0 108.9 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 168.01 24.51 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.583 0.629 . . . . 0.0 112.081 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -126.78 141.97 51.68 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.225 1.81 . . . . 0.0 106.921 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 CA--C 1.519 -0.214 0 C-N-CA 124.407 1.083 . . . . 0.0 110.766 -169.457 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--O 1.237 0.425 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 17.1 m -140.56 159.53 41.99 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.993 1.317 . . . . 0.0 111.127 -169.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 mm -77.55 156.55 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.76 15.62 4.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.451 1.5 . . . . 0.0 111.512 -169.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.33 157.76 36.24 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.647 1.579 . . . . 0.0 108.114 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.61 140.84 41.17 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.5 -153.91 20.0 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.93 135.65 50.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.46 70.74 8.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.846 1.258 . . . . 0.0 111.096 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -25.76 -59.82 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.431 2.692 . . . . 0.0 114.127 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -144.75 163.17 34.83 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.618 1.167 . . . . 0.0 108.923 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.43 146.38 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -124.48 -18.62 5.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.915 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.17 164.77 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.758 0.79 . . . . 0.0 111.68 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -150.1 157.81 43.51 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.597 1.959 . . . . 0.0 106.042 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.19 132.5 50.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.39 -8.99 78.91 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.525 1.059 . . . . 0.0 113.068 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.03 162.27 27.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.241 1.52 . . . . 0.0 109.896 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -113.17 141.99 46.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 pt -130.94 158.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.49 143.75 46.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -46.88 119.98 2.79 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.874 0.761 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.08 68.6 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.015 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.5 135.66 55.43 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.708 1.754 . . . . 0.0 108.175 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.69 134.55 52.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.85 -22.17 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.308 1.043 . . . . 0.0 111.495 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.55 -178.88 7.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.074 0.852 . . . . 0.0 109.808 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -135.91 145.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.92 134.79 54.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.779 2.032 . . . . 0.0 106.528 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.71 125.82 53.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.86 166.76 7.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.163 1.385 . . . . 0.0 107.788 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 56.06 30.28 16.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.919 0.888 . . . . 0.0 111.86 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 51.88 35.8 16.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.641 1.577 . . . . 0.0 112.279 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.77 173.03 11.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.625 1.97 . . . . 0.0 108.799 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.57 137.69 53.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.48 131.15 16.08 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.66 155.39 69.02 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.857 1.704 . . . . 0.0 110.61 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.0 mm -124.65 125.22 69.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.59 156.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 110.179 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.17 121.54 13.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.671 1.188 . . . . 0.0 108.425 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.71 -25.81 66.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.108 0.563 . . . . 0.0 111.535 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.38 156.95 33.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.343 1.457 . . . . 0.0 108.882 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -73.43 157.01 37.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.685 0.794 . . . . 0.0 111.061 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.42 -177.19 40.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.504 0.573 . . . . 0.0 112.261 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.6 mm -99.65 129.83 49.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.86 109.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -73.46 -45.47 54.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -157.16 157.14 33.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.82 135.81 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.41 8.07 29.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.24 1.016 . . . . 0.0 111.967 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -146.56 178.75 8.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.937 1.695 . . . . 0.0 108.783 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -144.74 169.42 18.06 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.904 1.282 . . . . 0.0 108.38 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.62 133.4 46.59 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.958 0.903 . . . . 0.0 109.325 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.11 -1.57 63.58 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.112 1.339 . . . . 0.0 114.158 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.9 152.02 44.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.844 1.822 . . . . 0.0 110.511 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -65.95 142.74 57.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.88 160.64 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.099 0.96 . . . . 0.0 109.665 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.86 167.05 23.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.59 -173.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.14 114.78 3.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.694 0.798 . . . . 0.0 108.94 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.81 68.39 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.194 1.378 . . . . 0.0 112.921 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.49 128.11 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.18 1.49 . . . . 0.0 109.293 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.5 131.58 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.506 0.722 . . . . 0.0 109.559 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 4' ' ' SER . 44.6 tp -85.32 -50.83 7.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 124.538 1.135 . . . . 0.0 108.787 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.29 168.95 24.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.212 0.529 . . . . 0.0 111.025 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -129.24 143.79 50.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.274 1.829 . . . . 0.0 106.937 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 110.337 -169.506 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.9 t . . . . . 0 C--O 1.238 0.491 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -140.13 159.17 42.78 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.684 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -78.14 157.24 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 14.56 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.441 1.496 . . . . 0.0 111.722 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -156.31 157.98 36.66 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.572 1.549 . . . . 0.0 108.136 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.06 140.34 40.28 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.012 -0.43 . . . . 0.0 110.036 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.81 -153.91 18.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 137.12 51.38 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.53 71.83 8.56 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.94 1.296 . . . . 0.0 111.332 -169.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -29.57 -59.26 0.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.941 2.496 . . . . 0.0 114.01 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.87 163.08 37.25 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.114 1.366 . . . . 0.0 108.633 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.77 148.38 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -131.18 26.11 4.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.99 0.916 . . . . 0.0 112.005 -169.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.37 162.35 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.562 1.145 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.79 159.25 44.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.089 1.756 . . . . 0.0 107.641 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.37 133.44 49.7 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 -6.4 83.54 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.222 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.01 165.82 20.99 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.483 1.642 . . . . 0.0 110.163 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -113.36 141.2 47.33 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.575 1.55 . . . . 0.0 107.009 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -130.52 163.36 36.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.055 0.942 . . . . 0.0 108.734 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -137.38 139.63 40.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -47.0 124.2 6.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.056 0.942 . . . . 0.0 110.634 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.56 74.35 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.66 -1.078 . . . . 0.0 113.763 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -64.41 143.65 57.75 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.469 1.635 . . . . 0.0 107.869 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.85 144.22 57.41 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.73 -31.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 110.346 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 -178.78 7.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 119.533 1.061 . . . . 0.0 109.416 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -134.67 145.01 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.36 128.64 52.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.652 1.981 . . . . 0.0 106.588 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.96 124.21 43.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.64 167.67 9.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.194 1.397 . . . . 0.0 107.753 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.2 mtm 54.99 31.59 16.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.057 0.943 . . . . 0.0 111.76 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.27 34.57 14.98 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.932 1.693 . . . . 0.0 112.585 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.4 mtt -142.7 173.66 11.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.479 1.911 . . . . 0.0 108.508 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -120.96 140.61 51.64 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.53 132.19 19.67 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.74 153.87 74.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.932 1.755 . . . . 0.0 110.843 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 mm -126.54 134.9 65.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.87 163.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.373 1.069 . . . . 0.0 110.253 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.39 113.04 2.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.631 1.173 . . . . 0.0 107.842 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.2 -17.04 62.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.311 0.244 . . . . 0.0 111.371 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.32 155.49 30.76 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.057 1.743 . . . . 0.0 108.959 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 m -69.23 158.21 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.903 0.881 . . . . 0.0 110.923 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.37 177.36 33.4 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 122.265 -0.272 . . . . 0.0 112.538 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -85.68 135.08 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -68.62 115.41 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -84.28 -48.3 9.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -157.66 129.55 7.01 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -81.93 137.2 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -110.02 5.3 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.048 0.939 . . . . 0.0 112.124 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -143.84 179.06 7.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.315 1.446 . . . . 0.0 108.612 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -145.38 163.9 33.15 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.548 1.139 . . . . 0.0 108.915 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.23 130.12 43.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.968 0.907 . . . . 0.0 109.716 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.17 -1.61 84.4 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.258 1.409 . . . . 0.0 113.804 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -70.64 153.74 42.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.767 1.783 . . . . 0.0 110.53 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.13 143.86 56.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.61 160.77 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.02 0.928 . . . . 0.0 109.488 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.48 167.72 21.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.976 -172.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 115.55 3.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 108.957 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.68 -0.7 74.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.052 1.311 . . . . 0.0 112.88 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -77.48 126.7 31.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.358 1.579 . . . . 0.0 109.093 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.71 129.74 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.16 -44.97 9.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.339 1.056 . . . . 0.0 109.331 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.78 165.12 37.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.751 0.786 . . . . 0.0 111.884 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -118.32 143.82 46.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.81 2.044 . . . . 0.0 106.586 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.519 -0.246 0 C-N-CA 124.72 1.208 . . . . 0.0 108.514 -174.261 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.237 0.406 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -138.44 155.28 48.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.927 1.291 . . . . 0.0 111.045 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.4 mp -70.02 147.67 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -108.6 4.69 24.27 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 ptp -154.11 163.68 39.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.279 0.945 . . . . 0.0 109.575 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.9 141.45 49.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.784 0.434 . . . . 0.0 110.175 173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.19 -152.93 20.32 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.91 140.15 51.8 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.9 tp -80.78 75.78 7.7 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.455 1.102 . . . . 0.0 111.592 -169.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -35.2 -58.15 0.56 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.348 2.259 . . . . 0.0 113.789 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -147.61 160.63 42.44 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.794 1.237 . . . . 0.0 108.743 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.2 143.58 32.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -124.32 -21.34 4.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.832 0.453 . . . . 0.0 111.992 -169.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.2 162.01 4.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.468 0.651 . . . . 0.0 111.557 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -149.59 158.91 44.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.266 1.826 . . . . 0.0 106.763 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.88 47.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.09 -6.94 83.2 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.112 -178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -68.42 164.93 19.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.316 1.558 . . . . 0.0 109.842 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -119.41 144.57 46.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.522 1.129 . . . . 0.0 108.005 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.25 159.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -133.69 143.99 48.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -48.54 121.31 4.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.874 0.761 . . . . 0.0 110.438 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.56 67.49 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -64.61 134.72 54.92 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.695 1.747 . . . . 0.0 108.074 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -67.7 133.03 48.59 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.32 -21.67 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.271 1.028 . . . . 0.0 111.424 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.74 8.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.151 0.981 . . . . 0.0 109.514 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.41 147.24 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -124.02 131.52 53.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.885 2.074 . . . . 0.0 106.515 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.23 124.71 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -169.07 166.4 10.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.824 1.249 . . . . 0.0 108.047 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.9 mtm 55.18 31.52 16.6 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.932 0.893 . . . . 0.0 111.854 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 52.22 35.21 16.23 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.79 1.636 . . . . 0.0 112.496 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.44 173.76 11.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.667 1.987 . . . . 0.0 108.665 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -118.61 142.53 47.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.49 128.44 19.14 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 -169.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.1 147.94 68.23 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.831 1.687 . . . . 0.0 109.996 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -121.08 121.88 66.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 m -114.95 157.2 15.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.631 1.173 . . . . 0.0 110.177 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 119.73 9.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.687 1.195 . . . . 0.0 108.25 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.18 -26.13 68.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.42 0.688 . . . . 0.0 111.572 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -157.38 155.51 30.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.581 1.552 . . . . 0.0 108.476 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 m -69.38 157.58 36.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.342 0.657 . . . . 0.0 110.605 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.39 -176.17 40.33 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 122.106 -0.371 . . . . 0.0 112.473 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -99.84 133.64 42.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.63 111.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -77.0 -45.2 28.14 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.39 151.66 26.58 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.55 134.19 48.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -106.27 3.76 28.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.672 0.789 . . . . 0.0 112.461 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -138.7 178.4 7.18 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.064 1.346 . . . . 0.0 109.284 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.04 159.89 41.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.648 1.179 . . . . 0.0 108.136 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.27 132.05 51.4 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.99 -3.62 86.9 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.093 1.33 . . . . 0.0 113.763 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -70.35 154.46 41.87 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.865 1.833 . . . . 0.0 110.68 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -66.47 143.39 57.12 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.42 160.54 14.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.038 0.935 . . . . 0.0 109.219 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.04 167.36 22.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.282 -171.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.31 113.39 2.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.98 5.7 85.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.487 1.041 . . . . 0.0 113.063 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.01 130.23 37.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.439 1.619 . . . . 0.0 107.233 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.17 141.42 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.84 -50.24 3.9 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.166 1.386 . . . . 0.0 108.661 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 165.83 33.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 111.928 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -128.69 139.15 52.38 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.44 1.896 . . . . 0.0 106.403 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.233 0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 110.274 -169.364 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.239 0.502 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -137.75 155.3 49.21 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.718 1.207 . . . . 0.0 111.458 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.26 147.86 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -108.51 5.38 25.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 ptp -153.88 163.03 40.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 109.827 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.53 140.86 50.07 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.653 0.381 . . . . 0.0 110.227 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 169.95 -153.65 21.91 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.23 137.62 44.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.64 121.18 14.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.84 -51.69 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -149.11 159.93 43.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.586 1.555 . . . . 0.0 108.493 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.09 142.89 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -120.76 -22.08 6.42 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.036 0.534 . . . . 0.0 111.506 -170.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.76 165.96 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.977 0.894 . . . . 0.0 111.153 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.73 154.09 36.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.43 50.65 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.67 -9.94 62.45 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.451 1.501 . . . . 0.0 112.989 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.4 172.22 12.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.913 1.357 . . . . 0.0 110.667 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -115.87 138.19 51.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.727 1.611 . . . . 0.0 107.094 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 pt -128.48 160.67 38.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.0 143.9 38.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -48.57 120.85 4.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.774 0.715 . . . . 0.0 110.467 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.81 -8.25 70.71 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.826 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.4 135.22 55.91 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.589 1.694 . . . . 0.0 108.051 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.41 133.69 49.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.12 -22.29 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.293 1.037 . . . . 0.0 111.617 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.06 178.06 10.12 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.592 0.757 . . . . 0.0 109.694 169.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.4 mt -136.78 142.03 39.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -120.46 131.19 54.64 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.278 1.831 . . . . 0.0 106.882 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.87 124.36 43.73 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -168.84 166.78 11.32 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.969 1.308 . . . . 0.0 108.065 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.2 mtm 55.26 31.32 16.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.015 0.926 . . . . 0.0 111.795 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.64 34.6 16.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.71 1.604 . . . . 0.0 112.515 -172.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.08 173.53 11.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.517 1.927 . . . . 0.0 108.659 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -118.72 141.67 48.39 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.66 128.31 18.92 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.45 149.63 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.947 1.764 . . . . 0.0 110.203 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mm -122.46 120.94 62.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.18 156.18 15.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.792 1.237 . . . . 0.0 110.183 -172.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 116.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.038 1.335 . . . . 0.0 108.63 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.43 -23.32 65.52 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.082 0.553 . . . . 0.0 111.768 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -154.54 162.04 41.34 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.522 1.529 . . . . 0.0 108.796 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -75.17 157.32 34.77 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.82 0.848 . . . . 0.0 110.96 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.62 174.75 33.83 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.354 0.502 . . . . 0.0 112.0 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.3 mm -85.57 134.3 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.74 101.77 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -71.48 -40.66 70.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -156.02 164.13 38.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.568 0.622 . . . . 0.0 109.335 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 t -125.87 135.09 64.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -105.5 -0.84 25.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 111.863 -169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -141.29 177.04 8.37 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.817 1.247 . . . . 0.0 110.693 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.16 169.01 21.68 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.311 1.444 . . . . 0.0 108.501 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.62 139.68 49.24 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.728 0.811 . . . . 0.0 109.271 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.45 -7.78 56.24 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.376 -1.236 . . . . 0.0 113.737 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -75.83 152.85 37.17 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.817 1.809 . . . . 0.0 110.952 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.91 145.38 54.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.034 0.934 . . . . 0.0 109.325 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.19 161.59 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.877 0.871 . . . . 0.0 109.952 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.36 168.48 19.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.091 -175.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.23 114.65 3.0 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.37 82.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.472 1.034 . . . . 0.0 112.976 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -78.87 125.82 29.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.454 1.627 . . . . 0.0 107.847 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.61 132.13 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.483 0.713 . . . . 0.0 109.961 -169.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.89 -50.53 7.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.931 1.292 . . . . 0.0 107.686 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -154.35 169.58 23.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.455 0.645 . . . . 0.0 111.893 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.24 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.517 1.927 . . . . 0.0 106.8 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.234 0.25 0 C-N-CA 124.199 1.0 . . . . 0.0 110.556 -169.828 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 C--O 1.235 0.341 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -136.62 154.59 50.61 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 110.635 -169.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.4 mp -69.6 141.84 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -102.77 5.66 38.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.695 -0.628 . . . . 0.0 112.529 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -156.27 164.28 38.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.3 1.04 . . . . 0.0 109.532 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.69 142.86 42.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.729 0.411 . . . . 0.0 110.312 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.54 -151.72 16.99 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.73 132.39 45.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 113.66 10.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -70.66 -59.18 2.97 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.015 0.926 . . . . 0.0 110.564 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -149.42 158.33 44.08 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.968 1.307 . . . . 0.0 109.182 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.28 145.73 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.171 1.389 . . . . 0.0 107.434 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.89 24.83 4.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.412 1.085 . . . . 0.0 111.055 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 m -132.83 165.52 32.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.083 1.353 . . . . 0.0 110.129 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -146.7 156.19 42.99 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.985 1.714 . . . . 0.0 106.519 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.32 133.52 55.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.46 -10.12 74.75 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.513 1.054 . . . . 0.0 112.864 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.08 170.35 11.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.045 1.422 . . . . 0.0 109.658 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -126.46 143.26 51.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 107.986 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.51 164.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.616 1.166 . . . . 0.0 108.784 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -136.05 141.64 44.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.708 1.203 . . . . 0.0 107.817 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -45.62 116.55 1.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 110.691 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -10.68 62.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.714 -1.048 . . . . 0.0 113.66 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -66.63 140.41 57.93 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.497 1.648 . . . . 0.0 108.499 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.94 138.99 56.39 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.5 -19.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.981 0.912 . . . . 0.0 112.151 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.53 178.4 9.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.705 1.202 . . . . 0.0 108.688 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -134.76 148.86 29.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -123.56 133.67 53.94 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.738 2.015 . . . . 0.0 106.745 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 123.8 46.42 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -168.83 167.3 11.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.764 1.225 . . . . 0.0 107.951 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 mtm 55.48 30.61 15.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.854 0.862 . . . . 0.0 111.861 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 53.13 35.3 19.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.857 1.663 . . . . 0.0 111.995 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -144.0 173.62 11.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.484 1.914 . . . . 0.0 108.644 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -119.23 140.53 50.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.3 131.79 19.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.56 152.46 74.79 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.892 1.728 . . . . 0.0 110.754 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.9 mm -123.46 118.65 55.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.85 157.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.466 1.106 . . . . 0.0 110.293 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 108.23 1.13 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.264 1.426 . . . . 0.0 107.441 170.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.02 -15.13 62.97 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 155.72 34.46 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.673 1.589 . . . . 0.0 108.509 171.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.94 159.66 33.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.18 0.992 . . . . 0.0 110.975 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.57 179.19 37.01 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 121.829 -0.544 . . . . 0.0 112.377 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -85.45 134.05 28.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.51 100.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -70.34 -40.24 74.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -156.87 162.88 39.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -114.83 7.98 15.91 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.741 0.816 . . . . 0.0 112.557 -168.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -140.73 175.59 9.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.761 1.224 . . . . 0.0 109.588 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -143.3 160.34 40.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.326 1.85 . . . . 0.0 107.182 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.36 127.64 33.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.23 -7.51 64.25 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.504 1.526 . . . . 0.0 113.407 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -74.77 153.66 38.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.5 1.65 . . . . 0.0 111.414 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.62 145.32 54.03 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.551 0.74 . . . . 0.0 109.117 170.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.55 159.83 14.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.752 0.821 . . . . 0.0 110.108 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.92 166.11 25.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -176.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.8 117.84 5.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.12 -0.8 82.15 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.682 1.134 . . . . 0.0 113.044 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.25 131.69 41.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.274 1.537 . . . . 0.0 108.176 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 t -70.95 135.09 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 -50.94 5.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 125.462 1.505 . . . . 0.0 108.894 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.18 168.75 20.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 112.062 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.24 140.09 52.09 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.663 1.985 . . . . 0.0 106.378 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 123.886 0.875 . . . . 0.0 112.446 -169.074 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.238 0.458 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 m -139.68 160.12 40.59 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.694 1.198 . . . . 0.0 111.03 -168.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.63 156.81 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.59 15.63 4.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.445 1.098 . . . . 0.0 112.129 -169.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 158.29 36.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.099 1.76 . . . . 0.0 107.91 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.71 141.08 38.18 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.884 -0.51 . . . . 0.0 109.762 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.08 -153.43 19.43 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 175.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.68 133.71 45.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.85 113.55 13.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -66.52 -56.09 12.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.045 0.938 . . . . 0.0 110.203 -170.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.52 161.4 42.21 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.419 1.488 . . . . 0.0 107.943 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.21 146.69 28.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.44 -19.77 5.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.029 0.532 . . . . 0.0 112.03 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.76 166.17 2.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.794 0.807 . . . . 0.0 111.791 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.78 160.26 42.92 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.627 1.971 . . . . 0.0 105.93 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.12 137.83 45.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.18 -7.39 75.67 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.472 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -70.74 162.85 28.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.448 1.624 . . . . 0.0 110.339 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -108.71 137.56 46.44 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 pt -128.2 161.27 36.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -138.73 141.68 38.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -47.51 120.64 3.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.959 0.8 . . . . 0.0 110.69 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -10.25 64.63 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.894 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.52 135.85 56.44 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.552 1.676 . . . . 0.0 108.237 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.21 134.13 49.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.53 -22.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.126 0.97 . . . . 0.0 111.534 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.57 -178.82 7.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.79 0.836 . . . . 0.0 109.615 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -137.28 146.37 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.4 tm? -121.53 136.21 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.677 1.991 . . . . 0.0 107.197 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -104.34 124.08 48.54 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.26 167.82 10.05 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 125.004 1.322 . . . . 0.0 107.923 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 54.9 32.72 18.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.906 0.883 . . . . 0.0 111.656 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.23 32.73 11.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.985 1.714 . . . . 0.0 112.681 -173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.8 mmm -142.16 173.26 11.68 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.579 1.952 . . . . 0.0 108.746 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -119.46 141.99 48.66 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.84 130.29 18.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.87 152.51 73.7 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.87 1.713 . . . . 0.0 110.566 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -123.68 121.83 63.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 m -113.39 157.72 13.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.726 1.21 . . . . 0.0 109.977 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 119.82 9.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.713 1.205 . . . . 0.0 108.237 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.77 -26.07 65.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.945 0.498 . . . . 0.0 111.336 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -157.12 155.87 31.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.536 1.534 . . . . 0.0 108.855 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.46 156.81 36.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.05 0.94 . . . . 0.0 111.085 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.8 177.23 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.363 0.506 . . . . 0.0 112.392 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -85.8 133.35 29.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 169.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.15 111.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -73.88 -46.66 43.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -156.57 158.92 37.97 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.55 131.53 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.83 -6.02 27.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.979 0.912 . . . . 0.0 112.555 -169.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -138.86 173.6 11.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.184 1.394 . . . . 0.0 109.045 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -147.79 170.53 17.39 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 109.129 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.28 128.91 39.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.66 1.02 87.7 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.148 1.356 . . . . 0.0 113.507 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.74 153.09 42.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.32 1.56 . . . . 0.0 110.097 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -76.02 143.39 41.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.72 159.62 14.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.592 0.711 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.77 167.01 23.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.308 -172.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 113.08 2.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.31 72.22 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.898 1.237 . . . . 0.0 113.106 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.83 126.33 30.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.435 1.618 . . . . 0.0 108.206 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.86 144.59 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.31 -49.5 2.96 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.514 1.526 . . . . 0.0 108.479 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.84 169.2 19.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.338 0.589 . . . . 0.0 111.642 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.48 144.89 51.45 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.311 1.845 . . . . 0.0 106.844 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.523 -0.095 0 C-N-CA 124.854 1.262 . . . . 0.0 110.66 -169.201 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.239 0.524 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -140.76 155.82 46.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.238 . . . . 0.0 110.667 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.8 mm -73.88 152.13 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.621 1.168 . . . . 0.0 107.993 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.89 11.61 14.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.386 0.675 . . . . 0.0 111.948 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -143.67 161.21 39.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.558 1.543 . . . . 0.0 108.343 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -90.01 131.51 35.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.63 11.55 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.4 142.35 50.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.0 tp -85.74 72.21 10.58 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.978 0.911 . . . . 0.0 110.833 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -27.68 -59.1 0.11 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.083 2.553 . . . . 0.0 114.081 -174.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.6 162.42 38.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.119 1.368 . . . . 0.0 108.527 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.87 147.67 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -131.34 25.46 4.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.192 0.997 . . . . 0.0 111.559 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.76 165.04 32.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.388 1.075 . . . . 0.0 110.484 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -148.97 158.08 43.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.983 1.713 . . . . 0.0 106.795 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.43 53.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.55 77.48 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.528 1.061 . . . . 0.0 112.787 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.05 167.68 17.1 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.142 1.471 . . . . 0.0 109.815 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -125.02 138.1 54.22 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -126.56 162.84 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.368 1.067 . . . . 0.0 108.198 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.9 143.11 48.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -47.87 126.96 11.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.58 0.752 . . . . 0.0 110.5 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.56 78.45 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.507 -1.163 . . . . 0.0 113.617 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.85 138.65 58.03 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.688 1.744 . . . . 0.0 107.884 169.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.89 137.94 57.52 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.06 -19.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.868 1.267 . . . . 0.0 111.429 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.88 -179.49 8.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.435 1.016 . . . . 0.0 109.336 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -136.19 139.02 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -106.11 136.11 46.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.803 2.041 . . . . 0.0 106.614 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.31 120.93 44.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -162.02 166.4 26.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 53.33 24.61 3.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt 47.38 42.68 14.46 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 126.12 1.768 . . . . 0.0 111.839 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.6 mmt -137.12 164.64 27.96 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.402 2.281 . . . . 0.0 106.988 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -112.14 140.73 46.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.73 122.79 14.61 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.24 151.59 35.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.988 2.458 . . . . 0.0 112.723 174.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mm -126.4 123.23 62.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.32 155.41 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.234 1.413 . . . . 0.0 110.105 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.28 124.09 21.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.145 0.978 . . . . 0.0 108.674 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -29.05 69.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.806 0.442 . . . . 0.0 111.573 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.1 ptm85 -157.21 156.61 32.87 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.611 1.164 . . . . 0.0 108.895 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -70.31 155.14 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.34 0.656 . . . . 0.0 110.492 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.17 177.2 36.71 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 122.119 -0.363 . . . . 0.0 112.39 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -85.42 133.39 29.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.6 109.59 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -78.06 -43.43 29.24 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -152.18 156.86 40.61 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.488 0.585 . . . . 0.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.4 129.47 74.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.4 -0.55 35.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.694 0.798 . . . . 0.0 111.983 -169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -139.73 176.26 8.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.821 1.249 . . . . 0.0 109.581 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.44 164.57 31.13 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.93 1.292 . . . . 0.0 108.579 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.4 128.13 32.84 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.955 0.902 . . . . 0.0 109.561 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.71 86.79 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.187 1.375 . . . . 0.0 114.02 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -70.5 154.74 41.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.955 1.877 . . . . 0.0 110.597 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.73 143.11 57.14 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.12 160.21 15.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -143.79 167.13 23.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.178 0.591 . . . . 0.0 111.017 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.18 114.53 3.49 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.55 1.58 74.22 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.972 1.272 . . . . 0.0 113.151 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.96 128.64 34.22 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.52 1.66 . . . . 0.0 108.123 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.64 133.78 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.335 0.654 . . . . 0.0 110.127 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.0 tp -87.28 -52.09 5.59 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.05 168.38 27.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.713 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 148.24 52.57 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.585 1.154 . . . . 0.0 108.337 174.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.516 -0.359 0 C-N-CA 125.358 1.463 . . . . 0.0 109.802 -169.125 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.154 0.502 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.14 146.48 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 169.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -139.32 160.53 39.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.516 1.127 . . . . 0.0 111.297 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.06 157.09 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.13 15.27 5.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 112.158 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.73 159.76 38.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.093 1.757 . . . . 0.0 107.984 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -79.29 141.14 37.3 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.98 -0.45 . . . . 0.0 109.879 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.79 -152.87 19.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.34 136.42 49.99 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.05 73.7 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.326 1.05 . . . . 0.0 111.542 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -27.18 -60.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.252 2.621 . . . . 0.0 114.01 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -146.3 161.87 39.37 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.714 1.206 . . . . 0.0 108.76 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.7 146.24 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.35 -19.96 5.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.74 0.416 . . . . 0.0 111.896 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.2 m -74.71 165.89 2.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.899 0.857 . . . . 0.0 111.942 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.56 159.67 43.49 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.72 2.008 . . . . 0.0 105.74 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.14 46.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.08 75.23 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.654 1.121 . . . . 0.0 113.378 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -71.67 163.74 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.453 1.626 . . . . 0.0 110.306 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -108.6 136.83 47.54 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.14 159.33 37.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -137.63 144.39 41.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -50.05 123.21 7.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.893 0.77 . . . . 0.0 110.359 -176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.39 -7.96 80.59 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.032 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -64.71 141.38 58.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.691 1.745 . . . . 0.0 107.814 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.86 143.21 55.85 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.44 -37.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.997 1.319 . . . . 0.0 109.512 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.28 -179.67 8.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.902 0.881 . . . . 0.0 109.536 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -135.56 142.94 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.8 tm? -119.14 134.05 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.633 1.973 . . . . 0.0 106.736 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.65 124.85 49.61 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -169.25 166.81 10.54 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.009 1.324 . . . . 0.0 107.879 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.7 mtm 55.41 30.95 15.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 51.84 35.11 14.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.875 1.67 . . . . 0.0 112.576 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -142.31 173.48 11.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.473 1.909 . . . . 0.0 108.566 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -119.16 143.48 47.2 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.64 127.41 17.52 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.66 150.28 68.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.953 1.768 . . . . 0.0 110.244 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -124.79 132.31 71.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -124.36 162.19 26.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.869 1.268 . . . . 0.0 110.286 -169.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 122.61 16.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.51 -22.38 61.79 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.82 0.448 . . . . 0.0 111.671 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.83 157.71 38.3 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 108.913 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -69.77 155.65 40.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.792 0.837 . . . . 0.0 111.227 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.14 176.86 37.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.755 0.693 . . . . 0.0 111.761 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.66 135.24 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -68.59 106.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.27 -40.93 62.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.3 161.5 40.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.34 132.79 70.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.22 -1.26 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.2 1.0 . . . . 0.0 112.369 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -139.8 176.17 8.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.269 1.428 . . . . 0.0 109.409 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -144.74 169.83 17.27 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.659 1.183 . . . . 0.0 108.734 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.76 133.69 47.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 0.0 109.685 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.0 -0.59 62.08 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.188 1.375 . . . . 0.0 114.325 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -71.43 153.06 42.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.977 1.888 . . . . 0.0 110.452 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -66.47 142.86 57.41 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.31 160.1 15.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.715 0.806 . . . . 0.0 109.692 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.12 167.26 22.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.4 -173.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.37 113.52 2.69 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.95 1.68 72.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.839 1.209 . . . . 0.0 113.086 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.94 126.57 31.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.443 1.621 . . . . 0.0 108.183 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.63 144.28 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 109.543 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.2 tp -109.95 -48.19 3.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.933 1.693 . . . . 0.0 109.393 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.98 170.86 19.36 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.782 0.719 . . . . 0.0 111.064 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -130.65 148.61 52.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.343 1.457 . . . . 0.0 108.104 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.29 165.57 14.67 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.338 1.455 . . . . 0.0 111.371 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -54.34 147.28 13.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.405 1.482 . . . . 0.0 111.726 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.17 152.94 39.71 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 m -58.85 -20.46 50.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -68.18 -28.68 67.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.488 1.115 . . . . 0.0 112.391 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.973 0.909 . . . . 0.0 109.395 -175.159 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.77 143.83 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -137.49 166.77 23.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.857 1.263 . . . . 0.0 110.951 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 7' ' ' MET . 5.0 mp -87.53 150.3 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 169.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 29.08 4.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 0.0 110.51 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.444 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.9 mpp? -145.1 162.59 36.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 107.385 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.75 133.6 42.84 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 169.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.24 -148.36 12.55 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.52 140.13 51.34 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.24 71.7 10.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -26.47 -59.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.501 2.72 . . . . 0.0 114.0 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.16 163.28 35.87 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.999 1.32 . . . . 0.0 108.385 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.64 147.42 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.62 27.18 4.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.145 0.978 . . . . 0.0 111.785 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.52 164.82 33.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.575 1.15 . . . . 0.0 110.301 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.31 158.35 44.04 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.901 1.681 . . . . 0.0 106.876 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.8 54.15 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.6 -8.96 78.76 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.88 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.14 166.81 17.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.122 1.461 . . . . 0.0 109.666 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -124.17 138.65 54.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.726 1.21 . . . . 0.0 107.774 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 pt -128.5 162.28 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.42 1.088 . . . . 0.0 108.429 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -131.29 145.35 51.84 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.462 1.505 . . . . 0.0 107.346 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.04 129.9 24.76 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.259 0.624 . . . . 0.0 110.537 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.48 -6.45 72.9 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.411 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.62 137.57 57.44 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.654 1.727 . . . . 0.0 107.816 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.79 135.88 56.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.74 -18.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.449 1.1 . . . . 0.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.95 178.91 9.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.245 0.93 . . . . 0.0 109.301 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -135.41 143.52 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.24 131.11 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.198 2.199 . . . . 0.0 106.552 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.35 125.55 50.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.57 167.2 8.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.4 1.48 . . . . 0.0 107.752 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 mtm 55.25 32.26 18.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.913 0.885 . . . . 0.0 111.745 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 51.65 33.72 11.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.864 1.666 . . . . 0.0 112.58 -172.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.6 mmm -140.87 172.05 13.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.646 1.979 . . . . 0.0 108.52 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -124.15 140.47 52.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.62 133.89 17.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.02 158.61 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.107 1.871 . . . . 0.0 111.795 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mm -125.6 126.33 70.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.99 157.47 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.014 1.326 . . . . 0.0 110.468 -169.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 121.94 15.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.594 0.757 . . . . 0.0 108.981 175.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.29 -25.85 66.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.052 0.541 . . . . 0.0 111.66 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 162.11 39.78 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.158 1.383 . . . . 0.0 108.981 169.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -65.18 158.17 26.8 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.951 0.9 . . . . 0.0 110.928 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.18 179.32 39.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.82 134.87 27.67 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.49 105.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.98 -47.89 67.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -160.11 150.13 18.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.46 0.573 . . . . 0.0 109.747 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.05 137.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -110.66 9.73 22.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.495 0.718 . . . . 0.0 111.851 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -147.45 -179.49 6.89 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.085 1.754 . . . . 0.0 108.595 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -143.03 168.11 20.48 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.891 1.276 . . . . 0.0 108.369 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.08 132.12 42.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.849 0.859 . . . . 0.0 109.17 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 -1.4 73.62 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.055 1.312 . . . . 0.0 114.161 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.21 153.13 42.69 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.865 1.833 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.9 143.15 57.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.92 158.7 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.167 0.987 . . . . 0.0 109.586 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.17 164.05 33.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.306 0.642 . . . . 0.0 110.793 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.21 112.76 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.98 0.912 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.52 -6.49 59.18 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.007 1.289 . . . . 0.0 112.714 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.04 139.18 46.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.279 1.539 . . . . 0.0 108.69 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.89 140.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.93 -53.48 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.544 1.538 . . . . 0.0 108.347 175.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.99 168.06 25.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.535 0.683 . . . . 0.0 111.119 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -125.3 144.3 50.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.832 2.053 . . . . 0.0 106.309 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt -122.13 169.58 10.73 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.618 1.167 . . . . 0.0 110.633 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.0 p -55.49 -41.22 72.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.717 0.807 . . . . 0.0 109.219 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.66 -33.62 23.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.732 1.613 . . . . 0.0 113.3 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -63.35 -15.95 58.96 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.121 0.873 . . . . 0.0 113.257 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -61.83 -23.16 66.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.42 1.009 . . . . 0.0 112.243 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 126.628 1.971 . . . . 0.0 110.747 175.458 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.656 ' N ' ' HG1' ' A' ' 72' ' ' THR . 22.5 m . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.77 142.36 41.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.61 158.9 43.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.836 1.254 . . . . 0.0 111.332 -169.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 5' ' ' ILE . 4.9 mp -76.91 153.91 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.01 17.65 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.28 1.432 . . . . 0.0 111.574 -170.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.04 156.24 34.06 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.651 1.581 . . . . 0.0 108.061 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.74 140.3 42.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.663 0.385 . . . . 0.0 110.226 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.29 -152.04 17.06 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.14 139.07 52.09 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.6 71.93 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.659 1.183 . . . . 0.0 111.331 -169.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -28.48 -59.21 0.12 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.987 2.515 . . . . 0.0 114.11 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.71 163.53 35.63 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.01 1.324 . . . . 0.0 108.624 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.16 148.26 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.63 23.86 4.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.191 0.996 . . . . 0.0 111.664 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.49 161.94 36.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.437 1.095 . . . . 0.0 110.1 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.75 159.64 43.95 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.927 1.691 . . . . 0.0 107.242 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 134.24 53.81 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -7.11 82.38 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.64 1.115 . . . . 0.0 113.269 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -69.94 165.07 22.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.439 1.619 . . . . 0.0 110.111 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -112.94 138.5 49.72 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.502 1.521 . . . . 0.0 107.018 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -128.92 163.93 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.958 0.903 . . . . 0.0 108.638 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -138.86 140.33 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -45.44 123.16 3.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.082 0.953 . . . . 0.0 110.852 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.15 74.72 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.442 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.34 139.63 58.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.663 1.732 . . . . 0.0 108.344 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.49 138.36 58.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.29 -19.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.215 1.006 . . . . 0.0 111.889 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.44 9.18 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.444 1.02 . . . . 0.0 109.302 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -134.96 145.66 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -119.87 131.41 55.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.072 2.149 . . . . 0.0 106.608 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.43 125.94 51.56 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -170.53 169.31 7.37 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.922 1.289 . . . . 0.0 107.838 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.4 ptt? 44.64 40.82 4.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 0.0 113.073 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 52.53 33.89 14.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.232 1.813 . . . . 0.0 113.098 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.3 mtt -143.82 170.92 14.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.115 1.766 . . . . 0.0 108.984 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -123.84 138.13 54.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.16 133.35 18.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.46 155.16 70.05 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.842 1.695 . . . . 0.0 111.076 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.27 127.52 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.6 157.28 17.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.38 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 116.43 5.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.71 1.204 . . . . 0.0 108.172 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.95 -25.02 66.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.037 0.535 . . . . 0.0 111.489 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -157.08 156.54 32.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.144 1.377 . . . . 0.0 108.763 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 m -74.97 156.41 36.33 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.645 0.778 . . . . 0.0 110.918 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.98 175.26 33.83 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.82 -0.55 . . . . 0.0 112.681 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.92 135.13 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 108.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -70.83 -46.62 62.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -159.47 156.03 27.56 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.9 135.97 47.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.01 1.83 24.67 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.317 0.647 . . . . 0.0 112.372 -169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -141.43 176.97 8.44 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.101 1.36 . . . . 0.0 109.444 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.8 163.22 35.7 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.886 1.275 . . . . 0.0 108.566 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.57 128.64 35.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.515 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.2 87.4 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.135 1.35 . . . . 0.0 113.942 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.4 154.32 42.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.985 1.892 . . . . 0.0 110.572 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.27 143.2 57.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.94 159.97 15.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 109.282 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.21 167.77 22.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.39 -171.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.32 111.36 1.73 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.05 1.83 66.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.951 1.262 . . . . 0.0 112.841 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -78.25 130.73 36.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.334 1.567 . . . . 0.0 108.002 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.37 143.34 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.268 0.485 . . . . 0.0 109.745 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.0 tp -100.51 -51.86 3.5 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.107 1.363 . . . . 0.0 108.902 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.89 168.49 23.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 111.719 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.75 141.72 51.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.973 2.109 . . . . 0.0 106.202 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.7 mt -120.9 156.44 32.01 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.272 1.029 . . . . 0.0 110.353 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -82.25 10.6 6.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.11 1.364 . . . . 0.0 111.803 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -145.72 150.24 35.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.956 1.702 . . . . 0.0 108.386 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.2 m 43.24 44.4 4.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 112.464 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.656 ' HG1' ' N ' ' A' ' 2' ' ' THR . 99.9 m -146.34 147.07 30.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.807 2.043 . . . . 0.0 106.492 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.606 1.563 . . . . 0.0 107.151 179.292 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t -129.77 129.87 66.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -141.35 163.12 33.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.307 1.443 . . . . 0.0 111.162 -168.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.21 152.81 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.56 26.81 4.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.501 1.12 . . . . 0.0 111.381 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.5 155.95 32.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.445 1.498 . . . . 0.0 108.001 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.32 140.29 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 122.072 -0.393 . . . . 0.0 110.019 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.42 -150.79 15.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.45 142.16 50.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -84.15 74.6 10.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.305 1.042 . . . . 0.0 110.552 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.43 -57.5 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.8 2.44 . . . . 0.0 113.865 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -147.11 161.75 40.23 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.998 1.319 . . . . 0.0 108.7 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.23 146.7 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -129.97 25.1 5.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.207 1.003 . . . . 0.0 111.525 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.59 163.68 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.416 1.087 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -147.55 156.72 43.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.22 1.808 . . . . 0.0 106.316 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 132.96 52.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.77 74.81 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.839 1.209 . . . . 0.0 113.066 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.68 163.44 27.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.331 1.566 . . . . 0.0 110.274 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -108.96 139.17 44.18 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.272 1.429 . . . . 0.0 107.148 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.18 163.18 34.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 170.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -139.63 137.34 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -44.33 123.2 3.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.2 1.0 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.48 71.82 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.639 -1.09 . . . . 0.0 113.54 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.1 138.85 58.03 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.512 1.656 . . . . 0.0 108.211 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.9 141.95 57.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.87 -18.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.814 1.245 . . . . 0.0 111.011 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.85 178.51 10.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.268 0.94 . . . . 0.0 109.061 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -133.86 145.05 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -117.61 133.15 56.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.287 2.235 . . . . 0.0 106.253 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -107.21 121.69 45.04 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 t -166.63 166.82 15.83 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.93 1.292 . . . . 0.0 108.1 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 51.66 29.81 6.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.34 1.056 . . . . 0.0 111.9 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 50.72 37.32 16.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.478 1.511 . . . . 0.0 112.306 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.7 mtm -139.36 170.37 16.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.529 1.932 . . . . 0.0 107.9 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -119.89 139.63 52.11 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.59 129.95 15.47 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.91 156.05 66.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.709 1.606 . . . . 0.0 111.14 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 125.77 72.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 156.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.821 1.249 . . . . 0.0 110.53 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 114.28 3.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.43 -24.8 67.29 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.571 0.349 . . . . 0.0 111.338 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -157.32 155.89 31.44 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.694 1.598 . . . . 0.0 108.565 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 m -77.49 158.37 29.98 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.731 0.812 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.86 177.28 35.72 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.8 mm -85.36 135.56 24.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.38 106.75 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -75.69 -39.58 57.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.05 158.14 38.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 109.37 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.46 124.88 73.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -92.41 -5.43 52.04 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 112.022 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -137.0 177.5 7.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.499 1.119 . . . . 0.0 109.617 -170.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -141.87 165.92 26.14 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.63 134.51 57.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.43 82.45 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.219 -1.323 . . . . 0.0 114.122 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -72.58 155.14 40.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.113 1.956 . . . . 0.0 110.685 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -66.37 143.88 56.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.35 160.24 17.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.066 0.946 . . . . 0.0 109.146 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.29 168.4 20.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.538 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.98 110.46 1.57 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.26 1.77 64.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.104 1.335 . . . . 0.0 112.839 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.8 128.38 33.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.287 1.544 . . . . 0.0 108.162 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 t -68.88 138.49 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -91.01 -51.89 5.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.592 1.157 . . . . 0.0 108.617 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.77 168.33 27.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.966 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.23 147.56 50.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.353 1.861 . . . . 0.0 106.621 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.99 166.53 14.33 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.69 1.196 . . . . 0.0 111.278 -169.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.2 p -60.11 -25.73 65.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.096 1.758 . . . . 0.0 113.557 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -152.81 170.72 19.62 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.614 1.566 . . . . 0.0 108.249 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 42.63 27.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 111.988 173.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -76.27 26.6 0.12 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.774 1.629 . . . . 0.0 113.596 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 124.229 1.011 . . . . 0.0 109.302 176.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.9 t -83.28 140.35 16.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -140.0 166.09 25.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.755 1.622 . . . . 0.0 109.913 -169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -94.59 155.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -132.9 27.61 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.787 1.235 . . . . 0.0 111.23 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 153.16 30.84 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.044 1.338 . . . . 0.0 108.05 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.48 138.58 40.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.48 -153.31 18.69 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.09 138.87 45.56 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.69 121.17 14.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -71.89 -54.83 8.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -150.09 161.09 43.05 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.573 1.549 . . . . 0.0 108.481 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.52 143.27 39.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.97 -21.58 7.06 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 111.942 -169.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.08 165.41 2.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.773 0.797 . . . . 0.0 111.44 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -147.6 153.94 40.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.48 129.88 44.17 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.22 -12.21 63.61 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.814 1.197 . . . . 0.0 112.639 -174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -70.08 168.69 15.0 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.906 1.353 . . . . 0.0 109.875 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -125.05 138.42 54.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.725 1.21 . . . . 0.0 107.901 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -129.29 158.8 41.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -135.86 142.22 44.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -47.03 120.95 3.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.704 0.684 . . . . 0.0 110.98 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.15 -11.34 67.5 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.849 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -64.47 142.84 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.551 1.676 . . . . 0.0 108.245 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.84 143.46 54.55 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -134.44 -37.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.595 1.158 . . . . 0.0 110.06 -171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.4 -179.02 7.78 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.08 0.952 . . . . 0.0 109.3 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -137.03 139.5 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -113.79 133.36 55.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.581 1.952 . . . . 0.0 106.943 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.88 124.12 47.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -167.57 166.47 14.09 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.507 1.123 . . . . 0.0 108.565 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.77 44.98 1.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.841 1.656 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.41 31.8 12.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.965 1.706 . . . . 0.0 113.126 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -139.14 169.35 17.95 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.177 1.791 . . . . 0.0 108.694 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.8 140.13 50.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.64 126.83 16.12 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.7 151.9 44.8 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.578 2.185 . . . . 0.0 112.432 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -128.15 131.95 68.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 169.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.67 160.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.094 1.358 . . . . 0.0 109.59 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.04 116.95 5.35 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.88 1.272 . . . . 0.0 108.52 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.22 -26.72 66.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.99 0.516 . . . . 0.0 111.4 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -157.77 161.16 38.43 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.568 1.547 . . . . 0.0 108.966 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -80.39 157.6 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 111.214 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.03 179.8 36.0 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.95 0.786 . . . . 0.0 111.857 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -85.94 136.48 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.54 98.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -69.53 -39.78 77.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -155.85 166.33 33.8 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.8 t -125.21 134.12 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -103.83 0.03 29.77 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.9 176.44 9.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.875 1.27 . . . . 0.0 109.966 -170.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.38 165.3 31.51 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 108.675 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.66 136.26 50.7 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.951 0.901 . . . . 0.0 108.799 172.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.11 -8.9 65.21 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.616 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -74.88 152.36 38.89 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.972 1.886 . . . . 0.0 110.942 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -68.14 145.22 54.58 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.067 0.947 . . . . 0.0 109.195 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 m -142.86 161.04 18.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 123.856 0.863 . . . . 0.0 109.721 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -144.07 167.27 22.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.347 -174.476 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.59 109.62 1.45 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.39 -0.35 57.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.339 1.447 . . . . 0.0 112.849 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.68 126.57 31.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.435 1.617 . . . . 0.0 108.697 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.8 145.41 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -113.77 -44.65 3.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.249 1.42 . . . . 0.0 109.411 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 171.0 18.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.981 0.81 . . . . 0.0 111.017 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -126.94 137.84 53.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.974 1.71 . . . . 0.0 106.577 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -118.78 159.24 24.07 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 111.305 -172.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.9 p -64.38 -30.0 71.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.113 0.965 . . . . 0.0 111.196 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -53.07 139.52 28.07 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.05 1.74 . . . . 0.0 112.054 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 m -139.58 13.63 2.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.898 1.279 . . . . 0.0 111.479 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -130.54 -41.24 1.21 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.995 0.816 . . . . 0.0 111.944 -169.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.659 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.605 ' N ' ' HG ' ' A' ' 71' ' ' SER . 94.0 m . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.8 146.71 30.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -170.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -139.05 158.66 43.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 110.646 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.74 149.74 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -112.0 8.09 20.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.262 0.625 . . . . 0.0 111.91 -170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -158.53 159.17 35.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.093 1.357 . . . . 0.0 108.918 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.04 140.49 41.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 110.291 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.92 -151.97 16.23 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.52 142.42 50.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.36 76.9 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.133 0.973 . . . . 0.0 110.649 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -37.68 -57.79 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.952 2.101 . . . . 0.0 113.43 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -148.28 161.4 41.59 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.183 1.393 . . . . 0.0 108.635 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -136.38 146.49 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -131.26 24.05 4.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.86 0.864 . . . . 0.0 112.094 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 m -131.83 162.18 39.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.561 1.144 . . . . 0.0 109.959 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.3 162.62 38.58 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.066 1.747 . . . . 0.0 107.155 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 135.76 43.68 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.84 -8.27 73.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.727 -1.04 . . . . 0.0 113.061 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.7 164.85 24.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.25 1.525 . . . . 0.0 110.033 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -120.03 140.55 50.81 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.96 1.304 . . . . 0.0 108.174 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -130.89 158.87 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.6 145.05 46.49 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -48.76 121.65 4.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.582 0.628 . . . . 0.0 110.525 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.28 78.37 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.601 -1.11 . . . . 0.0 113.824 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -63.52 138.66 58.59 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.66 1.73 . . . . 0.0 107.881 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.48 139.74 53.94 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.63 -30.69 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.64 1.176 . . . . 0.0 110.688 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.78 -178.93 7.72 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.7 1.136 . . . . 0.0 109.528 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.33 140.06 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.87 137.21 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.71 2.004 . . . . 0.0 106.336 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -114.78 124.06 50.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -169.31 169.76 8.91 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.958 1.303 . . . . 0.0 107.849 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 18.9 ptt? 44.7 41.27 4.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.767 1.227 . . . . 0.0 112.856 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.71 31.5 12.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.351 1.86 . . . . 0.0 113.183 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.38 170.04 16.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.71 1.604 . . . . 0.0 109.356 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.22 140.56 50.99 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.12 128.06 17.32 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.54 154.06 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.889 1.726 . . . . 0.0 110.756 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.65 133.02 69.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.6 m -125.06 161.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.389 1.076 . . . . 0.0 110.217 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.93 3.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.59 -20.45 65.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 0.0 111.756 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -154.23 160.29 41.75 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.656 1.582 . . . . 0.0 108.479 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -70.36 157.23 38.13 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.389 0.676 . . . . 0.0 110.805 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.65 -174.38 42.06 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.754 -0.591 . . . . 0.0 112.352 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.52 134.48 46.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.56 114.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -76.35 -46.37 27.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.49 155.53 30.51 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.74 129.2 70.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.96 -3.33 45.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.011 0.924 . . . . 0.0 112.569 -169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -136.55 177.44 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.307 1.043 . . . . 0.0 109.532 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -143.15 159.99 41.27 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.69 1.196 . . . . 0.0 108.224 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.34 130.77 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.53 86.97 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.182 1.372 . . . . 0.0 113.637 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.58 155.7 40.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.888 1.844 . . . . 0.0 110.799 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -67.55 144.94 55.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.37 159.84 15.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.06 0.944 . . . . 0.0 109.134 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.6 168.46 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.045 0.538 . . . . 0.0 111.701 -171.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.56 114.01 2.74 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.93 4.75 81.82 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.83 1.205 . . . . 0.0 113.005 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -79.87 123.43 27.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.382 1.591 . . . . 0.0 107.884 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.52 141.52 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.144 0.578 . . . . 0.0 109.695 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -106.71 -46.16 4.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.87 1.268 . . . . 0.0 109.46 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.24 161.44 41.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.129 0.877 . . . . 0.0 111.589 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -126.31 143.36 51.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.717 2.007 . . . . 0.0 106.272 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.49 153.65 33.82 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.997 0.919 . . . . 0.0 109.54 -169.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 m -61.65 -31.63 71.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.261 0.624 . . . . 0.0 111.731 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -23.43 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.418 0.687 . . . . 0.0 111.203 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.605 ' HG ' ' N ' ' A' ' 2' ' ' THR . 3.3 m -84.18 -41.27 17.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.669 0.788 . . . . 0.0 110.435 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.8 p -81.41 -36.85 29.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.513 0.597 . . . . 0.0 112.224 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 126.426 1.89 . . . . 0.0 110.742 -174.574 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.16 128.1 44.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 19.8 m -140.1 152.49 46.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.433 1.093 . . . . 0.0 111.229 -169.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.3 mp -66.82 147.23 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 26.19 5.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.529 0.732 . . . . 0.0 111.828 -171.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.43 164.34 38.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.806 2.042 . . . . 0.0 107.432 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -82.25 143.42 31.36 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 109.918 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.0 -152.27 17.97 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 117.972 0.351 . . . . 0.0 112.262 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.97 133.24 45.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 116.96 13.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -71.08 -62.32 1.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.179 0.592 . . . . 0.0 109.98 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -148.44 157.6 43.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.6 1.16 . . . . 0.0 110.262 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.17 149.19 28.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -124.47 -22.16 4.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 0.0 111.363 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.77 162.78 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.577 0.704 . . . . 0.0 111.657 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -148.71 160.93 42.71 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.276 1.831 . . . . 0.0 106.885 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 133.85 51.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.46 0.573 . . . . 0.0 109.552 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.29 -1.92 87.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.582 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -68.6 163.46 23.61 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.51 1.655 . . . . 0.0 110.036 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -108.35 138.58 44.4 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -129.22 160.06 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -138.85 140.76 38.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -47.17 120.88 3.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.029 0.831 . . . . 0.0 110.595 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.47 -8.65 66.65 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.55 -1.139 . . . . 0.0 113.855 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.99 134.1 54.41 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.69 1.745 . . . . 0.0 108.244 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.67 132.87 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.2 -22.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.932 0.893 . . . . 0.0 111.743 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 179.12 9.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.381 1.072 . . . . 0.0 109.218 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.2 mt -135.64 145.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.451 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -122.33 136.0 54.82 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.759 2.024 . . . . 0.0 106.799 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.57 124.14 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -169.33 166.34 10.49 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 107.862 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.8 mtm 55.62 31.78 17.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.909 0.884 . . . . 0.0 111.587 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 51.81 33.66 11.74 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.849 1.659 . . . . 0.0 112.567 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.2 mmt -141.24 173.34 11.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.745 2.018 . . . . 0.0 108.737 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.82 138.54 54.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.09 130.04 17.26 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.46 151.78 70.8 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.879 1.719 . . . . 0.0 110.425 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.29 124.02 70.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.44 158.51 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 110.196 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 115.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.718 1.207 . . . . 0.0 108.108 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.72 -23.57 66.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.099 0.56 . . . . 0.0 111.51 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -155.76 157.08 35.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.686 1.595 . . . . 0.0 108.483 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -71.66 157.68 37.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.22 -178.1 38.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 122.141 -0.349 . . . . 0.0 112.276 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.52 136.23 27.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.61 113.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.1 -52.4 9.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.01 131.87 8.86 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.335 0.516 . . . . 0.0 109.781 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.13 141.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -119.36 7.94 11.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.853 0.861 . . . . 0.0 112.621 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -141.71 175.12 9.95 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.679 1.192 . . . . 0.0 109.982 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -148.67 167.1 26.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.392 1.877 . . . . 0.0 108.254 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -59.69 135.25 57.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.712 0.805 . . . . 0.0 109.447 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.71 -1.48 77.96 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.052 1.31 . . . . 0.0 113.874 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.41 151.46 41.15 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.62 1.71 . . . . 0.0 110.529 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.49 144.85 53.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.44 159.78 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.632 0.773 . . . . 0.0 109.914 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.46 166.96 23.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.305 -174.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.14 112.46 2.65 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.64 59.89 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.169 1.366 . . . . 0.0 112.765 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -76.35 127.04 32.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.171 1.485 . . . . 0.0 108.961 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 t -66.18 128.33 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.641 0.776 . . . . 0.0 109.427 -170.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' H ' ' HA ' ' A' ' 4' ' ' SER . 65.1 tp -85.01 -44.88 12.67 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.15 0.98 . . . . 0.0 108.981 169.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -156.21 162.81 40.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.663 0.665 . . . . 0.0 112.371 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -115.11 147.58 40.04 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.454 2.302 . . . . 0.0 106.977 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.2 mt -125.23 153.26 43.42 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.626 1.17 . . . . 0.0 110.821 -169.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -79.01 44.58 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.499 1.52 . . . . 0.0 110.175 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.51 -35.35 74.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.277 1.031 . . . . 0.0 112.438 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 m -137.99 156.18 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.991 1.316 . . . . 0.0 108.989 -172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -56.71 134.23 54.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.41 1.084 . . . . 0.0 109.271 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.516 1.526 . . . . 0.0 108.279 -173.287 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.56 145.45 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -140.43 160.01 40.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.49 1.116 . . . . 0.0 111.709 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 5' ' ' ILE . 4.5 mp -76.11 152.91 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.76 15.86 5.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.313 1.445 . . . . 0.0 111.609 -169.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.28 157.38 35.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.664 1.585 . . . . 0.0 108.04 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.21 141.06 41.89 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.607 0.363 . . . . 0.0 110.214 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -152.68 18.27 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.48 138.52 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.16 71.73 9.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.839 1.255 . . . . 0.0 111.155 -169.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -30.61 -58.61 0.2 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.099 2.56 . . . . 0.0 114.069 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -146.83 160.51 42.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.038 1.335 . . . . 0.0 108.645 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -137.85 142.44 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -122.35 -22.5 5.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.768 0.427 . . . . 0.0 111.845 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.84 159.78 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.444 0.64 . . . . 0.0 111.185 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.42 160.08 44.01 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 126.328 1.851 . . . . 0.0 106.954 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.08 45.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.824 0.738 . . . . 0.0 109.429 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.16 -8.46 79.77 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.863 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -68.91 163.38 24.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.205 1.502 . . . . 0.0 109.881 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -119.9 139.52 52.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.866 1.266 . . . . 0.0 107.901 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 pt -129.81 157.34 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -133.99 144.18 48.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.54 122.37 7.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.885 0.766 . . . . 0.0 110.422 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.47 71.54 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.746 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -64.69 141.21 58.85 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.542 1.671 . . . . 0.0 108.121 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.36 144.32 55.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.195 0.598 . . . . 0.0 109.409 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 t -134.93 -38.35 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.385 . . . . 0.0 109.585 -170.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.53 -178.43 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.354 1.062 . . . . 0.0 108.994 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -134.1 145.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.88 128.13 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.593 1.957 . . . . 0.0 106.673 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.89 124.33 43.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.86 166.83 9.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.251 1.42 . . . . 0.0 107.757 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.4 mtm 54.98 32.49 18.17 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.95 0.9 . . . . 0.0 111.63 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 51.96 33.28 11.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.065 1.746 . . . . 0.0 112.629 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.9 mmt -141.05 173.52 11.4 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.665 1.986 . . . . 0.0 108.406 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.84 140.14 53.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.99 128.92 17.88 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.69 153.41 36.42 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.647 2.232 . . . . 0.0 112.732 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -126.38 130.01 71.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -124.62 159.3 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 124.712 1.205 . . . . 0.0 110.156 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 119.21 8.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.781 1.232 . . . . 0.0 109.022 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.6 -19.11 62.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.434 0.693 . . . . 0.0 111.935 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -154.16 159.73 41.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.812 1.645 . . . . 0.0 108.733 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -73.33 154.57 40.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.64 0.776 . . . . 0.0 110.496 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.7 -173.81 42.71 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.255 0.455 . . . . 0.0 112.255 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.14 136.81 40.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.74 115.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.3 -46.61 15.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -156.09 156.6 34.62 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.4 t -117.34 134.96 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.79 3.46 34.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.629 1.172 . . . . 0.0 113.064 -169.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -141.65 179.13 7.01 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.104 . . . . 0.0 109.298 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.67 161.33 40.11 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.324 1.45 . . . . 0.0 107.917 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.69 134.15 52.61 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.36 0.1 85.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.308 1.432 . . . . 0.0 113.789 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -72.24 156.06 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.647 . . . . 0.0 110.437 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.67 143.38 56.0 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.92 160.24 13.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.249 1.02 . . . . 0.0 109.396 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.9 167.03 23.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -172.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 114.7 3.11 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.797 0.839 . . . . 0.0 108.969 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.0 74.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.866 1.222 . . . . 0.0 112.809 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -75.87 129.6 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.366 1.583 . . . . 0.0 108.31 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.34 141.47 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.9 tp -108.03 -43.31 4.44 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.781 1.232 . . . . 0.0 110.329 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.08 165.51 36.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.231 0.923 . . . . 0.0 111.713 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -126.92 146.0 50.47 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.857 2.063 . . . . 0.0 106.605 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.8 mt -119.27 155.82 31.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.585 1.154 . . . . 0.0 110.3 -169.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 m -70.37 -7.88 46.35 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.23 160.39 42.53 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.517 1.053 . . . . 0.0 109.645 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -62.95 -42.67 99.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 m -148.12 144.37 27.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.77 0.714 . . . . 0.0 109.832 -169.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 . . . . . 0 C--O 1.248 1.01 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.55 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.58 144.72 35.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 m -142.65 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.475 1.51 . . . . 0.0 110.283 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.03 157.81 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.991 1.316 . . . . 0.0 107.831 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -136.1 26.02 3.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.116 1.367 . . . . 0.0 111.269 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 156.46 34.14 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.615 1.566 . . . . 0.0 107.909 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.34 139.28 36.65 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.658 -0.651 . . . . 0.0 109.62 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.74 -152.54 16.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.22 138.9 51.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 tp -83.0 71.69 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 111.111 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -27.49 -60.27 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.84 2.456 . . . . 0.0 113.731 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -145.09 162.7 36.35 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.244 1.018 . . . . 0.0 109.489 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.39 147.03 29.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -125.04 -27.43 3.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.042 0.537 . . . . 0.0 111.152 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.18 158.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.643 0.735 . . . . 0.0 110.841 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -153.35 156.56 38.56 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.226 1.81 . . . . 0.0 106.787 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 130.76 45.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.692 0.678 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.77 83.25 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.081 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -66.95 165.53 15.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.267 1.533 . . . . 0.0 109.502 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -123.38 139.66 53.8 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.146 . . . . 0.0 107.925 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -130.24 158.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.105 0.962 . . . . 0.0 108.628 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.78 146.42 49.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -48.26 121.45 4.38 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.634 0.652 . . . . 0.0 110.292 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.53 78.1 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.596 -1.113 . . . . 0.0 113.991 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -65.19 141.5 58.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.607 1.704 . . . . 0.0 108.115 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.09 145.06 56.28 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.046 0.538 . . . . 0.0 109.553 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -135.14 -38.7 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.2 1.4 . . . . 0.0 109.684 -172.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.65 -178.28 7.23 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.041 0.937 . . . . 0.0 109.521 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -135.4 143.76 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.11 132.03 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.822 2.049 . . . . 0.0 106.868 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -103.82 125.87 50.56 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -169.06 169.88 9.2 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.727 1.211 . . . . 0.0 107.872 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.6 ptt? 44.61 40.98 4.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.015 1.326 . . . . 0.0 113.032 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.28 33.32 15.27 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.313 1.845 . . . . 0.0 113.04 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -144.16 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.018 1.727 . . . . 0.0 109.158 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -120.78 139.37 53.21 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 169.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.16 132.05 19.98 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.4 153.03 74.95 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.844 1.696 . . . . 0.0 110.665 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -126.52 133.75 67.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.38 161.42 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.819 1.248 . . . . 0.0 110.404 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 117.48 6.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.375 1.47 . . . . 0.0 108.877 171.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.55 -22.07 65.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.961 0.505 . . . . 0.0 111.77 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -155.22 161.24 41.22 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.612 1.565 . . . . 0.0 108.836 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -72.72 159.17 34.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.886 0.874 . . . . 0.0 111.287 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.65 -176.33 38.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.436 0.541 . . . . 0.0 111.978 172.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.1 137.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.66 104.58 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -68.8 -51.07 44.72 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -160.22 135.39 7.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.235 0.471 . . . . 0.0 109.771 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.89 139.1 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.75 7.78 18.67 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.742 0.817 . . . . 0.0 111.643 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -142.82 177.2 8.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.263 1.825 . . . . 0.0 108.616 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -144.59 171.94 13.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.7 134.77 51.58 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.561 0.745 . . . . 0.0 109.582 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.17 2.78 54.71 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.01 1.291 . . . . 0.0 114.473 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -70.45 153.47 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.864 1.832 . . . . 0.0 110.118 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -66.02 143.56 57.28 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.04 159.32 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.798 0.839 . . . . 0.0 109.384 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.44 167.16 23.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.386 -172.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.66 110.47 1.73 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.24 1.2 62.8 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.144 1.354 . . . . 0.0 113.094 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -78.83 130.08 35.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.427 1.613 . . . . 0.0 108.434 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.37 149.12 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.806 . . . . 0.0 109.84 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.1 tp -119.65 -48.13 2.39 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.208 1.403 . . . . 0.0 109.654 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.08 166.31 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.75 0.705 . . . . 0.0 111.836 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.61 145.29 48.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.153 2.181 . . . . 0.0 106.77 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt -124.03 165.44 17.47 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.178 0.991 . . . . 0.0 112.567 -168.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -137.27 170.83 15.43 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.294 2.238 . . . . 0.0 108.235 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -152.3 165.59 34.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.427 1.891 . . . . 0.0 106.219 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 m -56.19 -16.76 5.77 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 114.19 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -68.24 -11.4 59.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.89 1.676 . . . . 0.0 113.419 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.035 1.334 . . . . 0.0 110.373 178.597 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.1 147.86 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -138.22 159.52 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.889 1.676 . . . . 0.0 110.089 -169.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.65 146.57 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -107.0 8.98 30.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 111.813 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.48 159.92 36.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.257 1.423 . . . . 0.0 108.891 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.96 142.38 38.38 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.782 0.433 . . . . 0.0 110.169 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.12 -152.81 19.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.52 139.05 45.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.45 118.16 10.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -69.85 -54.18 14.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -149.78 161.54 42.04 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.655 1.582 . . . . 0.0 108.069 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.6 t -134.3 140.6 45.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -115.42 -23.76 8.69 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.74 0.416 . . . . 0.0 111.631 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.19 165.09 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 123.76 0.824 . . . . 0.0 111.759 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -147.1 154.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.94 130.78 48.42 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.7 -10.59 68.6 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.563 1.078 . . . . 0.0 112.74 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -69.39 168.53 14.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.018 1.409 . . . . 0.0 109.815 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -125.48 140.73 52.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.863 1.265 . . . . 0.0 107.776 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -129.26 162.5 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.624 1.17 . . . . 0.0 108.495 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -133.19 141.61 48.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.711 1.604 . . . . 0.0 106.932 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -48.44 127.5 13.23 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.375 0.67 . . . . 0.0 110.937 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 -10.35 71.15 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.479 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.44 142.12 58.28 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.527 1.663 . . . . 0.0 107.167 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.68 152.88 44.53 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.644 0.735 . . . . 0.0 109.893 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -141.26 -35.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.337 1.455 . . . . 0.0 109.376 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.15 -179.15 7.44 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.942 0.897 . . . . 0.0 109.065 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.63 140.37 43.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -114.54 128.9 56.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.958 2.103 . . . . 0.0 106.82 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.32 125.88 45.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -170.45 169.6 7.37 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.82 1.248 . . . . 0.0 108.061 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.1 ptt? 44.66 40.34 4.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.136 1.374 . . . . 0.0 113.202 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.95 33.98 15.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.139 1.776 . . . . 0.0 112.853 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -143.73 170.9 14.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.264 1.825 . . . . 0.0 109.028 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -124.38 137.98 54.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.97 126.44 16.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.78 153.5 75.61 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.36 1.373 . . . . 0.0 111.014 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.99 130.12 74.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.54 159.77 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 124.622 1.169 . . . . 0.0 110.855 -169.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 116.59 5.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 108.439 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.84 -25.14 65.4 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.004 0.522 . . . . 0.0 111.696 173.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -156.17 154.01 30.16 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.673 1.589 . . . . 0.0 108.443 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -66.16 157.35 31.51 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.573 0.749 . . . . 0.0 110.394 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.69 -179.31 38.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -87.66 137.55 20.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.7 102.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -71.52 -41.19 69.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -156.63 162.56 39.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.55 134.03 67.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -102.43 -4.06 26.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.073 0.949 . . . . 0.0 112.732 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -141.36 179.55 6.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.746 1.218 . . . . 0.0 110.278 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -148.96 163.8 36.43 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.341 1.456 . . . . 0.0 108.634 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.85 137.19 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.8 0.84 . . . . 0.0 109.103 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.94 66.4 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.648 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.17 152.29 38.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.84 1.82 . . . . 0.0 111.066 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -68.17 146.0 53.82 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.026 0.931 . . . . 0.0 109.256 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.68 160.55 14.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 110.08 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -140.71 167.78 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.47 0.708 . . . . 0.0 110.992 -175.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.17 116.13 3.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.53 2.56 79.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.783 1.182 . . . . 0.0 113.119 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -78.28 123.19 26.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.468 1.634 . . . . 0.0 107.803 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 t -64.87 145.88 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.277 0.631 . . . . 0.0 109.808 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.7 tp -113.35 -45.89 3.11 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.786 1.235 . . . . 0.0 109.803 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.65 160.53 42.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.394 0.997 . . . . 0.0 112.315 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.63 141.46 51.99 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.015 2.126 . . . . 0.0 105.898 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -126.47 158.29 36.45 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.812 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.3 p -60.04 -43.38 95.39 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.467 0.651 . . . . 0.0 109.568 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -79.22 28.62 0.23 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.572 1.949 . . . . 0.0 112.427 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.0 m -78.82 49.99 0.96 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.486 -1.384 . . . . 0.0 110.213 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -61.7 155.59 22.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.318 1.447 . . . . 0.0 110.992 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.248 0.986 0 C-N-CA 125.77 1.628 . . . . 0.0 107.159 178.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t -129.5 139.39 51.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.6 m -138.89 165.05 28.06 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.801 1.24 . . . . 0.0 110.844 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.16 156.33 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 170.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.0 27.08 3.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.781 1.232 . . . . 0.0 110.892 -175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 156.82 34.35 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.733 1.613 . . . . 0.0 107.814 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.66 140.73 35.5 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.28 -151.91 16.76 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.56 137.01 45.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.55 119.91 23.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -76.84 -51.34 11.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.033 0.933 . . . . 0.0 111.049 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -150.31 158.91 44.68 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.824 1.649 . . . . 0.0 107.659 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.6 t -135.76 147.91 28.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -130.0 23.47 5.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 111.808 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.35 164.8 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.433 1.093 . . . . 0.0 110.564 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -146.79 158.2 43.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.137 1.775 . . . . 0.0 106.482 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.32 135.35 53.77 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.64 -7.96 80.79 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.833 1.206 . . . . 0.0 113.297 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.71 164.7 24.54 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.329 1.564 . . . . 0.0 110.372 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -109.58 137.58 47.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 107.255 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -128.83 162.29 36.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -137.13 144.55 43.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -49.98 124.63 10.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.81 0.732 . . . . 0.0 110.354 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.03 -8.41 77.95 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.62 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.66 134.63 54.67 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.569 1.684 . . . . 0.0 107.934 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -67.88 131.7 45.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.96 -19.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.231 1.013 . . . . 0.0 111.787 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.13 179.83 8.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 109.773 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -134.44 143.39 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -114.84 140.54 48.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.006 2.123 . . . . 0.0 107.105 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.46 123.14 47.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 t -167.41 169.66 12.07 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.789 1.235 . . . . 0.0 107.799 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 19.8 ptt? 44.96 39.9 4.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.807 1.243 . . . . 0.0 113.028 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 53.05 34.14 16.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.287 1.835 . . . . 0.0 112.821 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.5 mtp -144.08 167.8 21.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.088 1.755 . . . . 0.0 109.182 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.3 139.04 51.94 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.56 131.44 18.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.14 155.1 68.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.997 1.798 . . . . 0.0 111.087 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.74 124.5 66.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.75 156.31 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.952 1.301 . . . . 0.0 110.247 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.91 12.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.925 1.29 . . . . 0.0 108.868 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.36 -23.04 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.24 0.616 . . . . 0.0 111.992 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -154.58 161.6 41.54 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.183 1.793 . . . . 0.0 108.027 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -73.88 157.01 37.09 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.414 0.686 . . . . 0.0 110.504 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.47 36.24 Favored Glycine 0 CA--C 1.524 0.597 0 O-C-N 121.736 -0.602 . . . . 0.0 112.092 170.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.15 135.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.14 101.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -69.33 -41.3 76.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -156.57 163.53 39.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.567 0.621 . . . . 0.0 109.341 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -124.76 137.75 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -118.55 3.48 11.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -139.79 171.25 14.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.973 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -148.31 171.88 15.28 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.838 1.655 . . . . 0.0 108.913 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -57.98 133.44 55.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.08 0.552 . . . . 0.0 109.511 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.89 74.35 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.878 1.228 . . . . 0.0 113.562 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.22 139.63 50.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.301 1.551 . . . . 0.0 109.228 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -65.9 140.97 58.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.66 157.98 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.51 166.33 26.01 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.978 -171.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.3 108.19 1.05 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.35 0.1 58.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.266 1.413 . . . . 0.0 113.061 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -79.78 130.51 35.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.599 1.7 . . . . 0.0 108.65 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.66 150.05 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.757 0.823 . . . . 0.0 110.066 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.17 -51.61 2.21 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.935 1.694 . . . . 0.0 108.427 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.02 171.92 15.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.987 0.515 . . . . 0.0 110.799 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.92 148.73 50.95 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.478 1.111 . . . . 0.0 108.396 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -125.23 168.73 13.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.057 1.343 . . . . 0.0 112.415 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 p -54.92 143.91 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.366 1.466 . . . . 0.0 110.482 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -161.16 -51.82 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.797 0.839 . . . . 0.0 110.147 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 m -117.23 10.51 13.8 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 110.498 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -73.35 -12.08 60.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.526 2.731 . . . . 0.0 112.506 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 C--O 1.248 0.993 0 C-N-CA 126.65 1.98 . . . . 0.0 107.693 178.145 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 121.184 0.516 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.02 143.87 38.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 20.4 m -138.12 161.73 36.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.183 0.993 . . . . 0.0 111.982 -169.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -80.52 153.39 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -132.14 27.84 4.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.57 157.35 35.17 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.697 1.599 . . . . 0.0 107.858 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.63 141.97 34.46 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 171.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 -152.51 20.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.63 136.52 51.75 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.19 71.89 9.24 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.906 1.282 . . . . 0.0 111.03 -169.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -24.82 -59.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.431 2.692 . . . . 0.0 114.292 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -144.9 163.84 32.91 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.639 1.176 . . . . 0.0 108.991 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.88 146.52 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -122.68 -17.99 6.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.043 0.537 . . . . 0.0 111.648 -169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.98 166.73 2.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.685 0.755 . . . . 0.0 111.961 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -149.55 162.09 40.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.373 1.869 . . . . 0.0 106.039 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.49 138.23 51.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.706 0.685 . . . . 0.0 109.513 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.26 -5.94 70.2 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.727 -1.041 . . . . 0.0 113.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.86 166.84 18.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.311 1.555 . . . . 0.0 109.448 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -122.25 141.68 51.24 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -129.88 162.65 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.493 1.117 . . . . 0.0 108.292 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.73 140.66 44.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -46.4 123.81 5.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 110.788 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.69 -10.03 75.93 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.619 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.51 139.25 58.47 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.571 1.686 . . . . 0.0 108.145 170.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 142.99 57.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.15 -21.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.031 1.332 . . . . 0.0 110.728 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 179.42 8.73 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.62 0.768 . . . . 0.0 109.038 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -135.61 146.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.47 133.64 53.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.025 2.13 . . . . 0.0 106.358 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -107.87 125.3 51.3 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -170.01 165.97 9.34 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.039 1.336 . . . . 0.0 107.851 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 mtm 56.22 29.99 15.8 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.945 0.898 . . . . 0.0 111.856 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 52.0 35.61 16.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.586 1.555 . . . . 0.0 112.308 -171.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.54 172.93 12.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.602 1.961 . . . . 0.0 108.737 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -125.2 136.95 54.08 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.25 130.4 14.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.21 155.03 68.96 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.59 1.527 . . . . 0.0 110.555 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.3 mm -120.79 124.64 72.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 173.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 m -113.89 156.26 14.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.858 1.263 . . . . 0.0 110.678 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.61 118.66 8.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.507 1.123 . . . . 0.0 108.193 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.73 -25.78 67.45 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.147 0.579 . . . . 0.0 111.48 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -157.33 155.49 30.72 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.233 1.413 . . . . 0.0 108.621 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -70.93 157.34 38.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.421 0.688 . . . . 0.0 110.707 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.9 177.53 35.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 122.1 -0.375 . . . . 0.0 112.513 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.88 133.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 110.81 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.81 -44.9 60.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -156.78 159.42 38.27 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.36 138.11 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -116.67 12.38 14.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.236 1.014 . . . . 0.0 112.154 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -146.79 178.62 8.18 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.037 1.735 . . . . 0.0 108.763 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -144.84 169.61 17.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.065 1.346 . . . . 0.0 108.278 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.67 133.06 46.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.774 0.83 . . . . 0.0 109.232 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.54 -1.61 65.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.045 1.307 . . . . 0.0 114.15 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -71.31 153.31 42.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.807 1.803 . . . . 0.0 110.475 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -66.25 143.82 56.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.07 160.12 17.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.103 0.961 . . . . 0.0 109.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.18 166.62 24.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.285 -174.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 112.98 2.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.58 -1.94 64.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.15 1.357 . . . . 0.0 112.81 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -76.56 132.84 39.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.217 1.509 . . . . 0.0 109.106 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.26 130.27 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.455 0.702 . . . . 0.0 109.481 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 4' ' ' SER . 56.8 tp -82.84 -50.88 8.18 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.677 1.191 . . . . 0.0 108.494 169.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.32 171.05 20.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -171.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.96 148.8 51.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.115 1.366 . . . . 0.0 108.337 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -118.82 154.01 33.55 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.44 1.496 . . . . 0.0 109.779 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -75.57 30.75 0.1 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.726 1.611 . . . . 0.0 112.947 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -61.75 146.99 47.66 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -65.56 -17.04 64.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.829 1.252 . . . . 0.0 114.13 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -137.27 163.63 30.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 110.151 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.068 172.412 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.595 ' N ' ' HG ' ' A' ' 71' ' ' SER . 2.1 p . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.61 141.11 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -137.65 155.59 48.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.834 1.253 . . . . 0.0 111.173 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.4 mp -70.11 148.01 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -109.21 6.58 24.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.403 -0.811 . . . . 0.0 112.375 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 159.5 38.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.006 1.322 . . . . 0.0 108.945 -169.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.47 140.14 38.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.835 0.454 . . . . 0.0 109.912 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.21 -151.51 17.76 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.31 141.69 51.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.8 tp -83.06 77.25 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.437 1.095 . . . . 0.0 110.958 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -37.22 -56.33 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.232 2.213 . . . . 0.0 113.554 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -147.02 160.72 42.04 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.931 1.293 . . . . 0.0 108.832 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.74 142.58 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -120.78 -22.51 6.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.196 0.598 . . . . 0.0 111.216 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 m -74.97 161.32 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.659 0.742 . . . . 0.0 111.619 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -149.91 157.13 42.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.626 1.97 . . . . 0.0 106.284 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.86 130.91 45.52 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.795 0.725 . . . . 0.0 109.147 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.23 -9.06 77.0 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.467 1.032 . . . . 0.0 112.997 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.64 166.4 17.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.221 1.511 . . . . 0.0 109.831 170.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -122.92 142.28 50.98 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.3 pt -131.76 161.64 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 123.797 0.839 . . . . 0.0 108.871 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.94 143.76 40.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -46.1 122.94 4.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.981 0.81 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.61 -8.26 78.86 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.92 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -63.86 132.97 52.45 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.683 1.741 . . . . 0.0 107.402 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.0 137.07 43.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.2 -20.06 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.334 1.454 . . . . 0.0 110.878 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.17 -179.34 7.81 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.638 0.775 . . . . 0.0 108.989 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.63 145.61 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -121.15 130.62 53.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.152 2.181 . . . . 0.0 106.44 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.87 124.97 49.39 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -170.03 169.5 8.03 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.851 1.261 . . . . 0.0 107.852 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.0 ptt? 44.42 41.35 4.51 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.025 1.33 . . . . 0.0 112.922 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.78 31.93 11.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.378 1.871 . . . . 0.0 113.107 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.41 170.44 15.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.327 1.851 . . . . 0.0 109.093 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.46 139.19 54.15 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.58 129.44 17.52 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -169.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.45 149.29 80.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.53 1.487 . . . . 0.0 110.308 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.98 123.55 71.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -113.06 155.64 14.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.138 1.375 . . . . 0.0 110.91 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 121.04 12.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.801 1.24 . . . . 0.0 108.497 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.24 -30.17 70.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.162 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -157.16 155.86 31.68 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 109.207 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 m -71.75 155.47 40.42 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.736 0.814 . . . . 0.0 110.85 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.04 178.75 38.55 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.24 0.448 . . . . 0.0 112.008 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.62 134.96 27.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.45 107.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.21 -40.89 29.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.45 154.53 32.01 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 t -114.16 134.74 56.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.3 -3.52 31.15 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.873 0.869 . . . . 0.0 112.714 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -137.66 178.01 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.412 1.085 . . . . 0.0 109.958 -170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -142.42 163.61 32.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.779 1.232 . . . . 0.0 107.785 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -60.99 136.78 58.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.46 -4.3 78.46 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.314 -1.27 . . . . 0.0 114.06 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -72.67 155.31 40.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.005 1.903 . . . . 0.0 110.717 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.08 144.53 56.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.93 160.82 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.035 0.934 . . . . 0.0 109.238 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -145.93 166.69 25.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.052 -172.591 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.37 113.92 2.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 2.2 75.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.794 1.188 . . . . 0.0 112.892 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -77.81 127.29 32.18 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 1.566 . . . . 0.0 107.507 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.78 137.35 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.08 -50.93 5.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.817 1.247 . . . . 0.0 108.9 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 168.01 24.51 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.583 0.629 . . . . 0.0 112.081 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -126.78 141.97 51.68 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.225 1.81 . . . . 0.0 106.921 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.65 167.74 10.49 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.407 1.083 . . . . 0.0 110.766 -169.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 p -54.47 -39.37 67.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 110.531 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -64.92 -20.31 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.851 1.261 . . . . 0.0 113.489 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.595 ' HG ' ' N ' ' A' ' 2' ' ' THR . 18.5 m -76.3 6.52 5.42 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 p -57.33 153.98 11.39 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.17 0.895 . . . . 0.0 110.923 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 C--O 1.251 1.151 0 C-N-CA 125.881 1.673 . . . . 0.0 106.884 177.159 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.65 127.04 63.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 17.1 m -140.56 159.53 41.99 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.993 1.317 . . . . 0.0 111.127 -169.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 mm -77.55 156.55 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.76 15.62 4.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.451 1.5 . . . . 0.0 111.512 -169.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.33 157.76 36.24 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.647 1.579 . . . . 0.0 108.114 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.61 140.84 41.17 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.5 -153.91 20.0 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.93 135.65 50.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.46 70.74 8.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.846 1.258 . . . . 0.0 111.096 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -25.76 -59.82 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.431 2.692 . . . . 0.0 114.127 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -144.75 163.17 34.83 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.618 1.167 . . . . 0.0 108.923 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.43 146.38 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -124.48 -18.62 5.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.915 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.17 164.77 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.758 0.79 . . . . 0.0 111.68 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -150.1 157.81 43.51 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.597 1.959 . . . . 0.0 106.042 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.19 132.5 50.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.39 -8.99 78.91 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.525 1.059 . . . . 0.0 113.068 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.03 162.27 27.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.241 1.52 . . . . 0.0 109.896 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -113.17 141.99 46.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 pt -130.94 158.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.49 143.75 46.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -46.88 119.98 2.79 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.874 0.761 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.08 68.6 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.015 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.5 135.66 55.43 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.708 1.754 . . . . 0.0 108.175 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.69 134.55 52.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.85 -22.17 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.308 1.043 . . . . 0.0 111.495 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.55 -178.88 7.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.074 0.852 . . . . 0.0 109.808 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -135.91 145.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.92 134.79 54.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.779 2.032 . . . . 0.0 106.528 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.71 125.82 53.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.86 166.76 7.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.163 1.385 . . . . 0.0 107.788 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 56.06 30.28 16.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.919 0.888 . . . . 0.0 111.86 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 51.88 35.8 16.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.641 1.577 . . . . 0.0 112.279 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.77 173.03 11.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.625 1.97 . . . . 0.0 108.799 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.57 137.69 53.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.48 131.15 16.08 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.66 155.39 69.02 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.857 1.704 . . . . 0.0 110.61 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.0 mm -124.65 125.22 69.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.59 156.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 110.179 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.17 121.54 13.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.671 1.188 . . . . 0.0 108.425 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.71 -25.81 66.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.108 0.563 . . . . 0.0 111.535 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.38 156.95 33.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.343 1.457 . . . . 0.0 108.882 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -73.43 157.01 37.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.685 0.794 . . . . 0.0 111.061 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.42 -177.19 40.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.504 0.573 . . . . 0.0 112.261 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.6 mm -99.65 129.83 49.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.86 109.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -73.46 -45.47 54.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -157.16 157.14 33.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.82 135.81 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.41 8.07 29.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.24 1.016 . . . . 0.0 111.967 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -146.56 178.75 8.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.937 1.695 . . . . 0.0 108.783 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -144.74 169.42 18.06 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.904 1.282 . . . . 0.0 108.38 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.62 133.4 46.59 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.958 0.903 . . . . 0.0 109.325 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.11 -1.57 63.58 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.112 1.339 . . . . 0.0 114.158 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.9 152.02 44.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.844 1.822 . . . . 0.0 110.511 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -65.95 142.74 57.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.88 160.64 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.099 0.96 . . . . 0.0 109.665 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.86 167.05 23.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.59 -173.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.14 114.78 3.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.694 0.798 . . . . 0.0 108.94 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.81 68.39 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.194 1.378 . . . . 0.0 112.921 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.49 128.11 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.18 1.49 . . . . 0.0 109.293 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.5 131.58 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.506 0.722 . . . . 0.0 109.559 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 4' ' ' SER . 44.6 tp -85.32 -50.83 7.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 124.538 1.135 . . . . 0.0 108.787 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.29 168.95 24.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.212 0.529 . . . . 0.0 111.025 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -129.24 143.79 50.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.274 1.829 . . . . 0.0 106.937 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -116.71 155.63 28.53 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 110.337 -169.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -70.24 160.37 32.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.98 1.312 . . . . 0.0 110.525 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -149.04 160.62 43.16 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.846 1.258 . . . . 0.0 108.997 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -60.74 -24.61 65.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.804 1.241 . . . . 0.0 113.145 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 m -129.37 127.45 41.06 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.222 1.409 . . . . 0.0 108.098 -171.253 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.624 ' N ' ' HG ' ' A' ' 71' ' ' SER . 2.1 p . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.9 t -137.98 140.5 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -140.13 159.17 42.78 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.684 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -78.14 157.24 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 14.56 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.441 1.496 . . . . 0.0 111.722 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -156.31 157.98 36.66 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.572 1.549 . . . . 0.0 108.136 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.06 140.34 40.28 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.012 -0.43 . . . . 0.0 110.036 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.81 -153.91 18.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 137.12 51.38 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.53 71.83 8.56 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.94 1.296 . . . . 0.0 111.332 -169.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -29.57 -59.26 0.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.941 2.496 . . . . 0.0 114.01 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.87 163.08 37.25 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.114 1.366 . . . . 0.0 108.633 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.77 148.38 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -131.18 26.11 4.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.99 0.916 . . . . 0.0 112.005 -169.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.37 162.35 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.562 1.145 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.79 159.25 44.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.089 1.756 . . . . 0.0 107.641 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.37 133.44 49.7 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 -6.4 83.54 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.222 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.01 165.82 20.99 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.483 1.642 . . . . 0.0 110.163 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -113.36 141.2 47.33 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.575 1.55 . . . . 0.0 107.009 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -130.52 163.36 36.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.055 0.942 . . . . 0.0 108.734 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -137.38 139.63 40.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -47.0 124.2 6.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.056 0.942 . . . . 0.0 110.634 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.56 74.35 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.66 -1.078 . . . . 0.0 113.763 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -64.41 143.65 57.75 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.469 1.635 . . . . 0.0 107.869 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.85 144.22 57.41 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.73 -31.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 110.346 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 -178.78 7.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 119.533 1.061 . . . . 0.0 109.416 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -134.67 145.01 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.36 128.64 52.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.652 1.981 . . . . 0.0 106.588 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.96 124.21 43.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.64 167.67 9.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.194 1.397 . . . . 0.0 107.753 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.2 mtm 54.99 31.59 16.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.057 0.943 . . . . 0.0 111.76 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.27 34.57 14.98 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.932 1.693 . . . . 0.0 112.585 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.4 mtt -142.7 173.66 11.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.479 1.911 . . . . 0.0 108.508 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -120.96 140.61 51.64 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.53 132.19 19.67 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.74 153.87 74.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.932 1.755 . . . . 0.0 110.843 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 mm -126.54 134.9 65.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.87 163.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.373 1.069 . . . . 0.0 110.253 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.39 113.04 2.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.631 1.173 . . . . 0.0 107.842 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.2 -17.04 62.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.311 0.244 . . . . 0.0 111.371 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.32 155.49 30.76 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.057 1.743 . . . . 0.0 108.959 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 m -69.23 158.21 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.903 0.881 . . . . 0.0 110.923 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.37 177.36 33.4 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 122.265 -0.272 . . . . 0.0 112.538 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -85.68 135.08 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -68.62 115.41 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -84.28 -48.3 9.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -157.66 129.55 7.01 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -81.93 137.2 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -110.02 5.3 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.048 0.939 . . . . 0.0 112.124 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -143.84 179.06 7.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.315 1.446 . . . . 0.0 108.612 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -145.38 163.9 33.15 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.548 1.139 . . . . 0.0 108.915 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.23 130.12 43.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.968 0.907 . . . . 0.0 109.716 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.17 -1.61 84.4 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.258 1.409 . . . . 0.0 113.804 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -70.64 153.74 42.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.767 1.783 . . . . 0.0 110.53 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.13 143.86 56.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.61 160.77 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.02 0.928 . . . . 0.0 109.488 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.48 167.72 21.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.976 -172.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 115.55 3.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 108.957 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.68 -0.7 74.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.052 1.311 . . . . 0.0 112.88 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -77.48 126.7 31.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.358 1.579 . . . . 0.0 109.093 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.71 129.74 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.16 -44.97 9.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.339 1.056 . . . . 0.0 109.331 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.78 165.12 37.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.751 0.786 . . . . 0.0 111.884 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -118.32 143.82 46.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.81 2.044 . . . . 0.0 106.586 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.64 162.26 18.31 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.72 1.208 . . . . 0.0 108.514 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -57.99 -35.07 70.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.048 -0.408 . . . . 0.0 110.135 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.75 -28.19 67.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.536 1.135 . . . . 0.0 113.113 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 2' ' ' THR . 12.6 m -71.66 -20.27 61.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.714 0.688 . . . . 0.0 111.73 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -80.37 134.28 36.01 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 125.642 1.577 . . . . 0.0 107.012 -178.678 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.67 138.91 52.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -138.44 155.28 48.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.927 1.291 . . . . 0.0 111.045 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.4 mp -70.02 147.67 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -108.6 4.69 24.27 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 ptp -154.11 163.68 39.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.279 0.945 . . . . 0.0 109.575 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.9 141.45 49.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.784 0.434 . . . . 0.0 110.175 173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.19 -152.93 20.32 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.91 140.15 51.8 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.9 tp -80.78 75.78 7.7 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.455 1.102 . . . . 0.0 111.592 -169.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -35.2 -58.15 0.56 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.348 2.259 . . . . 0.0 113.789 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -147.61 160.63 42.44 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.794 1.237 . . . . 0.0 108.743 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.2 143.58 32.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -124.32 -21.34 4.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.832 0.453 . . . . 0.0 111.992 -169.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.2 162.01 4.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.468 0.651 . . . . 0.0 111.557 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -149.59 158.91 44.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.266 1.826 . . . . 0.0 106.763 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.88 47.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.09 -6.94 83.2 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.112 -178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -68.42 164.93 19.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.316 1.558 . . . . 0.0 109.842 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -119.41 144.57 46.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.522 1.129 . . . . 0.0 108.005 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.25 159.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -133.69 143.99 48.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -48.54 121.31 4.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.874 0.761 . . . . 0.0 110.438 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.56 67.49 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -64.61 134.72 54.92 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.695 1.747 . . . . 0.0 108.074 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -67.7 133.03 48.59 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.32 -21.67 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.271 1.028 . . . . 0.0 111.424 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.74 8.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.151 0.981 . . . . 0.0 109.514 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.41 147.24 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -124.02 131.52 53.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.885 2.074 . . . . 0.0 106.515 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.23 124.71 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -169.07 166.4 10.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.824 1.249 . . . . 0.0 108.047 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.9 mtm 55.18 31.52 16.6 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.932 0.893 . . . . 0.0 111.854 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 52.22 35.21 16.23 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.79 1.636 . . . . 0.0 112.496 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.44 173.76 11.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.667 1.987 . . . . 0.0 108.665 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -118.61 142.53 47.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.49 128.44 19.14 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 -169.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.1 147.94 68.23 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.831 1.687 . . . . 0.0 109.996 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -121.08 121.88 66.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 m -114.95 157.2 15.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.631 1.173 . . . . 0.0 110.177 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 119.73 9.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.687 1.195 . . . . 0.0 108.25 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.18 -26.13 68.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.42 0.688 . . . . 0.0 111.572 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -157.38 155.51 30.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.581 1.552 . . . . 0.0 108.476 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 m -69.38 157.58 36.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.342 0.657 . . . . 0.0 110.605 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.39 -176.17 40.33 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 122.106 -0.371 . . . . 0.0 112.473 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -99.84 133.64 42.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.63 111.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -77.0 -45.2 28.14 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.39 151.66 26.58 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.55 134.19 48.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -106.27 3.76 28.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.672 0.789 . . . . 0.0 112.461 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -138.7 178.4 7.18 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.064 1.346 . . . . 0.0 109.284 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.04 159.89 41.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.648 1.179 . . . . 0.0 108.136 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.27 132.05 51.4 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.99 -3.62 86.9 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.093 1.33 . . . . 0.0 113.763 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -70.35 154.46 41.87 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.865 1.833 . . . . 0.0 110.68 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -66.47 143.39 57.12 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.42 160.54 14.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.038 0.935 . . . . 0.0 109.219 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.04 167.36 22.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.282 -171.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.31 113.39 2.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.98 5.7 85.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.487 1.041 . . . . 0.0 113.063 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.01 130.23 37.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.439 1.619 . . . . 0.0 107.233 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.17 141.42 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.84 -50.24 3.9 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.166 1.386 . . . . 0.0 108.661 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 165.83 33.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 111.928 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -128.69 139.15 52.38 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.44 1.896 . . . . 0.0 106.403 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt -116.57 154.54 30.27 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 110.274 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -72.02 140.24 48.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.548 0.739 . . . . 0.0 109.412 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -155.6 138.17 15.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 169.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.03 -24.75 67.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.478 1.111 . . . . 0.0 113.671 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -20.69 63.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.788 0.722 . . . . 0.0 111.921 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.763 -178.459 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.649 0.262 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.94 141.92 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -137.75 155.3 49.21 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.718 1.207 . . . . 0.0 111.458 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.26 147.86 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -108.51 5.38 25.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 ptp -153.88 163.03 40.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 109.827 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.53 140.86 50.07 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.653 0.381 . . . . 0.0 110.227 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 169.95 -153.65 21.91 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.23 137.62 44.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.64 121.18 14.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.84 -51.69 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -149.11 159.93 43.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.586 1.555 . . . . 0.0 108.493 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.09 142.89 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -120.76 -22.08 6.42 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.036 0.534 . . . . 0.0 111.506 -170.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.76 165.96 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.977 0.894 . . . . 0.0 111.153 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.73 154.09 36.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.43 50.65 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.67 -9.94 62.45 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.451 1.501 . . . . 0.0 112.989 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.4 172.22 12.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.913 1.357 . . . . 0.0 110.667 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -115.87 138.19 51.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.727 1.611 . . . . 0.0 107.094 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 pt -128.48 160.67 38.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.0 143.9 38.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -48.57 120.85 4.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.774 0.715 . . . . 0.0 110.467 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.81 -8.25 70.71 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.826 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.4 135.22 55.91 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.589 1.694 . . . . 0.0 108.051 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.41 133.69 49.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.12 -22.29 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.293 1.037 . . . . 0.0 111.617 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.06 178.06 10.12 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.592 0.757 . . . . 0.0 109.694 169.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.4 mt -136.78 142.03 39.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -120.46 131.19 54.64 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.278 1.831 . . . . 0.0 106.882 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.87 124.36 43.73 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -168.84 166.78 11.32 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.969 1.308 . . . . 0.0 108.065 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.2 mtm 55.26 31.32 16.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.015 0.926 . . . . 0.0 111.795 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.64 34.6 16.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.71 1.604 . . . . 0.0 112.515 -172.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.08 173.53 11.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.517 1.927 . . . . 0.0 108.659 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -118.72 141.67 48.39 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.66 128.31 18.92 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.45 149.63 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.947 1.764 . . . . 0.0 110.203 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mm -122.46 120.94 62.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.18 156.18 15.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.792 1.237 . . . . 0.0 110.183 -172.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 116.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.038 1.335 . . . . 0.0 108.63 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.43 -23.32 65.52 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.082 0.553 . . . . 0.0 111.768 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -154.54 162.04 41.34 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.522 1.529 . . . . 0.0 108.796 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -75.17 157.32 34.77 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.82 0.848 . . . . 0.0 110.96 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.62 174.75 33.83 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.354 0.502 . . . . 0.0 112.0 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.3 mm -85.57 134.3 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.74 101.77 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -71.48 -40.66 70.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -156.02 164.13 38.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.568 0.622 . . . . 0.0 109.335 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 t -125.87 135.09 64.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -105.5 -0.84 25.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 111.863 -169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -141.29 177.04 8.37 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.817 1.247 . . . . 0.0 110.693 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.16 169.01 21.68 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.311 1.444 . . . . 0.0 108.501 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.62 139.68 49.24 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.728 0.811 . . . . 0.0 109.271 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.45 -7.78 56.24 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.376 -1.236 . . . . 0.0 113.737 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -75.83 152.85 37.17 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.817 1.809 . . . . 0.0 110.952 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.91 145.38 54.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.034 0.934 . . . . 0.0 109.325 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.19 161.59 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.877 0.871 . . . . 0.0 109.952 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.36 168.48 19.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.091 -175.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.23 114.65 3.0 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.37 82.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.472 1.034 . . . . 0.0 112.976 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -78.87 125.82 29.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.454 1.627 . . . . 0.0 107.847 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.61 132.13 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.483 0.713 . . . . 0.0 109.961 -169.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.89 -50.53 7.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.931 1.292 . . . . 0.0 107.686 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -154.35 169.58 23.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.455 0.645 . . . . 0.0 111.893 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.24 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.517 1.927 . . . . 0.0 106.8 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.35 151.08 42.86 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.199 1.0 . . . . 0.0 110.556 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -66.82 163.78 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.661 0.784 . . . . 0.0 109.546 169.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -58.79 150.95 22.42 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.149 -0.345 . . . . 0.0 110.133 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.6 m -58.99 -20.01 48.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 113.969 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -132.64 145.84 51.41 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.569 1.548 . . . . 0.0 108.131 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.129 1.372 . . . . 0.0 107.302 -177.07 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.85 138.82 51.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 169.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -136.62 154.59 50.61 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 110.635 -169.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 5' ' ' ILE . 5.4 mp -69.6 141.84 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -102.77 5.66 38.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.695 -0.628 . . . . 0.0 112.529 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -156.27 164.28 38.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.3 1.04 . . . . 0.0 109.532 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.69 142.86 42.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.729 0.411 . . . . 0.0 110.312 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.54 -151.72 16.99 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.73 132.39 45.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 113.66 10.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -70.66 -59.18 2.97 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.015 0.926 . . . . 0.0 110.564 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -149.42 158.33 44.08 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.968 1.307 . . . . 0.0 109.182 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.28 145.73 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.171 1.389 . . . . 0.0 107.434 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.89 24.83 4.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.412 1.085 . . . . 0.0 111.055 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 m -132.83 165.52 32.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.083 1.353 . . . . 0.0 110.129 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -146.7 156.19 42.99 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.985 1.714 . . . . 0.0 106.519 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.32 133.52 55.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.46 -10.12 74.75 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.513 1.054 . . . . 0.0 112.864 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.08 170.35 11.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.045 1.422 . . . . 0.0 109.658 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -126.46 143.26 51.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 107.986 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.51 164.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.616 1.166 . . . . 0.0 108.784 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -136.05 141.64 44.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.708 1.203 . . . . 0.0 107.817 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -45.62 116.55 1.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 110.691 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -10.68 62.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.714 -1.048 . . . . 0.0 113.66 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -66.63 140.41 57.93 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.497 1.648 . . . . 0.0 108.499 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.94 138.99 56.39 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.5 -19.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.981 0.912 . . . . 0.0 112.151 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.53 178.4 9.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.705 1.202 . . . . 0.0 108.688 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -134.76 148.86 29.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -123.56 133.67 53.94 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.738 2.015 . . . . 0.0 106.745 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 123.8 46.42 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -168.83 167.3 11.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.764 1.225 . . . . 0.0 107.951 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 mtm 55.48 30.61 15.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.854 0.862 . . . . 0.0 111.861 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 53.13 35.3 19.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.857 1.663 . . . . 0.0 111.995 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -144.0 173.62 11.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.484 1.914 . . . . 0.0 108.644 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -119.23 140.53 50.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.3 131.79 19.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.56 152.46 74.79 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.892 1.728 . . . . 0.0 110.754 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.9 mm -123.46 118.65 55.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.85 157.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.466 1.106 . . . . 0.0 110.293 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 108.23 1.13 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.264 1.426 . . . . 0.0 107.441 170.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.02 -15.13 62.97 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 155.72 34.46 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.673 1.589 . . . . 0.0 108.509 171.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.94 159.66 33.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.18 0.992 . . . . 0.0 110.975 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.57 179.19 37.01 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 121.829 -0.544 . . . . 0.0 112.377 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -85.45 134.05 28.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.51 100.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -70.34 -40.24 74.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -156.87 162.88 39.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -114.83 7.98 15.91 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.741 0.816 . . . . 0.0 112.557 -168.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -140.73 175.59 9.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.761 1.224 . . . . 0.0 109.588 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -143.3 160.34 40.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.326 1.85 . . . . 0.0 107.182 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.36 127.64 33.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.23 -7.51 64.25 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.504 1.526 . . . . 0.0 113.407 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -74.77 153.66 38.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.5 1.65 . . . . 0.0 111.414 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.62 145.32 54.03 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.551 0.74 . . . . 0.0 109.117 170.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.55 159.83 14.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.752 0.821 . . . . 0.0 110.108 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.92 166.11 25.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -176.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.8 117.84 5.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.12 -0.8 82.15 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.682 1.134 . . . . 0.0 113.044 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.25 131.69 41.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.274 1.537 . . . . 0.0 108.176 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 t -70.95 135.09 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 -50.94 5.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 125.462 1.505 . . . . 0.0 108.894 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.18 168.75 20.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 112.062 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.24 140.09 52.09 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.663 1.985 . . . . 0.0 106.378 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt -123.23 169.48 11.24 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.886 0.875 . . . . 0.0 112.446 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p -58.92 -15.59 13.54 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.741 2.016 . . . . 0.0 114.183 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -143.83 161.47 38.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.606 1.562 . . . . 0.0 109.651 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.17 -61.16 1.91 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.066 0.946 . . . . 0.0 109.791 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -153.21 151.65 30.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.18 1.392 . . . . 0.0 108.928 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.666 1.986 . . . . 0.0 106.414 170.102 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 118.56 -0.733 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.93 126.1 59.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 m -139.68 160.12 40.59 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.694 1.198 . . . . 0.0 111.03 -168.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.63 156.81 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.59 15.63 4.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.445 1.098 . . . . 0.0 112.129 -169.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 158.29 36.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.099 1.76 . . . . 0.0 107.91 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.71 141.08 38.18 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.884 -0.51 . . . . 0.0 109.762 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.08 -153.43 19.43 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 175.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.68 133.71 45.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.85 113.55 13.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -66.52 -56.09 12.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.045 0.938 . . . . 0.0 110.203 -170.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.52 161.4 42.21 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.419 1.488 . . . . 0.0 107.943 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.21 146.69 28.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.44 -19.77 5.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.029 0.532 . . . . 0.0 112.03 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.76 166.17 2.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.794 0.807 . . . . 0.0 111.791 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.78 160.26 42.92 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.627 1.971 . . . . 0.0 105.93 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.12 137.83 45.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.18 -7.39 75.67 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.472 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -70.74 162.85 28.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.448 1.624 . . . . 0.0 110.339 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -108.71 137.56 46.44 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 pt -128.2 161.27 36.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -138.73 141.68 38.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -47.51 120.64 3.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.959 0.8 . . . . 0.0 110.69 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -10.25 64.63 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.894 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.52 135.85 56.44 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.552 1.676 . . . . 0.0 108.237 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.21 134.13 49.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.53 -22.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.126 0.97 . . . . 0.0 111.534 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.57 -178.82 7.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.79 0.836 . . . . 0.0 109.615 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -137.28 146.37 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.4 tm? -121.53 136.21 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.677 1.991 . . . . 0.0 107.197 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -104.34 124.08 48.54 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.26 167.82 10.05 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 125.004 1.322 . . . . 0.0 107.923 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 54.9 32.72 18.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.906 0.883 . . . . 0.0 111.656 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.23 32.73 11.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.985 1.714 . . . . 0.0 112.681 -173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.8 mmm -142.16 173.26 11.68 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.579 1.952 . . . . 0.0 108.746 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -119.46 141.99 48.66 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.84 130.29 18.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.87 152.51 73.7 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.87 1.713 . . . . 0.0 110.566 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -123.68 121.83 63.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 m -113.39 157.72 13.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.726 1.21 . . . . 0.0 109.977 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 119.82 9.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.713 1.205 . . . . 0.0 108.237 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.77 -26.07 65.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.945 0.498 . . . . 0.0 111.336 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -157.12 155.87 31.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.536 1.534 . . . . 0.0 108.855 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.46 156.81 36.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.05 0.94 . . . . 0.0 111.085 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.8 177.23 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.363 0.506 . . . . 0.0 112.392 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -85.8 133.35 29.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 169.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.15 111.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -73.88 -46.66 43.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -156.57 158.92 37.97 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.55 131.53 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.83 -6.02 27.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.979 0.912 . . . . 0.0 112.555 -169.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -138.86 173.6 11.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.184 1.394 . . . . 0.0 109.045 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -147.79 170.53 17.39 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 109.129 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.28 128.91 39.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.66 1.02 87.7 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.148 1.356 . . . . 0.0 113.507 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.74 153.09 42.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.32 1.56 . . . . 0.0 110.097 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -76.02 143.39 41.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.72 159.62 14.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.592 0.711 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.77 167.01 23.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.308 -172.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 113.08 2.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.31 72.22 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.898 1.237 . . . . 0.0 113.106 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.83 126.33 30.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.435 1.618 . . . . 0.0 108.206 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.86 144.59 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.31 -49.5 2.96 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.514 1.526 . . . . 0.0 108.479 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.84 169.2 19.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.338 0.589 . . . . 0.0 111.642 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.48 144.89 51.45 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.311 1.845 . . . . 0.0 106.844 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.6 152.17 39.58 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.854 1.262 . . . . 0.0 110.66 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 m -76.2 -14.52 60.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.121 0.568 . . . . 0.0 110.888 169.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.93 76.89 4.45 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.8 m -69.87 72.56 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.895 1.678 . . . . 0.0 111.338 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 p -59.93 -25.89 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.021 1.328 . . . . 0.0 113.224 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 126.218 1.807 . . . . 0.0 107.0 -172.174 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -130.57 137.63 55.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -140.76 155.82 46.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.238 . . . . 0.0 110.667 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.8 mm -73.88 152.13 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.621 1.168 . . . . 0.0 107.993 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.89 11.61 14.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.386 0.675 . . . . 0.0 111.948 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -143.67 161.21 39.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.558 1.543 . . . . 0.0 108.343 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -90.01 131.51 35.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.63 11.55 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.4 142.35 50.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.0 tp -85.74 72.21 10.58 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.978 0.911 . . . . 0.0 110.833 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -27.68 -59.1 0.11 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.083 2.553 . . . . 0.0 114.081 -174.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.6 162.42 38.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.119 1.368 . . . . 0.0 108.527 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.87 147.67 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -131.34 25.46 4.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.192 0.997 . . . . 0.0 111.559 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.76 165.04 32.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.388 1.075 . . . . 0.0 110.484 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -148.97 158.08 43.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.983 1.713 . . . . 0.0 106.795 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.43 53.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.55 77.48 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.528 1.061 . . . . 0.0 112.787 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.05 167.68 17.1 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.142 1.471 . . . . 0.0 109.815 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -125.02 138.1 54.22 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -126.56 162.84 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.368 1.067 . . . . 0.0 108.198 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.9 143.11 48.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -47.87 126.96 11.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.58 0.752 . . . . 0.0 110.5 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.56 78.45 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.507 -1.163 . . . . 0.0 113.617 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.85 138.65 58.03 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.688 1.744 . . . . 0.0 107.884 169.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.89 137.94 57.52 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.06 -19.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.868 1.267 . . . . 0.0 111.429 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.88 -179.49 8.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.435 1.016 . . . . 0.0 109.336 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -136.19 139.02 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -106.11 136.11 46.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.803 2.041 . . . . 0.0 106.614 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.31 120.93 44.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -162.02 166.4 26.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 53.33 24.61 3.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt 47.38 42.68 14.46 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 126.12 1.768 . . . . 0.0 111.839 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.6 mmt -137.12 164.64 27.96 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.402 2.281 . . . . 0.0 106.988 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -112.14 140.73 46.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.73 122.79 14.61 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.24 151.59 35.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.988 2.458 . . . . 0.0 112.723 174.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mm -126.4 123.23 62.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.32 155.41 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.234 1.413 . . . . 0.0 110.105 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.28 124.09 21.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.145 0.978 . . . . 0.0 108.674 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -29.05 69.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.806 0.442 . . . . 0.0 111.573 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.1 ptm85 -157.21 156.61 32.87 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.611 1.164 . . . . 0.0 108.895 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -70.31 155.14 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.34 0.656 . . . . 0.0 110.492 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.17 177.2 36.71 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 122.119 -0.363 . . . . 0.0 112.39 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -85.42 133.39 29.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.6 109.59 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -78.06 -43.43 29.24 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -152.18 156.86 40.61 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.488 0.585 . . . . 0.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.4 129.47 74.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.4 -0.55 35.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.694 0.798 . . . . 0.0 111.983 -169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -139.73 176.26 8.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.821 1.249 . . . . 0.0 109.581 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.44 164.57 31.13 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.93 1.292 . . . . 0.0 108.579 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.4 128.13 32.84 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.955 0.902 . . . . 0.0 109.561 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.71 86.79 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.187 1.375 . . . . 0.0 114.02 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -70.5 154.74 41.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.955 1.877 . . . . 0.0 110.597 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.73 143.11 57.14 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.12 160.21 15.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -143.79 167.13 23.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.178 0.591 . . . . 0.0 111.017 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.18 114.53 3.49 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.55 1.58 74.22 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.972 1.272 . . . . 0.0 113.151 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.96 128.64 34.22 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.52 1.66 . . . . 0.0 108.123 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.64 133.78 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.335 0.654 . . . . 0.0 110.127 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.0 tp -87.28 -52.09 5.59 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.05 168.38 27.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.713 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 148.24 52.57 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.585 1.154 . . . . 0.0 108.337 174.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.16 147.42 43.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.358 1.463 . . . . 0.0 109.802 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 m -61.16 -22.45 64.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.5 0.72 . . . . 0.0 112.066 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.96 -34.53 65.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.477 1.111 . . . . 0.0 112.54 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 m -125.28 -19.46 5.09 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.9 m -71.37 -36.21 71.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.379 0.536 . . . . 0.0 110.087 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 . . . . . 0 C--O 1.249 1.049 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.644 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.239 0.55 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -139.32 160.53 39.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.516 1.127 . . . . 0.0 111.297 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.06 157.09 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.13 15.27 5.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 112.158 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.73 159.76 38.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.093 1.757 . . . . 0.0 107.984 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -79.29 141.14 37.3 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.98 -0.45 . . . . 0.0 109.879 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.79 -152.87 19.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.34 136.42 49.99 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.05 73.7 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.326 1.05 . . . . 0.0 111.542 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -27.18 -60.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.252 2.621 . . . . 0.0 114.01 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -146.3 161.87 39.37 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.714 1.206 . . . . 0.0 108.76 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.7 146.24 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.35 -19.96 5.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.74 0.416 . . . . 0.0 111.896 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.2 m -74.71 165.89 2.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.899 0.857 . . . . 0.0 111.942 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.56 159.67 43.49 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.72 2.008 . . . . 0.0 105.74 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.14 46.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.08 75.23 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.654 1.121 . . . . 0.0 113.378 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -71.67 163.74 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.453 1.626 . . . . 0.0 110.306 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -108.6 136.83 47.54 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.14 159.33 37.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -137.63 144.39 41.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -50.05 123.21 7.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.893 0.77 . . . . 0.0 110.359 -176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.39 -7.96 80.59 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.032 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -64.71 141.38 58.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.691 1.745 . . . . 0.0 107.814 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.86 143.21 55.85 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.44 -37.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.997 1.319 . . . . 0.0 109.512 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.28 -179.67 8.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.902 0.881 . . . . 0.0 109.536 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -135.56 142.94 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.8 tm? -119.14 134.05 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.633 1.973 . . . . 0.0 106.736 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.65 124.85 49.61 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -169.25 166.81 10.54 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.009 1.324 . . . . 0.0 107.879 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.7 mtm 55.41 30.95 15.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 51.84 35.11 14.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.875 1.67 . . . . 0.0 112.576 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -142.31 173.48 11.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.473 1.909 . . . . 0.0 108.566 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -119.16 143.48 47.2 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.64 127.41 17.52 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.66 150.28 68.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.953 1.768 . . . . 0.0 110.244 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -124.79 132.31 71.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -124.36 162.19 26.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.869 1.268 . . . . 0.0 110.286 -169.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 122.61 16.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.51 -22.38 61.79 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.82 0.448 . . . . 0.0 111.671 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.83 157.71 38.3 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 108.913 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -69.77 155.65 40.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.792 0.837 . . . . 0.0 111.227 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.14 176.86 37.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.755 0.693 . . . . 0.0 111.761 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.66 135.24 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -68.59 106.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.27 -40.93 62.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.3 161.5 40.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.34 132.79 70.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.22 -1.26 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.2 1.0 . . . . 0.0 112.369 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -139.8 176.17 8.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.269 1.428 . . . . 0.0 109.409 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -144.74 169.83 17.27 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.659 1.183 . . . . 0.0 108.734 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.76 133.69 47.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 0.0 109.685 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.0 -0.59 62.08 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.188 1.375 . . . . 0.0 114.325 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -71.43 153.06 42.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.977 1.888 . . . . 0.0 110.452 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -66.47 142.86 57.41 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.31 160.1 15.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.715 0.806 . . . . 0.0 109.692 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.12 167.26 22.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.4 -173.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.37 113.52 2.69 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.95 1.68 72.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.839 1.209 . . . . 0.0 113.086 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.94 126.57 31.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.443 1.621 . . . . 0.0 108.183 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.63 144.28 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 109.543 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.2 tp -109.95 -48.19 3.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.933 1.693 . . . . 0.0 109.393 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.98 170.86 19.36 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.782 0.719 . . . . 0.0 111.064 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -130.65 148.61 52.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.343 1.457 . . . . 0.0 108.104 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.234 0.244 0 C-N-CA 125.338 1.455 . . . . 0.0 111.371 -169.707 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.235 0.332 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -137.49 166.77 23.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.857 1.263 . . . . 0.0 110.951 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 7' ' ' MET . 5.0 mp -87.53 150.3 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 169.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 29.08 4.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 0.0 110.51 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.444 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.9 mpp? -145.1 162.59 36.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 107.385 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.75 133.6 42.84 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 169.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.24 -148.36 12.55 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.52 140.13 51.34 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.24 71.7 10.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -26.47 -59.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.501 2.72 . . . . 0.0 114.0 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.16 163.28 35.87 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.999 1.32 . . . . 0.0 108.385 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.64 147.42 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.62 27.18 4.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.145 0.978 . . . . 0.0 111.785 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.52 164.82 33.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.575 1.15 . . . . 0.0 110.301 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.31 158.35 44.04 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.901 1.681 . . . . 0.0 106.876 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.8 54.15 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.6 -8.96 78.76 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.88 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.14 166.81 17.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.122 1.461 . . . . 0.0 109.666 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -124.17 138.65 54.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.726 1.21 . . . . 0.0 107.774 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 pt -128.5 162.28 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.42 1.088 . . . . 0.0 108.429 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -131.29 145.35 51.84 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.462 1.505 . . . . 0.0 107.346 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.04 129.9 24.76 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.259 0.624 . . . . 0.0 110.537 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.48 -6.45 72.9 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.411 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.62 137.57 57.44 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.654 1.727 . . . . 0.0 107.816 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.79 135.88 56.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.74 -18.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.449 1.1 . . . . 0.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.95 178.91 9.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.245 0.93 . . . . 0.0 109.301 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -135.41 143.52 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.24 131.11 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.198 2.199 . . . . 0.0 106.552 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.35 125.55 50.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.57 167.2 8.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.4 1.48 . . . . 0.0 107.752 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 mtm 55.25 32.26 18.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.913 0.885 . . . . 0.0 111.745 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 51.65 33.72 11.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.864 1.666 . . . . 0.0 112.58 -172.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.6 mmm -140.87 172.05 13.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.646 1.979 . . . . 0.0 108.52 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -124.15 140.47 52.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.62 133.89 17.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.02 158.61 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.107 1.871 . . . . 0.0 111.795 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mm -125.6 126.33 70.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.99 157.47 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.014 1.326 . . . . 0.0 110.468 -169.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 121.94 15.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.594 0.757 . . . . 0.0 108.981 175.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.29 -25.85 66.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.052 0.541 . . . . 0.0 111.66 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 162.11 39.78 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.158 1.383 . . . . 0.0 108.981 169.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -65.18 158.17 26.8 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.951 0.9 . . . . 0.0 110.928 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.18 179.32 39.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.82 134.87 27.67 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.49 105.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.98 -47.89 67.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -160.11 150.13 18.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.46 0.573 . . . . 0.0 109.747 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.05 137.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -110.66 9.73 22.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.495 0.718 . . . . 0.0 111.851 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -147.45 -179.49 6.89 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.085 1.754 . . . . 0.0 108.595 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -143.03 168.11 20.48 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.891 1.276 . . . . 0.0 108.369 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.08 132.12 42.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.849 0.859 . . . . 0.0 109.17 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 -1.4 73.62 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.055 1.312 . . . . 0.0 114.161 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.21 153.13 42.69 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.865 1.833 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.9 143.15 57.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.92 158.7 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.167 0.987 . . . . 0.0 109.586 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.17 164.05 33.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.306 0.642 . . . . 0.0 110.793 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.21 112.76 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.98 0.912 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.52 -6.49 59.18 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.007 1.289 . . . . 0.0 112.714 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.04 139.18 46.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.279 1.539 . . . . 0.0 108.69 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.89 140.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.93 -53.48 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.544 1.538 . . . . 0.0 108.347 175.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.99 168.06 25.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.535 0.683 . . . . 0.0 111.119 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -125.3 144.3 50.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.832 2.053 . . . . 0.0 106.309 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.519 -0.246 0 C-N-CA 124.618 1.167 . . . . 0.0 110.633 -169.291 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.238 0.461 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.61 158.9 43.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.836 1.254 . . . . 0.0 111.332 -169.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.9 mp -76.91 153.91 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.01 17.65 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.28 1.432 . . . . 0.0 111.574 -170.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.04 156.24 34.06 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.651 1.581 . . . . 0.0 108.061 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.74 140.3 42.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.663 0.385 . . . . 0.0 110.226 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.29 -152.04 17.06 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.14 139.07 52.09 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.6 71.93 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.659 1.183 . . . . 0.0 111.331 -169.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -28.48 -59.21 0.12 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.987 2.515 . . . . 0.0 114.11 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.71 163.53 35.63 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.01 1.324 . . . . 0.0 108.624 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.16 148.26 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.63 23.86 4.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.191 0.996 . . . . 0.0 111.664 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.49 161.94 36.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.437 1.095 . . . . 0.0 110.1 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.75 159.64 43.95 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.927 1.691 . . . . 0.0 107.242 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 134.24 53.81 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -7.11 82.38 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.64 1.115 . . . . 0.0 113.269 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -69.94 165.07 22.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.439 1.619 . . . . 0.0 110.111 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -112.94 138.5 49.72 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.502 1.521 . . . . 0.0 107.018 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -128.92 163.93 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.958 0.903 . . . . 0.0 108.638 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -138.86 140.33 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -45.44 123.16 3.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.082 0.953 . . . . 0.0 110.852 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.15 74.72 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.442 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.34 139.63 58.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.663 1.732 . . . . 0.0 108.344 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.49 138.36 58.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.29 -19.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.215 1.006 . . . . 0.0 111.889 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.44 9.18 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.444 1.02 . . . . 0.0 109.302 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -134.96 145.66 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -119.87 131.41 55.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.072 2.149 . . . . 0.0 106.608 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.43 125.94 51.56 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -170.53 169.31 7.37 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.922 1.289 . . . . 0.0 107.838 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.4 ptt? 44.64 40.82 4.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 0.0 113.073 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 52.53 33.89 14.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.232 1.813 . . . . 0.0 113.098 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.3 mtt -143.82 170.92 14.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.115 1.766 . . . . 0.0 108.984 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -123.84 138.13 54.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.16 133.35 18.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.46 155.16 70.05 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.842 1.695 . . . . 0.0 111.076 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.27 127.52 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.6 157.28 17.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.38 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 116.43 5.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.71 1.204 . . . . 0.0 108.172 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.95 -25.02 66.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.037 0.535 . . . . 0.0 111.489 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -157.08 156.54 32.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.144 1.377 . . . . 0.0 108.763 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 m -74.97 156.41 36.33 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.645 0.778 . . . . 0.0 110.918 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.98 175.26 33.83 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.82 -0.55 . . . . 0.0 112.681 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.92 135.13 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 108.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -70.83 -46.62 62.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -159.47 156.03 27.56 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.9 135.97 47.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.01 1.83 24.67 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.317 0.647 . . . . 0.0 112.372 -169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -141.43 176.97 8.44 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.101 1.36 . . . . 0.0 109.444 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.8 163.22 35.7 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.886 1.275 . . . . 0.0 108.566 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.57 128.64 35.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.515 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.2 87.4 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.135 1.35 . . . . 0.0 113.942 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.4 154.32 42.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.985 1.892 . . . . 0.0 110.572 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.27 143.2 57.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.94 159.97 15.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 109.282 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.21 167.77 22.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.39 -171.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.32 111.36 1.73 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.05 1.83 66.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.951 1.262 . . . . 0.0 112.841 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -78.25 130.73 36.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.334 1.567 . . . . 0.0 108.002 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.37 143.34 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.268 0.485 . . . . 0.0 109.745 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.0 tp -100.51 -51.86 3.5 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.107 1.363 . . . . 0.0 108.902 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.89 168.49 23.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 111.719 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.75 141.72 51.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.973 2.109 . . . . 0.0 106.202 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 N--CA 1.462 0.136 0 C-N-CA 124.272 1.029 . . . . 0.0 110.353 -169.582 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.238 0.483 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -141.35 163.12 33.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.307 1.443 . . . . 0.0 111.162 -168.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.21 152.81 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.56 26.81 4.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.501 1.12 . . . . 0.0 111.381 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.5 155.95 32.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.445 1.498 . . . . 0.0 108.001 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.32 140.29 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 122.072 -0.393 . . . . 0.0 110.019 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.42 -150.79 15.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.45 142.16 50.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -84.15 74.6 10.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.305 1.042 . . . . 0.0 110.552 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.43 -57.5 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.8 2.44 . . . . 0.0 113.865 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -147.11 161.75 40.23 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.998 1.319 . . . . 0.0 108.7 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.23 146.7 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -129.97 25.1 5.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.207 1.003 . . . . 0.0 111.525 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.59 163.68 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.416 1.087 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -147.55 156.72 43.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.22 1.808 . . . . 0.0 106.316 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 132.96 52.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.77 74.81 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.839 1.209 . . . . 0.0 113.066 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.68 163.44 27.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.331 1.566 . . . . 0.0 110.274 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -108.96 139.17 44.18 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.272 1.429 . . . . 0.0 107.148 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.18 163.18 34.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 170.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -139.63 137.34 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -44.33 123.2 3.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.2 1.0 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.48 71.82 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.639 -1.09 . . . . 0.0 113.54 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.1 138.85 58.03 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.512 1.656 . . . . 0.0 108.211 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.9 141.95 57.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.87 -18.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.814 1.245 . . . . 0.0 111.011 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.85 178.51 10.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.268 0.94 . . . . 0.0 109.061 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -133.86 145.05 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -117.61 133.15 56.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.287 2.235 . . . . 0.0 106.253 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -107.21 121.69 45.04 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 t -166.63 166.82 15.83 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.93 1.292 . . . . 0.0 108.1 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 51.66 29.81 6.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.34 1.056 . . . . 0.0 111.9 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 50.72 37.32 16.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.478 1.511 . . . . 0.0 112.306 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.7 mtm -139.36 170.37 16.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.529 1.932 . . . . 0.0 107.9 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -119.89 139.63 52.11 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.59 129.95 15.47 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.91 156.05 66.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.709 1.606 . . . . 0.0 111.14 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 125.77 72.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 156.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.821 1.249 . . . . 0.0 110.53 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 114.28 3.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.43 -24.8 67.29 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.571 0.349 . . . . 0.0 111.338 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -157.32 155.89 31.44 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.694 1.598 . . . . 0.0 108.565 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 m -77.49 158.37 29.98 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.731 0.812 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.86 177.28 35.72 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.8 mm -85.36 135.56 24.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.38 106.75 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -75.69 -39.58 57.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.05 158.14 38.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 109.37 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.46 124.88 73.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -92.41 -5.43 52.04 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 112.022 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -137.0 177.5 7.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.499 1.119 . . . . 0.0 109.617 -170.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -141.87 165.92 26.14 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.63 134.51 57.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.43 82.45 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.219 -1.323 . . . . 0.0 114.122 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -72.58 155.14 40.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.113 1.956 . . . . 0.0 110.685 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -66.37 143.88 56.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.35 160.24 17.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.066 0.946 . . . . 0.0 109.146 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.29 168.4 20.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.538 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.98 110.46 1.57 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.26 1.77 64.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.104 1.335 . . . . 0.0 112.839 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.8 128.38 33.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.287 1.544 . . . . 0.0 108.162 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 t -68.88 138.49 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -91.01 -51.89 5.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.592 1.157 . . . . 0.0 108.617 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.77 168.33 27.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.966 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.23 147.56 50.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.353 1.861 . . . . 0.0 106.621 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--O 1.231 0.093 0 C-N-CA 124.69 1.196 . . . . 0.0 111.278 -169.276 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.239 0.5 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -140.0 166.09 25.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.755 1.622 . . . . 0.0 109.913 -169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -94.59 155.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -132.9 27.61 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.787 1.235 . . . . 0.0 111.23 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 153.16 30.84 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.044 1.338 . . . . 0.0 108.05 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.48 138.58 40.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.48 -153.31 18.69 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.09 138.87 45.56 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.69 121.17 14.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -71.89 -54.83 8.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -150.09 161.09 43.05 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.573 1.549 . . . . 0.0 108.481 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.52 143.27 39.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.97 -21.58 7.06 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 111.942 -169.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.08 165.41 2.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.773 0.797 . . . . 0.0 111.44 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -147.6 153.94 40.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.48 129.88 44.17 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.22 -12.21 63.61 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.814 1.197 . . . . 0.0 112.639 -174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -70.08 168.69 15.0 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.906 1.353 . . . . 0.0 109.875 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -125.05 138.42 54.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.725 1.21 . . . . 0.0 107.901 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -129.29 158.8 41.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -135.86 142.22 44.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -47.03 120.95 3.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.704 0.684 . . . . 0.0 110.98 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.15 -11.34 67.5 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.849 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -64.47 142.84 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.551 1.676 . . . . 0.0 108.245 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.84 143.46 54.55 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -134.44 -37.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.595 1.158 . . . . 0.0 110.06 -171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.4 -179.02 7.78 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.08 0.952 . . . . 0.0 109.3 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -137.03 139.5 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -113.79 133.36 55.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.581 1.952 . . . . 0.0 106.943 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.88 124.12 47.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -167.57 166.47 14.09 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.507 1.123 . . . . 0.0 108.565 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.77 44.98 1.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.841 1.656 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.41 31.8 12.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.965 1.706 . . . . 0.0 113.126 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -139.14 169.35 17.95 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.177 1.791 . . . . 0.0 108.694 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.8 140.13 50.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.64 126.83 16.12 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.7 151.9 44.8 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.578 2.185 . . . . 0.0 112.432 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -128.15 131.95 68.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 169.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.67 160.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.094 1.358 . . . . 0.0 109.59 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.04 116.95 5.35 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.88 1.272 . . . . 0.0 108.52 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.22 -26.72 66.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.99 0.516 . . . . 0.0 111.4 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -157.77 161.16 38.43 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.568 1.547 . . . . 0.0 108.966 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -80.39 157.6 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 111.214 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.03 179.8 36.0 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.95 0.786 . . . . 0.0 111.857 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -85.94 136.48 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.54 98.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -69.53 -39.78 77.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -155.85 166.33 33.8 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.8 t -125.21 134.12 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -103.83 0.03 29.77 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.9 176.44 9.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.875 1.27 . . . . 0.0 109.966 -170.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.38 165.3 31.51 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 108.675 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.66 136.26 50.7 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.951 0.901 . . . . 0.0 108.799 172.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.11 -8.9 65.21 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.616 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -74.88 152.36 38.89 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.972 1.886 . . . . 0.0 110.942 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -68.14 145.22 54.58 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.067 0.947 . . . . 0.0 109.195 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 m -142.86 161.04 18.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 123.856 0.863 . . . . 0.0 109.721 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -144.07 167.27 22.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.347 -174.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.59 109.62 1.45 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.39 -0.35 57.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.339 1.447 . . . . 0.0 112.849 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.68 126.57 31.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.435 1.617 . . . . 0.0 108.697 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.8 145.41 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -113.77 -44.65 3.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.249 1.42 . . . . 0.0 109.411 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 171.0 18.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.981 0.81 . . . . 0.0 111.017 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -126.94 137.84 53.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.974 1.71 . . . . 0.0 106.577 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 111.305 -172.254 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.239 0.534 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -139.05 158.66 43.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 110.646 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.74 149.74 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -112.0 8.09 20.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.262 0.625 . . . . 0.0 111.91 -170.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -158.53 159.17 35.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.093 1.357 . . . . 0.0 108.918 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.04 140.49 41.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 110.291 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.92 -151.97 16.23 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.52 142.42 50.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.36 76.9 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.133 0.973 . . . . 0.0 110.649 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -37.68 -57.79 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.952 2.101 . . . . 0.0 113.43 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -148.28 161.4 41.59 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.183 1.393 . . . . 0.0 108.635 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -136.38 146.49 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -131.26 24.05 4.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.86 0.864 . . . . 0.0 112.094 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 m -131.83 162.18 39.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.561 1.144 . . . . 0.0 109.959 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.3 162.62 38.58 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.066 1.747 . . . . 0.0 107.155 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 135.76 43.68 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.84 -8.27 73.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.727 -1.04 . . . . 0.0 113.061 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.7 164.85 24.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.25 1.525 . . . . 0.0 110.033 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -120.03 140.55 50.81 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.96 1.304 . . . . 0.0 108.174 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -130.89 158.87 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.6 145.05 46.49 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -48.76 121.65 4.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.582 0.628 . . . . 0.0 110.525 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.28 78.37 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.601 -1.11 . . . . 0.0 113.824 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -63.52 138.66 58.59 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.66 1.73 . . . . 0.0 107.881 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.48 139.74 53.94 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.63 -30.69 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.64 1.176 . . . . 0.0 110.688 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.78 -178.93 7.72 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.7 1.136 . . . . 0.0 109.528 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.33 140.06 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.87 137.21 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.71 2.004 . . . . 0.0 106.336 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -114.78 124.06 50.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -169.31 169.76 8.91 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.958 1.303 . . . . 0.0 107.849 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 18.9 ptt? 44.7 41.27 4.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.767 1.227 . . . . 0.0 112.856 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.71 31.5 12.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.351 1.86 . . . . 0.0 113.183 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.38 170.04 16.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.71 1.604 . . . . 0.0 109.356 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.22 140.56 50.99 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.12 128.06 17.32 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.54 154.06 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.889 1.726 . . . . 0.0 110.756 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.65 133.02 69.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.6 m -125.06 161.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.389 1.076 . . . . 0.0 110.217 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.93 3.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.59 -20.45 65.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 0.0 111.756 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -154.23 160.29 41.75 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.656 1.582 . . . . 0.0 108.479 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -70.36 157.23 38.13 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.389 0.676 . . . . 0.0 110.805 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.65 -174.38 42.06 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.754 -0.591 . . . . 0.0 112.352 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.52 134.48 46.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.56 114.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -76.35 -46.37 27.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.49 155.53 30.51 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.74 129.2 70.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.96 -3.33 45.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.011 0.924 . . . . 0.0 112.569 -169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -136.55 177.44 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.307 1.043 . . . . 0.0 109.532 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -143.15 159.99 41.27 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.69 1.196 . . . . 0.0 108.224 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.34 130.77 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.53 86.97 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.182 1.372 . . . . 0.0 113.637 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.58 155.7 40.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.888 1.844 . . . . 0.0 110.799 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -67.55 144.94 55.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.37 159.84 15.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.06 0.944 . . . . 0.0 109.134 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.6 168.46 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.045 0.538 . . . . 0.0 111.701 -171.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.56 114.01 2.74 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.93 4.75 81.82 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.83 1.205 . . . . 0.0 113.005 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -79.87 123.43 27.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.382 1.591 . . . . 0.0 107.884 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.52 141.52 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.144 0.578 . . . . 0.0 109.695 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -106.71 -46.16 4.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.87 1.268 . . . . 0.0 109.46 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.24 161.44 41.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.129 0.877 . . . . 0.0 111.589 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -126.31 143.36 51.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.717 2.007 . . . . 0.0 106.272 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 CA--C 1.521 -0.158 0 C-N-CA 123.997 0.919 . . . . 0.0 109.54 -169.393 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--O 1.238 0.45 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 19.8 m -140.1 152.49 46.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.433 1.093 . . . . 0.0 111.229 -169.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.3 mp -66.82 147.23 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 26.19 5.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.529 0.732 . . . . 0.0 111.828 -171.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.43 164.34 38.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.806 2.042 . . . . 0.0 107.432 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -82.25 143.42 31.36 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 109.918 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.0 -152.27 17.97 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 117.972 0.351 . . . . 0.0 112.262 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.97 133.24 45.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 116.96 13.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -71.08 -62.32 1.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.179 0.592 . . . . 0.0 109.98 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -148.44 157.6 43.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.6 1.16 . . . . 0.0 110.262 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.17 149.19 28.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -124.47 -22.16 4.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 0.0 111.363 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.77 162.78 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.577 0.704 . . . . 0.0 111.657 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -148.71 160.93 42.71 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.276 1.831 . . . . 0.0 106.885 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 133.85 51.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.46 0.573 . . . . 0.0 109.552 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.29 -1.92 87.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.582 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -68.6 163.46 23.61 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.51 1.655 . . . . 0.0 110.036 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -108.35 138.58 44.4 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -129.22 160.06 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -138.85 140.76 38.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -47.17 120.88 3.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.029 0.831 . . . . 0.0 110.595 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.47 -8.65 66.65 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.55 -1.139 . . . . 0.0 113.855 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.99 134.1 54.41 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.69 1.745 . . . . 0.0 108.244 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.67 132.87 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.2 -22.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.932 0.893 . . . . 0.0 111.743 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 179.12 9.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.381 1.072 . . . . 0.0 109.218 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.2 mt -135.64 145.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.451 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -122.33 136.0 54.82 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.759 2.024 . . . . 0.0 106.799 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.57 124.14 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -169.33 166.34 10.49 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 107.862 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.8 mtm 55.62 31.78 17.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.909 0.884 . . . . 0.0 111.587 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 51.81 33.66 11.74 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.849 1.659 . . . . 0.0 112.567 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.2 mmt -141.24 173.34 11.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.745 2.018 . . . . 0.0 108.737 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.82 138.54 54.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.09 130.04 17.26 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.46 151.78 70.8 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.879 1.719 . . . . 0.0 110.425 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.29 124.02 70.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.44 158.51 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 110.196 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 115.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.718 1.207 . . . . 0.0 108.108 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.72 -23.57 66.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.099 0.56 . . . . 0.0 111.51 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -155.76 157.08 35.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.686 1.595 . . . . 0.0 108.483 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -71.66 157.68 37.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.22 -178.1 38.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 122.141 -0.349 . . . . 0.0 112.276 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.52 136.23 27.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.61 113.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.1 -52.4 9.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.01 131.87 8.86 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.335 0.516 . . . . 0.0 109.781 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.13 141.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -119.36 7.94 11.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.853 0.861 . . . . 0.0 112.621 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -141.71 175.12 9.95 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.679 1.192 . . . . 0.0 109.982 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -148.67 167.1 26.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.392 1.877 . . . . 0.0 108.254 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -59.69 135.25 57.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.712 0.805 . . . . 0.0 109.447 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.71 -1.48 77.96 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.052 1.31 . . . . 0.0 113.874 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.41 151.46 41.15 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.62 1.71 . . . . 0.0 110.529 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.49 144.85 53.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.44 159.78 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.632 0.773 . . . . 0.0 109.914 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.46 166.96 23.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.305 -174.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.14 112.46 2.65 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.64 59.89 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.169 1.366 . . . . 0.0 112.765 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -76.35 127.04 32.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.171 1.485 . . . . 0.0 108.961 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 t -66.18 128.33 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.641 0.776 . . . . 0.0 109.427 -170.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' H ' ' HA ' ' A' ' 4' ' ' SER . 65.1 tp -85.01 -44.88 12.67 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.15 0.98 . . . . 0.0 108.981 169.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -156.21 162.81 40.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.663 0.665 . . . . 0.0 112.371 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -115.11 147.58 40.04 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.454 2.302 . . . . 0.0 106.977 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--O 1.232 0.175 0 C-N-CA 124.626 1.17 . . . . 0.0 110.821 -169.576 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -140.43 160.01 40.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.49 1.116 . . . . 0.0 111.709 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.5 mp -76.11 152.91 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.76 15.86 5.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.313 1.445 . . . . 0.0 111.609 -169.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.28 157.38 35.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.664 1.585 . . . . 0.0 108.04 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.21 141.06 41.89 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.607 0.363 . . . . 0.0 110.214 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -152.68 18.27 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.48 138.52 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.16 71.73 9.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.839 1.255 . . . . 0.0 111.155 -169.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -30.61 -58.61 0.2 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.099 2.56 . . . . 0.0 114.069 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -146.83 160.51 42.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.038 1.335 . . . . 0.0 108.645 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -137.85 142.44 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -122.35 -22.5 5.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.768 0.427 . . . . 0.0 111.845 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.84 159.78 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.444 0.64 . . . . 0.0 111.185 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.42 160.08 44.01 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 126.328 1.851 . . . . 0.0 106.954 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.08 45.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.824 0.738 . . . . 0.0 109.429 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.16 -8.46 79.77 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.863 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -68.91 163.38 24.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.205 1.502 . . . . 0.0 109.881 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -119.9 139.52 52.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.866 1.266 . . . . 0.0 107.901 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 pt -129.81 157.34 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -133.99 144.18 48.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.54 122.37 7.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.885 0.766 . . . . 0.0 110.422 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.47 71.54 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.746 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -64.69 141.21 58.85 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.542 1.671 . . . . 0.0 108.121 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.36 144.32 55.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.195 0.598 . . . . 0.0 109.409 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 t -134.93 -38.35 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.385 . . . . 0.0 109.585 -170.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.53 -178.43 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.354 1.062 . . . . 0.0 108.994 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -134.1 145.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.88 128.13 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.593 1.957 . . . . 0.0 106.673 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.89 124.33 43.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.86 166.83 9.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.251 1.42 . . . . 0.0 107.757 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.4 mtm 54.98 32.49 18.17 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.95 0.9 . . . . 0.0 111.63 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 51.96 33.28 11.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.065 1.746 . . . . 0.0 112.629 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.9 mmt -141.05 173.52 11.4 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.665 1.986 . . . . 0.0 108.406 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.84 140.14 53.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.99 128.92 17.88 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.69 153.41 36.42 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.647 2.232 . . . . 0.0 112.732 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -126.38 130.01 71.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -124.62 159.3 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 124.712 1.205 . . . . 0.0 110.156 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 119.21 8.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.781 1.232 . . . . 0.0 109.022 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.6 -19.11 62.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.434 0.693 . . . . 0.0 111.935 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -154.16 159.73 41.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.812 1.645 . . . . 0.0 108.733 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -73.33 154.57 40.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.64 0.776 . . . . 0.0 110.496 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.7 -173.81 42.71 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.255 0.455 . . . . 0.0 112.255 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.14 136.81 40.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.74 115.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.3 -46.61 15.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -156.09 156.6 34.62 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.4 t -117.34 134.96 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.79 3.46 34.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.629 1.172 . . . . 0.0 113.064 -169.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -141.65 179.13 7.01 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.104 . . . . 0.0 109.298 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.67 161.33 40.11 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.324 1.45 . . . . 0.0 107.917 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.69 134.15 52.61 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.36 0.1 85.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.308 1.432 . . . . 0.0 113.789 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -72.24 156.06 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.647 . . . . 0.0 110.437 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.67 143.38 56.0 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.92 160.24 13.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.249 1.02 . . . . 0.0 109.396 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.9 167.03 23.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -172.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 114.7 3.11 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.797 0.839 . . . . 0.0 108.969 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.0 74.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.866 1.222 . . . . 0.0 112.809 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -75.87 129.6 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.366 1.583 . . . . 0.0 108.31 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.34 141.47 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.9 tp -108.03 -43.31 4.44 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.781 1.232 . . . . 0.0 110.329 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.08 165.51 36.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.231 0.923 . . . . 0.0 111.713 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -126.92 146.0 50.47 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.857 2.063 . . . . 0.0 106.605 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.232 0.147 0 C-N-CA 124.585 1.154 . . . . 0.0 110.3 -169.453 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 C--O 1.239 0.531 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 m -142.65 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.475 1.51 . . . . 0.0 110.283 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.03 157.81 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.991 1.316 . . . . 0.0 107.831 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -136.1 26.02 3.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.116 1.367 . . . . 0.0 111.269 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 156.46 34.14 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.615 1.566 . . . . 0.0 107.909 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.34 139.28 36.65 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.658 -0.651 . . . . 0.0 109.62 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.74 -152.54 16.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.22 138.9 51.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 tp -83.0 71.69 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 111.111 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -27.49 -60.27 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.84 2.456 . . . . 0.0 113.731 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -145.09 162.7 36.35 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.244 1.018 . . . . 0.0 109.489 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.39 147.03 29.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -125.04 -27.43 3.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.042 0.537 . . . . 0.0 111.152 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.18 158.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.643 0.735 . . . . 0.0 110.841 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -153.35 156.56 38.56 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.226 1.81 . . . . 0.0 106.787 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 130.76 45.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.692 0.678 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.77 83.25 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.081 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -66.95 165.53 15.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.267 1.533 . . . . 0.0 109.502 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -123.38 139.66 53.8 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.146 . . . . 0.0 107.925 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -130.24 158.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.105 0.962 . . . . 0.0 108.628 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.78 146.42 49.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -48.26 121.45 4.38 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.634 0.652 . . . . 0.0 110.292 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.53 78.1 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.596 -1.113 . . . . 0.0 113.991 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -65.19 141.5 58.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.607 1.704 . . . . 0.0 108.115 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.09 145.06 56.28 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.046 0.538 . . . . 0.0 109.553 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -135.14 -38.7 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.2 1.4 . . . . 0.0 109.684 -172.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.65 -178.28 7.23 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.041 0.937 . . . . 0.0 109.521 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -135.4 143.76 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.11 132.03 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.822 2.049 . . . . 0.0 106.868 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -103.82 125.87 50.56 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -169.06 169.88 9.2 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.727 1.211 . . . . 0.0 107.872 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.6 ptt? 44.61 40.98 4.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.015 1.326 . . . . 0.0 113.032 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.28 33.32 15.27 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.313 1.845 . . . . 0.0 113.04 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -144.16 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.018 1.727 . . . . 0.0 109.158 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -120.78 139.37 53.21 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 169.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.16 132.05 19.98 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.4 153.03 74.95 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.844 1.696 . . . . 0.0 110.665 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -126.52 133.75 67.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.38 161.42 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.819 1.248 . . . . 0.0 110.404 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 117.48 6.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.375 1.47 . . . . 0.0 108.877 171.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.55 -22.07 65.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.961 0.505 . . . . 0.0 111.77 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -155.22 161.24 41.22 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.612 1.565 . . . . 0.0 108.836 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -72.72 159.17 34.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.886 0.874 . . . . 0.0 111.287 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.65 -176.33 38.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.436 0.541 . . . . 0.0 111.978 172.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.1 137.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.66 104.58 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -68.8 -51.07 44.72 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -160.22 135.39 7.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.235 0.471 . . . . 0.0 109.771 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.89 139.1 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.75 7.78 18.67 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.742 0.817 . . . . 0.0 111.643 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -142.82 177.2 8.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.263 1.825 . . . . 0.0 108.616 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -144.59 171.94 13.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.7 134.77 51.58 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.561 0.745 . . . . 0.0 109.582 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.17 2.78 54.71 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.01 1.291 . . . . 0.0 114.473 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -70.45 153.47 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.864 1.832 . . . . 0.0 110.118 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -66.02 143.56 57.28 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.04 159.32 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.798 0.839 . . . . 0.0 109.384 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.44 167.16 23.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.386 -172.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.66 110.47 1.73 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.24 1.2 62.8 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.144 1.354 . . . . 0.0 113.094 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -78.83 130.08 35.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.427 1.613 . . . . 0.0 108.434 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.37 149.12 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.806 . . . . 0.0 109.84 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.1 tp -119.65 -48.13 2.39 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.208 1.403 . . . . 0.0 109.654 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.08 166.31 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.75 0.705 . . . . 0.0 111.836 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.61 145.29 48.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.153 2.181 . . . . 0.0 106.77 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.232 0.184 0 C-N-CA 124.178 0.991 . . . . 0.0 112.567 -168.913 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.241 0.618 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -138.22 159.52 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.889 1.676 . . . . 0.0 110.089 -169.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.65 146.57 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -107.0 8.98 30.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 111.813 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.48 159.92 36.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.257 1.423 . . . . 0.0 108.891 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.96 142.38 38.38 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.782 0.433 . . . . 0.0 110.169 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.12 -152.81 19.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.52 139.05 45.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.45 118.16 10.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -69.85 -54.18 14.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -149.78 161.54 42.04 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.655 1.582 . . . . 0.0 108.069 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.6 t -134.3 140.6 45.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -115.42 -23.76 8.69 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.74 0.416 . . . . 0.0 111.631 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.19 165.09 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 123.76 0.824 . . . . 0.0 111.759 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -147.1 154.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.94 130.78 48.42 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.7 -10.59 68.6 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.563 1.078 . . . . 0.0 112.74 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -69.39 168.53 14.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.018 1.409 . . . . 0.0 109.815 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -125.48 140.73 52.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.863 1.265 . . . . 0.0 107.776 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -129.26 162.5 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.624 1.17 . . . . 0.0 108.495 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -133.19 141.61 48.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.711 1.604 . . . . 0.0 106.932 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -48.44 127.5 13.23 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.375 0.67 . . . . 0.0 110.937 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 -10.35 71.15 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.479 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.44 142.12 58.28 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.527 1.663 . . . . 0.0 107.167 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.68 152.88 44.53 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.644 0.735 . . . . 0.0 109.893 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -141.26 -35.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.337 1.455 . . . . 0.0 109.376 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.15 -179.15 7.44 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.942 0.897 . . . . 0.0 109.065 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.63 140.37 43.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -114.54 128.9 56.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.958 2.103 . . . . 0.0 106.82 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.32 125.88 45.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -170.45 169.6 7.37 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.82 1.248 . . . . 0.0 108.061 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.1 ptt? 44.66 40.34 4.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.136 1.374 . . . . 0.0 113.202 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.95 33.98 15.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.139 1.776 . . . . 0.0 112.853 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -143.73 170.9 14.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.264 1.825 . . . . 0.0 109.028 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -124.38 137.98 54.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.97 126.44 16.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.78 153.5 75.61 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.36 1.373 . . . . 0.0 111.014 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.99 130.12 74.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.54 159.77 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 124.622 1.169 . . . . 0.0 110.855 -169.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 116.59 5.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 108.439 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.84 -25.14 65.4 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.004 0.522 . . . . 0.0 111.696 173.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -156.17 154.01 30.16 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.673 1.589 . . . . 0.0 108.443 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -66.16 157.35 31.51 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.573 0.749 . . . . 0.0 110.394 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.69 -179.31 38.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -87.66 137.55 20.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.7 102.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -71.52 -41.19 69.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -156.63 162.56 39.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.55 134.03 67.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -102.43 -4.06 26.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.073 0.949 . . . . 0.0 112.732 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -141.36 179.55 6.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.746 1.218 . . . . 0.0 110.278 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -148.96 163.8 36.43 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.341 1.456 . . . . 0.0 108.634 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.85 137.19 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.8 0.84 . . . . 0.0 109.103 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.94 66.4 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.648 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.17 152.29 38.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.84 1.82 . . . . 0.0 111.066 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -68.17 146.0 53.82 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.026 0.931 . . . . 0.0 109.256 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.68 160.55 14.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 110.08 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -140.71 167.78 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.47 0.708 . . . . 0.0 110.992 -175.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.17 116.13 3.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.53 2.56 79.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.783 1.182 . . . . 0.0 113.119 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -78.28 123.19 26.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.468 1.634 . . . . 0.0 107.803 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 t -64.87 145.88 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.277 0.631 . . . . 0.0 109.808 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.7 tp -113.35 -45.89 3.11 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.786 1.235 . . . . 0.0 109.803 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.65 160.53 42.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.394 0.997 . . . . 0.0 112.315 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.63 141.46 51.99 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.015 2.126 . . . . 0.0 105.898 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.812 -169.576 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.238 0.472 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.6 m -138.89 165.05 28.06 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.801 1.24 . . . . 0.0 110.844 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.16 156.33 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 170.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.0 27.08 3.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.781 1.232 . . . . 0.0 110.892 -175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 156.82 34.35 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.733 1.613 . . . . 0.0 107.814 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.66 140.73 35.5 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.28 -151.91 16.76 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.56 137.01 45.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.55 119.91 23.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -76.84 -51.34 11.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.033 0.933 . . . . 0.0 111.049 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -150.31 158.91 44.68 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.824 1.649 . . . . 0.0 107.659 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.6 t -135.76 147.91 28.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -130.0 23.47 5.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 111.808 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.35 164.8 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.433 1.093 . . . . 0.0 110.564 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -146.79 158.2 43.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.137 1.775 . . . . 0.0 106.482 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.32 135.35 53.77 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.64 -7.96 80.79 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.833 1.206 . . . . 0.0 113.297 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.71 164.7 24.54 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.329 1.564 . . . . 0.0 110.372 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -109.58 137.58 47.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 107.255 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -128.83 162.29 36.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -137.13 144.55 43.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -49.98 124.63 10.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.81 0.732 . . . . 0.0 110.354 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.03 -8.41 77.95 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.62 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.66 134.63 54.67 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.569 1.684 . . . . 0.0 107.934 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -67.88 131.7 45.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.96 -19.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.231 1.013 . . . . 0.0 111.787 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.13 179.83 8.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 109.773 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -134.44 143.39 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -114.84 140.54 48.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.006 2.123 . . . . 0.0 107.105 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.46 123.14 47.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 t -167.41 169.66 12.07 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.789 1.235 . . . . 0.0 107.799 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 19.8 ptt? 44.96 39.9 4.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.807 1.243 . . . . 0.0 113.028 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 53.05 34.14 16.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.287 1.835 . . . . 0.0 112.821 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.5 mtp -144.08 167.8 21.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.088 1.755 . . . . 0.0 109.182 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.3 139.04 51.94 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.56 131.44 18.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.14 155.1 68.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.997 1.798 . . . . 0.0 111.087 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.74 124.5 66.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.75 156.31 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.952 1.301 . . . . 0.0 110.247 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.91 12.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.925 1.29 . . . . 0.0 108.868 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.36 -23.04 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.24 0.616 . . . . 0.0 111.992 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -154.58 161.6 41.54 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.183 1.793 . . . . 0.0 108.027 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -73.88 157.01 37.09 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.414 0.686 . . . . 0.0 110.504 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.47 36.24 Favored Glycine 0 CA--C 1.524 0.597 0 O-C-N 121.736 -0.602 . . . . 0.0 112.092 170.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.15 135.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.14 101.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -69.33 -41.3 76.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -156.57 163.53 39.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.567 0.621 . . . . 0.0 109.341 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -124.76 137.75 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -118.55 3.48 11.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -139.79 171.25 14.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.973 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -148.31 171.88 15.28 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.838 1.655 . . . . 0.0 108.913 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -57.98 133.44 55.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.08 0.552 . . . . 0.0 109.511 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.89 74.35 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.878 1.228 . . . . 0.0 113.562 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.22 139.63 50.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.301 1.551 . . . . 0.0 109.228 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -65.9 140.97 58.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.66 157.98 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.51 166.33 26.01 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.978 -171.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.3 108.19 1.05 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.35 0.1 58.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.266 1.413 . . . . 0.0 113.061 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -79.78 130.51 35.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.599 1.7 . . . . 0.0 108.65 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.66 150.05 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.757 0.823 . . . . 0.0 110.066 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.17 -51.61 2.21 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.935 1.694 . . . . 0.0 108.427 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.02 171.92 15.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.987 0.515 . . . . 0.0 110.799 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.92 148.73 50.95 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.478 1.111 . . . . 0.0 108.396 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--O 1.233 0.195 0 C-N-CA 125.057 1.343 . . . . 0.0 112.415 -169.165 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 C--O 1.239 0.512 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 20.4 m -138.12 161.73 36.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.183 0.993 . . . . 0.0 111.982 -169.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -80.52 153.39 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -132.14 27.84 4.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.57 157.35 35.17 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.697 1.599 . . . . 0.0 107.858 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.63 141.97 34.46 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 171.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 -152.51 20.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.63 136.52 51.75 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.19 71.89 9.24 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.906 1.282 . . . . 0.0 111.03 -169.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -24.82 -59.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.431 2.692 . . . . 0.0 114.292 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -144.9 163.84 32.91 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.639 1.176 . . . . 0.0 108.991 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.88 146.52 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -122.68 -17.99 6.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.043 0.537 . . . . 0.0 111.648 -169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.98 166.73 2.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.685 0.755 . . . . 0.0 111.961 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -149.55 162.09 40.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.373 1.869 . . . . 0.0 106.039 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.49 138.23 51.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.706 0.685 . . . . 0.0 109.513 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.26 -5.94 70.2 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.727 -1.041 . . . . 0.0 113.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.86 166.84 18.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.311 1.555 . . . . 0.0 109.448 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -122.25 141.68 51.24 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -129.88 162.65 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.493 1.117 . . . . 0.0 108.292 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.73 140.66 44.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -46.4 123.81 5.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 110.788 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.69 -10.03 75.93 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.619 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.51 139.25 58.47 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.571 1.686 . . . . 0.0 108.145 170.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 142.99 57.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.15 -21.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.031 1.332 . . . . 0.0 110.728 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 179.42 8.73 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.62 0.768 . . . . 0.0 109.038 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -135.61 146.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.47 133.64 53.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.025 2.13 . . . . 0.0 106.358 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -107.87 125.3 51.3 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -170.01 165.97 9.34 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.039 1.336 . . . . 0.0 107.851 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 mtm 56.22 29.99 15.8 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.945 0.898 . . . . 0.0 111.856 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 52.0 35.61 16.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.586 1.555 . . . . 0.0 112.308 -171.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.54 172.93 12.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.602 1.961 . . . . 0.0 108.737 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -125.2 136.95 54.08 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.25 130.4 14.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.21 155.03 68.96 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.59 1.527 . . . . 0.0 110.555 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.3 mm -120.79 124.64 72.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 173.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 m -113.89 156.26 14.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.858 1.263 . . . . 0.0 110.678 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.61 118.66 8.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.507 1.123 . . . . 0.0 108.193 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.73 -25.78 67.45 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.147 0.579 . . . . 0.0 111.48 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -157.33 155.49 30.72 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.233 1.413 . . . . 0.0 108.621 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -70.93 157.34 38.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.421 0.688 . . . . 0.0 110.707 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.9 177.53 35.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 122.1 -0.375 . . . . 0.0 112.513 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.88 133.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 110.81 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.81 -44.9 60.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -156.78 159.42 38.27 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.36 138.11 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -116.67 12.38 14.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.236 1.014 . . . . 0.0 112.154 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -146.79 178.62 8.18 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.037 1.735 . . . . 0.0 108.763 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -144.84 169.61 17.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.065 1.346 . . . . 0.0 108.278 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.67 133.06 46.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.774 0.83 . . . . 0.0 109.232 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.54 -1.61 65.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.045 1.307 . . . . 0.0 114.15 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -71.31 153.31 42.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.807 1.803 . . . . 0.0 110.475 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -66.25 143.82 56.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.07 160.12 17.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.103 0.961 . . . . 0.0 109.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.18 166.62 24.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.285 -174.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 112.98 2.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.58 -1.94 64.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.15 1.357 . . . . 0.0 112.81 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -76.56 132.84 39.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.217 1.509 . . . . 0.0 109.106 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.26 130.27 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.455 0.702 . . . . 0.0 109.481 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 4' ' ' SER . 56.8 tp -82.84 -50.88 8.18 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.677 1.191 . . . . 0.0 108.494 169.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.32 171.05 20.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -171.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.96 148.8 51.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.115 1.366 . . . . 0.0 108.337 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 C--O 1.232 0.143 0 C-N-CA 125.44 1.496 . . . . 0.0 109.779 -170.52 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 C--O 1.239 0.506 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -137.65 155.59 48.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.834 1.253 . . . . 0.0 111.173 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.4 mp -70.11 148.01 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -109.21 6.58 24.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.403 -0.811 . . . . 0.0 112.375 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 159.5 38.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.006 1.322 . . . . 0.0 108.945 -169.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.47 140.14 38.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.835 0.454 . . . . 0.0 109.912 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.21 -151.51 17.76 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.31 141.69 51.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.8 tp -83.06 77.25 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.437 1.095 . . . . 0.0 110.958 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -37.22 -56.33 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.232 2.213 . . . . 0.0 113.554 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -147.02 160.72 42.04 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.931 1.293 . . . . 0.0 108.832 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.74 142.58 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -120.78 -22.51 6.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.196 0.598 . . . . 0.0 111.216 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 m -74.97 161.32 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.659 0.742 . . . . 0.0 111.619 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -149.91 157.13 42.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.626 1.97 . . . . 0.0 106.284 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.86 130.91 45.52 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.795 0.725 . . . . 0.0 109.147 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.23 -9.06 77.0 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.467 1.032 . . . . 0.0 112.997 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.64 166.4 17.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.221 1.511 . . . . 0.0 109.831 170.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -122.92 142.28 50.98 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.3 pt -131.76 161.64 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 123.797 0.839 . . . . 0.0 108.871 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.94 143.76 40.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -46.1 122.94 4.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.981 0.81 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.61 -8.26 78.86 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.92 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -63.86 132.97 52.45 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.683 1.741 . . . . 0.0 107.402 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.0 137.07 43.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.2 -20.06 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.334 1.454 . . . . 0.0 110.878 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.17 -179.34 7.81 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.638 0.775 . . . . 0.0 108.989 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.63 145.61 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -121.15 130.62 53.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.152 2.181 . . . . 0.0 106.44 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.87 124.97 49.39 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -170.03 169.5 8.03 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.851 1.261 . . . . 0.0 107.852 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.0 ptt? 44.42 41.35 4.51 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.025 1.33 . . . . 0.0 112.922 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.78 31.93 11.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.378 1.871 . . . . 0.0 113.107 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.41 170.44 15.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.327 1.851 . . . . 0.0 109.093 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.46 139.19 54.15 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.58 129.44 17.52 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -169.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.45 149.29 80.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.53 1.487 . . . . 0.0 110.308 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.98 123.55 71.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -113.06 155.64 14.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.138 1.375 . . . . 0.0 110.91 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 121.04 12.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.801 1.24 . . . . 0.0 108.497 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.24 -30.17 70.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.162 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -157.16 155.86 31.68 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 109.207 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 m -71.75 155.47 40.42 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.736 0.814 . . . . 0.0 110.85 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.04 178.75 38.55 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.24 0.448 . . . . 0.0 112.008 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.62 134.96 27.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.45 107.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.21 -40.89 29.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.45 154.53 32.01 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 t -114.16 134.74 56.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.3 -3.52 31.15 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.873 0.869 . . . . 0.0 112.714 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -137.66 178.01 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.412 1.085 . . . . 0.0 109.958 -170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -142.42 163.61 32.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.779 1.232 . . . . 0.0 107.785 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -60.99 136.78 58.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.46 -4.3 78.46 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.314 -1.27 . . . . 0.0 114.06 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -72.67 155.31 40.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.005 1.903 . . . . 0.0 110.717 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.08 144.53 56.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.93 160.82 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.035 0.934 . . . . 0.0 109.238 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -145.93 166.69 25.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.052 -172.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.37 113.92 2.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 2.2 75.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.794 1.188 . . . . 0.0 112.892 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -77.81 127.29 32.18 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 1.566 . . . . 0.0 107.507 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.78 137.35 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.08 -50.93 5.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.817 1.247 . . . . 0.0 108.9 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 168.01 24.51 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.583 0.629 . . . . 0.0 112.081 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -126.78 141.97 51.68 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.225 1.81 . . . . 0.0 106.921 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 CA--C 1.519 -0.214 0 C-N-CA 124.407 1.083 . . . . 0.0 110.766 -169.457 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--O 1.237 0.425 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 17.1 m -140.56 159.53 41.99 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.993 1.317 . . . . 0.0 111.127 -169.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 mm -77.55 156.55 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.76 15.62 4.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.451 1.5 . . . . 0.0 111.512 -169.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.33 157.76 36.24 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.647 1.579 . . . . 0.0 108.114 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.61 140.84 41.17 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.5 -153.91 20.0 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.93 135.65 50.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.46 70.74 8.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.846 1.258 . . . . 0.0 111.096 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -25.76 -59.82 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.431 2.692 . . . . 0.0 114.127 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -144.75 163.17 34.83 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.618 1.167 . . . . 0.0 108.923 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.43 146.38 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -124.48 -18.62 5.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.915 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.17 164.77 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.758 0.79 . . . . 0.0 111.68 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -150.1 157.81 43.51 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.597 1.959 . . . . 0.0 106.042 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.19 132.5 50.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.39 -8.99 78.91 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.525 1.059 . . . . 0.0 113.068 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.03 162.27 27.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.241 1.52 . . . . 0.0 109.896 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -113.17 141.99 46.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 pt -130.94 158.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.49 143.75 46.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -46.88 119.98 2.79 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.874 0.761 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.08 68.6 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.015 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.5 135.66 55.43 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.708 1.754 . . . . 0.0 108.175 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.69 134.55 52.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.85 -22.17 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.308 1.043 . . . . 0.0 111.495 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.55 -178.88 7.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.074 0.852 . . . . 0.0 109.808 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -135.91 145.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.92 134.79 54.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.779 2.032 . . . . 0.0 106.528 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.71 125.82 53.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.86 166.76 7.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.163 1.385 . . . . 0.0 107.788 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 56.06 30.28 16.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.919 0.888 . . . . 0.0 111.86 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 51.88 35.8 16.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.641 1.577 . . . . 0.0 112.279 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.77 173.03 11.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.625 1.97 . . . . 0.0 108.799 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.57 137.69 53.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.48 131.15 16.08 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.66 155.39 69.02 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.857 1.704 . . . . 0.0 110.61 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.0 mm -124.65 125.22 69.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.59 156.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 110.179 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.17 121.54 13.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.671 1.188 . . . . 0.0 108.425 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.71 -25.81 66.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.108 0.563 . . . . 0.0 111.535 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.38 156.95 33.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.343 1.457 . . . . 0.0 108.882 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -73.43 157.01 37.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.685 0.794 . . . . 0.0 111.061 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.42 -177.19 40.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.504 0.573 . . . . 0.0 112.261 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.6 mm -99.65 129.83 49.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.86 109.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -73.46 -45.47 54.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -157.16 157.14 33.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.82 135.81 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.41 8.07 29.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.24 1.016 . . . . 0.0 111.967 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -146.56 178.75 8.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.937 1.695 . . . . 0.0 108.783 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -144.74 169.42 18.06 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.904 1.282 . . . . 0.0 108.38 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.62 133.4 46.59 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.958 0.903 . . . . 0.0 109.325 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.11 -1.57 63.58 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.112 1.339 . . . . 0.0 114.158 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.9 152.02 44.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.844 1.822 . . . . 0.0 110.511 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -65.95 142.74 57.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.88 160.64 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.099 0.96 . . . . 0.0 109.665 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.86 167.05 23.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.59 -173.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.14 114.78 3.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.694 0.798 . . . . 0.0 108.94 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.81 68.39 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.194 1.378 . . . . 0.0 112.921 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.49 128.11 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.18 1.49 . . . . 0.0 109.293 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.5 131.58 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.506 0.722 . . . . 0.0 109.559 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 4' ' ' SER . 44.6 tp -85.32 -50.83 7.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 124.538 1.135 . . . . 0.0 108.787 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.29 168.95 24.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.212 0.529 . . . . 0.0 111.025 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -129.24 143.79 50.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.274 1.829 . . . . 0.0 106.937 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 110.337 -169.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.9 t . . . . . 0 C--O 1.238 0.491 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -140.13 159.17 42.78 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.684 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -78.14 157.24 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 14.56 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.441 1.496 . . . . 0.0 111.722 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -156.31 157.98 36.66 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.572 1.549 . . . . 0.0 108.136 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.06 140.34 40.28 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.012 -0.43 . . . . 0.0 110.036 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.81 -153.91 18.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 137.12 51.38 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.53 71.83 8.56 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.94 1.296 . . . . 0.0 111.332 -169.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -29.57 -59.26 0.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.941 2.496 . . . . 0.0 114.01 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.87 163.08 37.25 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.114 1.366 . . . . 0.0 108.633 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.77 148.38 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -131.18 26.11 4.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.99 0.916 . . . . 0.0 112.005 -169.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.37 162.35 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.562 1.145 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.79 159.25 44.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.089 1.756 . . . . 0.0 107.641 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.37 133.44 49.7 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 -6.4 83.54 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.222 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.01 165.82 20.99 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.483 1.642 . . . . 0.0 110.163 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -113.36 141.2 47.33 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.575 1.55 . . . . 0.0 107.009 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -130.52 163.36 36.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.055 0.942 . . . . 0.0 108.734 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -137.38 139.63 40.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -47.0 124.2 6.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.056 0.942 . . . . 0.0 110.634 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.56 74.35 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.66 -1.078 . . . . 0.0 113.763 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -64.41 143.65 57.75 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.469 1.635 . . . . 0.0 107.869 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.85 144.22 57.41 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.73 -31.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 110.346 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 -178.78 7.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 119.533 1.061 . . . . 0.0 109.416 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -134.67 145.01 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.36 128.64 52.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.652 1.981 . . . . 0.0 106.588 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.96 124.21 43.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.64 167.67 9.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.194 1.397 . . . . 0.0 107.753 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.2 mtm 54.99 31.59 16.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.057 0.943 . . . . 0.0 111.76 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.27 34.57 14.98 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.932 1.693 . . . . 0.0 112.585 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.4 mtt -142.7 173.66 11.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.479 1.911 . . . . 0.0 108.508 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -120.96 140.61 51.64 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.53 132.19 19.67 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.74 153.87 74.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.932 1.755 . . . . 0.0 110.843 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 mm -126.54 134.9 65.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.87 163.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.373 1.069 . . . . 0.0 110.253 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.39 113.04 2.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.631 1.173 . . . . 0.0 107.842 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.2 -17.04 62.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.311 0.244 . . . . 0.0 111.371 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.32 155.49 30.76 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.057 1.743 . . . . 0.0 108.959 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 m -69.23 158.21 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.903 0.881 . . . . 0.0 110.923 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.37 177.36 33.4 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 122.265 -0.272 . . . . 0.0 112.538 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -85.68 135.08 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -68.62 115.41 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -84.28 -48.3 9.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -157.66 129.55 7.01 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -81.93 137.2 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -110.02 5.3 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.048 0.939 . . . . 0.0 112.124 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -143.84 179.06 7.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.315 1.446 . . . . 0.0 108.612 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -145.38 163.9 33.15 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.548 1.139 . . . . 0.0 108.915 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.23 130.12 43.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.968 0.907 . . . . 0.0 109.716 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.17 -1.61 84.4 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.258 1.409 . . . . 0.0 113.804 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -70.64 153.74 42.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.767 1.783 . . . . 0.0 110.53 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.13 143.86 56.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.61 160.77 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.02 0.928 . . . . 0.0 109.488 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.48 167.72 21.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.976 -172.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 115.55 3.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 108.957 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.68 -0.7 74.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.052 1.311 . . . . 0.0 112.88 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -77.48 126.7 31.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.358 1.579 . . . . 0.0 109.093 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.71 129.74 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.16 -44.97 9.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.339 1.056 . . . . 0.0 109.331 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.78 165.12 37.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.751 0.786 . . . . 0.0 111.884 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -118.32 143.82 46.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.81 2.044 . . . . 0.0 106.586 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.519 -0.246 0 C-N-CA 124.72 1.208 . . . . 0.0 108.514 -174.261 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.237 0.406 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -138.44 155.28 48.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.927 1.291 . . . . 0.0 111.045 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.4 mp -70.02 147.67 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -108.6 4.69 24.27 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 ptp -154.11 163.68 39.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.279 0.945 . . . . 0.0 109.575 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.9 141.45 49.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.784 0.434 . . . . 0.0 110.175 173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.19 -152.93 20.32 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.91 140.15 51.8 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.9 tp -80.78 75.78 7.7 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.455 1.102 . . . . 0.0 111.592 -169.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -35.2 -58.15 0.56 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.348 2.259 . . . . 0.0 113.789 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -147.61 160.63 42.44 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.794 1.237 . . . . 0.0 108.743 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.2 143.58 32.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -124.32 -21.34 4.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.832 0.453 . . . . 0.0 111.992 -169.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.2 162.01 4.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.468 0.651 . . . . 0.0 111.557 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -149.59 158.91 44.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.266 1.826 . . . . 0.0 106.763 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.88 47.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.09 -6.94 83.2 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.112 -178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -68.42 164.93 19.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.316 1.558 . . . . 0.0 109.842 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -119.41 144.57 46.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.522 1.129 . . . . 0.0 108.005 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.25 159.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -133.69 143.99 48.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -48.54 121.31 4.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.874 0.761 . . . . 0.0 110.438 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.56 67.49 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -64.61 134.72 54.92 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.695 1.747 . . . . 0.0 108.074 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -67.7 133.03 48.59 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.32 -21.67 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.271 1.028 . . . . 0.0 111.424 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.74 8.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.151 0.981 . . . . 0.0 109.514 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.41 147.24 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -124.02 131.52 53.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.885 2.074 . . . . 0.0 106.515 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.23 124.71 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -169.07 166.4 10.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.824 1.249 . . . . 0.0 108.047 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.9 mtm 55.18 31.52 16.6 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.932 0.893 . . . . 0.0 111.854 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 52.22 35.21 16.23 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.79 1.636 . . . . 0.0 112.496 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.44 173.76 11.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.667 1.987 . . . . 0.0 108.665 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -118.61 142.53 47.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.49 128.44 19.14 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 -169.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.1 147.94 68.23 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.831 1.687 . . . . 0.0 109.996 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -121.08 121.88 66.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 m -114.95 157.2 15.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.631 1.173 . . . . 0.0 110.177 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 119.73 9.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.687 1.195 . . . . 0.0 108.25 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.18 -26.13 68.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.42 0.688 . . . . 0.0 111.572 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -157.38 155.51 30.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.581 1.552 . . . . 0.0 108.476 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 m -69.38 157.58 36.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.342 0.657 . . . . 0.0 110.605 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.39 -176.17 40.33 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 122.106 -0.371 . . . . 0.0 112.473 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -99.84 133.64 42.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.63 111.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -77.0 -45.2 28.14 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.39 151.66 26.58 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.55 134.19 48.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -106.27 3.76 28.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.672 0.789 . . . . 0.0 112.461 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -138.7 178.4 7.18 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.064 1.346 . . . . 0.0 109.284 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.04 159.89 41.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.648 1.179 . . . . 0.0 108.136 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.27 132.05 51.4 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.99 -3.62 86.9 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.093 1.33 . . . . 0.0 113.763 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -70.35 154.46 41.87 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.865 1.833 . . . . 0.0 110.68 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -66.47 143.39 57.12 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.42 160.54 14.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.038 0.935 . . . . 0.0 109.219 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.04 167.36 22.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.282 -171.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.31 113.39 2.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.98 5.7 85.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.487 1.041 . . . . 0.0 113.063 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.01 130.23 37.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.439 1.619 . . . . 0.0 107.233 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.17 141.42 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.84 -50.24 3.9 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.166 1.386 . . . . 0.0 108.661 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 165.83 33.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 111.928 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -128.69 139.15 52.38 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.44 1.896 . . . . 0.0 106.403 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 C--O 1.233 0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 110.274 -169.364 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.239 0.502 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -137.75 155.3 49.21 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.718 1.207 . . . . 0.0 111.458 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.26 147.86 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -108.51 5.38 25.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 ptp -153.88 163.03 40.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 109.827 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.53 140.86 50.07 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.653 0.381 . . . . 0.0 110.227 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 169.95 -153.65 21.91 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.23 137.62 44.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.64 121.18 14.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.84 -51.69 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -149.11 159.93 43.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.586 1.555 . . . . 0.0 108.493 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.09 142.89 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -120.76 -22.08 6.42 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.036 0.534 . . . . 0.0 111.506 -170.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.76 165.96 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.977 0.894 . . . . 0.0 111.153 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.73 154.09 36.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.43 50.65 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.67 -9.94 62.45 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.451 1.501 . . . . 0.0 112.989 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.4 172.22 12.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.913 1.357 . . . . 0.0 110.667 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -115.87 138.19 51.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.727 1.611 . . . . 0.0 107.094 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 pt -128.48 160.67 38.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.0 143.9 38.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -48.57 120.85 4.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.774 0.715 . . . . 0.0 110.467 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.81 -8.25 70.71 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.826 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.4 135.22 55.91 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.589 1.694 . . . . 0.0 108.051 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.41 133.69 49.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.12 -22.29 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.293 1.037 . . . . 0.0 111.617 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.06 178.06 10.12 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.592 0.757 . . . . 0.0 109.694 169.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.4 mt -136.78 142.03 39.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -120.46 131.19 54.64 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.278 1.831 . . . . 0.0 106.882 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.87 124.36 43.73 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -168.84 166.78 11.32 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.969 1.308 . . . . 0.0 108.065 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.2 mtm 55.26 31.32 16.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.015 0.926 . . . . 0.0 111.795 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.64 34.6 16.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.71 1.604 . . . . 0.0 112.515 -172.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.08 173.53 11.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.517 1.927 . . . . 0.0 108.659 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -118.72 141.67 48.39 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.66 128.31 18.92 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.45 149.63 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.947 1.764 . . . . 0.0 110.203 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mm -122.46 120.94 62.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.18 156.18 15.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.792 1.237 . . . . 0.0 110.183 -172.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 116.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.038 1.335 . . . . 0.0 108.63 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.43 -23.32 65.52 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.082 0.553 . . . . 0.0 111.768 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -154.54 162.04 41.34 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.522 1.529 . . . . 0.0 108.796 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -75.17 157.32 34.77 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.82 0.848 . . . . 0.0 110.96 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.62 174.75 33.83 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.354 0.502 . . . . 0.0 112.0 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.3 mm -85.57 134.3 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.74 101.77 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -71.48 -40.66 70.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -156.02 164.13 38.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.568 0.622 . . . . 0.0 109.335 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 t -125.87 135.09 64.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -105.5 -0.84 25.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 111.863 -169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -141.29 177.04 8.37 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.817 1.247 . . . . 0.0 110.693 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.16 169.01 21.68 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.311 1.444 . . . . 0.0 108.501 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.62 139.68 49.24 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.728 0.811 . . . . 0.0 109.271 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.45 -7.78 56.24 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.376 -1.236 . . . . 0.0 113.737 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -75.83 152.85 37.17 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.817 1.809 . . . . 0.0 110.952 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.91 145.38 54.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.034 0.934 . . . . 0.0 109.325 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.19 161.59 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.877 0.871 . . . . 0.0 109.952 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.36 168.48 19.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.091 -175.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.23 114.65 3.0 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.37 82.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.472 1.034 . . . . 0.0 112.976 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -78.87 125.82 29.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.454 1.627 . . . . 0.0 107.847 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.61 132.13 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.483 0.713 . . . . 0.0 109.961 -169.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.89 -50.53 7.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.931 1.292 . . . . 0.0 107.686 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -154.35 169.58 23.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.455 0.645 . . . . 0.0 111.893 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.24 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.517 1.927 . . . . 0.0 106.8 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.234 0.25 0 C-N-CA 124.199 1.0 . . . . 0.0 110.556 -169.828 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 C--O 1.235 0.341 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -136.62 154.59 50.61 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 110.635 -169.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.4 mp -69.6 141.84 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -102.77 5.66 38.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.695 -0.628 . . . . 0.0 112.529 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -156.27 164.28 38.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.3 1.04 . . . . 0.0 109.532 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.69 142.86 42.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.729 0.411 . . . . 0.0 110.312 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.54 -151.72 16.99 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.73 132.39 45.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 113.66 10.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -70.66 -59.18 2.97 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.015 0.926 . . . . 0.0 110.564 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -149.42 158.33 44.08 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.968 1.307 . . . . 0.0 109.182 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.28 145.73 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.171 1.389 . . . . 0.0 107.434 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.89 24.83 4.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.412 1.085 . . . . 0.0 111.055 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 m -132.83 165.52 32.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.083 1.353 . . . . 0.0 110.129 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -146.7 156.19 42.99 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.985 1.714 . . . . 0.0 106.519 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.32 133.52 55.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.46 -10.12 74.75 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.513 1.054 . . . . 0.0 112.864 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.08 170.35 11.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.045 1.422 . . . . 0.0 109.658 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -126.46 143.26 51.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 107.986 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.51 164.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.616 1.166 . . . . 0.0 108.784 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -136.05 141.64 44.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.708 1.203 . . . . 0.0 107.817 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -45.62 116.55 1.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 110.691 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -10.68 62.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.714 -1.048 . . . . 0.0 113.66 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -66.63 140.41 57.93 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.497 1.648 . . . . 0.0 108.499 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.94 138.99 56.39 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.5 -19.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.981 0.912 . . . . 0.0 112.151 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.53 178.4 9.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.705 1.202 . . . . 0.0 108.688 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -134.76 148.86 29.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -123.56 133.67 53.94 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.738 2.015 . . . . 0.0 106.745 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 123.8 46.42 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -168.83 167.3 11.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.764 1.225 . . . . 0.0 107.951 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 mtm 55.48 30.61 15.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.854 0.862 . . . . 0.0 111.861 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 53.13 35.3 19.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.857 1.663 . . . . 0.0 111.995 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -144.0 173.62 11.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.484 1.914 . . . . 0.0 108.644 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -119.23 140.53 50.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.3 131.79 19.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.56 152.46 74.79 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.892 1.728 . . . . 0.0 110.754 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.9 mm -123.46 118.65 55.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.85 157.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.466 1.106 . . . . 0.0 110.293 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 108.23 1.13 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.264 1.426 . . . . 0.0 107.441 170.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.02 -15.13 62.97 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 155.72 34.46 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.673 1.589 . . . . 0.0 108.509 171.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.94 159.66 33.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.18 0.992 . . . . 0.0 110.975 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.57 179.19 37.01 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 121.829 -0.544 . . . . 0.0 112.377 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -85.45 134.05 28.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.51 100.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -70.34 -40.24 74.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -156.87 162.88 39.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -114.83 7.98 15.91 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.741 0.816 . . . . 0.0 112.557 -168.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -140.73 175.59 9.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.761 1.224 . . . . 0.0 109.588 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -143.3 160.34 40.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.326 1.85 . . . . 0.0 107.182 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.36 127.64 33.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.23 -7.51 64.25 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.504 1.526 . . . . 0.0 113.407 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -74.77 153.66 38.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.5 1.65 . . . . 0.0 111.414 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.62 145.32 54.03 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.551 0.74 . . . . 0.0 109.117 170.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.55 159.83 14.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.752 0.821 . . . . 0.0 110.108 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.92 166.11 25.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -176.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.8 117.84 5.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.12 -0.8 82.15 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.682 1.134 . . . . 0.0 113.044 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.25 131.69 41.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.274 1.537 . . . . 0.0 108.176 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 t -70.95 135.09 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 -50.94 5.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 125.462 1.505 . . . . 0.0 108.894 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.18 168.75 20.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 112.062 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.24 140.09 52.09 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.663 1.985 . . . . 0.0 106.378 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 123.886 0.875 . . . . 0.0 112.446 -169.074 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.238 0.458 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 m -139.68 160.12 40.59 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.694 1.198 . . . . 0.0 111.03 -168.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.63 156.81 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.59 15.63 4.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.445 1.098 . . . . 0.0 112.129 -169.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 158.29 36.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.099 1.76 . . . . 0.0 107.91 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.71 141.08 38.18 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.884 -0.51 . . . . 0.0 109.762 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.08 -153.43 19.43 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 175.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.68 133.71 45.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.85 113.55 13.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -66.52 -56.09 12.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.045 0.938 . . . . 0.0 110.203 -170.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.52 161.4 42.21 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.419 1.488 . . . . 0.0 107.943 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.21 146.69 28.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.44 -19.77 5.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.029 0.532 . . . . 0.0 112.03 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.76 166.17 2.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.794 0.807 . . . . 0.0 111.791 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.78 160.26 42.92 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.627 1.971 . . . . 0.0 105.93 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.12 137.83 45.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.18 -7.39 75.67 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.472 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -70.74 162.85 28.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.448 1.624 . . . . 0.0 110.339 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -108.71 137.56 46.44 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 pt -128.2 161.27 36.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -138.73 141.68 38.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -47.51 120.64 3.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.959 0.8 . . . . 0.0 110.69 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -10.25 64.63 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.894 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.52 135.85 56.44 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.552 1.676 . . . . 0.0 108.237 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.21 134.13 49.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.53 -22.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.126 0.97 . . . . 0.0 111.534 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.57 -178.82 7.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.79 0.836 . . . . 0.0 109.615 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -137.28 146.37 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.4 tm? -121.53 136.21 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.677 1.991 . . . . 0.0 107.197 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -104.34 124.08 48.54 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.26 167.82 10.05 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 125.004 1.322 . . . . 0.0 107.923 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 54.9 32.72 18.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.906 0.883 . . . . 0.0 111.656 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.23 32.73 11.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.985 1.714 . . . . 0.0 112.681 -173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.8 mmm -142.16 173.26 11.68 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.579 1.952 . . . . 0.0 108.746 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -119.46 141.99 48.66 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.84 130.29 18.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.87 152.51 73.7 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.87 1.713 . . . . 0.0 110.566 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -123.68 121.83 63.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 m -113.39 157.72 13.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.726 1.21 . . . . 0.0 109.977 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 119.82 9.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.713 1.205 . . . . 0.0 108.237 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.77 -26.07 65.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.945 0.498 . . . . 0.0 111.336 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -157.12 155.87 31.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.536 1.534 . . . . 0.0 108.855 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.46 156.81 36.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.05 0.94 . . . . 0.0 111.085 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.8 177.23 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.363 0.506 . . . . 0.0 112.392 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -85.8 133.35 29.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 169.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.15 111.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -73.88 -46.66 43.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -156.57 158.92 37.97 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.55 131.53 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.83 -6.02 27.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.979 0.912 . . . . 0.0 112.555 -169.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -138.86 173.6 11.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.184 1.394 . . . . 0.0 109.045 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -147.79 170.53 17.39 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 109.129 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.28 128.91 39.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.66 1.02 87.7 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.148 1.356 . . . . 0.0 113.507 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.74 153.09 42.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.32 1.56 . . . . 0.0 110.097 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -76.02 143.39 41.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.72 159.62 14.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.592 0.711 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.77 167.01 23.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.308 -172.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 113.08 2.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.31 72.22 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.898 1.237 . . . . 0.0 113.106 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.83 126.33 30.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.435 1.618 . . . . 0.0 108.206 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.86 144.59 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.31 -49.5 2.96 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.514 1.526 . . . . 0.0 108.479 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.84 169.2 19.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.338 0.589 . . . . 0.0 111.642 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.48 144.89 51.45 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.311 1.845 . . . . 0.0 106.844 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.523 -0.095 0 C-N-CA 124.854 1.262 . . . . 0.0 110.66 -169.201 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.239 0.524 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -140.76 155.82 46.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.238 . . . . 0.0 110.667 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.8 mm -73.88 152.13 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.621 1.168 . . . . 0.0 107.993 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.89 11.61 14.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.386 0.675 . . . . 0.0 111.948 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -143.67 161.21 39.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.558 1.543 . . . . 0.0 108.343 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -90.01 131.51 35.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.63 11.55 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.4 142.35 50.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.0 tp -85.74 72.21 10.58 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.978 0.911 . . . . 0.0 110.833 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -27.68 -59.1 0.11 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.083 2.553 . . . . 0.0 114.081 -174.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.6 162.42 38.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.119 1.368 . . . . 0.0 108.527 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.87 147.67 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -131.34 25.46 4.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.192 0.997 . . . . 0.0 111.559 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.76 165.04 32.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.388 1.075 . . . . 0.0 110.484 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -148.97 158.08 43.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.983 1.713 . . . . 0.0 106.795 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.43 53.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.55 77.48 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.528 1.061 . . . . 0.0 112.787 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.05 167.68 17.1 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.142 1.471 . . . . 0.0 109.815 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -125.02 138.1 54.22 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -126.56 162.84 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.368 1.067 . . . . 0.0 108.198 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.9 143.11 48.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -47.87 126.96 11.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.58 0.752 . . . . 0.0 110.5 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.56 78.45 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.507 -1.163 . . . . 0.0 113.617 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.85 138.65 58.03 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.688 1.744 . . . . 0.0 107.884 169.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.89 137.94 57.52 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.06 -19.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.868 1.267 . . . . 0.0 111.429 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.88 -179.49 8.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.435 1.016 . . . . 0.0 109.336 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -136.19 139.02 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -106.11 136.11 46.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.803 2.041 . . . . 0.0 106.614 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.31 120.93 44.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -162.02 166.4 26.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 53.33 24.61 3.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt 47.38 42.68 14.46 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 126.12 1.768 . . . . 0.0 111.839 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.6 mmt -137.12 164.64 27.96 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.402 2.281 . . . . 0.0 106.988 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -112.14 140.73 46.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.73 122.79 14.61 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.24 151.59 35.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.988 2.458 . . . . 0.0 112.723 174.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mm -126.4 123.23 62.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.32 155.41 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.234 1.413 . . . . 0.0 110.105 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.28 124.09 21.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.145 0.978 . . . . 0.0 108.674 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -29.05 69.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.806 0.442 . . . . 0.0 111.573 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.1 ptm85 -157.21 156.61 32.87 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.611 1.164 . . . . 0.0 108.895 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -70.31 155.14 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.34 0.656 . . . . 0.0 110.492 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.17 177.2 36.71 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 122.119 -0.363 . . . . 0.0 112.39 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -85.42 133.39 29.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.6 109.59 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -78.06 -43.43 29.24 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -152.18 156.86 40.61 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.488 0.585 . . . . 0.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.4 129.47 74.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.4 -0.55 35.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.694 0.798 . . . . 0.0 111.983 -169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -139.73 176.26 8.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.821 1.249 . . . . 0.0 109.581 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.44 164.57 31.13 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.93 1.292 . . . . 0.0 108.579 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.4 128.13 32.84 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.955 0.902 . . . . 0.0 109.561 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.71 86.79 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.187 1.375 . . . . 0.0 114.02 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -70.5 154.74 41.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.955 1.877 . . . . 0.0 110.597 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.73 143.11 57.14 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.12 160.21 15.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -143.79 167.13 23.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.178 0.591 . . . . 0.0 111.017 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.18 114.53 3.49 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.55 1.58 74.22 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.972 1.272 . . . . 0.0 113.151 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.96 128.64 34.22 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.52 1.66 . . . . 0.0 108.123 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.64 133.78 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.335 0.654 . . . . 0.0 110.127 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.0 tp -87.28 -52.09 5.59 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.05 168.38 27.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.713 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 148.24 52.57 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.585 1.154 . . . . 0.0 108.337 174.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.516 -0.359 0 C-N-CA 125.358 1.463 . . . . 0.0 109.802 -169.125 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.154 0.502 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.14 146.48 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 169.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -139.32 160.53 39.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.516 1.127 . . . . 0.0 111.297 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mm -75.06 157.09 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.13 15.27 5.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 112.158 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.73 159.76 38.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.093 1.757 . . . . 0.0 107.984 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -79.29 141.14 37.3 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.98 -0.45 . . . . 0.0 109.879 170.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.79 -152.87 19.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.34 136.42 49.99 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.05 73.7 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.326 1.05 . . . . 0.0 111.542 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -27.18 -60.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.252 2.621 . . . . 0.0 114.01 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -146.3 161.87 39.37 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.714 1.206 . . . . 0.0 108.76 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -135.7 146.24 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.35 -19.96 5.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.74 0.416 . . . . 0.0 111.896 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.2 m -74.71 165.89 2.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.899 0.857 . . . . 0.0 111.942 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.56 159.67 43.49 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.72 2.008 . . . . 0.0 105.74 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.14 46.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.08 75.23 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.654 1.121 . . . . 0.0 113.378 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -71.67 163.74 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.453 1.626 . . . . 0.0 110.306 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -108.6 136.83 47.54 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -127.14 159.33 37.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -137.63 144.39 41.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -50.05 123.21 7.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.893 0.77 . . . . 0.0 110.359 -176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.39 -7.96 80.59 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.612 -1.104 . . . . 0.0 114.032 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -64.71 141.38 58.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.691 1.745 . . . . 0.0 107.814 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.86 143.21 55.85 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.44 -37.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.997 1.319 . . . . 0.0 109.512 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.28 -179.67 8.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.902 0.881 . . . . 0.0 109.536 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -135.56 142.94 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.405 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.8 tm? -119.14 134.05 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.633 1.973 . . . . 0.0 106.736 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.65 124.85 49.61 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -169.25 166.81 10.54 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.009 1.324 . . . . 0.0 107.879 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.7 mtm 55.41 30.95 15.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 51.84 35.11 14.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.875 1.67 . . . . 0.0 112.576 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -142.31 173.48 11.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.473 1.909 . . . . 0.0 108.566 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -119.16 143.48 47.2 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.64 127.41 17.52 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.66 150.28 68.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.953 1.768 . . . . 0.0 110.244 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -124.79 132.31 71.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -124.36 162.19 26.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.869 1.268 . . . . 0.0 110.286 -169.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.18 122.61 16.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.51 -22.38 61.79 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.82 0.448 . . . . 0.0 111.671 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.83 157.71 38.3 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 108.913 175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -69.77 155.65 40.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.792 0.837 . . . . 0.0 111.227 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.14 176.86 37.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.755 0.693 . . . . 0.0 111.761 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.66 135.24 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -68.59 106.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.27 -40.93 62.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.3 161.5 40.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.34 132.79 70.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.22 -1.26 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.2 1.0 . . . . 0.0 112.369 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -139.8 176.17 8.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.269 1.428 . . . . 0.0 109.409 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -144.74 169.83 17.27 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.659 1.183 . . . . 0.0 108.734 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.76 133.69 47.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 0.0 109.685 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.0 -0.59 62.08 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.188 1.375 . . . . 0.0 114.325 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -71.43 153.06 42.55 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.977 1.888 . . . . 0.0 110.452 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -66.47 142.86 57.41 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.31 160.1 15.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.715 0.806 . . . . 0.0 109.692 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.12 167.26 22.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.4 -173.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.37 113.52 2.69 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.95 1.68 72.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.839 1.209 . . . . 0.0 113.086 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.94 126.57 31.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.443 1.621 . . . . 0.0 108.183 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 t -63.63 144.28 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 109.543 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.2 tp -109.95 -48.19 3.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.933 1.693 . . . . 0.0 109.393 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.98 170.86 19.36 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.782 0.719 . . . . 0.0 111.064 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -130.65 148.61 52.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.343 1.457 . . . . 0.0 108.104 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.29 165.57 14.67 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.338 1.455 . . . . 0.0 111.371 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -54.34 147.28 13.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.405 1.482 . . . . 0.0 111.726 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.17 152.94 39.71 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 m -58.85 -20.46 50.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -68.18 -28.68 67.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.488 1.115 . . . . 0.0 112.391 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.973 0.909 . . . . 0.0 109.395 -175.159 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.77 143.83 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -137.49 166.77 23.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.857 1.263 . . . . 0.0 110.951 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 7' ' ' MET . 5.0 mp -87.53 150.3 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 169.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 29.08 4.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 0.0 110.51 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.444 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.9 mpp? -145.1 162.59 36.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 107.385 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.75 133.6 42.84 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 169.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.24 -148.36 12.55 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.52 140.13 51.34 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.24 71.7 10.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.375 1.07 . . . . 0.0 110.126 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -26.47 -59.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.501 2.72 . . . . 0.0 114.0 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.16 163.28 35.87 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.999 1.32 . . . . 0.0 108.385 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.9 t -136.64 147.42 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.62 27.18 4.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.145 0.978 . . . . 0.0 111.785 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.52 164.82 33.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.575 1.15 . . . . 0.0 110.301 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.31 158.35 44.04 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.901 1.681 . . . . 0.0 106.876 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.8 54.15 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.6 -8.96 78.76 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.88 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.14 166.81 17.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.122 1.461 . . . . 0.0 109.666 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -124.17 138.65 54.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.726 1.21 . . . . 0.0 107.774 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 pt -128.5 162.28 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.42 1.088 . . . . 0.0 108.429 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -131.29 145.35 51.84 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.462 1.505 . . . . 0.0 107.346 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.04 129.9 24.76 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.259 0.624 . . . . 0.0 110.537 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.48 -6.45 72.9 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.411 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.62 137.57 57.44 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.654 1.727 . . . . 0.0 107.816 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.79 135.88 56.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.74 -18.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.449 1.1 . . . . 0.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.95 178.91 9.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.245 0.93 . . . . 0.0 109.301 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -135.41 143.52 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.24 131.11 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.198 2.199 . . . . 0.0 106.552 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.35 125.55 50.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.57 167.2 8.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.4 1.48 . . . . 0.0 107.752 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.5 mtm 55.25 32.26 18.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.913 0.885 . . . . 0.0 111.745 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.2 mttm 51.65 33.72 11.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.864 1.666 . . . . 0.0 112.58 -172.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.6 mmm -140.87 172.05 13.23 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.646 1.979 . . . . 0.0 108.52 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -124.15 140.47 52.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.62 133.89 17.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.02 158.61 56.04 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.107 1.871 . . . . 0.0 111.795 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mm -125.6 126.33 70.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.99 157.47 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.014 1.326 . . . . 0.0 110.468 -169.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 121.94 15.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.594 0.757 . . . . 0.0 108.981 175.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.29 -25.85 66.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.052 0.541 . . . . 0.0 111.66 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 162.11 39.78 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.158 1.383 . . . . 0.0 108.981 169.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -65.18 158.17 26.8 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.951 0.9 . . . . 0.0 110.928 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.18 179.32 39.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.82 134.87 27.67 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.49 105.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.98 -47.89 67.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -160.11 150.13 18.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.46 0.573 . . . . 0.0 109.747 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.05 137.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -110.66 9.73 22.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.495 0.718 . . . . 0.0 111.851 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -147.45 -179.49 6.89 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.085 1.754 . . . . 0.0 108.595 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -143.03 168.11 20.48 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.891 1.276 . . . . 0.0 108.369 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.08 132.12 42.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.849 0.859 . . . . 0.0 109.17 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.8 -1.4 73.62 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.055 1.312 . . . . 0.0 114.161 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.21 153.13 42.69 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.865 1.833 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.9 143.15 57.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.92 158.7 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.167 0.987 . . . . 0.0 109.586 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.17 164.05 33.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.306 0.642 . . . . 0.0 110.793 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.21 112.76 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.98 0.912 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.52 -6.49 59.18 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.007 1.289 . . . . 0.0 112.714 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.04 139.18 46.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.279 1.539 . . . . 0.0 108.69 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.89 140.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.93 -53.48 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.544 1.538 . . . . 0.0 108.347 175.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.99 168.06 25.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.535 0.683 . . . . 0.0 111.119 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -125.3 144.3 50.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.832 2.053 . . . . 0.0 106.309 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt -122.13 169.58 10.73 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.618 1.167 . . . . 0.0 110.633 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.0 p -55.49 -41.22 72.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.717 0.807 . . . . 0.0 109.219 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.66 -33.62 23.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.732 1.613 . . . . 0.0 113.3 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -63.35 -15.95 58.96 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.121 0.873 . . . . 0.0 113.257 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -61.83 -23.16 66.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.42 1.009 . . . . 0.0 112.243 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 126.628 1.971 . . . . 0.0 110.747 175.458 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.656 ' N ' ' HG1' ' A' ' 72' ' ' THR . 22.5 m . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.77 142.36 41.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.61 158.9 43.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.836 1.254 . . . . 0.0 111.332 -169.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.9 mp -76.91 153.91 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.01 17.65 4.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.28 1.432 . . . . 0.0 111.574 -170.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.04 156.24 34.06 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.651 1.581 . . . . 0.0 108.061 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.74 140.3 42.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.663 0.385 . . . . 0.0 110.226 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.29 -152.04 17.06 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.14 139.07 52.09 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.6 71.93 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.659 1.183 . . . . 0.0 111.331 -169.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -28.48 -59.21 0.12 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.987 2.515 . . . . 0.0 114.11 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.71 163.53 35.63 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.01 1.324 . . . . 0.0 108.624 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.16 148.26 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.63 23.86 4.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.191 0.996 . . . . 0.0 111.664 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.49 161.94 36.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.437 1.095 . . . . 0.0 110.1 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.75 159.64 43.95 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.927 1.691 . . . . 0.0 107.242 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 134.24 53.81 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.0 -7.11 82.38 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.64 1.115 . . . . 0.0 113.269 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -69.94 165.07 22.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.439 1.619 . . . . 0.0 110.111 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -112.94 138.5 49.72 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.502 1.521 . . . . 0.0 107.018 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 pt -128.92 163.93 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.958 0.903 . . . . 0.0 108.638 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -138.86 140.33 38.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -45.44 123.16 3.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.082 0.953 . . . . 0.0 110.852 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.15 74.72 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.442 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -65.34 139.63 58.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.663 1.732 . . . . 0.0 108.344 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.49 138.36 58.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.29 -19.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.215 1.006 . . . . 0.0 111.889 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.44 9.18 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.444 1.02 . . . . 0.0 109.302 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -134.96 145.66 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -119.87 131.41 55.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.072 2.149 . . . . 0.0 106.608 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.43 125.94 51.56 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -170.53 169.31 7.37 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.922 1.289 . . . . 0.0 107.838 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.4 ptt? 44.64 40.82 4.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 0.0 113.073 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 52.53 33.89 14.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.232 1.813 . . . . 0.0 113.098 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.3 mtt -143.82 170.92 14.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.115 1.766 . . . . 0.0 108.984 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -123.84 138.13 54.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.16 133.35 18.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.46 155.16 70.05 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.842 1.695 . . . . 0.0 111.076 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.27 127.52 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.6 157.28 17.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.38 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 116.43 5.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.71 1.204 . . . . 0.0 108.172 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.95 -25.02 66.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.037 0.535 . . . . 0.0 111.489 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -157.08 156.54 32.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.144 1.377 . . . . 0.0 108.763 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 m -74.97 156.41 36.33 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.645 0.778 . . . . 0.0 110.918 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.98 175.26 33.83 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.82 -0.55 . . . . 0.0 112.681 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.92 135.13 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 108.92 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -70.83 -46.62 62.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -159.47 156.03 27.56 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.9 135.97 47.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.01 1.83 24.67 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.317 0.647 . . . . 0.0 112.372 -169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -141.43 176.97 8.44 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.101 1.36 . . . . 0.0 109.444 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.8 163.22 35.7 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.886 1.275 . . . . 0.0 108.566 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.57 128.64 35.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.515 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.2 87.4 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.135 1.35 . . . . 0.0 113.942 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.4 154.32 42.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.985 1.892 . . . . 0.0 110.572 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.27 143.2 57.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.94 159.97 15.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 109.282 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.21 167.77 22.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.39 -171.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.32 111.36 1.73 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.05 1.83 66.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.951 1.262 . . . . 0.0 112.841 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -78.25 130.73 36.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.334 1.567 . . . . 0.0 108.002 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.37 143.34 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.268 0.485 . . . . 0.0 109.745 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.0 tp -100.51 -51.86 3.5 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.107 1.363 . . . . 0.0 108.902 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.89 168.49 23.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 111.719 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.75 141.72 51.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.973 2.109 . . . . 0.0 106.202 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.7 mt -120.9 156.44 32.01 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.272 1.029 . . . . 0.0 110.353 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -82.25 10.6 6.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.11 1.364 . . . . 0.0 111.803 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -145.72 150.24 35.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.956 1.702 . . . . 0.0 108.386 -174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.2 m 43.24 44.4 4.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 112.464 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.656 ' HG1' ' N ' ' A' ' 2' ' ' THR . 99.9 m -146.34 147.07 30.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.807 2.043 . . . . 0.0 106.492 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.606 1.563 . . . . 0.0 107.151 179.292 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t -129.77 129.87 66.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -141.35 163.12 33.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.307 1.443 . . . . 0.0 111.162 -168.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.21 152.81 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.56 26.81 4.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.501 1.12 . . . . 0.0 111.381 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.5 155.95 32.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.445 1.498 . . . . 0.0 108.001 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.32 140.29 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 122.072 -0.393 . . . . 0.0 110.019 174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.42 -150.79 15.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.45 142.16 50.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -84.15 74.6 10.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.305 1.042 . . . . 0.0 110.552 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.43 -57.5 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.8 2.44 . . . . 0.0 113.865 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -147.11 161.75 40.23 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.998 1.319 . . . . 0.0 108.7 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.23 146.7 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -129.97 25.1 5.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.207 1.003 . . . . 0.0 111.525 -168.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.59 163.68 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.416 1.087 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -147.55 156.72 43.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.22 1.808 . . . . 0.0 106.316 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.46 132.96 52.78 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.77 74.81 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.839 1.209 . . . . 0.0 113.066 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.68 163.44 27.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.331 1.566 . . . . 0.0 110.274 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -108.96 139.17 44.18 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.272 1.429 . . . . 0.0 107.148 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.18 163.18 34.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 170.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -139.63 137.34 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -44.33 123.2 3.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.2 1.0 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.48 71.82 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.639 -1.09 . . . . 0.0 113.54 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.1 138.85 58.03 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.512 1.656 . . . . 0.0 108.211 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.9 141.95 57.47 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.87 -18.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.814 1.245 . . . . 0.0 111.011 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.85 178.51 10.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.268 0.94 . . . . 0.0 109.061 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -133.86 145.05 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -117.61 133.15 56.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.287 2.235 . . . . 0.0 106.253 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -107.21 121.69 45.04 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 t -166.63 166.82 15.83 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.93 1.292 . . . . 0.0 108.1 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 51.66 29.81 6.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.34 1.056 . . . . 0.0 111.9 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 50.72 37.32 16.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.478 1.511 . . . . 0.0 112.306 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.7 mtm -139.36 170.37 16.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.529 1.932 . . . . 0.0 107.9 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -119.89 139.63 52.11 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.59 129.95 15.47 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.91 156.05 66.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.709 1.606 . . . . 0.0 111.14 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 125.77 72.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 156.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.821 1.249 . . . . 0.0 110.53 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 114.28 3.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.43 -24.8 67.29 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.571 0.349 . . . . 0.0 111.338 173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -157.32 155.89 31.44 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.694 1.598 . . . . 0.0 108.565 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 m -77.49 158.37 29.98 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.731 0.812 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.86 177.28 35.72 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.8 mm -85.36 135.56 24.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.38 106.75 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -75.69 -39.58 57.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.05 158.14 38.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 109.37 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.46 124.88 73.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -92.41 -5.43 52.04 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.838 0.855 . . . . 0.0 112.022 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -137.0 177.5 7.81 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.499 1.119 . . . . 0.0 109.617 -170.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -141.87 165.92 26.14 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.63 134.51 57.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.43 82.45 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.219 -1.323 . . . . 0.0 114.122 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -72.58 155.14 40.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 120.113 1.956 . . . . 0.0 110.685 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -66.37 143.88 56.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.35 160.24 17.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.066 0.946 . . . . 0.0 109.146 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -145.29 168.4 20.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.538 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.98 110.46 1.57 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.26 1.77 64.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.104 1.335 . . . . 0.0 112.839 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.8 128.38 33.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.287 1.544 . . . . 0.0 108.162 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 t -68.88 138.49 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -91.01 -51.89 5.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.592 1.157 . . . . 0.0 108.617 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.77 168.33 27.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.966 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.23 147.56 50.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.353 1.861 . . . . 0.0 106.621 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.99 166.53 14.33 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.69 1.196 . . . . 0.0 111.278 -169.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.2 p -60.11 -25.73 65.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.096 1.758 . . . . 0.0 113.557 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -152.81 170.72 19.62 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.614 1.566 . . . . 0.0 108.249 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 42.63 27.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 111.988 173.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -76.27 26.6 0.12 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.774 1.629 . . . . 0.0 113.596 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 124.229 1.011 . . . . 0.0 109.302 176.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.9 t -83.28 140.35 16.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -140.0 166.09 25.57 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.755 1.622 . . . . 0.0 109.913 -169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -94.59 155.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -132.9 27.61 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.787 1.235 . . . . 0.0 111.23 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 153.16 30.84 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.044 1.338 . . . . 0.0 108.05 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.48 138.58 40.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.48 -153.31 18.69 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.09 138.87 45.56 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.69 121.17 14.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -71.89 -54.83 8.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -150.09 161.09 43.05 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.573 1.549 . . . . 0.0 108.481 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.52 143.27 39.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.97 -21.58 7.06 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 111.942 -169.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.08 165.41 2.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.773 0.797 . . . . 0.0 111.44 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -147.6 153.94 40.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.48 129.88 44.17 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.22 -12.21 63.61 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.814 1.197 . . . . 0.0 112.639 -174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -70.08 168.69 15.0 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.906 1.353 . . . . 0.0 109.875 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -125.05 138.42 54.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.725 1.21 . . . . 0.0 107.901 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -129.29 158.8 41.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -135.86 142.22 44.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -47.03 120.95 3.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.704 0.684 . . . . 0.0 110.98 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.15 -11.34 67.5 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.849 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -64.47 142.84 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.551 1.676 . . . . 0.0 108.245 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.84 143.46 54.55 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -134.44 -37.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.595 1.158 . . . . 0.0 110.06 -171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.4 -179.02 7.78 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.08 0.952 . . . . 0.0 109.3 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -137.03 139.5 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -113.79 133.36 55.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.581 1.952 . . . . 0.0 106.943 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.88 124.12 47.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -167.57 166.47 14.09 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.507 1.123 . . . . 0.0 108.565 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.77 44.98 1.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.841 1.656 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.41 31.8 12.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.965 1.706 . . . . 0.0 113.126 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -139.14 169.35 17.95 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.177 1.791 . . . . 0.0 108.694 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.8 140.13 50.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.64 126.83 16.12 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.7 151.9 44.8 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.578 2.185 . . . . 0.0 112.432 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -128.15 131.95 68.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 169.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.67 160.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.094 1.358 . . . . 0.0 109.59 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.04 116.95 5.35 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.88 1.272 . . . . 0.0 108.52 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.22 -26.72 66.74 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.99 0.516 . . . . 0.0 111.4 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -157.77 161.16 38.43 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.568 1.547 . . . . 0.0 108.966 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -80.39 157.6 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 111.214 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.03 179.8 36.0 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.95 0.786 . . . . 0.0 111.857 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -85.94 136.48 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.54 98.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -69.53 -39.78 77.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -155.85 166.33 33.8 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.8 t -125.21 134.12 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -103.83 0.03 29.77 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.9 176.44 9.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.875 1.27 . . . . 0.0 109.966 -170.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -148.38 165.3 31.51 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.093 1.357 . . . . 0.0 108.675 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.66 136.26 50.7 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.951 0.901 . . . . 0.0 108.799 172.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.11 -8.9 65.21 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.616 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -74.88 152.36 38.89 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.972 1.886 . . . . 0.0 110.942 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -68.14 145.22 54.58 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.067 0.947 . . . . 0.0 109.195 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 m -142.86 161.04 18.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 123.856 0.863 . . . . 0.0 109.721 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -144.07 167.27 22.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.347 -174.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.59 109.62 1.45 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.39 -0.35 57.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.339 1.447 . . . . 0.0 112.849 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.68 126.57 31.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.435 1.617 . . . . 0.0 108.697 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 t -64.8 145.41 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -113.77 -44.65 3.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.249 1.42 . . . . 0.0 109.411 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 171.0 18.53 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.981 0.81 . . . . 0.0 111.017 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -126.94 137.84 53.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.974 1.71 . . . . 0.0 106.577 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -118.78 159.24 24.07 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 111.305 -172.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.9 p -64.38 -30.0 71.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.113 0.965 . . . . 0.0 111.196 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -53.07 139.52 28.07 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.05 1.74 . . . . 0.0 112.054 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 m -139.58 13.63 2.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.898 1.279 . . . . 0.0 111.479 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 p -130.54 -41.24 1.21 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.995 0.816 . . . . 0.0 111.944 -169.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.659 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.605 ' N ' ' HG ' ' A' ' 71' ' ' SER . 94.0 m . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.8 146.71 30.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -170.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -139.05 158.66 43.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 110.646 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.74 149.74 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -112.0 8.09 20.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.262 0.625 . . . . 0.0 111.91 -170.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -158.53 159.17 35.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.093 1.357 . . . . 0.0 108.918 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.04 140.49 41.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 110.291 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.92 -151.97 16.23 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.52 142.42 50.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.36 76.9 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.133 0.973 . . . . 0.0 110.649 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -37.68 -57.79 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.952 2.101 . . . . 0.0 113.43 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -148.28 161.4 41.59 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.183 1.393 . . . . 0.0 108.635 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -136.38 146.49 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -131.26 24.05 4.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.86 0.864 . . . . 0.0 112.094 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 m -131.83 162.18 39.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.561 1.144 . . . . 0.0 109.959 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.3 162.62 38.58 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.066 1.747 . . . . 0.0 107.155 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 135.76 43.68 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.84 -8.27 73.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.727 -1.04 . . . . 0.0 113.061 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.7 164.85 24.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.25 1.525 . . . . 0.0 110.033 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -120.03 140.55 50.81 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.96 1.304 . . . . 0.0 108.174 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 pt -130.89 158.87 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -135.6 145.05 46.49 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -48.76 121.65 4.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.582 0.628 . . . . 0.0 110.525 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.28 78.37 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.601 -1.11 . . . . 0.0 113.824 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -63.52 138.66 58.59 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.66 1.73 . . . . 0.0 107.881 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.48 139.74 53.94 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.63 -30.69 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.64 1.176 . . . . 0.0 110.688 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.78 -178.93 7.72 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.7 1.136 . . . . 0.0 109.528 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.33 140.06 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.87 137.21 47.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.71 2.004 . . . . 0.0 106.336 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -114.78 124.06 50.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -169.31 169.76 8.91 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.958 1.303 . . . . 0.0 107.849 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 18.9 ptt? 44.7 41.27 4.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.767 1.227 . . . . 0.0 112.856 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 53.71 31.5 12.93 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.351 1.86 . . . . 0.0 113.183 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.38 170.04 16.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.71 1.604 . . . . 0.0 109.356 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.22 140.56 50.99 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -136.12 128.06 17.32 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.54 154.06 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.889 1.726 . . . . 0.0 110.756 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.65 133.02 69.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.6 m -125.06 161.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.389 1.076 . . . . 0.0 110.217 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.93 3.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.59 -20.45 65.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 0.0 111.756 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -154.23 160.29 41.75 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.656 1.582 . . . . 0.0 108.479 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -70.36 157.23 38.13 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.389 0.676 . . . . 0.0 110.805 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.65 -174.38 42.06 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.754 -0.591 . . . . 0.0 112.352 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.52 134.48 46.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.56 114.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -76.35 -46.37 27.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.49 155.53 30.51 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.74 129.2 70.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.96 -3.33 45.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.011 0.924 . . . . 0.0 112.569 -169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -136.55 177.44 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.307 1.043 . . . . 0.0 109.532 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -143.15 159.99 41.27 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.69 1.196 . . . . 0.0 108.224 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.34 130.77 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.53 86.97 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.182 1.372 . . . . 0.0 113.637 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.58 155.7 40.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.888 1.844 . . . . 0.0 110.799 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -67.55 144.94 55.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.37 159.84 15.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.06 0.944 . . . . 0.0 109.134 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.6 168.46 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.045 0.538 . . . . 0.0 111.701 -171.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.56 114.01 2.74 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.93 4.75 81.82 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.83 1.205 . . . . 0.0 113.005 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -79.87 123.43 27.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.382 1.591 . . . . 0.0 107.884 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.52 141.52 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.144 0.578 . . . . 0.0 109.695 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -106.71 -46.16 4.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.87 1.268 . . . . 0.0 109.46 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.24 161.44 41.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.129 0.877 . . . . 0.0 111.589 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -126.31 143.36 51.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.717 2.007 . . . . 0.0 106.272 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.49 153.65 33.82 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.997 0.919 . . . . 0.0 109.54 -169.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 m -61.65 -31.63 71.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.261 0.624 . . . . 0.0 111.731 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -23.43 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.418 0.687 . . . . 0.0 111.203 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.605 ' HG ' ' N ' ' A' ' 2' ' ' THR . 3.3 m -84.18 -41.27 17.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.669 0.788 . . . . 0.0 110.435 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.8 p -81.41 -36.85 29.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.513 0.597 . . . . 0.0 112.224 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 126.426 1.89 . . . . 0.0 110.742 -174.574 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.16 128.1 44.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 19.8 m -140.1 152.49 46.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.433 1.093 . . . . 0.0 111.229 -169.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.3 mp -66.82 147.23 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 26.19 5.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.529 0.732 . . . . 0.0 111.828 -171.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.43 164.34 38.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.806 2.042 . . . . 0.0 107.432 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -82.25 143.42 31.36 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 109.918 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.0 -152.27 17.97 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 117.972 0.351 . . . . 0.0 112.262 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.97 133.24 45.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 116.96 13.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -71.08 -62.32 1.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.179 0.592 . . . . 0.0 109.98 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -148.44 157.6 43.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.6 1.16 . . . . 0.0 110.262 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.17 149.19 28.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -124.47 -22.16 4.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 0.0 111.363 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.77 162.78 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.577 0.704 . . . . 0.0 111.657 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -148.71 160.93 42.71 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.276 1.831 . . . . 0.0 106.885 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 133.85 51.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.46 0.573 . . . . 0.0 109.552 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.29 -1.92 87.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.582 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -68.6 163.46 23.61 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.51 1.655 . . . . 0.0 110.036 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -108.35 138.58 44.4 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 pt -129.22 160.06 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -138.85 140.76 38.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -47.17 120.88 3.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.029 0.831 . . . . 0.0 110.595 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.47 -8.65 66.65 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.55 -1.139 . . . . 0.0 113.855 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.99 134.1 54.41 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.69 1.745 . . . . 0.0 108.244 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.67 132.87 48.31 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.2 -22.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.932 0.893 . . . . 0.0 111.743 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 179.12 9.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.381 1.072 . . . . 0.0 109.218 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.2 mt -135.64 145.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.451 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -122.33 136.0 54.82 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.759 2.024 . . . . 0.0 106.799 -176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.57 124.14 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -169.33 166.34 10.49 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 107.862 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.8 mtm 55.62 31.78 17.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.909 0.884 . . . . 0.0 111.587 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 51.81 33.66 11.74 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.849 1.659 . . . . 0.0 112.567 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.2 mmt -141.24 173.34 11.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.745 2.018 . . . . 0.0 108.737 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.82 138.54 54.61 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.09 130.04 17.26 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.46 151.78 70.8 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.879 1.719 . . . . 0.0 110.425 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.29 124.02 70.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.6 m -114.44 158.51 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.731 1.212 . . . . 0.0 110.196 -170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.45 115.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.718 1.207 . . . . 0.0 108.108 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.72 -23.57 66.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.099 0.56 . . . . 0.0 111.51 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -155.76 157.08 35.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.686 1.595 . . . . 0.0 108.483 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -71.66 157.68 37.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.22 -178.1 38.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 122.141 -0.349 . . . . 0.0 112.276 173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.4 mm -95.52 136.23 27.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.61 113.81 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.1 -52.4 9.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.01 131.87 8.86 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.335 0.516 . . . . 0.0 109.781 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.13 141.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -119.36 7.94 11.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.853 0.861 . . . . 0.0 112.621 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -141.71 175.12 9.95 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.679 1.192 . . . . 0.0 109.982 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -148.67 167.1 26.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.392 1.877 . . . . 0.0 108.254 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -59.69 135.25 57.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.712 0.805 . . . . 0.0 109.447 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.71 -1.48 77.96 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.052 1.31 . . . . 0.0 113.874 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.41 151.46 41.15 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.62 1.71 . . . . 0.0 110.529 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.49 144.85 53.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.44 159.78 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.632 0.773 . . . . 0.0 109.914 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.46 166.96 23.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.305 -174.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.14 112.46 2.65 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.64 59.89 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.169 1.366 . . . . 0.0 112.765 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -76.35 127.04 32.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.171 1.485 . . . . 0.0 108.961 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 t -66.18 128.33 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.641 0.776 . . . . 0.0 109.427 -170.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' H ' ' HA ' ' A' ' 4' ' ' SER . 65.1 tp -85.01 -44.88 12.67 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.15 0.98 . . . . 0.0 108.981 169.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -156.21 162.81 40.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.663 0.665 . . . . 0.0 112.371 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -115.11 147.58 40.04 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.454 2.302 . . . . 0.0 106.977 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.2 mt -125.23 153.26 43.42 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.626 1.17 . . . . 0.0 110.821 -169.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -79.01 44.58 0.57 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.499 1.52 . . . . 0.0 110.175 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.51 -35.35 74.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.277 1.031 . . . . 0.0 112.438 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 m -137.99 156.18 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.991 1.316 . . . . 0.0 108.989 -172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -56.71 134.23 54.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.41 1.084 . . . . 0.0 109.271 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.516 1.526 . . . . 0.0 108.279 -173.287 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.56 145.45 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -140.43 160.01 40.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.49 1.116 . . . . 0.0 111.709 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.5 mp -76.11 152.91 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.76 15.86 5.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.313 1.445 . . . . 0.0 111.609 -169.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.28 157.38 35.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.664 1.585 . . . . 0.0 108.04 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.21 141.06 41.89 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.607 0.363 . . . . 0.0 110.214 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -152.68 18.27 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.48 138.52 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.16 71.73 9.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.839 1.255 . . . . 0.0 111.155 -169.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -30.61 -58.61 0.2 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.099 2.56 . . . . 0.0 114.069 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -146.83 160.51 42.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.038 1.335 . . . . 0.0 108.645 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -137.85 142.44 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -122.35 -22.5 5.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.768 0.427 . . . . 0.0 111.845 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.84 159.78 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.444 0.64 . . . . 0.0 111.185 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.42 160.08 44.01 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 126.328 1.851 . . . . 0.0 106.954 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.08 45.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.824 0.738 . . . . 0.0 109.429 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.16 -8.46 79.77 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.863 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -68.91 163.38 24.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.205 1.502 . . . . 0.0 109.881 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -119.9 139.52 52.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.866 1.266 . . . . 0.0 107.901 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 pt -129.81 157.34 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -133.99 144.18 48.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -50.54 122.37 7.05 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.885 0.766 . . . . 0.0 110.422 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.47 71.54 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.746 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -64.69 141.21 58.85 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.542 1.671 . . . . 0.0 108.121 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.36 144.32 55.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.195 0.598 . . . . 0.0 109.409 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 t -134.93 -38.35 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.164 1.385 . . . . 0.0 109.585 -170.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.53 -178.43 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.354 1.062 . . . . 0.0 108.994 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -134.1 145.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.88 128.13 52.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.593 1.957 . . . . 0.0 106.673 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.89 124.33 43.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.86 166.83 9.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.251 1.42 . . . . 0.0 107.757 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.4 mtm 54.98 32.49 18.17 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.95 0.9 . . . . 0.0 111.63 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 51.96 33.28 11.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.065 1.746 . . . . 0.0 112.629 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.9 mmt -141.05 173.52 11.4 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.665 1.986 . . . . 0.0 108.406 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.84 140.14 53.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.99 128.92 17.88 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.69 153.41 36.42 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.647 2.232 . . . . 0.0 112.732 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -126.38 130.01 71.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -124.62 159.3 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 124.712 1.205 . . . . 0.0 110.156 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.83 119.21 8.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.781 1.232 . . . . 0.0 109.022 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.6 -19.11 62.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.434 0.693 . . . . 0.0 111.935 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -154.16 159.73 41.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.812 1.645 . . . . 0.0 108.733 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -73.33 154.57 40.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.64 0.776 . . . . 0.0 110.496 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.7 -173.81 42.71 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.255 0.455 . . . . 0.0 112.255 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.14 136.81 40.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.74 115.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.3 -46.61 15.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -156.09 156.6 34.62 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.4 t -117.34 134.96 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.79 3.46 34.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.629 1.172 . . . . 0.0 113.064 -169.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -141.65 179.13 7.01 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.104 . . . . 0.0 109.298 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.67 161.33 40.11 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.324 1.45 . . . . 0.0 107.917 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.69 134.15 52.61 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.36 0.1 85.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.308 1.432 . . . . 0.0 113.789 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -72.24 156.06 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.647 . . . . 0.0 110.437 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.67 143.38 56.0 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.92 160.24 13.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.249 1.02 . . . . 0.0 109.396 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.9 167.03 23.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -172.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 114.7 3.11 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.797 0.839 . . . . 0.0 108.969 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.0 74.64 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.866 1.222 . . . . 0.0 112.809 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -75.87 129.6 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.366 1.583 . . . . 0.0 108.31 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.34 141.47 17.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.9 tp -108.03 -43.31 4.44 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.781 1.232 . . . . 0.0 110.329 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -155.08 165.51 36.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.231 0.923 . . . . 0.0 111.713 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -126.92 146.0 50.47 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.857 2.063 . . . . 0.0 106.605 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.8 mt -119.27 155.82 31.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.585 1.154 . . . . 0.0 110.3 -169.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 m -70.37 -7.88 46.35 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.23 160.39 42.53 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.517 1.053 . . . . 0.0 109.645 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -62.95 -42.67 99.89 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 m -148.12 144.37 27.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.77 0.714 . . . . 0.0 109.832 -169.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 . . . . . 0 C--O 1.248 1.01 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.55 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.58 144.72 35.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 m -142.65 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.475 1.51 . . . . 0.0 110.283 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.03 157.81 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.991 1.316 . . . . 0.0 107.831 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -136.1 26.02 3.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.116 1.367 . . . . 0.0 111.269 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 156.46 34.14 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.615 1.566 . . . . 0.0 107.909 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.34 139.28 36.65 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.658 -0.651 . . . . 0.0 109.62 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.74 -152.54 16.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.22 138.9 51.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 tp -83.0 71.69 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 111.111 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -27.49 -60.27 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.84 2.456 . . . . 0.0 113.731 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -145.09 162.7 36.35 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.244 1.018 . . . . 0.0 109.489 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.39 147.03 29.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -125.04 -27.43 3.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.042 0.537 . . . . 0.0 111.152 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.18 158.22 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.643 0.735 . . . . 0.0 110.841 172.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -153.35 156.56 38.56 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.226 1.81 . . . . 0.0 106.787 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 130.76 45.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.692 0.678 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 -6.77 83.25 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.081 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -66.95 165.53 15.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.267 1.533 . . . . 0.0 109.502 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -123.38 139.66 53.8 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.146 . . . . 0.0 107.925 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -130.24 158.68 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.105 0.962 . . . . 0.0 108.628 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.78 146.42 49.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -48.26 121.45 4.38 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.634 0.652 . . . . 0.0 110.292 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.29 -7.53 78.1 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.596 -1.113 . . . . 0.0 113.991 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -65.19 141.5 58.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.607 1.704 . . . . 0.0 108.115 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.09 145.06 56.28 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.046 0.538 . . . . 0.0 109.553 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.1 t -135.14 -38.7 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.2 1.4 . . . . 0.0 109.684 -172.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.65 -178.28 7.23 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.041 0.937 . . . . 0.0 109.521 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -135.4 143.76 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.11 132.03 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.822 2.049 . . . . 0.0 106.868 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -103.82 125.87 50.56 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -169.06 169.88 9.2 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.727 1.211 . . . . 0.0 107.872 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.6 ptt? 44.61 40.98 4.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.015 1.326 . . . . 0.0 113.032 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.28 33.32 15.27 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.313 1.845 . . . . 0.0 113.04 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -144.16 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.018 1.727 . . . . 0.0 109.158 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -120.78 139.37 53.21 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 169.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.16 132.05 19.98 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.4 153.03 74.95 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.844 1.696 . . . . 0.0 110.665 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -126.52 133.75 67.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.38 161.42 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.819 1.248 . . . . 0.0 110.404 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.56 117.48 6.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.375 1.47 . . . . 0.0 108.877 171.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.55 -22.07 65.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.961 0.505 . . . . 0.0 111.77 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -155.22 161.24 41.22 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.612 1.565 . . . . 0.0 108.836 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -72.72 159.17 34.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.886 0.874 . . . . 0.0 111.287 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.65 -176.33 38.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.436 0.541 . . . . 0.0 111.978 172.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.1 137.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.66 104.58 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -68.8 -51.07 44.72 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -160.22 135.39 7.97 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.235 0.471 . . . . 0.0 109.771 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.89 139.1 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.75 7.78 18.67 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.742 0.817 . . . . 0.0 111.643 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -142.82 177.2 8.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.263 1.825 . . . . 0.0 108.616 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -144.59 171.94 13.68 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.7 134.77 51.58 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.561 0.745 . . . . 0.0 109.582 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.17 2.78 54.71 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.01 1.291 . . . . 0.0 114.473 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -70.45 153.47 42.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.864 1.832 . . . . 0.0 110.118 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -66.02 143.56 57.28 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.04 159.32 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.798 0.839 . . . . 0.0 109.384 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.44 167.16 23.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.386 -172.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.66 110.47 1.73 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.24 1.2 62.8 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.144 1.354 . . . . 0.0 113.094 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -78.83 130.08 35.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.427 1.613 . . . . 0.0 108.434 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.37 149.12 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.806 . . . . 0.0 109.84 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.1 tp -119.65 -48.13 2.39 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.208 1.403 . . . . 0.0 109.654 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.08 166.31 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.75 0.705 . . . . 0.0 111.836 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.61 145.29 48.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.153 2.181 . . . . 0.0 106.77 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt -124.03 165.44 17.47 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.178 0.991 . . . . 0.0 112.567 -168.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -137.27 170.83 15.43 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.294 2.238 . . . . 0.0 108.235 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -152.3 165.59 34.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.427 1.891 . . . . 0.0 106.219 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 m -56.19 -16.76 5.77 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 114.19 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -68.24 -11.4 59.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.89 1.676 . . . . 0.0 113.419 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.035 1.334 . . . . 0.0 110.373 178.597 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.1 147.86 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -138.22 159.52 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.889 1.676 . . . . 0.0 110.089 -169.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.65 146.57 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -107.0 8.98 30.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 111.813 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.48 159.92 36.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.257 1.423 . . . . 0.0 108.891 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.96 142.38 38.38 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.782 0.433 . . . . 0.0 110.169 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.12 -152.81 19.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.52 139.05 45.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.45 118.16 10.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -69.85 -54.18 14.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -149.78 161.54 42.04 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.655 1.582 . . . . 0.0 108.069 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.6 t -134.3 140.6 45.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -115.42 -23.76 8.69 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.74 0.416 . . . . 0.0 111.631 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.19 165.09 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 123.76 0.824 . . . . 0.0 111.759 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -147.1 154.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.94 130.78 48.42 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.7 -10.59 68.6 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.563 1.078 . . . . 0.0 112.74 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -69.39 168.53 14.22 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.018 1.409 . . . . 0.0 109.815 170.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -125.48 140.73 52.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.863 1.265 . . . . 0.0 107.776 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -129.26 162.5 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.624 1.17 . . . . 0.0 108.495 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -133.19 141.61 48.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.711 1.604 . . . . 0.0 106.932 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -48.44 127.5 13.23 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.375 0.67 . . . . 0.0 110.937 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 -10.35 71.15 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.479 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.44 142.12 58.28 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.527 1.663 . . . . 0.0 107.167 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -66.68 152.88 44.53 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.644 0.735 . . . . 0.0 109.893 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -141.26 -35.52 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.337 1.455 . . . . 0.0 109.376 -169.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.15 -179.15 7.44 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.942 0.897 . . . . 0.0 109.065 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.63 140.37 43.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -114.54 128.9 56.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.958 2.103 . . . . 0.0 106.82 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.32 125.88 45.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -170.45 169.6 7.37 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.82 1.248 . . . . 0.0 108.061 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.1 ptt? 44.66 40.34 4.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.136 1.374 . . . . 0.0 113.202 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.95 33.98 15.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.139 1.776 . . . . 0.0 112.853 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.6 mtt -143.73 170.9 14.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.264 1.825 . . . . 0.0 109.028 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -124.38 137.98 54.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.97 126.44 16.63 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.78 153.5 75.61 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.36 1.373 . . . . 0.0 111.014 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.99 130.12 74.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.54 159.77 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 124.622 1.169 . . . . 0.0 110.855 -169.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 116.59 5.36 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.415 1.086 . . . . 0.0 108.439 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.84 -25.14 65.4 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.004 0.522 . . . . 0.0 111.696 173.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -156.17 154.01 30.16 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.673 1.589 . . . . 0.0 108.443 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -66.16 157.35 31.51 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.573 0.749 . . . . 0.0 110.394 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.69 -179.31 38.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -87.66 137.55 20.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.7 102.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -71.52 -41.19 69.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -156.63 162.56 39.85 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 t -125.55 134.03 67.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -102.43 -4.06 26.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.073 0.949 . . . . 0.0 112.732 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -141.36 179.55 6.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.746 1.218 . . . . 0.0 110.278 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -148.96 163.8 36.43 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.341 1.456 . . . . 0.0 108.634 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.85 137.19 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.8 0.84 . . . . 0.0 109.103 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.94 66.4 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.354 -1.248 . . . . 0.0 113.648 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.17 152.29 38.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.84 1.82 . . . . 0.0 111.066 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -68.17 146.0 53.82 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.026 0.931 . . . . 0.0 109.256 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -144.68 160.55 14.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 110.08 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -140.71 167.78 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.47 0.708 . . . . 0.0 110.992 -175.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.17 116.13 3.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.53 2.56 79.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.783 1.182 . . . . 0.0 113.119 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -78.28 123.19 26.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.468 1.634 . . . . 0.0 107.803 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 t -64.87 145.88 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.277 0.631 . . . . 0.0 109.808 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.7 tp -113.35 -45.89 3.11 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.786 1.235 . . . . 0.0 109.803 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.65 160.53 42.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.394 0.997 . . . . 0.0 112.315 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.63 141.46 51.99 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.015 2.126 . . . . 0.0 105.898 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -126.47 158.29 36.45 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.812 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.3 p -60.04 -43.38 95.39 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.467 0.651 . . . . 0.0 109.568 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -79.22 28.62 0.23 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.572 1.949 . . . . 0.0 112.427 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.0 m -78.82 49.99 0.96 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.486 -1.384 . . . . 0.0 110.213 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -61.7 155.59 22.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.318 1.447 . . . . 0.0 110.992 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.248 0.986 0 C-N-CA 125.77 1.628 . . . . 0.0 107.159 178.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t -129.5 139.39 51.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.6 m -138.89 165.05 28.06 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.801 1.24 . . . . 0.0 110.844 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.16 156.33 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 170.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.0 27.08 3.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.781 1.232 . . . . 0.0 110.892 -175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 156.82 34.35 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.733 1.613 . . . . 0.0 107.814 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.66 140.73 35.5 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 171.28 -151.91 16.76 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.56 137.01 45.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.55 119.91 23.18 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -170.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -76.84 -51.34 11.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.033 0.933 . . . . 0.0 111.049 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -150.31 158.91 44.68 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.824 1.649 . . . . 0.0 107.659 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.6 t -135.76 147.91 28.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -130.0 23.47 5.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 111.808 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.35 164.8 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.433 1.093 . . . . 0.0 110.564 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -146.79 158.2 43.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.137 1.775 . . . . 0.0 106.482 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.32 135.35 53.77 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.64 -7.96 80.79 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.833 1.206 . . . . 0.0 113.297 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.71 164.7 24.54 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.329 1.564 . . . . 0.0 110.372 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -109.58 137.58 47.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 107.255 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -128.83 162.29 36.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -137.13 144.55 43.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -49.98 124.63 10.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.81 0.732 . . . . 0.0 110.354 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.03 -8.41 77.95 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.62 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.66 134.63 54.67 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.569 1.684 . . . . 0.0 107.934 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -67.88 131.7 45.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.96 -19.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.231 1.013 . . . . 0.0 111.787 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.13 179.83 8.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 109.773 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -134.44 143.39 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -114.84 140.54 48.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.006 2.123 . . . . 0.0 107.105 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.46 123.14 47.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 t -167.41 169.66 12.07 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.789 1.235 . . . . 0.0 107.799 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 19.8 ptt? 44.96 39.9 4.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.807 1.243 . . . . 0.0 113.028 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 53.05 34.14 16.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.287 1.835 . . . . 0.0 112.821 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.5 mtp -144.08 167.8 21.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.088 1.755 . . . . 0.0 109.182 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -118.3 139.04 51.94 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.56 131.44 18.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.14 155.1 68.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.997 1.798 . . . . 0.0 111.087 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.74 124.5 66.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.75 156.31 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.952 1.301 . . . . 0.0 110.247 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.91 12.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.925 1.29 . . . . 0.0 108.868 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.36 -23.04 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.24 0.616 . . . . 0.0 111.992 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -154.58 161.6 41.54 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.183 1.793 . . . . 0.0 108.027 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -73.88 157.01 37.09 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.414 0.686 . . . . 0.0 110.504 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.7 175.47 36.24 Favored Glycine 0 CA--C 1.524 0.597 0 O-C-N 121.736 -0.602 . . . . 0.0 112.092 170.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.15 135.83 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.14 101.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -69.33 -41.3 76.83 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -156.57 163.53 39.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.567 0.621 . . . . 0.0 109.341 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -124.76 137.75 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -118.55 3.48 11.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -139.79 171.25 14.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.973 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -148.31 171.88 15.28 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.838 1.655 . . . . 0.0 108.913 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -57.98 133.44 55.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.08 0.552 . . . . 0.0 109.511 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.89 74.35 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.878 1.228 . . . . 0.0 113.562 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.22 139.63 50.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.301 1.551 . . . . 0.0 109.228 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -65.9 140.97 58.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.66 157.98 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -145.51 166.33 26.01 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.978 -171.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.3 108.19 1.05 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.35 0.1 58.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.266 1.413 . . . . 0.0 113.061 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -79.78 130.51 35.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.599 1.7 . . . . 0.0 108.65 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.66 150.05 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.757 0.823 . . . . 0.0 110.066 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -120.17 -51.61 2.21 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.935 1.694 . . . . 0.0 108.427 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.02 171.92 15.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.987 0.515 . . . . 0.0 110.799 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.92 148.73 50.95 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.478 1.111 . . . . 0.0 108.396 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -125.23 168.73 13.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.057 1.343 . . . . 0.0 112.415 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 p -54.92 143.91 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.366 1.466 . . . . 0.0 110.482 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -161.16 -51.82 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.797 0.839 . . . . 0.0 110.147 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 m -117.23 10.51 13.8 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 110.498 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -73.35 -12.08 60.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.526 2.731 . . . . 0.0 112.506 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 C--O 1.248 0.993 0 C-N-CA 126.65 1.98 . . . . 0.0 107.693 178.145 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 121.184 0.516 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.02 143.87 38.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 20.4 m -138.12 161.73 36.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.183 0.993 . . . . 0.0 111.982 -169.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -80.52 153.39 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -132.14 27.84 4.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.682 1.193 . . . . 0.0 111.155 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.57 157.35 35.17 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.697 1.599 . . . . 0.0 107.858 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -80.63 141.97 34.46 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 171.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 -152.51 20.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.63 136.52 51.75 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.19 71.89 9.24 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.906 1.282 . . . . 0.0 111.03 -169.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -24.82 -59.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.431 2.692 . . . . 0.0 114.292 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -144.9 163.84 32.91 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.639 1.176 . . . . 0.0 108.991 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.88 146.52 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -122.68 -17.99 6.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.043 0.537 . . . . 0.0 111.648 -169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.98 166.73 2.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.685 0.755 . . . . 0.0 111.961 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -149.55 162.09 40.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.373 1.869 . . . . 0.0 106.039 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.49 138.23 51.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.706 0.685 . . . . 0.0 109.513 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.26 -5.94 70.2 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.727 -1.041 . . . . 0.0 113.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -69.86 166.84 18.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.311 1.555 . . . . 0.0 109.448 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -122.25 141.68 51.24 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -129.88 162.65 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.493 1.117 . . . . 0.0 108.292 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.73 140.66 44.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -46.4 123.81 5.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 110.788 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.69 -10.03 75.93 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.619 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.51 139.25 58.47 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.571 1.686 . . . . 0.0 108.145 170.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 142.99 57.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.15 -21.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.031 1.332 . . . . 0.0 110.728 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 179.42 8.73 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.62 0.768 . . . . 0.0 109.038 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -135.61 146.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.47 133.64 53.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.025 2.13 . . . . 0.0 106.358 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -107.87 125.3 51.3 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -170.01 165.97 9.34 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.039 1.336 . . . . 0.0 107.851 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 42.3 mtm 56.22 29.99 15.8 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.945 0.898 . . . . 0.0 111.856 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 52.0 35.61 16.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.586 1.555 . . . . 0.0 112.308 -171.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.54 172.93 12.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.602 1.961 . . . . 0.0 108.737 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -125.2 136.95 54.08 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.25 130.4 14.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.21 155.03 68.96 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.59 1.527 . . . . 0.0 110.555 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.3 mm -120.79 124.64 72.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 173.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 m -113.89 156.26 14.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.858 1.263 . . . . 0.0 110.678 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.61 118.66 8.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.507 1.123 . . . . 0.0 108.193 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.73 -25.78 67.45 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.147 0.579 . . . . 0.0 111.48 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -157.33 155.49 30.72 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.233 1.413 . . . . 0.0 108.621 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -70.93 157.34 38.34 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.421 0.688 . . . . 0.0 110.707 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.9 177.53 35.03 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 122.1 -0.375 . . . . 0.0 112.513 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.88 133.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 110.81 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.81 -44.9 60.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -156.78 159.42 38.27 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.36 138.11 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -116.67 12.38 14.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.236 1.014 . . . . 0.0 112.154 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -146.79 178.62 8.18 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.037 1.735 . . . . 0.0 108.763 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -144.84 169.61 17.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.065 1.346 . . . . 0.0 108.278 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.67 133.06 46.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.774 0.83 . . . . 0.0 109.232 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.54 -1.61 65.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.045 1.307 . . . . 0.0 114.15 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -71.31 153.31 42.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.807 1.803 . . . . 0.0 110.475 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -66.25 143.82 56.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.07 160.12 17.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.103 0.961 . . . . 0.0 109.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.18 166.62 24.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.285 -174.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 112.98 2.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.58 -1.94 64.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.15 1.357 . . . . 0.0 112.81 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -76.56 132.84 39.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.217 1.509 . . . . 0.0 109.106 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.26 130.27 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.455 0.702 . . . . 0.0 109.481 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 4' ' ' SER . 56.8 tp -82.84 -50.88 8.18 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.677 1.191 . . . . 0.0 108.494 169.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.32 171.05 20.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -171.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.96 148.8 51.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.115 1.366 . . . . 0.0 108.337 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -118.82 154.01 33.55 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.44 1.496 . . . . 0.0 109.779 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 m -75.57 30.75 0.1 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.726 1.611 . . . . 0.0 112.947 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.75 146.99 47.66 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -65.56 -17.04 64.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.829 1.252 . . . . 0.0 114.13 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -137.27 163.63 30.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 110.151 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.068 172.412 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.595 ' N ' ' HG ' ' A' ' 71' ' ' SER . 2.1 p . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.61 141.11 45.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -137.65 155.59 48.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.834 1.253 . . . . 0.0 111.173 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.4 mp -70.11 148.01 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -109.21 6.58 24.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.403 -0.811 . . . . 0.0 112.375 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 159.5 38.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.006 1.322 . . . . 0.0 108.945 -169.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.47 140.14 38.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.835 0.454 . . . . 0.0 109.912 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.21 -151.51 17.76 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.31 141.69 51.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.8 tp -83.06 77.25 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.437 1.095 . . . . 0.0 110.958 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -37.22 -56.33 0.94 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.232 2.213 . . . . 0.0 113.554 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -147.02 160.72 42.04 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.931 1.293 . . . . 0.0 108.832 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.74 142.58 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -120.78 -22.51 6.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.196 0.598 . . . . 0.0 111.216 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 m -74.97 161.32 4.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.659 0.742 . . . . 0.0 111.619 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -149.91 157.13 42.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.626 1.97 . . . . 0.0 106.284 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.86 130.91 45.52 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.795 0.725 . . . . 0.0 109.147 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.23 -9.06 77.0 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.467 1.032 . . . . 0.0 112.997 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.64 166.4 17.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.221 1.511 . . . . 0.0 109.831 170.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -122.92 142.28 50.98 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.3 pt -131.76 161.64 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 123.797 0.839 . . . . 0.0 108.871 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.94 143.76 40.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -46.1 122.94 4.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.981 0.81 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.61 -8.26 78.86 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.92 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -63.86 132.97 52.45 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.683 1.741 . . . . 0.0 107.402 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.0 137.07 43.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.2 -20.06 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.334 1.454 . . . . 0.0 110.878 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.17 -179.34 7.81 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.638 0.775 . . . . 0.0 108.989 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.63 145.61 31.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -121.15 130.62 53.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.152 2.181 . . . . 0.0 106.44 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.87 124.97 49.39 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -170.03 169.5 8.03 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.851 1.261 . . . . 0.0 107.852 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.0 ptt? 44.42 41.35 4.51 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.025 1.33 . . . . 0.0 112.922 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.78 31.93 11.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.378 1.871 . . . . 0.0 113.107 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.41 170.44 15.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.327 1.851 . . . . 0.0 109.093 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.46 139.19 54.15 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.58 129.44 17.52 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -169.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.45 149.29 80.24 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.53 1.487 . . . . 0.0 110.308 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.98 123.55 71.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -113.06 155.64 14.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.138 1.375 . . . . 0.0 110.91 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 121.04 12.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.801 1.24 . . . . 0.0 108.497 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.24 -30.17 70.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.162 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -157.16 155.86 31.68 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 109.207 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 m -71.75 155.47 40.42 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.736 0.814 . . . . 0.0 110.85 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.04 178.75 38.55 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.24 0.448 . . . . 0.0 112.008 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.62 134.96 27.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.45 107.64 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.21 -40.89 29.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.45 154.53 32.01 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 t -114.16 134.74 56.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.3 -3.52 31.15 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.873 0.869 . . . . 0.0 112.714 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -137.66 178.01 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.412 1.085 . . . . 0.0 109.958 -170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -142.42 163.61 32.38 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.779 1.232 . . . . 0.0 107.785 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -60.99 136.78 58.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.46 -4.3 78.46 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.314 -1.27 . . . . 0.0 114.06 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -72.67 155.31 40.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.005 1.903 . . . . 0.0 110.717 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -67.08 144.53 56.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.93 160.82 15.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.035 0.934 . . . . 0.0 109.238 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -145.93 166.69 25.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.052 -172.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.37 113.92 2.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 2.2 75.7 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.794 1.188 . . . . 0.0 112.892 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -77.81 127.29 32.18 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 1.566 . . . . 0.0 107.507 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.78 137.35 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.5 tp -93.08 -50.93 5.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.817 1.247 . . . . 0.0 108.9 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 168.01 24.51 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.583 0.629 . . . . 0.0 112.081 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -126.78 141.97 51.68 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.225 1.81 . . . . 0.0 106.921 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.65 167.74 10.49 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.407 1.083 . . . . 0.0 110.766 -169.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 p -54.47 -39.37 67.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 110.531 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -64.92 -20.31 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.851 1.261 . . . . 0.0 113.489 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.595 ' HG ' ' N ' ' A' ' 2' ' ' THR . 18.5 m -76.3 6.52 5.42 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 p -57.33 153.98 11.39 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.17 0.895 . . . . 0.0 110.923 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 C--O 1.251 1.151 0 C-N-CA 125.881 1.673 . . . . 0.0 106.884 177.159 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.65 127.04 63.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 65' ' ' LEU . 17.1 m -140.56 159.53 41.99 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.993 1.317 . . . . 0.0 111.127 -169.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 mm -77.55 156.55 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.76 15.62 4.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.451 1.5 . . . . 0.0 111.512 -169.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -156.33 157.76 36.24 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.647 1.579 . . . . 0.0 108.114 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -76.61 140.84 41.17 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.5 -153.91 20.0 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.93 135.65 50.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.46 70.74 8.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.846 1.258 . . . . 0.0 111.096 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -25.76 -59.82 0.07 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.431 2.692 . . . . 0.0 114.127 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -144.75 163.17 34.83 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.618 1.167 . . . . 0.0 108.923 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.43 146.38 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -124.48 -18.62 5.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.915 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.17 164.77 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.758 0.79 . . . . 0.0 111.68 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -150.1 157.81 43.51 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.597 1.959 . . . . 0.0 106.042 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.19 132.5 50.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.39 -8.99 78.91 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.525 1.059 . . . . 0.0 113.068 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.03 162.27 27.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.241 1.52 . . . . 0.0 109.896 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -113.17 141.99 46.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.6 pt -130.94 158.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -135.49 143.75 46.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -46.88 119.98 2.79 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.874 0.761 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.08 68.6 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.015 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.5 135.66 55.43 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.708 1.754 . . . . 0.0 108.175 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.69 134.55 52.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.85 -22.17 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.308 1.043 . . . . 0.0 111.495 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.55 -178.88 7.48 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.074 0.852 . . . . 0.0 109.808 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -135.91 145.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.92 134.79 54.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.779 2.032 . . . . 0.0 106.528 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.71 125.82 53.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -170.86 166.76 7.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.163 1.385 . . . . 0.0 107.788 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 56.06 30.28 16.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.919 0.888 . . . . 0.0 111.86 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 51.88 35.8 16.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.641 1.577 . . . . 0.0 112.279 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.8 mtm -141.77 173.03 11.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.625 1.97 . . . . 0.0 108.799 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.57 137.69 53.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.48 131.15 16.08 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.66 155.39 69.02 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.857 1.704 . . . . 0.0 110.61 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.0 mm -124.65 125.22 69.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.59 156.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 110.179 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.17 121.54 13.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.671 1.188 . . . . 0.0 108.425 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.71 -25.81 66.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.108 0.563 . . . . 0.0 111.535 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.38 156.95 33.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.343 1.457 . . . . 0.0 108.882 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -73.43 157.01 37.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.685 0.794 . . . . 0.0 111.061 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.42 -177.19 40.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.504 0.573 . . . . 0.0 112.261 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.6 mm -99.65 129.83 49.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.86 109.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -73.46 -45.47 54.03 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -157.16 157.14 33.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.82 135.81 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.41 8.07 29.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.24 1.016 . . . . 0.0 111.967 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -146.56 178.75 8.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.937 1.695 . . . . 0.0 108.783 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -144.74 169.42 18.06 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.904 1.282 . . . . 0.0 108.38 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.62 133.4 46.59 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.958 0.903 . . . . 0.0 109.325 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.11 -1.57 63.58 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.112 1.339 . . . . 0.0 114.158 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.9 152.02 44.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.844 1.822 . . . . 0.0 110.511 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -65.95 142.74 57.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.88 160.64 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.099 0.96 . . . . 0.0 109.665 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -143.86 167.05 23.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.59 -173.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.14 114.78 3.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.694 0.798 . . . . 0.0 108.94 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.81 68.39 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.194 1.378 . . . . 0.0 112.921 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.49 128.11 33.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.18 1.49 . . . . 0.0 109.293 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.5 131.58 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.506 0.722 . . . . 0.0 109.559 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 4' ' ' SER . 44.6 tp -85.32 -50.83 7.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 124.538 1.135 . . . . 0.0 108.787 170.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.29 168.95 24.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.212 0.529 . . . . 0.0 111.025 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -129.24 143.79 50.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.274 1.829 . . . . 0.0 106.937 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -116.71 155.63 28.53 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.929 1.292 . . . . 0.0 110.337 -169.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.9 m -70.24 160.37 32.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.98 1.312 . . . . 0.0 110.525 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -149.04 160.62 43.16 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.846 1.258 . . . . 0.0 108.997 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -60.74 -24.61 65.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.804 1.241 . . . . 0.0 113.145 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 m -129.37 127.45 41.06 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.222 1.409 . . . . 0.0 108.098 -171.253 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.624 ' N ' ' HG ' ' A' ' 71' ' ' SER . 2.1 p . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.9 t -137.98 140.5 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -140.13 159.17 42.78 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.684 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -78.14 157.24 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 14.56 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.441 1.496 . . . . 0.0 111.722 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -156.31 157.98 36.66 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.572 1.549 . . . . 0.0 108.136 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -77.06 140.34 40.28 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.012 -0.43 . . . . 0.0 110.036 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.81 -153.91 18.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.77 137.12 51.38 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.53 71.83 8.56 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.94 1.296 . . . . 0.0 111.332 -169.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -29.57 -59.26 0.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.941 2.496 . . . . 0.0 114.01 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -146.87 163.08 37.25 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.114 1.366 . . . . 0.0 108.633 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.77 148.38 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -131.18 26.11 4.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.99 0.916 . . . . 0.0 112.005 -169.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.37 162.35 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.562 1.145 . . . . 0.0 110.346 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -148.79 159.25 44.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.089 1.756 . . . . 0.0 107.641 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.37 133.44 49.7 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 -6.4 83.54 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.222 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.01 165.82 20.99 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.483 1.642 . . . . 0.0 110.163 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -113.36 141.2 47.33 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.575 1.55 . . . . 0.0 107.009 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 pt -130.52 163.36 36.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.055 0.942 . . . . 0.0 108.734 170.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -137.38 139.63 40.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -47.0 124.2 6.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.056 0.942 . . . . 0.0 110.634 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.56 74.35 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.66 -1.078 . . . . 0.0 113.763 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -64.41 143.65 57.75 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.469 1.635 . . . . 0.0 107.869 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.85 144.22 57.41 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.73 -31.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 110.346 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 -178.78 7.54 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 119.533 1.061 . . . . 0.0 109.416 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -134.67 145.01 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.36 128.64 52.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.652 1.981 . . . . 0.0 106.588 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.96 124.21 43.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.64 167.67 9.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.194 1.397 . . . . 0.0 107.753 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.2 mtm 54.99 31.59 16.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.057 0.943 . . . . 0.0 111.76 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.27 34.57 14.98 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.932 1.693 . . . . 0.0 112.585 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.4 mtt -142.7 173.66 11.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.479 1.911 . . . . 0.0 108.508 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -120.96 140.61 51.64 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.53 132.19 19.67 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.74 153.87 74.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.932 1.755 . . . . 0.0 110.843 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 mm -126.54 134.9 65.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.87 163.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.373 1.069 . . . . 0.0 110.253 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.39 113.04 2.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.631 1.173 . . . . 0.0 107.842 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.2 -17.04 62.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.311 0.244 . . . . 0.0 111.371 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.32 155.49 30.76 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.057 1.743 . . . . 0.0 108.959 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 m -69.23 158.21 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.903 0.881 . . . . 0.0 110.923 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.37 177.36 33.4 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 122.265 -0.272 . . . . 0.0 112.538 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -85.68 135.08 25.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -68.62 115.41 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -84.28 -48.3 9.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -157.66 129.55 7.01 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -81.93 137.2 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -110.02 5.3 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.048 0.939 . . . . 0.0 112.124 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -143.84 179.06 7.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.315 1.446 . . . . 0.0 108.612 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -145.38 163.9 33.15 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.548 1.139 . . . . 0.0 108.915 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.23 130.12 43.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.968 0.907 . . . . 0.0 109.716 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.17 -1.61 84.4 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.258 1.409 . . . . 0.0 113.804 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -70.64 153.74 42.55 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.767 1.783 . . . . 0.0 110.53 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.13 143.86 56.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.61 160.77 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.02 0.928 . . . . 0.0 109.488 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.48 167.72 21.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.976 -172.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.53 115.55 3.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 108.957 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.68 -0.7 74.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.052 1.311 . . . . 0.0 112.88 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -77.48 126.7 31.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.358 1.579 . . . . 0.0 109.093 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.71 129.74 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.16 -44.97 9.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.339 1.056 . . . . 0.0 109.331 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.78 165.12 37.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.751 0.786 . . . . 0.0 111.884 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -118.32 143.82 46.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.81 2.044 . . . . 0.0 106.586 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.64 162.26 18.31 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.72 1.208 . . . . 0.0 108.514 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -57.99 -35.07 70.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.048 -0.408 . . . . 0.0 110.135 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.75 -28.19 67.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.536 1.135 . . . . 0.0 113.113 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 2' ' ' THR . 12.6 m -71.66 -20.27 61.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.714 0.688 . . . . 0.0 111.73 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -80.37 134.28 36.01 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 125.642 1.577 . . . . 0.0 107.012 -178.678 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.67 138.91 52.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -138.44 155.28 48.61 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.927 1.291 . . . . 0.0 111.045 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.4 mp -70.02 147.67 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -108.6 4.69 24.27 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 ptp -154.11 163.68 39.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.279 0.945 . . . . 0.0 109.575 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.9 141.45 49.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.784 0.434 . . . . 0.0 110.175 173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.19 -152.93 20.32 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.91 140.15 51.8 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.9 tp -80.78 75.78 7.7 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.455 1.102 . . . . 0.0 111.592 -169.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -35.2 -58.15 0.56 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.348 2.259 . . . . 0.0 113.789 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -147.61 160.63 42.44 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.794 1.237 . . . . 0.0 108.743 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.2 143.58 32.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -124.32 -21.34 4.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.832 0.453 . . . . 0.0 111.992 -169.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.2 162.01 4.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.468 0.651 . . . . 0.0 111.557 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -149.59 158.91 44.61 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.266 1.826 . . . . 0.0 106.763 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 131.88 47.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.09 -6.94 83.2 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.112 -178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -68.42 164.93 19.9 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.316 1.558 . . . . 0.0 109.842 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -119.41 144.57 46.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.522 1.129 . . . . 0.0 108.005 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.25 159.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -133.69 143.99 48.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -48.54 121.31 4.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.874 0.761 . . . . 0.0 110.438 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.56 67.49 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -64.61 134.72 54.92 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.695 1.747 . . . . 0.0 108.074 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -67.7 133.03 48.59 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.32 -21.67 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.271 1.028 . . . . 0.0 111.424 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.84 -179.74 8.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.151 0.981 . . . . 0.0 109.514 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.41 147.24 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -124.02 131.52 53.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.885 2.074 . . . . 0.0 106.515 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.23 124.71 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -169.07 166.4 10.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.824 1.249 . . . . 0.0 108.047 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.9 mtm 55.18 31.52 16.6 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.932 0.893 . . . . 0.0 111.854 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 52.22 35.21 16.23 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.79 1.636 . . . . 0.0 112.496 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.44 173.76 11.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.667 1.987 . . . . 0.0 108.665 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -118.61 142.53 47.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.49 128.44 19.14 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 -169.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.1 147.94 68.23 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.831 1.687 . . . . 0.0 109.996 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -121.08 121.88 66.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 m -114.95 157.2 15.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.631 1.173 . . . . 0.0 110.177 -169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.93 119.73 9.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.687 1.195 . . . . 0.0 108.25 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.18 -26.13 68.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.42 0.688 . . . . 0.0 111.572 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -157.38 155.51 30.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.581 1.552 . . . . 0.0 108.476 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 m -69.38 157.58 36.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.342 0.657 . . . . 0.0 110.605 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.39 -176.17 40.33 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 122.106 -0.371 . . . . 0.0 112.473 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -99.84 133.64 42.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.63 111.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -77.0 -45.2 28.14 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.39 151.66 26.58 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.55 134.19 48.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -106.27 3.76 28.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.672 0.789 . . . . 0.0 112.461 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -138.7 178.4 7.18 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.064 1.346 . . . . 0.0 109.284 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.04 159.89 41.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.648 1.179 . . . . 0.0 108.136 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.27 132.05 51.4 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.99 -3.62 86.9 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.093 1.33 . . . . 0.0 113.763 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -70.35 154.46 41.87 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.865 1.833 . . . . 0.0 110.68 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -66.47 143.39 57.12 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.42 160.54 14.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.038 0.935 . . . . 0.0 109.219 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.04 167.36 22.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.282 -171.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.31 113.39 2.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.98 5.7 85.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.487 1.041 . . . . 0.0 113.063 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.01 130.23 37.18 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.439 1.619 . . . . 0.0 107.233 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.17 141.42 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.84 -50.24 3.9 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.166 1.386 . . . . 0.0 108.661 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 165.83 33.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 111.928 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -128.69 139.15 52.38 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.44 1.896 . . . . 0.0 106.403 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt -116.57 154.54 30.27 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 110.274 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -72.02 140.24 48.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.548 0.739 . . . . 0.0 109.412 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -155.6 138.17 15.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 169.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -64.03 -24.75 67.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.478 1.111 . . . . 0.0 113.671 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -20.69 63.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.788 0.722 . . . . 0.0 111.921 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.763 -178.459 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.649 0.262 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.94 141.92 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -137.75 155.3 49.21 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.718 1.207 . . . . 0.0 111.458 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.26 147.86 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -108.51 5.38 25.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -170.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 ptp -153.88 163.03 40.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.321 0.964 . . . . 0.0 109.827 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -71.53 140.86 50.07 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.653 0.381 . . . . 0.0 110.227 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 169.95 -153.65 21.91 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.23 137.62 44.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.64 121.18 14.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.84 -51.69 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -149.11 159.93 43.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.586 1.555 . . . . 0.0 108.493 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.09 142.89 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -120.76 -22.08 6.42 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.036 0.534 . . . . 0.0 111.506 -170.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.76 165.96 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.977 0.894 . . . . 0.0 111.153 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.73 154.09 36.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.43 50.65 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.67 -9.94 62.45 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.451 1.501 . . . . 0.0 112.989 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -74.4 172.22 12.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.913 1.357 . . . . 0.0 110.667 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -115.87 138.19 51.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.727 1.611 . . . . 0.0 107.094 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 pt -128.48 160.67 38.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.0 143.9 38.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -48.57 120.85 4.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.774 0.715 . . . . 0.0 110.467 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.81 -8.25 70.71 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.826 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.4 135.22 55.91 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.589 1.694 . . . . 0.0 108.051 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.41 133.69 49.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.12 -22.29 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.293 1.037 . . . . 0.0 111.617 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.06 178.06 10.12 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.592 0.757 . . . . 0.0 109.694 169.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.4 mt -136.78 142.03 39.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.7 tm? -120.46 131.19 54.64 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.278 1.831 . . . . 0.0 106.882 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -98.87 124.36 43.73 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -168.84 166.78 11.32 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.969 1.308 . . . . 0.0 108.065 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 46.2 mtm 55.26 31.32 16.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.015 0.926 . . . . 0.0 111.795 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.64 34.6 16.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.71 1.604 . . . . 0.0 112.515 -172.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.0 mtm -143.08 173.53 11.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.517 1.927 . . . . 0.0 108.659 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -118.72 141.67 48.39 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.66 128.31 18.92 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.45 149.63 69.1 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.947 1.764 . . . . 0.0 110.203 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mm -122.46 120.94 62.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.18 156.18 15.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.792 1.237 . . . . 0.0 110.183 -172.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 116.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.038 1.335 . . . . 0.0 108.63 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.43 -23.32 65.52 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.082 0.553 . . . . 0.0 111.768 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -154.54 162.04 41.34 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.522 1.529 . . . . 0.0 108.796 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -75.17 157.32 34.77 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.82 0.848 . . . . 0.0 110.96 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.62 174.75 33.83 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.354 0.502 . . . . 0.0 112.0 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.3 mm -85.57 134.3 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.74 101.77 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -71.48 -40.66 70.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -156.02 164.13 38.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.568 0.622 . . . . 0.0 109.335 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 t -125.87 135.09 64.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -105.5 -0.84 25.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 111.863 -169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -141.29 177.04 8.37 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.817 1.247 . . . . 0.0 110.693 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.16 169.01 21.68 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.311 1.444 . . . . 0.0 108.501 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -56.62 139.68 49.24 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.728 0.811 . . . . 0.0 109.271 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.45 -7.78 56.24 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.376 -1.236 . . . . 0.0 113.737 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -75.83 152.85 37.17 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.817 1.809 . . . . 0.0 110.952 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -67.91 145.38 54.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.034 0.934 . . . . 0.0 109.325 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.19 161.59 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.877 0.871 . . . . 0.0 109.952 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.36 168.48 19.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.091 -175.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.23 114.65 3.0 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.37 82.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.472 1.034 . . . . 0.0 112.976 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -78.87 125.82 29.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.454 1.627 . . . . 0.0 107.847 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.61 132.13 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.483 0.713 . . . . 0.0 109.961 -169.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.1 tp -85.89 -50.53 7.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.931 1.292 . . . . 0.0 107.686 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -154.35 169.58 23.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.455 0.645 . . . . 0.0 111.893 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.24 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.517 1.927 . . . . 0.0 106.8 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.35 151.08 42.86 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.199 1.0 . . . . 0.0 110.556 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -66.82 163.78 18.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.661 0.784 . . . . 0.0 109.546 169.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -58.79 150.95 22.42 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.149 -0.345 . . . . 0.0 110.133 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.6 m -58.99 -20.01 48.86 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 113.969 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -132.64 145.84 51.41 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.569 1.548 . . . . 0.0 108.131 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.129 1.372 . . . . 0.0 107.302 -177.07 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.85 138.82 51.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 169.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -136.62 154.59 50.61 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 110.635 -169.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 5' ' ' ILE . 5.4 mp -69.6 141.84 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -102.77 5.66 38.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.695 -0.628 . . . . 0.0 112.529 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -156.27 164.28 38.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.3 1.04 . . . . 0.0 109.532 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -75.69 142.86 42.42 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.729 0.411 . . . . 0.0 110.312 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 170.54 -151.72 16.99 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.73 132.39 45.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 113.66 10.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -70.66 -59.18 2.97 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.015 0.926 . . . . 0.0 110.564 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -149.42 158.33 44.08 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.968 1.307 . . . . 0.0 109.182 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -129.28 145.73 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.171 1.389 . . . . 0.0 107.434 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.89 24.83 4.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.412 1.085 . . . . 0.0 111.055 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 m -132.83 165.52 32.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.083 1.353 . . . . 0.0 110.129 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -146.7 156.19 42.99 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.985 1.714 . . . . 0.0 106.519 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.32 133.52 55.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.46 -10.12 74.75 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.513 1.054 . . . . 0.0 112.864 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.08 170.35 11.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.045 1.422 . . . . 0.0 109.658 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -126.46 143.26 51.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 107.986 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.51 164.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.616 1.166 . . . . 0.0 108.784 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -136.05 141.64 44.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.708 1.203 . . . . 0.0 107.817 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -45.62 116.55 1.2 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 110.691 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.99 -10.68 62.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.714 -1.048 . . . . 0.0 113.66 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -66.63 140.41 57.93 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.497 1.648 . . . . 0.0 108.499 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.94 138.99 56.39 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.5 -19.44 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.981 0.912 . . . . 0.0 112.151 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.53 178.4 9.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.705 1.202 . . . . 0.0 108.688 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -134.76 148.86 29.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.5 tm? -123.56 133.67 53.94 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.738 2.015 . . . . 0.0 106.745 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 123.8 46.42 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -168.83 167.3 11.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.764 1.225 . . . . 0.0 107.951 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 mtm 55.48 30.61 15.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.854 0.862 . . . . 0.0 111.861 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 53.13 35.3 19.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.857 1.663 . . . . 0.0 111.995 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 78.1 mtm -144.0 173.62 11.56 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.484 1.914 . . . . 0.0 108.644 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -119.23 140.53 50.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.3 131.79 19.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.56 152.46 74.79 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.892 1.728 . . . . 0.0 110.754 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.9 mm -123.46 118.65 55.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.85 157.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.466 1.106 . . . . 0.0 110.293 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 108.23 1.13 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.264 1.426 . . . . 0.0 107.441 170.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.02 -15.13 62.97 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 155.72 34.46 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.673 1.589 . . . . 0.0 108.509 171.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.94 159.66 33.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.18 0.992 . . . . 0.0 110.975 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.57 179.19 37.01 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 121.829 -0.544 . . . . 0.0 112.377 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -85.45 134.05 28.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.51 100.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -70.34 -40.24 74.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -156.87 162.88 39.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -114.83 7.98 15.91 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.741 0.816 . . . . 0.0 112.557 -168.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -140.73 175.59 9.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.761 1.224 . . . . 0.0 109.588 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -143.3 160.34 40.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.326 1.85 . . . . 0.0 107.182 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.36 127.64 33.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.23 -7.51 64.25 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.504 1.526 . . . . 0.0 113.407 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -74.77 153.66 38.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.5 1.65 . . . . 0.0 111.414 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.62 145.32 54.03 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.551 0.74 . . . . 0.0 109.117 170.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.55 159.83 14.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.752 0.821 . . . . 0.0 110.108 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -141.92 166.11 25.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.067 -176.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.8 117.84 5.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.12 -0.8 82.15 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.682 1.134 . . . . 0.0 113.044 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.25 131.69 41.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.274 1.537 . . . . 0.0 108.176 175.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 t -70.95 135.09 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.36 -50.94 5.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 125.462 1.505 . . . . 0.0 108.894 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.18 168.75 20.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 112.062 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.24 140.09 52.09 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.663 1.985 . . . . 0.0 106.378 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt -123.23 169.48 11.24 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.886 0.875 . . . . 0.0 112.446 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p -58.92 -15.59 13.54 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.741 2.016 . . . . 0.0 114.183 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -143.83 161.47 38.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.606 1.562 . . . . 0.0 109.651 -169.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 p -69.17 -61.16 1.91 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.066 0.946 . . . . 0.0 109.791 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 m -153.21 151.65 30.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.18 1.392 . . . . 0.0 108.928 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.666 1.986 . . . . 0.0 106.414 170.102 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 118.56 -0.733 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.93 126.1 59.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 m -139.68 160.12 40.59 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.694 1.198 . . . . 0.0 111.03 -168.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.63 156.81 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.59 15.63 4.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.445 1.098 . . . . 0.0 112.129 -169.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 158.29 36.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.099 1.76 . . . . 0.0 107.91 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -78.71 141.08 38.18 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.884 -0.51 . . . . 0.0 109.762 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 172.08 -153.43 19.43 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 175.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.68 133.71 45.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -75.85 113.55 13.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -169.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -66.52 -56.09 12.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.045 0.938 . . . . 0.0 110.203 -170.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.52 161.4 42.21 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.419 1.488 . . . . 0.0 107.943 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -136.21 146.69 28.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -124.44 -19.77 5.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.029 0.532 . . . . 0.0 112.03 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.76 166.17 2.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.794 0.807 . . . . 0.0 111.791 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -147.78 160.26 42.92 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.627 1.971 . . . . 0.0 105.93 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.12 137.83 45.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.18 -7.39 75.67 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.472 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -70.74 162.85 28.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.448 1.624 . . . . 0.0 110.339 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -108.71 137.56 46.44 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 pt -128.2 161.27 36.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -138.73 141.68 38.89 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -47.51 120.64 3.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.959 0.8 . . . . 0.0 110.69 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -10.25 64.63 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.894 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -64.52 135.85 56.44 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.552 1.676 . . . . 0.0 108.237 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -68.21 134.13 49.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.53 -22.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.126 0.97 . . . . 0.0 111.534 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.57 -178.82 7.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.79 0.836 . . . . 0.0 109.615 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -137.28 146.37 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' A' ' 9' ' ' GLY . 1.4 tm? -121.53 136.21 54.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.677 1.991 . . . . 0.0 107.197 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -104.34 124.08 48.54 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -169.26 167.82 10.05 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 125.004 1.322 . . . . 0.0 107.923 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 43.8 mtm 54.9 32.72 18.43 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.906 0.883 . . . . 0.0 111.656 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.23 32.73 11.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.985 1.714 . . . . 0.0 112.681 -173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.8 mmm -142.16 173.26 11.68 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.579 1.952 . . . . 0.0 108.746 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -119.46 141.99 48.66 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.84 130.29 18.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.87 152.51 73.7 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.87 1.713 . . . . 0.0 110.566 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.4 mm -123.68 121.83 63.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 m -113.39 157.72 13.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.726 1.21 . . . . 0.0 109.977 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 119.82 9.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.713 1.205 . . . . 0.0 108.237 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.77 -26.07 65.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.945 0.498 . . . . 0.0 111.336 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -157.12 155.87 31.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.536 1.534 . . . . 0.0 108.855 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.46 156.81 36.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.05 0.94 . . . . 0.0 111.085 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.8 177.23 33.73 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.363 0.506 . . . . 0.0 112.392 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -85.8 133.35 29.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 169.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.15 111.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -73.88 -46.66 43.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -156.57 158.92 37.97 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.55 131.53 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.83 -6.02 27.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.979 0.912 . . . . 0.0 112.555 -169.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -138.86 173.6 11.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.184 1.394 . . . . 0.0 109.045 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -147.79 170.53 17.39 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.914 1.286 . . . . 0.0 109.129 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.28 128.91 39.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.66 1.02 87.7 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.148 1.356 . . . . 0.0 113.507 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.74 153.09 42.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.32 1.56 . . . . 0.0 110.097 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -76.02 143.39 41.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.72 159.62 14.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.592 0.711 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -144.77 167.01 23.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.308 -172.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.64 113.08 2.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.31 72.22 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.898 1.237 . . . . 0.0 113.106 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -76.83 126.33 30.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.435 1.618 . . . . 0.0 108.206 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.86 144.59 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -172.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.31 -49.5 2.96 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.514 1.526 . . . . 0.0 108.479 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.84 169.2 19.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.338 0.589 . . . . 0.0 111.642 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.48 144.89 51.45 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.311 1.845 . . . . 0.0 106.844 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.6 152.17 39.58 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.854 1.262 . . . . 0.0 110.66 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.4 m -76.2 -14.52 60.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.121 0.568 . . . . 0.0 110.888 169.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.93 76.89 4.45 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 169.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.8 m -69.87 72.56 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.895 1.678 . . . . 0.0 111.338 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 p -59.93 -25.89 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.021 1.328 . . . . 0.0 113.224 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 126.218 1.807 . . . . 0.0 107.0 -172.174 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -130.57 137.63 55.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -140.76 155.82 46.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.238 . . . . 0.0 110.667 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.8 mm -73.88 152.13 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.621 1.168 . . . . 0.0 107.993 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -116.89 11.61 14.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.386 0.675 . . . . 0.0 111.948 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -143.67 161.21 39.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.558 1.543 . . . . 0.0 108.343 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -90.01 131.51 35.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.63 11.55 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.4 142.35 50.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.0 tp -85.74 72.21 10.58 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.978 0.911 . . . . 0.0 110.833 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -27.68 -59.1 0.11 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.083 2.553 . . . . 0.0 114.081 -174.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.6 162.42 38.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.119 1.368 . . . . 0.0 108.527 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.87 147.67 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -131.34 25.46 4.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.192 0.997 . . . . 0.0 111.559 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.76 165.04 32.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.388 1.075 . . . . 0.0 110.484 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -148.97 158.08 43.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.983 1.713 . . . . 0.0 106.795 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.67 133.43 53.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.55 77.48 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.528 1.061 . . . . 0.0 112.787 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.05 167.68 17.1 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.142 1.471 . . . . 0.0 109.815 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -125.02 138.1 54.22 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.7 pt -126.56 162.84 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.368 1.067 . . . . 0.0 108.198 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.9 143.11 48.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -47.87 126.96 11.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.58 0.752 . . . . 0.0 110.5 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.56 78.45 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.507 -1.163 . . . . 0.0 113.617 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.85 138.65 58.03 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.688 1.744 . . . . 0.0 107.884 169.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.89 137.94 57.52 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.06 -19.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.868 1.267 . . . . 0.0 111.429 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.88 -179.49 8.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.435 1.016 . . . . 0.0 109.336 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -136.19 139.02 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -106.11 136.11 46.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.803 2.041 . . . . 0.0 106.614 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.31 120.93 44.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -162.02 166.4 26.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.1 mpp? 53.33 24.61 3.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt 47.38 42.68 14.46 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 126.12 1.768 . . . . 0.0 111.839 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.6 mmt -137.12 164.64 27.96 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.402 2.281 . . . . 0.0 106.988 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -112.14 140.73 46.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.73 122.79 14.61 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.24 151.59 35.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.988 2.458 . . . . 0.0 112.723 174.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mm -126.4 123.23 62.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.32 155.41 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 125.234 1.413 . . . . 0.0 110.105 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.28 124.09 21.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.145 0.978 . . . . 0.0 108.674 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -29.05 69.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.806 0.442 . . . . 0.0 111.573 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.1 ptm85 -157.21 156.61 32.87 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.611 1.164 . . . . 0.0 108.895 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -70.31 155.14 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.34 0.656 . . . . 0.0 110.492 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.17 177.2 36.71 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 122.119 -0.363 . . . . 0.0 112.39 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -85.42 133.39 29.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.6 109.59 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -78.06 -43.43 29.24 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -152.18 156.86 40.61 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.488 0.585 . . . . 0.0 109.885 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.4 129.47 74.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.4 -0.55 35.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.694 0.798 . . . . 0.0 111.983 -169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -139.73 176.26 8.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.821 1.249 . . . . 0.0 109.581 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -145.44 164.57 31.13 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.93 1.292 . . . . 0.0 108.579 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -55.4 128.13 32.84 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.955 0.902 . . . . 0.0 109.561 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.38 -1.71 86.79 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.187 1.375 . . . . 0.0 114.02 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -70.5 154.74 41.56 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.955 1.877 . . . . 0.0 110.597 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.73 143.11 57.14 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.12 160.21 15.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -143.79 167.13 23.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.178 0.591 . . . . 0.0 111.017 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.18 114.53 3.49 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.55 1.58 74.22 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.972 1.272 . . . . 0.0 113.151 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -77.96 128.64 34.22 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.52 1.66 . . . . 0.0 108.123 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.64 133.78 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.335 0.654 . . . . 0.0 110.127 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.0 tp -87.28 -52.09 5.59 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -156.05 168.38 27.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.926 0.393 . . . . 0.0 110.713 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 148.24 52.57 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.585 1.154 . . . . 0.0 108.337 174.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.16 147.42 43.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.358 1.463 . . . . 0.0 109.802 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 m -61.16 -22.45 64.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.5 0.72 . . . . 0.0 112.066 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.96 -34.53 65.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.477 1.111 . . . . 0.0 112.54 172.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 m -125.28 -19.46 5.09 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.9 m -71.37 -36.21 71.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.379 0.536 . . . . 0.0 110.087 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 . . . . . 0 C--O 1.249 1.049 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.644 . . . . . . . . 0 0 . 1 stop_ save_